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3. Abbreviations 
 
3’-UTR  3’-untranslated region 
5’-UTR  5’-untranslated region 
A. thaliana  Arabidopsis thaliana 
BCLL   B-cell chronic lymphocytic leukaemia 
C. elegans  Caenorhabditis elegans 
ChIP   chromatin immunoprecipitation 
D. melanogaster Drosophila melanogaster 
Dnd1   Dead-end 1 
dsRNA  double-stranded RNA 
EGFP   enhanced green fluorescent protein 
endo-siRNA  endogenous siRNA 
Imp8   Importin 8 
IRES   internal ribosome entry site 
kDa   kilodalton 
miRNA  microRNA 
miRNA*  microRNA star 
miRNP  miRNA-ribonucleoprotein complex 
MOV10  Moloney leukemia virus 10 
NMD   nonsense-mediated decay 
orf   open reading frame 
PABP   Poly(A)-binding protein 
PAZ   piwi-argonaute-zwille 
P-bodies  processing bodies 
piRNA  Piwi-interacting RNA 
PIWI   P-element induced wimpy testis 
RBM4   RNA binding motif protein 4 
RISC   RNA-induced silencing complex 
RHA   RNA helicase A 
RNAi   RNA interference 
SG   Stress granule 
siRNA   small interfering RNA 
snoRNA  small nucleolar RNAs 
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SNP   single nucleotide polymorphism 
S. pombe  Schizosaccharomyces pombe 
SV40 NLS  Simian virus 40 nuclear localization signal  
TNRC6B  trinucleotide repeat-containing 6B 
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4. Summary 
 
microRNAs (miRNAs) are small non-coding RNAs of 21-24 nt in size, which are 
endogenously expressed in higher eukaryotes and play important roles in processes 
such as tissue development and stress response and in several diseases including 
cancers. In mammals, miRNAs guide proteins of the Argonaute family (Ago proteins) 
to partially complementary sequences typically located in the 3’-untranslated regions 
(3’-UTRs) of specific target mRNAs, leading to translational repression or mRNA 
degradation. To gain further insight into the function of human miRNAs, we analyzed 
the protein as well as the RNA composition of miRNA-Ago protein complexes in 
molecular detail.  
To identify novel Ago-interacting proteins, we isolated Ago complexes and 
investigated them by mass spectrometry and co-immunoprecipitation experiments. 
We found that trinucleotide repeat-containing 6B (TNRC6B), Moloney leukemia virus 
10 (MOV10), RNA binding motif protein 4 (RBM4) and Importin 8 (Imp8) interact with 
human Ago proteins. Moreover, using RNA interference and EGFP and dual 
luciferase reporter assays, we demonstrated that these factors are required for 
miRNA function, indicating that we have identified new components of the miRNA 
pathway. Intriguingly, depletion of Imp8 does not affect the levels of mature miRNAs 
or the interaction of miRNAs with Ago proteins, but is required for efficient association 
of Ago-miRNA complexes with their target mRNAs. Thus, Imp8 is the first factor 
acting at the level of target mRNA binding, establishing a novel layer of regulation for 
the miRNA pathway. Imp8 is an Importin-β-like protein, which has previously been 
implicated in nuclear import of substrate proteins1, 2. In line with these results, we 
demonstrated that a detectable fraction of Ago2 localizes to the nucleus of human 
cells. Moreover, knockdown of Imp8 by RNAi reduces the nuclear signal of Ago2, 
suggesting that Imp8 affects the nuclear localization of Ago2. Therefore, our data 
suggest that Imp8 has a dual function both in the cytoplasmic miRNA pathway and in 
nuclear transport of Ago proteins.  
To identify small RNAs, which associate with human Ago proteins, we isolated, 
cloned and sequenced small RNAs bound to Ago1 and Ago2 complexes. In addition 
to known miRNAs, we found several small RNAs, which derive from small nucleolar 
RNAs (snoRNAs). We therefore investigated the function of one particular small 
RNA, which is derived from the snoRNA ACA45 and showed that it functions like a 
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miRNA. Interestingly, this small RNA is processed by the miRNA maturation factor 
Dicer, but does not require the microprocessor complex that is essential for 
processing of primary miRNA transcripts. Thus, we have identified a novel biogenesis 
pathway of a new class of small RNAs that can function like miRNAs.  
To experimentally identify mRNAs that are stably associated with miRNA-Ago protein 
complexes, we isolated and analyzed Ago1 and Ago2-bound mRNAs by cloning and 
sequencing and by microarray hybridization techniques. Using dual luciferase 
reporter assays, we demonstrated that many Ago-associated mRNAs are indeed 
miRNA targets. Therefore, we have developed a method allowing for the 
identification of miRNA target mRNAs from cell lines or tissues of interest 
independently of computational predictions.  
In a project that was independent of our studies on Ago protein complexes, we 
investigated structural and functional requirements for the activity of small interfering 
RNAs (siRNAs). siRNAs are small double-stranded RNAs of appr. 21 nt in size, 
which trigger the sequence-specific endonucleolytic degradation of perfectly 
complementary target transcripts upon binding to Ago23, 4. However, both single 
strands of a siRNA duplex can potentially have unwanted “off-target effects” by 
repressing partially complementary target mRNAs through binding to their 3’-UTRs5-8. 
We therefore developed a method to selectively inhibit the activity of the siRNA 
strand that is dispensable for target silencing (“passenger strand”) through chemical 
modification of its 5’-end. This method could be a useful tool for the design of highly 
specific siRNAs.  
Taken together, we have analyzed the composition of Ago-miRNA protein complexes 
by a variety of methods and identified novel protein factors of the miRNA pathway, a 
novel class of small RNAs as well as a panel of previously unknown miRNA target 
mRNAs. The techniques for the purification and the analysis of Ago complexes that 
were developed in this study will provide useful tools for future analyses of miRNA 
pathway factors, small RNAs and miRNA target mRNAs from any tissue or cell line of 
interest.   
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5. Introduction 
 
The biology of gene inactivation is a major focus of research since several decades. 
Specific gene inactivation can involve a variety of mechanisms including gene 
mutation or deletion, repression of transcription, translational repression, 
destabilization of mRNAs and degradation of protein products. In the laboratory, the 
inactivation of specific genes can be utilized to investigate their functions. However, 
methods to generate organisms with mutant genes or gene deletions are often time-
consuming and more convenient techniques to silence gene expression were 
needed. One prominent method to achieve specific gene silencing is the transfection 
of oligonucleotides antisense to an mRNA of interest. Such antisense 
oligonucleotides bind to complementary mRNAs in a sequence-specific manner and 
lead to their destabilization9. However, antisense-mediated inhibition of mRNAs 
requires the presence of high (stoichiometric) amounts of antisense oligonucleotides. 
In contrast, small double-stranded RNAs can trigger highly efficient sequence-
specific catalytic degradation of complementary target RNAs through endonucleolytic 
cleavage in a process termed RNA interference (RNAi). Because RNAi is based on a 
catalytic mechanism, it is effective at lower (sub-stoichiometric) concentrations 
compared to antisense-mediated gene silencing. RNAi was first shown in 1998, when 
Andrew Fire and Craig Mello made the surprising observation that double-stranded 
RNA (dsRNA) acts as a very potent trigger to silence complementary genes in 
Caenorhabditis elegans (C. elegans)10. Subsequent studies showed that the minimal 
triggers of RNAi are small interfering RNAs (siRNAs) of appr. 21 nucleotides (nt) in 
size that act as guides to silence complementary transcripts through endonucleolytic 
cleavage11, 12. Since these reports, the field of small RNA-guided gene silencing has 
rapidly expanded. To date, a variety of different endogenously expressed small RNA 
species has been identified in the majority of eukaryotes, with Saccharomyces 
cerevisiae (S. cerevisiae) being a notable exception. Moreover, it is now apparent 
that small RNAs can also act through many mechanisms which are different from 
endonucleolytic cleavage13, 14. Many studies have investigated the biological roles of 
small RNAs as well as their biogenesis pathways and their functions. The following 
introductory sections summarize known small RNA biogenesis pathways and their 
functions in mammals, together with the proteins that mediate their mechanisms of 
action.  
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5.1. Classes of Mammalian Small RNAs 
 
Since the discovery of RNAi and the identification of siRNAs, numerous small RNA 
species have been identified, most of which derive from longer double-stranded RNA 
precursor molecules.  
siRNAs are appr. 21 nt small double-stranded RNAs, which trigger silencing of 
perfectly complementary RNA molecules through endonucleolytic cleavage15. They 
carry characteristic phosphate groups on their 5’ ends and 2 nt overhangs on their 3’ 
ends16-18. Until recently, it was assumed that siRNAs in mammals can only derive 
from exogenous sources of double-stranded RNA such as viral replication 
intermediates. However, more recent studies reported that endogenous siRNAs 
(endo-siRNAs) are present in mouse oocytes and may act to suppress 
transposons19-21.  
microRNAs (miRNAs) are 21-24 nt in size and can trigger translational inhibition or 
deadenylation of target mRNAs by binding to partially complementary sites in their 
3’-untranslated regions (3’-UTRs)13. miRNAs are endogenously expressed in most 
eukaryotes and have diverse biological roles, e.g. in organ development, stress 
response and in various diseases including cancer22.  
Piwi-interacting RNAs (piRNAs) are single-stranded germline-specific small RNAs of 
24-30 nt in size which are thought to silence transposons, possibly through an RNAi-
like mechanism23. They carry characteristic methyl groups on the 2’-OH groups of 
their 3’ terminal nucleotides24, 25.  
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5.2.  Biogenesis of Small RNAs in Mammals 
 
5.2.1. microRNA Biogenesis 
 
miRNAs are small RNAs of 21-24 nt in size which are endogenously expressed in 
most eukaryotes. Although the expression of particular miRNAs can be highly 
specific to a certain developmental stage or to a tissue, miRNA expression in general 
is thought to be ubiquitous throughout different tissues26. Many miRNA genes are 
evolutionarily conserved, suggesting that miRNAs can have important biological 
functions27.  
miRNAs are typically transcribed as primary transcripts (pri-miRNAs) by RNA 
polymerases II or III in the nucleus (figure 1)28, 29. In many cases, miRNA genes are 
genomically clustered such that pri-miRNA transcripts contain multiple mature miRNA 
sequences30-32. Pri-miRNAs are further processed in the nucleus by a multiprotein 
complex termed microprocessor which contains the RNase III enzyme Drosha and 
the dsRNA binding protein DGCR833-37. Microprocessor generates hairpin-structured 
pre-miRNAs, which are exported to the cytoplasm by the nuclear export receptor 
exportin 538-40. In the cytoplasm, the RNase III-like enzyme Dicer cleaves off the 
precursor loop to generate double-stranded intermediates containing the mature 
miRNA and the corresponding duplex counterpart which is termed “miRNA star” 
(miRNA*)41. These intermediates typically contain 5’ phosphate groups and 2 nt 
overhangs on the 3’-ends. One strand of the intermediate is incorporated into a 
miRNA-ribonucleoprotein complex (miRNP), which contains a member of the Ago 
subfamily of Argonaute proteins (Ago 1-4 in humans)42. Ago proteins directly bind to 
miRNAs and are the mediators of miRNA function. Small RNA loading to Ago 
proteins involves Dicer and the dsRNA binding proteins TRBP and/or PACT43-46. 
Additionally, helicases such as RNA helicase A (RHA) are likely to be required for 
efficient separation of the duplex strands47. Interestingly, unwinding of the duplex 
could be facilitated by Ago2 itself. Ago2 cleaves the precursor hairpins of some 
miRNAs on the miRNA* side of the stem, yielding a nicked processing intermediate48. 
miRNA/miRNA* duplices from such processed hairpins are probably easier to 
unwind. Consistently, overexpression of Ago2 was reported to increase mature 
miRNA levels in some cell types48. Loading of the single strands to miRNPs is mainly 
determined by the relative thermodynamic stability of the miRNA/miRNA* duplex 
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ends, such that the strand that is less stably paired at its 5’ end becomes 
incorporated into a miRNP (“asymmetry rules”)49, 50. The mechanism underlying 
these asymmetry rules has not yet been completely resolved in mammalian cells. In 
Drosophila melanogaster (D. melanogaster) cells, the dsRNA binding protein R2D2 
acts as an asymmetry sensor by binding to the more stable duplex end, thereby 
directing Ago2 to interact with the less stable duplex end51. PACT and TRBP are 
mammalian homologs of R2D2, and further studies will be required to investigate 
whether their function is similar to R2D2. Despite the evidence supporting the 
asymmetry rules, thermodynamic asymmetry does not reliably predict strand 
selection of all known duplices, and it is likely that additional determinants of strand 
selection exist which have yet to be defined. In most cases, the mature miRNA is 
preferentially incorporated into a miRNP, whereas the miRNA* sequence is 
degraded. However, not all miRNA* species are instable and a recent study 
suggested that some miRNA* sequences are functional, similar to mature miRNAs52.  
Upon binding to an Argonaute protein, miRNAs serve to guide the miRNP to partially 
complementary target sites on mRNAs. miRNPs can trigger target mRNA repression 
through translation inhibition or mRNA destabilization (section 5.3.1.2.)13.  
In addition, miRNAs can be generated from large introns of protein-coding genes. 
miRNA precursors are released from introns by the microprocessor complex before 
mRNA splicing is completed53.  
Moreover, small introns which are released by the spliceosome can serve as pre-
miRNAs54-56. Such miRNA precursors bypass Drosha/microprocessor processing and 
directly serve as substrates for nuclear export by exportin 5 and processing by Dicer. 
According to their biogenesis, such miRNAs have been termed mitrons. Furthermore, 
it was recently described that some snoRNAs serve as precursors of functional small 
RNAs that act like miRNAs57, 58. miRNA target repression by such miRNAs is Drosha-
independent, suggesting that snoRNA-derived miRNAs can bypass Drosha 
processing (publication 7, section 11).  
 12
  
Figure 1: miRNA biogenesis pathways. MiRNA precursor transcripts are synthesized in the nucleus 
(upper panel). Pre-miRNAs are mostly processed from primary miRNA transcripts (upper middle 
panel) or from large introns of pre-mRNAs (upper right panel). Alternatively, they can be released from 
small hairpin-structured introns of pre-mRNAs by the spliceosome (upper left panel). Pre-miRNAs are 
exported into the cytoplasm by Exportin 5. They are further processed by Dicer to yield a 
miRNA/miRNA* processing intermediate (lower panel). Mature miRNAs are loaded to Ago protein 
complexes, whereas miRNA* sequences are mostly degraded. After loading, miRNAs guide Ago 
proteins to partially or perfectly complementary target sites on mRNAs, allowing for post-transcriptional 
gene silencing through different mechanisms.  
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5.2.2. piRNA Biogenesis 
 
piRNA biogenesis is currently less well understood than miRNA biogenesis, and 
there are many questions that remain to be addressed. In contrast to miRNAs which 
are expressed throughout different tissues, piRNA expression has only been 
detected in germ cells and is most prominent in testes. piRNAs are single-stranded 
small RNAs of 24-30 nt in size which bind to Piwi proteins, a subclass of Argonaute 
proteins which is mainly expressed in germ cells59-61. piRNA sequences are not 
conserved across species, but piRNAs are expressed from syntenic regions. Most 
piRNA sequence reads (>80%) that have been obtained from RNA cloning and deep 
sequencing approaches map to discrete genomic clusters59, 60. In contrast to single 
miRNA sequences that can be highly abundant in small RNA libraries, most piRNA 
sequences are only present as single reads in libraries, with hundreds or thousands 
of different reads originating from each piRNA cluster. Interestingly, piRNA 
expression in testes changes during stages of sperm development. piRNAs which 
are expressed before the pachytene stage of meiosis arise from genomic clusters 
that frequently bear repetitive elements62. In contrast, piRNAs which are found from 
the pachytene stage until the round spermatid stage derive from a different set of 
genomic clusters with a lower repeat content59, 60. Unlike miRNAs, the genomic 
context of piRNAs does not allow to calculate stable hairpin precursor structures, 
suggesting that piRNA biogenesis is different from miRNA processing. Loss-of-
function studies in zebrafish and flies indicated that piRNA expression is independent 
of Dicer63, 64. Since Dicer is capable of processing double-stranded RNA into small 
RNAs, these data suggest that piRNAs are processed from single-stranded precursor 
transcripts rather than from long double-stranded RNA. Nevertheless, studies in D. 
melanogaster showed that piRNAs can derive from corresponding sense and 
antisense transcripts of repetitive sequences65, 66. piRNAs from antisense transcripts 
are mainly bound by the Piwi proteins Piwi and aubergine, whereas piRNAs from 
sense transcripts are incorporated into Ago3, a Piwi protein in D. melanogaster. 
Sense and antisense piRNAs are frequently found in pairs such that there is a 10 nt 
sequence compementarity of their 5’ ends. This relation suggests an amplification 
mechanism in piRNA biogenesis that utilizes endonucleolytic activities of Piwi 
proteins to generate piRNAs65, 66: Piwi or aubergine is loaded with a sense piRNA 
and cleaves the long antisense transcript to generate the 5’ end of a piRNA which will 
 14
be incorporated into Ago3. Most likely, the 3’ end of the antisense piRNA is 
generated by exonucleolytic processing. After 3’ end trimming, piRNAs become 
methylated by a methylase which is a homolog of the plant protein Hen1 (mHen1 in 
mice and DmHen1 in D. melanogaster)24, 67-69. Methylation occurs at the 2’ OH 
groups of the piRNA 3’ termini. DmHen1 mutants express shorter piRNAs, and 
piRNA levels are generally lower than in wild-type animals, suggesting that 
methylation may stabilize piRNAs, possibly by preventing aberrant exonucleolytic 
processing from the 3’ end67. Once the antisense piRNA is generated, the 
amplification cycle generates a new sense piRNA via the same “ping-pong” 
mechanism. In mice, this model is supported by deep sequencing studies of pre-
pachytene piRNAs which are bound to the Piwi protein Mili (figure 2)62. However, it is 
unclear if all piRNAs are synthesized via the ping-pong mechanism. While this model 
may explain piRNA amplification, the initiating event for the amplification cycle 
remains to be determined. One possible mechanism that could initiate the ping-pong 
cycle is maternal transmission of piRNAs to the progeny which has been observed in 
D. melanogaster70.  
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Figure 2: Ping-Pong model of piRNA biogenesis in mice. Bidirectional transcription from repetitive 
elements or piRNA clusters generates sense and antisense transcripts. MILI together with a piRNA 
cleaves one transcript strand to define the 5’ end of a piRNA, which is subsequently incorporated into 
MIWI2. The 3’ end of the MIWI2-associated piRNA is generated through exonucleolytic processing by 
an unknown nuclease, followed by 2’ O methylation by mHen1. MIWI2 then binds and cleaves a 
transcript of the opposing transcript strand to define the 5’ end of a piRNA, which is subsequently 
incorporated into MILI. Again, the 3’ end of the new piRNA is generated and modified by 
exonucleolytic processing and 2’ O methylation. The Ping-Pong model yields pairs of piRNAs with a 
10 nt complementarity in their 5’ regions. In mammals, the event that generates the first piRNA to 
initiate the cycle is unknown. 
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5.2.3. siRNAs from Exogenous Sources 
 
siRNAs are small RNAs of appr. 21 nt in size which guide sequence-specific 
cleavage of highly complementary target RNA molecules by RNAi. Early reports 
showed that siRNAs are endogenously expressed in plants12 and that they can also 
function in mammals when delivered by transfection11, but evidence for the presence 
of endogenous siRNAs in mammals remained elusive for several years. However, 
mammalian cells express Dicer which can generate siRNAs from dsRNA16, 41. An 
exogenous source of dsRNA are viral replication intermediates. Consistently, the 
RNAi pathway was demonstrated to be an important component of antiviral defence 
mechanisms in plants and in Drosophila71, 72, and Dicer contributes to an antiviral 
response to influenza virus in mammalian cells73.  
siRNA biogenesis resembles the final steps of miRNA maturation (figure 3, left 
panel). Dicer processes long dsRNA to double-stranded siRNAs, which carry 
5’-phosphate groups and 2 nt overhangs on their 3’-ends16-18. In contrast to miRNAs, 
which can repress translation in mammals through binding to human Ago1-4, siRNA-
guided target cleavage only depends on Ago2, because only Ago2 has 
endonucleolytic activity3, 4. The effector complex of RNAi which contains Ago2 is 
referred to as RNA-induced silencing complex (RISC)74. It contains a single-stranded 
siRNA  termed “guide strand” which guides target RNA cleavage. The opposing 
strand of the duplex (passenger strand) is mostly degraded. RISC loading is 
influenced by the same asymmetry rules that also determine miRNA loading49, 50. 
Similar to miRNP loading, this process is facilitated by the double-stranded RNA 
binding proteins TRBP and/or PACT43-46. Moreover, it was recently demonstrated that 
Ago2 itself facilitates RISC maturation by cleaving the passenger strand75-77. The 
cleavage fragments of the passenger strand are less stably bound to the guide 
strand and are expected to rapidly dissociate, yielding cleavage-competent RISC 
loaded with a single-stranded siRNA.  
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Figure 3: siRNA biogenesis pathways. siRNAs from exogenous sources of long double-stranded RNA 
are generated and loaded onto Ago2 by a complex containing Dicer and TRBP and/or PACT (left 
panel). RISC maturation is facilitated by the endonucleolytic activity of Ago2: Cleavage of the 
passenger strand by Ago2 facilitates the formation of active guide strand-RISC and vice versa. The 
formation of guide strand-RISC is preferred in most cases (bold arrow). Endo-siRNAs derive from 
endogenous sources of double-stranded RNA such as bidirectional transcription of repetitive 
elements, transcription of inverted repeats and pairs of genes and pseudogenes (right panel). Endo-
siRNAs are processed by Dicer. However, it is currently unknown whether the endo-siRNA pathway 
requires TRBP, PACT and involves Ago2-guided siRNA passenger strand cleavage.  
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5.2.4. Endo-siRNA Biogenesis 
 
Endogenous siRNAs (endo-siRNAs) were discovered early in plants and later also in 
several animal species12, 78. However, small RNA cloning approaches from somatic 
mammalian cells have mainly identified miRNAs, and evidence for the presence of 
endo-siRNAs in mammals remained elusive for several years. Very recently, endo-
siRNAs were found to be expressed in Drosophila cells and in mouse oocytes20, 21, 79, 
80. These siRNAs are appr. 21 nt in length and derive from various sources of long 
dsRNA, including antisense transcript pairs of genes and pseudogenes, bidirectional 
transcription of repetitive elements and inverted repeats (figure 3, right panel). It is 
currently unclear whether mammalian endo-siRNA are generated by the same 
pathway as siRNAs from exogenous sources. However, both pathways require 
Dicer21, 80.  
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5.3.     Argonaute Proteins and the Functions of Mammalian Small  
           RNAs 
 
Argonaute proteins were named after a mutation in Arabidopsis thaliana (A. thaliana) 
which causes a squid-like phenotype by affecting proper leaf development81. 
Although the number of Argonaute proteins strongly varies across different species, 
Argonaute proteins are present in all higher eukaryotes investigated. Mounting 
evidence indicates that these proteins are key factors of different small RNA-guided 
gene silencing pathways. Based on sequence homology, the Argonaute protein 
family can be subdivided into the Piwi and Ago protein families. Whereas humans 
express hsAgo1-4, mice have five different Ago proteins (mmAgo1-5)82. The Piwi 
protein family has been named after its founding member, the D. melanogaster 
protein P-element induced wimpy testis (PIWI)83. It consists of four proteins in 
humans, HIWI1-3 and HILI, and three proteins in mice, MIWI1, MIWI2 and MILI. 
Whereas Ago proteins are ubiquitously expressed throughout different tissues, the 
expression of mammalian Piwi proteins is thought to be restricted to germ cells84.  
Argonaute proteins are characterized by piwi-argonaute-zwille (PAZ) and PIWI 
domains85 which have distinct roles in small RNA binding and function. The PAZ 
domain binds the 2 nt 3’-overhangs of small RNAs which are typical for Dicer 
processing products86, 87. The PIWI domain is structurally similar to RNase H88, 89. 
Indeed, the PIWI domain of some Argonaute proteins serves to cleave RNA 
substrates that are complementary to the bound small RNA. Such Ago proteins are 
termed “slicer”. Similar to RNaseH, this endonucleolytic activity depends on a 
catalytic triad, which typically consists of a DDH motif. In case of human Ago2, the 
triad consists of D(597), D(669) and H(807)89, 90. However, not all Argonaute proteins 
contain a DDH triad and are catalytically active. Moreover, some Argonaute proteins 
like human Ago3 contain a DDH triad but are catalytically inactive, indicating that the 
presence of the triad is not sufficient for cleavage activity. The region between the 
PAZ and PIWI domains contains a third functionally important module which is 
referred to as MID domain. It harbors a basic pocket that binds the characteristic 
5’-phosphate groups of Dicer-processed small RNAs and anchors the small RNA on 
the protein surface91, 92.  
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Despite the structural similarities among all Argonaute proteins, they are involved in 
different small RNA pathways with distinct functions such as translational regulation 
and transposon suppression.  
 21
 5.3.1. Ago Proteins and Small RNA Functions in Somatic Cells 
 
5.3.1.1. Subcellular Localization of Ago Proteins – Insights and Open   
                Questions 
 
Ago proteins localize to cytoplasmic RNA granules which are known as processing 
(P-) bodies or GW bodies93-95. P-bodies are enriched in proteins that act in various 
pathways of mRNA metabolism such as nonsense-mediated decay (NMD), 
deadenylation and decapping. Therefore, P-bodies are considered as cellular sites of 
mRNA surveillance and decay96. The observation that Ago proteins localize to 
P-bodies suggested that these granules could also play a role in the miRNA pathway 
or even be essential for miRNA function. Indeed, there are several lines of evidence 
that support this hypothesis: First, several Ago-interacting proteins such as 
GW182/TNRC6A, TNRC6B, RCK/p54, Dcp1a and Dcp2 localize to P-bodies97-100. At 
least three of these proteins, RCK/p54, GW182/TNRC6A and TNRC6B, are essential 
for the miRNA pathway94, 97, 99. Second, mRNAs can be targeted to P-bodies in a 
miRNA-dependent manner94, 101, 102. Additionally, Ago proteins that carry mutations in 
the PAZ domain which abolish miRNA binding do not localize to P-bodies 
anymore103. Taken together, these data put forward a model in which miRNAs 
together with Ago proteins bind to their target mRNAs and induce mRNP aggregation 
and sequestration into P-bodies (figure 4). These mRNAs may be subsequently 
degraded in P-bodies by the deadenylation and decapping machinery and the 5’->3’ 
exonuclease Xrn1 or only translationally inhibited. Interestingly, it was shown that the 
CAT-1 mRNA can be translationally repressed by miR-122 and stored in P-bodies101. 
Upon cellular stress, CAT-1 mRNA is released from P-bodies by the AU-rich element 
binding protein HuR and efficiently translated. Thus, the recruitment of mRNAs to P-
bodies is not a general commitment for decay but can be reversible at least in some 
cases.  
Despite the evidence supporting a role of P-bodies in the miRNA pathway, recent 
studies proposed that P-bodies are formed as a consequence of mRNA silencing 
pathways but are not required for the functional integrity of the miRNA pathway97, 104: 
P-bodies are thought to be highly dynamic structures, and it was demonstrated that 
the formation of visible P-bodies is sensitive to downregulation of several P-body 
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components94, 97, 104, 105. Importantly, some P-body components such as LSm1 and 
LSm3 are required for visible P-body formation but not for miRNA function, indicating 
that macroscopic P-bodies are not essential for the miRNA pathway97, 104, 105. 
Conversely, knockdown of miRNA pathway factors such as Dicer and Drosha 
depletes P-bodies. P-body formation can be rescued by expressing an artificial small 
RNA target together with the corresponding small RNA, suggesting that silencing 
pathways such as the miRNA pathway are upstream triggers of P-body formation104, 
106. However, although the knockdown of LSm proteins demonstrated that visible P-
bodies are not essential for miRNA function, these experiments do not exclude the 
presence of sub-microscopic P-bodies, which could be required for the miRNA 
pathway. Clearly, high-resolution techniques such as electron microscopy will be 
needed to address this possibility.  
P-bodies share several protein components with another class of cytoplasmic foci, 
so-called stress granules107. Stress granules (SG’s) are formed upon various forms of 
cellular stress such as heat shock or oxidative conditions. SG assembly is triggered 
by phosphorylation of the translation initiation factor eIF2α, which reduces the 
availability of the eIF2α-GTP–tRNAiMet complex for translation initiation and causes 
accumulation of stalled 48S pre-initiation complexes, which lack the initiation factors 
eIF2 and eIF5107. A recent quantitative analysis of Ago protein localization revealed 
that only a minor portion of enhanced green fluorescent protein- (EGFP)-tagged 
Ago2 (1.3%) localizes to P-bodies and that the majority of Ago2 is diffusely 
distributed throughout the cytoplasm108. Importantly, EGFP-Ago2 is also present in 
SG’s. Photobleaching experiments showed that the pool of EGFP-Ago2 that localizes 
to SG’s is more dynamic than the pool in P-bodies. Moreover, EGFP-Ago2 fails to 
localize to SG’s but still localizes to P-bodies in Dicer knockout cells108. These data 
would be consistent with the hypothesis that miRNAs repress their targets in SG’s 
rather than in P-bodies. However, the fact that Ago2 localizes to P-bodies in Dicer-
deficient cells could also be due to additional Dicer-independent pathways that target 
Ago2 to P-bodies such as Dicer-independent small RNA pools which have recently 
been reported109.  
One possible model to reconcile the data for P-bodies and stress granules is shown 
in figure 4: Upon cellular stress, 48S translation pre-initiation complexes which are 
inhibited by miRNAs (for details, see section 5.3.1.2.2.) could rapidly aggregate and 
be sequestered to stress granules. As stress granules frequently localize in the 
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vicinity of P-bodies, it is possible that repressed mRNAs are exchanged between 
these foci. Thus, miRNA targets could shuttle from stress granules to P-bodies after 
remodelling and removal of 40S subunits and some translation intitiation factors 
which are not present in P-bodies such as eIF2 and eIF3. P-bodies could represent a 
more static storage site for some mRNAs and a site of decay for other mRNAs. 
However, miRNAs function in the absence of cellular stress and it is unknown 
whether SG’s or related structures exist under such conditions. Thus, it is likely that a 
stress-granule-independent pathway exists which sorts repressed miRNA targets to 
P-bodies.  
Although immunofluorescence experiments of mammalian Ago proteins typically 
show a mainly cytoplasmic staining pattern, several studies have focused on the 
localization and possible functions of Ago proteins in the nucleus. Nuclear functions 
of Ago proteins have been reported in many species such as Schizosaccharomyces 
pombe (S. pombe), D. melanogaster, C. elegans and in plants110, but nuclear Ago 
functions in mammalian cells are still a matter of debate. Sub-cellular fractionation 
experiments showed that Ago proteins are present in nuclear fractions, but these 
studies did not rule out the possibility that Ago signals could be due to an association 
with the outer nuclear envelope4, 111. Similarly, nuclear transcripts such as U6 snRNA 
or 7SK RNA can be depleted by RNAi, suggesting that Ago2 may be present and 
active in the nucleus (figure 4, upper panel). It was, however, not excluded that these 
transcripts could transiently shuttle through the cytoplasm, allowing for degradation 
by Ago2111.  
In S. pombe, Ago guides transcriptional silencing by guiding heterochromatin 
formation14. Indeed, it was also shown in human cells that transfected siRNAs 
directed to promoter regions can either lead to transcriptional gene silencing or gene 
activation, depending on the target site within the promoter112-116. Chromatin 
immunoprecipitation (ChIP) experiments revealed that Ago proteins were recruited to 
the targeted promoters after siRNA transfection113-116. Moreover, transcriptional 
modulation was sensitive to the knockdown of Ago1 and/or Ago2, suggesting that 
these proteins can silence or activate gene expression when loaded with promoter-
directed siRNAs (figure 4, upper panel). However, evidence that endo-siRNAs can 
guide transcriptional silencing in human cells remains elusive, and therefore it is 
currently unclear whether these silencing mechanisms are biologically relevant in 
humans. It will therefore be interesting to determine whether specific Ago-interacting 
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proteins are involved in this pathway and to investigate whether their roles are 
evolutionarily conserved. The present study describes the identification of Importin 8 
(Imp8) as an Ago-interacting protein that can modulate nuclear localization of Ago 
proteins (publication 8).  
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Figure 4: Subcellular localization of Ago proteins. In the cytoplasm, miRNAs and Ago protein 
complexes could be recruited to translating mRNAs and induce ribosome drop-off and co-translational 
repression (upper left panel). Alternatively, Ago protein complexes could bind to 48S pre-initiation 
complexes to repress translation initiation by preventing joining of the 60S ribosomal subunit (middle 
panel). Upon cellular stress, repressed pre-initiation complexes could be sequestered to Stress 
Granules (middle right panel). This requires remodelling of the complexes, as GW182 and TNRC6B 
are absent from Stress Granules. Alternatively, Repressed complexes could be sequestered to P-
bodies (lower panel). Again, this requires remodelling, because 40S subunits, poly(A) binding protein 
(PABP), eIF2 and eIF3 are absent from P-bodies. It is also conceivable that repressed mRNPs are 
transferred from Stress Granules to P-bodies after remodelling, because both types of granules 
frequently localize close to each other. Repressed mRNAs can either be degraded in P-bodies or 
released by the RNA binding protein HuR to resume translation. In the nucleus, Ago proteins could 
bind to promoter elements to guide transcriptional gene activation or gene silencing. Additionally, 
Ago2 could cleave nuclear transcripts. Please note that several factors such as eIF6 have been 
omitted from the figure for simplicity. 
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5.3.1.2. Ago Protein Complexes and Mechanisms of microRNA Function 
 
In somatic mammalian cells, Ago proteins bind to miRNAs57, 117 which serve as 
guides to recruit Ago proteins to partially complementary target sites on mRNAs. 
Upon binding to their target mRNAs, Ago proteins trigger posttranscriptional 
repression. Indeed, tethering of Ago proteins to mRNAs revealed that Ago binding is 
sufficient to repress a target mRNA, suggesting that Ago proteins are crucial 
mediators of miRNA function118. The following sections will focus on the mechanisms 
of posttranscriptional repression that are triggered by miRNAs and Ago proteins.  
 
5.3.1.2.1. Determinants of microRNA – Target Interactions 
 
MiRNAs can potentially regulate a high number of target mRNAs. Therefore many 
different experimental and computational approaches have tried to define principles 
of typical miRNA-miRNA target interactions to enable computational miRNA target 
predictions with high accuracy119.  
An early study showed that the 5’-regions of metazoan miRNAs are more conserved 
than the 3’-parts, suggesting that they might be crucial for miRNA function120. Such 
5’-regions (nt 1-8 or nt 2-8) of miRNAs have been termed “seed sequences”. 
Consistent with miRNA conservation data, miRNA-guided repression is relieved 
when pairing of the miRNA seed sequence to the miRNA target site is disrupted by 
mutations, indicating that seed pairing is important for target repression121-123. 
Moreover, miRNA seed matches are highly conserved in human 3’-UTRs124. 
Likewise, conserved miRNA seed matches display a significantly lower single 
nucleotide polymorphism (SNP) frequency than other conserved 3’-UTR elements, 
indicating that miRNA seed pairing is under negative selective pressure and that 
SNPs in many miRNA seed binding sites are likely to be deleterious125. These 
experimental and computational data suggested that the miRNA seed pairing is the 
most crucial determinant of miRNA targeting. However, it was shown early that single 
mismatches in the seed region can be compensated by a high degree of 
complementarity in the 3’ part of the miRNA sequence121. Thus, miRNA seed pairing 
is important but not always required for repression.  
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In addition to the properties of the miRNA target site itself, the surrounding context of 
the target 3’-UTR influences miRNA-guided repression. Statistically, miRNA target 
sites in long 3’-UTRs are more efficient when located at the beginning or at the end of 
the 3’-UTR126. Moreover, an AU-rich 3’-UTR context statistically enhances the 
efficiency of miRNA target sites, most likely because those target sites are more 
accessible than others126, 127.  
Interestingly, a recent report showed that a miRNA which targets an mRNA in a 
particular cell type can fail to suppress the same target in a different cell type128. 
These data suggested that miRNA-target interactions do not only depend on the 
properties of the miRNA and the target mRNA, but are also determined by other, cell-
type specific factors. Such factors could be RNA binding proteins that either 
contribute to or prevent silencing of specific target mRNAs. Indeed, it was shown that 
miRNP access to 3’-UTRs can be blocked by the RNA binding protein Dead-end 1 
(Dnd1), which binds to U-rich 3’-UTR elements129.  
The above-described paradigm that miRNPs can suppress mRNAs by binding to 
their 3’-UTRs is supported by many experimental and computational results. In 
contrast, miRNA binding to open reading frames (orf’s) is thought to be unlikely, 
because translating ribosomes are expected to interfere with the binding of miRNPs. 
Indeed, a recent report showed that a mutation of a stop codon that generates a 
longer orf efficiently destroys miRNA binding sites that are located in the extended orf 
downstream of the mutated stop codon130.  
Interestingly, it was recently demonstrated that miRNPs can bind to the 5’-UTRs of 
ribosomal mRNAs and thereby suppress translation of the corresponding ribosomal 
proteins131. These results are consistent with earlier observations that fusion of 
miRNA binding sites to the 5’-UTRs of reporter constructs can trigger their 
repression123. Clearly, more studies are required to investigate whether miRNA 
binding to 5’-UTRs is a frequent event or limited to a small set of target mRNAs.  
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 5.3.1.2.2. Mechanisms of microRNA-Guided Translational Repression 
  
Early studies in Caenorhabditis elegans (C. elegans) showed that the miRNA lin-4 
acts to repress the expression of the lin-14 gene by binding to regulatory elements in 
the 3’-UTR of the lin-14 mRNA132-134. Interestingly, neither the levels of the lin-14 
mRNA nor its poly(A)-tail length was affected by lin-4, arguing that lin-4 represses 
protein translation rather than mRNA stability135. Notably, polysome association of 
the lin-14 mRNA was not altered by lin-4, suggesting that this miRNA inhibits 
translation at a step after initiation. Consistently, several studies showed that miRNAs 
as well as miRNA target mRNAs co-sediment with polysomes, arguing that miRNAs 
inhibit translation at the steps of elongation or termination135-137. Moreover, 
disassembly of polysomes by various agents co-ordinately shifts miRNAs, Argonaute 
proteins and miRNA targets to lighter polysome gradient fractions, suggesting that 
miRNPs may physically associate with polyribosomes136, 138, 139. Consequently, it was 
postulated that miRNAs induce rapid “ribosome drop-off” from target mRNAs (figure 
5)136. Ribosome drop-off from translating mRNAs implies the production of immature 
polypeptide chains. Interestingly, it was shown that nascent polypeptide chains which 
are translated from miRNA target reporter constructs cannot be captured by 
antibodies directed to the N-terminus, suggesting that such nascent polypeptides 
may be rapidly degraded by a protease139. However, direct evidence for this model 
remains elusive. Consistent with miRNA-guided repression of translation elongation, 
two studies reported that internal ribosome entry site (IRES)-mediated translation of 
reporter mRNAs can be inhibited by miRNAs, similar to cap-dependent translation136, 
140. Since mechanisms of IRES-mediated (cap-independent) and cap-dependent 
translation initiation are different, these data argue for miRNA-guided repression at 
post-initiation steps.  
In spite of the evidence supporting miRNA-guided inhibition of translation elongation, 
other publications argue for miRNA-guided repression at the initiation step. Several 
lines of evidence suggest that miRNA function interferes with cap-dependent 
translation initiation: Reporter mRNAs which bear non-functional ApppN caps are 
resistant to miRNA-guided translation repression in vitro and in cell culture systems, 
whereas their m7G-capped counterparts are efficiently repressed, suggesting that the 
cap is involved in miRNA function141-143. Moreover, IRES-mediated translation was 
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found to be resistant to miRNA-guided repression in some studies102, 141. 
Consistently, addition of the cap-binding complex eIF4F relieves miRNA target 
repression in vitro, suggesting that miRNA function is related to the cap structure142. 
An attractive explanation for these observations is provided by a study which 
demonstrated that human Ago2 itself contains a motif that directly binds to the m7G 
cap structure144. Mutational analysis showed that this motif is required for 
translational repression but is dispensable for endonucleolytic activity of Ago2. Thus, 
miRNA-loaded Ago2 may directly inhibit translation initiation by competing with the 
eIF4F complex for m7G cap binding, thereby preventing the assembly of a functional 
initiation complex. However, experiments in Drosophila cells suggested that the cap-
binding motif of Ago2 is also required for the interaction with GW182145. GW182 is a 
protein which interacts with Argonaute proteins and is required for translational 
repression downstream of miRNA binding146. Therefore, the phenotype of Ago 
mutants in the cap-binding domain could partly be due to their inability to recruit 
GW182 to miRNA target mRNAs.  
The model that miRNAs act on translation initiation is further supported by the finding 
that a high molecular weight complex containing TRBP, Ago2 and Dicer associates 
with the translation initiation factor eIF6147. Depletion of eIF6 by RNAi abrogates 
miRNA silencing in C. elegans and in human cells. Interestingly, eIF6 is known to 
inhibit 80S ribosome assembly148, raising the possibility that recruitment of eIF6 to 
mRNAs by the miRNA pathway could block translation initiation by preventing 60S 
subunit joining (figure 5). This model is also consistent with the observation that 
miRNA reporter constructs specifically associate with components of the 40S 
ribosomal subunit, but associate with fewer 60S subunits compared to reporters 
where miRNA binding sites were mutated149. Moreover, primer extension 
experiments revealed that the AUG start codon of repressed reporter constructs is 
covered by a complex, suggesting that 40S subunits occupy the AUG codon of 
repressed mRNAs149. Thus, it is likely that translation initiation of miRNA target 
mRNAs is blocked after scanning of the 5’-UTR for the start codon and before joining 
of the 60S subunit (figure 5).   
Both models for miRNA function – initiation inhibition and elongation inhibition – are 
highly controversial. It is currently unclear whether opposing results are due to the 
different reporter systems or assays that have been used, or whether mechanisms of 
miRNA function could even be miRNA and/or miRNA target-specific. Most evidence 
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for an involvement of miRNAs in translation elongation is based on co-sedimentation 
studies of miRNAs, miRNA target mRNAs and Argonaute proteins with 
polyribosomes. Importantly, co-sedimentation does not necessarily imply physical 
interaction, and a recent study has challenged many interpretations of co-
sedimentation data: In Drosophila cell extracts, miRNAs can induce the formation of 
heavy mRNP aggregates which are similar in size to polysomes and have therefore 
been termed “pseudo-polysomes”143. It is therefore possible that such pseudo-
polysomes were misinterpreted as polysomes in some of the studies which aimed to 
argue for the inhibition of translation elongation. However, pseudo-polysomes have 
only been observed in Drosophila in vitro systems so far and it is unclear whether 
pseudo-polysomes exist in other species and other experimental systems as well.  
In conclusion, miRNA mechanisms of translational repression are not completely 
resolved and further studies will be required to fully elucidate miRNA function.  
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Figure 5: Possible mechanisms of miRNA and Ago protein function. Translation initiation involves the 
binding of the poly(A) binding protein (PABP) and the eIF4F complex to the mRNA, followed by joining 
of the 43S complex which contains the 40S ribosomal subunit and eIF3 (upper panels). Subsequently, 
the 43S complex scans the 5’-UTR for the AUG start codon. Translation elongation starts after joining 
of the 60S ribosomal subunit and dissociation of eIF3. It was proposed that Ago proteins and miRNAs 
inhibit translation during elongation by inducing ribosome drop-off (upper right panel). In contrast, it 
has been suggested by others that Ago proteins and miRNAs act on the 48S pre-initiation complex 
(middle panel) to prevent joining of the 60S ribosomal subunit, possibly in cooperation with eIF6. It is 
controversial whether Ago2 directly displaces eIF4E from the m7G cap structure to inhibit translation 
initiation. GW182 and/or TNRC6B are thought to be generally required for miRNA function and are 
therefore expected to cooperate with Ago proteins in all known types of repression. Many repressed 
mRNAs are instable, because GW proteins can trigger deadenylation and subsequent decapping and 
mRNA degradation (lower panels). Please note that several translation initiation factors have been 
omitted from the figure for simplification. Please also note that the exact composition of the repressed 
pre-initiation complex has not yet been determined and is therefore hypothetical. 
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5.3.1.2.3.  MicroRNA-Guided Destabilization of Target mRNAs 
 
Biochemical analyses of human Ago proteins revealed that Ago2 is an endonuclease 
that cleaves target RNAs which are highly complementary to the small RNA bound by 
Ago23, 4. Indeed, it was shown that miR-196 can trigger endonucleolytic cleavage of 
the HoxB8 mRNA in mice150. However, miRNAs have only very few perfectly 
complementary targets in mammals and it is therefore unlikely that endonucleolytic 
cleavage is a widespread mechanism of miRNA function in these species. 
Nevertheless, mounting evidence indicates that miRNAs can not only trigger 
translational inhibition, but also destabilization of many target mRNAs151-158. Such 
mRNA degradation processes involve recruitment of the deadenylation machinery 
rather than endonucleolytic cleavage by Ago2153, 158, 159. The repressive effects of 
miRNAs and Ago proteins on target mRNAs depend on members of a conserved 
family of RNA binding proteins with Glycine-Tryptophan (GW) repeats that interact 
with Ago proteins94, 99, 146, 160(see also publication 1, section 11). In humans, this 
family comprises TNRC6A (GW182), TNRC6B and TNRC6C, whereas Drosophila 
cells only express one family member, GW182. Experiments, which utilized tethering 
approaches of Ago1 and GW182 to mRNAs, revealed that Drosophila GW182 is 
required for target mRNA degradation and translational repression downstream of 
Ago1 mRNA binding159. Inhibition of the interaction of GW and Ago proteins by using 
competing peptides relieves miRNA-guided silencing in vitro and in cell culture, 
suggesting that the interaction of GW182 and Ago proteins is required for miRNA-
guided repression145, 161.  
GW182-triggered target mRNA degradation, but not translational repression requires 
the decapping DCP1:DCP2 complex as well as components of the deadenylation 
machinery, CAF1 and NOT1 (figure 5, lower panel)145. Consistently, human Ago1 
and Ago2 interact with Dcp1a and Dcp2103. These data put forward a model in which 
miRNAs together with Ago proteins act to recruit proteins of the GW family to miRNA 
target mRNAs. GW proteins, in turn, trigger translational repression and often 
deadenylation and subsequent decapping of target mRNAs, which can eventually 
lead to mRNA degradation.  
Recent proteome- and transcriptome-wide studies which utilized microarray and 
mass spectrometry approaches showed that the relative contribution of translational 
repression and mRNA destabilization to miRNA-guided repression varies depending 
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on the individual miRNA target151, 157. Further studies will be required to find elements 
on 3’-UTR’s and protein factors such as specific RNA binding proteins that determine 
the mechanisms of target repression.  
 
 34
5.3.1.2.4. Other Mechanisms of microRNA Function 
 
Recent reports suggest that miRNAs are also capable of activating translation162, 163. 
While miRNA-guided repession is predominant in proliferating cells, translation 
activation occurs during cell cycle arrest and can involve binding of miRNPs to AU-
rich elements. Interestingly, miRNAs can repress and activate translation of the same 
targets, depending on the cell cycle stage163. Notably, most studies on miRNA 
function have been performed in rapidly proliferating cell lines, raising the possibility 
that miRNA-guided translation activation might be a more general mechanism in 
resting cells. However, comprehensive analyses of miRNA targets during cell cycle 
arrest, which could provide more general support for such mechanisms, have not yet 
been performed.  
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 5.3.1.3. Ago2 and RNA Interference (RNAi) 
 
siRNAs trigger the cleavage of complementary target RNAs by binding to an 
Argonaute protein with endonucleolytic activity. Ago2 is the only human Ago protein 
with such “slicer” activity and it is therefore essential for RNAi3, 4. Biochemical studies 
showed that the cleavage reaction requires Mg2+ ions, is ATP-independent and 
generates products with 5’-phosphates and 3’-OH groups164, 165. Because siRNAs, 
which are generated by Dicer, carry 5’-phosphate groups, several groups have 
investigated a possible involvement of the 5’-phosphate in RNAi. To rule out 
phosphorylation of siRNAs by cellular kinases, these experiments employed 
chemically modified siRNAs with 5’-methoxy (CH3O) groups, which cannot be 
phosphorylated. It is now widely accepted that the 5’-phosphate is required for RNAi, 
but it has been controversially discussed whether single-stranded siRNAs can form 
active RISC when lacking a 5’-phosphate3, 18, 90, 166-168. Because chemically 
synthesized siRNAs are usually not phosphorylated, they have to be modified by 
cellular kinases in order to be active. Interestingly, it was recently shown that the 
kinase hClp1 phosphorylates siRNAs on their 5’-ends and is required for their 
activity169.  
While RISC loading likely involves the formation of larger complexes, mature siRNA-
loaded active RISC can be as small as 100 kilodalton (kDa), and it was demonstrated 
that Ago2 together with a single-stranded siRNA can form a minimal RISC90, 170. It 
therefore appears likely that Ago2-mediated endonucleolytic target RNA cleavage 
requires less factors than miRNA-guided repression, which targets translation 
initiation, elongation or mRNA stability through more complex mechanisms. However, 
depletion of the miRNA pathway factors GW182 and TNRC6B affects miRNA-guided 
mRNA cleavage, suggesting that these proteins enhance the efficiency of RNAi99, 146.  
 
RNAi was initially regarded as a highly specific process by which siRNAs can trigger 
the sequence-dependent degradation of perfectly complementary target RNAs. 
Therefore, RNAi is widely being used as a research tool to study loss-of-function 
phenotypes of particular genes of interest. However, mounting evidence suggests 
that siRNAs can downregulate a large number of partially complementary “off-target” 
transcripts in addition to their target. Similar to miRNA target mRNAs, siRNA off-
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targets contain many sites in their 3’-UTRs which are complementary to nt 1-8 of the 
siRNA, i.e. the siRNA seed sequence5-8. Therefore, siRNA off-targeting resembles 
miRNA-guided repression and it is likely that siRNAs repress their off-targets by 
binding to all Ago proteins171. Indeed, siRNAs are efficiently loaded to human Ago1-
4, similar to miRNAs3. Notably, thermodynamic asymmetry is often not sufficient to 
completely prevent incorporation of siRNA passenger strands into Ago protein 
complexes, indicating that both strands of siRNA duplices can potentially have off-
targets49, 50 (see also publication 4, section 11). siRNA off-target effects may cause 
false-positive results in loss-of-function experiments. Furthermore, off-target effects 
are an obstacle for therapeutic applications of siRNAs. Therefore, the reduction of 
siRNA off-target effects is a major goal of siRNA research. This thesis describes an 
efficient method to prevent the incorporation of the passenger strand into RISC to 
block its off-target effects (publication 4).  
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 5.3.2. Ago2 and endo-siRNAs 
 
Endo-siRNAs are present in mouse oocytes and derive from various sources of 
dsRNA including pairs of gene and complementary pseudogene transcripts and 
repetitive elements21, 80. Transposon transcripts containing perfectly complementary 
binding sites for endo-siRNAs are upregulated in Dicer- or Ago2-deficient oocytes, 
suggesting that endo-siRNAs could target these repetitive elements, possibly through 
Ago2-mediated endonucleolytic cleavage21, 80. However, a direct proof of endo-siRNA 
function is still missing.  
In addition to transposon suppression, endo-siRNAs, which derive from gene-
pseudogene pairs, are complementary to coding genes. Indeed, it was shown that 
Dicer and Ago2 mutants have elevated levels of endo-siRNA target mRNAs21, 80. 
Importantly, those target mRNAs with a higher number of siRNA target sites are more 
strongly upregulated in Dicer-deficient mice than mRNAs with fewer matches21. 
Collectively, these data suggest that endo-siRNAs regulate several protein-coding 
genes.  
Although mammalian endo-siRNAs have only been found in oocytes so far, loss of 
Ago2 causes severe developmental defects in somatic tissues such as failure to 
close the neural tube and swelling inside the pericardial membrane3. It remains to be 
investigated whether these somatic phenotypes are due to the function of Ago2 in 
miRNA-guided repression or its function in the endo-siRNA pathway, which might 
play a role in somatic development as well.  
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 5.3.3. Piwi Proteins, piRNAs and Transposon Silencing in the Germline 
 
Since their discovery, Piwi proteins have emerged as essential guardians of the 
genome in germ cells, and it becomes clear that they play key-roles in transposon 
suppression23.  In mammals, insight into the function of Piwi proteins is largely based 
on knockout studies of the three Piwi family members in mice, MIWI, MIWI2 and 
MILI. Loss of MILI or MIWI2 causes apoptosis of sperm cells around the pachytene 
stage of meiosis172, 173, whereas defects in MIWI-deficient mice occur later at the 
haploid, round spermatid stage174. Interestingly, both MILI- and MIWI2-deficient 
sperm cells display increased levels of DNA double-strand breaks, as assessed by 
staining of phoshorylated H2AX. Moreover, MILI- and MIWI2-deficient mice show 
higher levels of transposon transcripts172, 173. These phenotypes could be explained 
by a model in which MILI and MIWI2 bind piRNAs from repetitive elements, which 
guide them to transposon transcripts. These transcripts could be repressed through 
RNAi-like degradation and/or transcriptional silencing. Loss of silencing in MILI- and 
MIWI2-deficient mice may lead to transposon “de-repression” and accumulation of 
DNA double-strand breaks. This model is supported by the observation that pre-
pachytene piRNAs frequently derive from repetitive elements62. Notably, all Piwi 
proteins in mice carry the catalytic DDH triad that is required for endonucleolytic 
activity. Indeed, it has been observed that the rat Piwi protein Riwi co-fractionates 
with an endonucleolytic activity61. However, transposon cleavage activity of 
immunopurified Piwi proteins has not yet been observed in in vitro systems.  
Because germline defects in MIWI-deficient mice manifest later than the meiotic 
phenotypes of MILI and MIWI2, it is possible that MIWI plays a different role in 
spermatogenesis. This hypothesis is supported by the finding that MIWI binds to 
mRNAs of proteins that are involved in spermatogenesis174. Thus, MIWI might play a 
role that is similar to the function of Ago proteins in somatic cells.  
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5.4.  Biological Roles of Animal miRNAs 
 
Since their discovery, miRNAs are emerging as crucial regulators of diverse 
biological processes in higher eukaryotes. It was described early that lin-4 and let-7, 
the founding members of the miRNA family, are involved in the development of C. 
elegans larvae, because mutants exhibit defects in developmental timing133, 175. Other 
pioneering studies showed that miRNAs control asymmetric specification of certain 
C. elegans neurons176-178. Today, numerous studies indicate that miRNAs are 
important developmental regulators in many species including mice and humans179. 
For example, mice deficent in the miR-17-92 cluster die shortly after birth with lung 
and heart defects180. Moreover, this miRNA cluster is also essential for B-cell 
development180. In contrast, miR-155 regulates cytokine production of T-cells and is 
required for proper T-cell development181.  
Beside their role during development, it soon became apparent that the miRNA 
network is frequently de-regulated in cancer. The first evidence that miRNAs could 
function as tumor suppressors came from a study which reported that patients with B-
cell chronic lymphocytic leukemia (BCLL) frequently carry deletions in the 13q14 
locus which contains genes of miR-15a and miR-16-1182. More recent reports have 
shown that let-7 functions as a tumor suppressor in lung cancer by suppressing the 
Ras oncogenes183, 184. Today, several other tumor suppressor miRNAs have been 
characterized. In contrast to these miRNAs, other miRNAs can function as 
oncogenes when aberrantly expressed in certain cell types. For example, miR-21 is 
frequently upregulated in glioblastomas, and inhibition of miR-21 triggers apoptosis, 
indicating that miR-21 is important for glioblastoma cell survival185, 186. Thus, miRNAs 
can act both as oncogenes and tumor suppressors, depending on the particular 
miRNA and the cell type. The importance of miRNAs in tumor biology is further 
corroborated by the finding that the expression of different miRNA pathway proteins 
is de-regulated in various cancer types. For instance, the genes for human Ago1, 
Ago3 and Ago4 are located in a region on chromosome 1 (1p34-35) which is 
frequently deleted in Wilms tumors of the kidney and in neuroblastomas187. 
Moreover, reduced Dicer expression is significantly correlated with poor prognosis in 
lung cancer188. Similarly, a recent study identified a mutation in TRBP which affects 
overall levels of mature miRNAs, destabilizes Dicer and frequently occurs in colon 
and endometrial tumors189. Importantly, re-introduction of TRBP into cancer cells 
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inhibits tumor growth and restores mature miRNA levels, suggesting that the miRNA 
pathway has growth-suppressive functions in these tumors189.   
Taken together, miRNAs have diverse roles in development and in various diseases. 
To date, several miRNA targets have been characterized that may account for some 
of the phenotypes that are associated with the overexpression or the loss of certain 
miRNAs. However, it is widely assumed that each miRNA regulates many targets 
and it still remains a major challenge of the miRNA field to identify and to 
characterize these miRNA targets and their potential biological roles. This thesis 
describes a novel method to experimentally identify miRNA target mRNAs from their 
physical association with Ago protein complexes, providing a useful tool to find new 
miRNA targets (publications 2 and 8).  
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 5.5.  Aims of the PhD Thesis 
 
Ago proteins are central components of siRNA- and miRNA-guided gene silencing 
complexes, because they are present in a complex together with small RNAs as well 
as their target RNAs. Moreover, Ago proteins likely bind to a variety of auxiliary 
protein factors that are important for small RNA-guided gene silencing. Therefore, the 
aim of this thesis is to purify Ago complexes and to identify and functionally 
characterize their protein, small RNA and mRNA components: 
1) It is well established that Ago proteins associate with upstream factors of the 
miRNA biogenesis pathway such as Dicer and TRBP. However, very little is known 
about Ago-interacting proteins that function after the loading of miRNAs to Ago 
proteins: Firstly, it is unclear whether miRNPs find their target sites on 3’-UTRs by 
passive diffusion and base-pairing or whether additional factors exist which promote 
or antagonize binding of Ago proteins to their targets. Secondly, factors that are 
recruited by Ago proteins to achieve miRNA-guided translational repression and 
mRNA decay of miRNA targets are essentially unknown. Thirdly, it is unclear whether 
other 3’-UTR binding proteins could interact with Ago proteins to enhance or to 
relieve gene silencing. Thus, this thesis mainly focuses on novel Ago-associated 
proteins that function downstream of miRNA loading (publications 1, 3 and 8). We 
therefore aim to purify human Ago1-4 protein complexes by immunoprecipitating 
tagged and endogenous Ago proteins with appropriate antibodies, followed by the 
identification of interacting proteins by mass spectrometry. Next, we want to validate 
such interactions by different experimental approaches such as co-
immunoprecipitation and in vitro binding assays. Finally, we aim to functionally 
investigate possible roles of Ago-interacting proteins in small RNA-guided gene 
silencing, using EGFP- or luciferase-based reporter systems for miRNA function.  
2) Since Ago proteins are direct binding partners for different types of small RNAs, a 
second aim of this thesis is to identify novel types of small RNAs from 
immunopurified Ago protein complexes by RNA cloning and deep sequencing 
methods. After identifying these small RNAs, we will characterize them functionally, 
i.e. test whether they could act like known small RNAs such as miRNAs or siRNAs 
(publication 7). Importantly, the human transcriptome contains many small RNA 
sequences that are derived from various non-coding RNAs such as tRNAs, rRNAs 
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and scRNAs, and it is unclear which of these small RNAs are functionally 
incorporated into Ago protein complexes109.  
3) Bioinformatic miRNA target prediction algorithms are mostly based on 
assumptions such as perfect base-pairing of the miRNA seed sequence with the 
target site, which are true for many, but not all miRNA target sites119, 121. Thus, it is 
likely that some of the predicted target sites are not functional. Conversely, some 
miRNA targets with non-canonical binding sites (e.g. sites with imperfect base-pairing 
of the seed sequence) are probably missed by most prediction algorithms. Therefore, 
an unbiased experimental method to identify miRNA target mRNAs is needed. 
Because Ago proteins physically associate with miRNA target mRNAs, we aim to 
establish a method to identify miRNA targets from immunoprecipitated Ago protein 
complexes by cloning and sequencing (publication 2) or microarray analyses 
(publication 8) of Ago-associated mRNAs. 
In an independent project, we analyzed siRNA activities aiming at the improvement of 
RNAi specificity and efficiency. SiRNA off-target effects (sequence-specific 
downregulation of mRNAs that are unrelated to the siRNA target) are a major 
problem for siRNA applications in research and in medical therapies (section 
5.3.1.3.).  Depending on their incorporation into RISC, both strands of an siRNA 
duplex can potentially have off-target effects49, 50. However, strands that are not 
incorporated into RISC will not have sequence-specific off-target effects, and only 
one strand (the guide strand) is required for silencing, while the opposing strand 
(passenger strand) is dispensable. Therefore, we chemically modified siRNA 5’-ends 
and analyzed incorporation into RISC (publication 4).  
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 6.  Discussion 
 
6.1.  Proteomic and Functional Analyses of Human Ago Protein  
        Complexes 
 
To identify new proteins that function in the miRNA pathway, we purified complexes 
of all four human Ago proteins and analyzed their composition by using mass 
spectrometry and co-immunoprecipitation experiments. (publications 1, 3, and 8). We 
identified the novel Ago-associated proteins TNRC6B and MOV10 and showed that 
they are required for miRNA-guided gene silencing (publication 1). TNRC6B belongs 
to a conserved family of proteins with glycine-tryptophan (GW) repeats which 
comprises three proteins in humans, TNRC6A/GW182, TNRC6B, and TNRC6C. 
Similar to TNRC6B, its human homologs TNRC6A/GW18294 and TNRC6C190 as well 
as GW proteins in other species are required for miRNA-guided gene silencing146, 160. 
Studies in Drosophila revealed that GW proteins most likely function by recruiting the 
deadenylation machinery to mRNAs which are targeted by Ago proteins and 
miRNAs, thereby destabilizing the mRNAs159. However, in cells where mRNA decay 
was inhibited by knockdown of decapping enzymes, GW proteins are still required for 
miRNA-guided translational repression, indicating that they play a role in translational 
repression as well159. Today, the exact mechanisms by which GW proteins trigger 
silencing are still unclear. However, it was recently shown that the domain which 
triggers silencing maps to the C-terminal GW repeats (“silencing domain”)190. Further 
studies will be required to fully elucidate the mechanisms of these central players of 
miRNA-guided gene silencing.  
MOV10 is a putative RNA helicase and a homolog of the Drosophila protein 
armitage. Armitage is required for RISC assembly and siRNA function in Drosophila 
cell lysates, suggesting that the function of this putative helicase could be 
conserved191, 192. It is conceivable that MOV10 might help to unwind miRNA/miRNA* 
intermediates, thereby enabling efficient loading of RISC and miRNPs with small 
RNAs. However, this has not been tested yet and the precise function of MOV10 is 
still unknown.  
After this initial study, we characterized the proteomic composition of Ago protein 
complexes in more detail and found that Ago proteins reside in at least three different 
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complexes of different sizes (publication 3). The two larger complexes contain 
mRNAs and may therefore represent repressed mRNPs. We showed that in the large 
complexes, Ago proteins specifically associate with many RNA helicases in a RNA-
dependent and independent manner. For instance, RHA and DDX36 associate with 
Ago proteins in an RNA-independent manner. Interestingly, it was later shown that 
RHA is required for RNAi, and it was proposed that it could be involved in RISC 
loading47. Moreover, we identified several mRNA binding proteins that specifically co-
immunpoprecipitate with Ago1 and Ago2 in an RNA-dependent manner, suggesting 
that miRNPs may act in concert with these mRNA binding proteins to achieve 
repression of target mRNAs. Consistently, we demonstrated that RNA binding motif 
protein 4 (RBM4) is essential for repression of several miRNA targets, although its 
interaction with Ago proteins is RNA-dependent. This observation could be explained 
by a model, in which RBM4 binds to miRNA target mRNAs prior to miRNP binding. It 
may help to recruit Ago proteins to the target mRNAs or to stabilize the interaction of 
Ago proteins with miRNA target mRNAs. In this case, mRNAs would have to be 
marked by RBM4 or similar RNA binding proteins to become susceptible to Ago 
protein recruitment and miRNA-guided repression. The logical consequence of such 
a model would be that not all mRNAs with predicted miRNA binding sites are actually 
miRNA targets, but only those that contain binding sites for RBM4 or similar proteins. 
Consequently, it would be expected that RBM4 strongly associates with miRNA 
target mRNAs. Indeed, it has been observed that LARK, the Drosophila homolog of 
RBM4, associates with a pool of mRNAs that is strongly enriched in predicted miRNA 
binding sites193. Nevertheless, it is also possible that RBM4 could be a more general 
3’-UTR remodelling factor with additional roles in the miRNA pathway, because it was 
recently reported that RBM4 suppresses m7G-cap-dependent translation through CU-
rich elements in the 3’-UTRs194. 
Next we extended our studies to include Ago3 and Ago4 in our proteomic and 
functional analyses. We found that Imp8 specifically interacts with Ago1-4 in an RNA-
independent manner (publication 8). Imp8 belongs to a family of Importin β-like 
proteins that are involved in nuclear import of protein substrates1, 195, raising the 
possibility that Imp8 could be a nuclear import receptor for Ago proteins. Nuclear 
functions of mammalian Ago proteins such as nuclear RNAi and Ago-dependent 
transcriptional silencing are controversially discussed in the small RNA research field 
(section 5.3.1.1.), because most studies on nuclear Ago functions rely on artificial 
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overexpression of small RNAs, and endogenous small RNAs that clearly function in 
the nucleus have not yet been identified. Moreover, the pathways that Ago proteins 
utilize for nuclear silencing are still unknown. Importantly, the subcellular localization 
of Ago proteins is also a matter of debate, because subcellular fractionation 
experiments suggest that a significant fraction of Ago proteins is in the nucleus, while 
most immunofluorescent approaches display a mainly cytoplasmic staining pattern. 
Therefore, we generated a monoclonal antibody to human Ago2 and re-investigated 
whether Ago2 localizes to the nucleus (publication 5). Interestingly, we found that 
Ago2 localizes to both the cytoplasm and the nucleus. The staining intensity from 
both compartments was strongly decreased when Ago2 was depleted by RNAi, 
suggesting that the nuclear signal was Ago2-specific. Strikingly, the localization of 
endogenous Ago2 was shifted towards the cytoplasm after knockdown of Imp8. 
Similar results were obtained with a cell line expressing EGFP-tagged Ago2 
(publications 6 and 8). Thus, Imp8 affects nuclear localization of Ago2. Taken 
together, these data would be consistent with a model in which Imp8 imports Ago2 
into the nucleus. However, the observation that Imp8 modulates the nuclear Ago2 
pool could potentially also be due to indirect effects. For instance, a protein that 
strongly associates with Ago2 could be imported into the nucleus by Imp8, and its 
depletion from the nucleus after Imp8 knockdown might co-deplete Ago2 from the 
nucleus. In line with such a model, Ago2 lacks classical nuclear localization signals 
and it remains to be addressed which domains of Ago2 are responsible for nuclear 
targeting. Clearly, in vitro assays such as nuclear import assays of recombinant Ago 
proteins will be needed to resolve whether Imp8 directly imports Ago proteins into the 
nucleus. Notably, a significant portion of Ago2 remains in the nucleus after 
knockdown of Imp8, raising the possibility that other import receptors could contribute 
to nuclear Ago2 import as well. Alternatively, these results could be due to residual 
levels of Imp8 after siRNA transfection.  
In conclusion, the finding that Imp8 modulates Ago protein localization is intriguing 
because Imp8 may be part of a pathway that facilitates nuclear functions of 
Argonaute proteins. Interestingly, the germline-specific Argonaute protein MIWI2 is 
mainly localized to the nucleus196. Thus, further studies will be required to analyze 
whether Imp8 is a nuclear import receptor for MIWI2 with possible roles in germ cell 
maintenance.  
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In addition to its role for Ago protein localization, we noticed that Imp8 co-localizes 
with Ago proteins in cytoplasmic P-bodies (publication 8) which have been implicated 
in miRNA-guided gene silencing96. This result and the fact that Imp8 interacts with 
Ago proteins suggested that Imp8 could play a role in the miRNA pathway. We 
demonstrated that Imp8 is indeed required for miRNA-guided gene silencing. In 
contrast to known miRNA pathway factors which function in miRNA maturation (e.g., 
Dicer and Drosha) or in steps downstream of target mRNA binding (e.g., TNRC6B 
and GW182), Imp8 is required for efficient binding of Ago proteins to their target 
mRNAs, as shown by microarray analysis of Ago2-associated miRNA targets. Thus, 
we identified Imp8 as the first factor that positively regulates miRNP binding to target 
mRNAs. Interestingly, we found that miRNA target mRNAs are not enriched in anti-
Imp8 immunoprecipitates, suggesting that Imp8 does not stably interact with Ago2 on 
target mRNAs. Consistently, mass spectrometry analyses revealed that Imp8 co-
immunoprecipitates with low molecular weight complexes of Ago2, but not with 
heavier complexes containing mRNAs (publication 3). Thus, Imp8 may preferentially 
interact with Ago proteins prior to target mRNA binding (see model in Figure 7, 
publication 8). It thererfore remains to be investigated how Imp8 promotes the Ago- 
target mRNA interaction, although it interacts with mRNA-free miRNPs rather than 
with repressed mRNPs. Intriguingly, it was proposed that Importin β-like proteins 
could serve as chaperones for their substrate proteins by preventing unspecific 
aggregation with nucleic acids into insoluble complexes195. We showed that 
knockdown of Imp8 does neither affect the levels of soluble Ago proteins nor their 
stability. However, it appears possible that Imp8 helps to maintain an active 
conformation of Ago proteins that is required for stable binding of target mRNAs. In 
such a model, Imp8 could bind to Ago proteins which are released from P-bodies and 
help to maintain the active conformation until the miRNP is recruited to a new miRNA 
target mRNA (Figure 7, publication 8). Notably, structural analysis of the Thermus 
thermophilus Argonaute protein revealed that the ternary complex of Argonaute 
together with a guide strand and a target RNA adopts a different conformation than 
the binary complex of Argonaute with the guide strand. The nucleic acid binding 
channel between the PAZ domain and the PIWI domain widens to accept the target 
RNA197. Thus, target mRNA binding involves conformational changes, and it is 
tempting to speculate that Imp8 might be involved in maintaining a conformation that 
is capable of undergoing such rearrangements. However, we demonstrated that 
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while Imp8 is required for miRNA-guided repression of imperfectly complementary 
targets, it is dispensable for RNAi. RNAi also requires transient binding of Ago2 to the 
target mRNA. It therefore remains to be investigated whether RNAi and miRNA-
guided repression requires different Ago protein conformations and whether one of 
them is specifically promoted by Imp8. Alternatively, Imp8 could promote a 
posttranslational modification of Ago proteins that is essential for stable target mRNA 
binding.  
Considering that Imp8 is involved in nuclear targeting of Ago proteins as well as in 
Ago protein recruitment to target mRNAs, we wanted to investigate whether these 
two roles are linked or separable. We therefore targeted Ago2 to the nucleus in an 
Imp8-independent manner by fusing a SV40 nuclear localization signal (Simian virus 
40 NLS) to its N-terminus (publication 8). Interestingly, we found that SV40 NLS-
Ago2 binds to miRNA target mRNAs in an Imp8-dependent manner, similar to wild-
type Ago2. Thus, it appears that the role of Imp8 in the miRNA pathway is 
independent of its effects on the nuclear localization of Ago2. However, additional 
experiments could be performed to elucidate the relation between the two roles of 
Imp8 in more detail. For example, a search for Imp8 mutants that fail to target Ago2 
to the nucleus but are still capable of targeting Ago2 to target mRNAs (or vice versa) 
may provide further insight into the two mechanisms of Imp8 function.  
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 6.2. Identification and Functional Analyses of Ago-Associated  
         Small RNAs  
 
In addition to identifying Ago-associated proteins, we reasoned that purifying Ago1 
and Ago2 complexes might help to find novel functional small RNAs, because small 
RNA pools from purified Ago proteins are expected contain less non-functional small 
RNA sequences (such as random degradation products of ribosomal RNAs or 
tRNAs) than total RNA pools. We therefore generated libraries of Ago1- and Ago2-
associated small RNAs (publication 7). We were able to demonstrate for the first time 
that a snoRNA, ACA45, can serve as a precursor for a small RNA, which is 
incorporated into Ago complexes and functions as a miRNA. This small RNA 
represses its targets in a Drosha-independent manner but requires Dicer, suggesting 
that ACA45 directly serves as a Dicer substrate and bypasses Drosha processing. 
Moreover, we identified several other snoRNA-derived small RNA sequences in 
libraries from anti-Ago2 immunoprecipitates, indicating that snoRNA-derived small 
RNAs constitute a novel class of miRNA-like molecules. Thus, we have 
demonstrated that the purification of Ago proteins provides a useful tool to find novel 
functional small RNA molecules. Considering the numerous miRNA biogenesis 
pathways that have been described to date (e.g. processing from distinct genes, 
introns, snoRNAs and the mirtron pathway), it appears that the miRNA pathway can 
be fuelled by a variety of different substrates. It is therefore possible that in addition 
to snoRNAs, other non-coding RNA species can also serve as miRNA precursors, if 
they are structurally similar to pri-miRNAs or to processing intermediates of the 
miRNA pathway. The use of deep sequencing and cloning approaches from anti-
Ago1-4 immunoprecipitates could help to identify such novel small RNA species.  
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 6.3. Identification and Functional Analyses of Ago-Associated    
         Target RNAs  
 
Having specific antibodies to human Ago proteins in hand, we decided to extend our 
analyses to identify mRNAs that specifically associate with human Ago complexes. 
Because miRNAs guide Ago proteins to their target mRNAs, it was expected that 
immunoprecipitation of Ago proteins under appropriate conditions could be used to 
purify a transcript pool that is highly enriched in miRNA targets. Importantly, searches 
for miRNA target mRNAs were long hampered by the fact that it is difficult for target 
prediction algorithms to separate the noise of non-functional seed matches from 
functional miRNA target sites. Therefore, methods to identify miRNA targets in an 
unbiased manner were needed. Thus, we biochemically purified human Ago1 and 
Ago2 complexes by using monoclonal antibodies, isolated RNA from the 
immunoprecipitates and cloned long associated transcripts (publication 2). Using 
luciferase reporter assays for a panel of candidate mRNAs, we were able to 
demonstrate that many of the most abundant mRNAs in our libraries are repressed 
by miRNAs, demonstrating that our method is a useful tool to experimentally identify 
miRNA targets. This study demonstrated for the first time that it is possible to 
biochemically identify miRNA target mRNAs from mammalian cells. Similar results 
were obtained in an earlier study in Drosophila cells198. Subsequent studies in 
mammalian cells (including publication 8) employed microarray analyses of Ago-
associated mRNAs compared to total RNA pools, because this allows to normalize 
for the overall abundance of each transcript in total RNA pools and may reduce the 
number of false-positive miRNA targets199-202. These analyzes showed that the Ago-
associated mRNA pool is significantly enriched in miRNA seed matches, 
corroborating that this method is a valid tool for miRNA target identification. However, 
transcripts that associate with Ago proteins could potentially be targeted by any 
miRNA that is expressed in the cells used. Thus, it remains a challenge to identify the 
miRNA(s) and their target site(s) for each Ago-associated target mRNA. One 
possibility is to overexpress or to inhibit a particular miRNA and to identify the 
transcripts that join or disappear from the pool of Ago-associated mRNAs upon 
overexpression or inhibition. At least for miRNA overexpression, it has been 
demonstrated that the 3’-UTRs of those differentially associated transcripts are highly 
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enriched in seed matches for the overexpressed miRNA, suggesting that such 
methods can be used to assign Ago-associated target mRNAs to a miRNA of 
interest198, 200, 201. However, miRNA overexpression could potentially create artifacts. 
Therefore, a method that inhibits endogenous miRNAs is expected to yield more 
reliable results compared to miRNA overexpression. Using qPCR experiments, we 
demonstrated that the let-7 target Hmga2 mRNA is efficiently depleted from Ago2 
immunoprecipitates upon antisense inhibition of let-7, providing a proof of principle 
for such a technique (publication 8). However, in order to map miRNA binding sites to 
a narrow region of the target 3’-UTRs, different techniques would be required. For 
example, limited RNase digestion of the Ago2-miRNA-mRNA complex, followed by 
cloning and deep sequencing of target mRNA fragments that are protected by the 
Ago complexes may help to identify miRNA binding sites.  
Interestingly, we found that in addition to target mRNAs, anti-Ago2 
immunoprecipitates contain several highly enriched long non-coding transcripts such 
as H19 or MALAT-1. The interaction of these transcripts with Ago2 was validated by 
qPCR. Thus, it is likely that miRNAs target these transcripts, and it will be interesting 
to investigate the miRNA targeting mechanisms as well as the biological role of these 
interactions. Thus, our method has revealed unexpected interactions of Ago2 with 
non-coding transcripts, and application of this method to other cell lines and tissues 
will probably extend the knowledge about the functions and targeting mechanisms of 
Ago proteins and miRNAs.  
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6.4.  Reduction of siRNA Off-Target Effects by Blocking  
        5’-Phosphorylation of the Passenger Strand  
 
Finally, we wanted to re-investigate the role of the 5’-phosphate for the function of 
siRNAs (publication 4). Although it is known that siRNAs require a 5’-phosphate 
group to be functional, its precise role has been a matter of controversy in the past3, 
18, 90, 166-168. siRNAs which are transfected into cells or incubated with cell lysates 
become rapidly 5’-phosphorylated by the cellular kinase hClp1169. We therefore used 
siRNA derivatives for our study that carried 5’-methoxy (CH3O) groups to selectively 
block 5’-phosphorylation of one or both of the single strands. Interestingly, we found 
that single-stranded siRNAs are incorporated into RISC, irrespective of their 5’-
phosphorylation status. However, when double-stranded siRNAs were loaded to 
Ago2, only those duplex strands where incorporated that carried a 5’-phosphate: 
Selective modification of one duplex strand with a 5’-methoxy group serves to 
exclude the modified strand from RISC, while the other strand is effectively 
incorporated and active. Considering these results, we asked whether it is possible to 
modulate the off-target activities of siRNAs with 5’-methoxy groups. In addition to 
their target mRNA, siRNAs can repress many off-target mRNAs by imperfectly base-
pairing to their 3’-UTRs, similar to miRNAs (section 5.3.1.3.). Because these off-
target effects substantially lower the specificity of siRNAs, they represent a major 
problem for the use of siRNAs in research and in clinical trials. Importantly, both 
siRNA strands can potentially have off-target effects, because the thermodynamic 
asymmetry of siRNA duplices does not completely prevent RISC loading of 
passenger strands in many cases49, 50. Using transcriptome-wide microarray 
analyses of siRNA off-target effects, we were able to demonstrate that 5’-methoxy 
groups on passenger strands can be used to selectively block their off-targeting 
activity. Thus, this modification may be a useful tool for the design of highly specific 
siRNAs.  
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Summary
RNA silencing processes are guided by small RNAs
known as siRNAs and microRNAs (miRNAs) [1–4].
They reside in ribonucleoprotein complexes, which
guide the cleavage of complementary mRNAs [3, 4] or
affect stability and translation of partial complemen-
tary mRNAs [1, 2, 5]. Argonaute (Ago) proteins are at
the heart of silencing effector complexes and bind
the single-stranded siRNA and miRNA [4, 6]. Our bio-
chemical analysis revealed that Ago2 is present in
a pre-miRNA processing complex that is able to trans-
fer themiRNA intoa target-mRNAcleavingcomplex. To
gain insight into the function and composition of RNA
silencing complexes, we purified Ago1- and Ago2-
containing complexes from human cells. Several
known Ago1- and/or Ago2-associated proteins includ-
ing Dicer were identified, but also two novel factors,
the putative RNA helicase MOV10, and the RNA recog-
nition motif (RRM)-containing protein TNRC6B/
KIAA1093. The new proteins localize, similar to Ago
proteins, to mRNA-degrading cytoplasmic P bodies,
and they are functionally required to mediate miRNA-
guided mRNA cleavage.
Results and Discussion
Proteomic Analysis of Human Ago1 and Ago2
Complexes
We generated HeLa-cell lines stably expressing FLAG/
HA-tagged Ago1 or Ago2 [7] and biochemically copuri-
fied Ago-associated proteins from HeLa-cell cytoplas-
mic extracts by double-affinity purification. Cytoplasmic
extract was first passed over anti-FLAG-antibody-
coated beads. Bound proteins were eluted under native
*Correspondence: meister@biochem.mpg.de (G.M.); ttuschl@rockefeller.
edu (T.T.)
6 Present address: Max Planck Institute for Biochemistry, Am Klop-
ferspitz 18, D-82152 Martinsried, Germany.conditions with FLAG peptides, and the eluate was sub-
sequently incubated with anti-HA-antibody-coated
beads. The bound proteins were recovered and ana-
lyzed by SDS-PAGE and silver staining (Figure 1A, lanes
2 and 3). The visible bands were subjected to ESI tan-
dem MS (LC-MS/MS) analysis. The most prominent pro-
teins with molecular weights of about 100 kDa were
identified as FLAG/HA-tagged Ago2 (lane 2) and Ago1
(lane 3). Additionally, Gemin3 and Gemin4, two proteins
previously reported to be associated with human Ago2
[8], were also copurified with FLAG/HA-Ago2. The
RNase III enzyme Dicer was also found to be stably
associated with Ago1 and Ago2, consistent with very
recent reports [9].
Among the silver-stained bands in both purifications,
we identified four proteins that have not been previously
linked to small-RNA-regulated gene silencing in human
systems. The 175 kDa band was identified as TNRC6B
isoform 1, also known as KIAA1093, a poorly character-
ized protein. The gene is annotated as trinucleotide re-
peat containing 6B, which encodes glycine-tryptophan
(GW) repeats. The amino acid sequence of TNRC6B also
contains an RNA recognition motif (RRM) at the C ter-
minus, suggesting TNRC6B may function as a single-
stranded-RNA binding protein. The 130 kDa band
was identified as MOV10, a putative DExD-box helicase.
MOV10 is a candidate ortholog of the plant protein SDE-
3 and the Drosophila melanogaster protein Armitage
[10–12], both of which are involved in RNAi. A third pro-
tein migrating at about 70 kDa was identified as the argi-
nine methyltransferase PRMT5. The protein migrating at
50 kDa was found to be the translation factor eEF1a.
The specific interactions of the affinity-purified com-
ponents of the Ago complexes with Ago1 and Ago2 pro-
teins were further examined by cotransfection and co-
immunoprecipitation (co-IP) experiments. N-terminally
tagged FLAG/HA-Ago1, FLAG/HA-Ago2, or FLAG/HA-
GFP was cotransfected with N-terminally tagged myc-
TNRC6B into HEK 293 cells (Figure 1B). Myc-TNRC6B
coimmunoprecipitated with FLAG/HA-Ago1 and FLAG/
HA-Ago2 (lanes 5 and 6), and myc-TNRC6B was absent
in the FLAG/HA-GFP co-IP (lane 7). FLAG/HA-Ago1,
FLAG/HA-Ago2, and FLAG/HA-GFP IPs were tested
for association with PRMT5 via a specific polyclonal
anti-PRMT5 antibody (Figure 1B, right panel). PRMT5
was detected only in the FLAG/HA-Ago1 and FLAG/
HA-Ago2 IPs (lanes 9 and 10) and not in the FLAG/
HA-GFP control IP (lane 11). To verify a specific inter-
action of MOV10 with the Ago proteins, N-terminally
FLAG/HA-tagged MOV10 was cotransfected with N-
terminally tagged myc-Ago1 or myc-Ago2 (Figure 1C).
The FLAG/HA-tagged proteins were immunoprecipi-
tated with anti-FLAG beads, and the bound proteins
were analyzed by western blotting against the myc-tag
(middle and right panel) and the FLAG/HA-tag (left
panel). FLAG/HA-MOV10 coprecipitated with myc-Ago1
and myc-Ago2 (lanes 4 and 6), whereas no Ago proteins
were detected in the FLAG/HA-GFP control IP (lanes 3
and 5). We were unable to confirm an association of
eEF1a with Ago1 or Ago2 via coimmunoprecipitation
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(A) Ago protein complexes were double-affinity-purified from HeLa cells stably transfected with FLAG/HA-tagged Ago1 (lane 3) and Ago2 (lane 2)
plasmids. The proteins were separated by SDS-PAGE followed by silver staining and identification of the bands by ESI tandem MS (LC-MS/MS).
The asterisks indicate so-far-unidentified proteins. Lanes 1 and 4 show molecular-weight markers.
(B) FLAG/HA-tagged Ago1 (lanes 1 and 5), FLAG/HA-tagged Ago2 (lanes 2 and 6), and FLAG/HA-tagged GFP (lanes 3 and 7) were cotransfected
with myc-TNRC6B. In lanes 4 and 8, no FLAG/HA plasmid was cotransfected. Anti-FLAG immunoprecipitates were analyzed by western blotting
with anti-HA (lanes 1–4) or anti-myc antibodies (lanes 5–8). FLAG/HA-tagged Ago1 (lane 9), FLAG/HA-tagged Ago2 (lane 10), and FLAG/HA-
tagged GFP (lane 11) were transfected into 293 HEK cells. Anti-FLAG immunoprecipitates were analyzed by western blotting with specific poly-
clonal anti-PRMT5 antibodies.
(C) FLAG/HA-tagged MOV10 (lanes 2, 4, 6) and FLAG/HA-tagged GFP (lanes 1, 3, 5) were cotransfected with myc-tagged Ago1 (lanes 3 and 4) or
with myc-tagged Ago2 (lanes 5 and 6). Anti-FLAG immunoprecipitates were analyzed by western blotting with anti-HA (lanes 1 and 2) or anti-myc
antibodies (lanes 3–6).
(D) FLAG/HA-tagged Ago2 (lane 1), FLAG/HA-tagged MOV10 (lane 2), and FLAG/HA-tagged GFP were transfected into HEK 293 cells. RNA was
extracted from anti-FLAG immunoprecipitates and analyzed by northern blotting with a probe specific to miR-16. Total RNA extracted from HEK
293 cells is shown in lane 4.approaches. Therefore, it is unclear whether the binding
of eEF1a to the Ago2 complex is specific.
Ago proteins specifically associate with mature
miRNAs [7]. We therefore investigated whether MOV10
interacts with miRNA-loaded Ago protein complexes.
We transiently transfected FLAG/HA-tagged Ago2,
FLAG/HA-tagged MOV10, and FLAG/HA-tagged GFP
into HEK 293 cells (Figure 1D). FLAG/HA-tagged pro-
teins were immunoprecipitated with anti-FLAG antibod-
ies. Coprecipitated RNAs were extracted from the beads
and analyzed by northern blotting with a probe specificto miR-16, a highly abundant miRNA in HEK 293 cells.
miR-16 was specifically detected in the FLAG/HA-Ago2
as well as the FLAG/HA-MOV10 immunoprecipitate
(lanes 1 and 2), and this detection is indicative of an
interaction of MOV10 with mature-miRNA-containing
Ago protein complexes. No signal was observed in the
control-IP (lane 3).
Taken together, our results indicate that MOV10,
TNRC6B, and PRMT5 specifically associate with Ago
proteins. We were unable to detect MOV10 and
PRMT5 in the FLAG/HA-Ago1 purification, presumably
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with TNRC6B and MOV10 in Cytoplasmic P
Bodies
(A) FLAG/HA-Ago1 was transiently ex-
pressed in HEK 293 cells, and the fixed cells
were probed with rabbit anti-FLAG and
monoclonal mouse anti-GW182 antibodies.
The cells were stained with secondary fluo-
rescein-conjugated anti-mouse and Texas
Red-conjugated anti-rabbit antibodies. The
cells were analyzed with a TCS SP2 confocal
laser microscope (Leica). (A1) shows FLAG/
HA-Ago1, (A4) shows FLAG/HA-Ago2, and
(A2) and (A5) show GW182 localization. (A3)
and (A6) show the merged images.
(B) FLAG/HA-Ago1 (B1–3 and B7–9), FLAG/HA-
Ago2 (B4–6 and B10–12), and myc-TNRC6B
(B1–6) as well as myc-MOV10 (B7–12) were
coexpressed in HEK 293 cells. The fixed cells
were probed with mouse anti-HA and rabbit
anti-myc antibodies. Protein localization was
analyzed as described in (A).because the amounts available for purified FLAG/HA-
Ago1 complexes were less compared to FLAG/HA-
Ago2 complexes (Figure 1A, compare lane 2 and 3).
MOV10 and TNRC6B Colocalize with Ago Proteins
in Cytoplasmic P Bodies
Recently, it has been demonstrated that Ago proteins as
well as miRNAs localize to specific cytoplasmic loci
termed processing bodies, or P bodies [13–15]. Further-
more, TNRC6B is a protein homologous to the P body
component GW182 [16], which is also known asTNRC6A. Therefore, we tested whether the novel bio-
chemically identified Ago-complex components localize
to P bodies as well. We transiently expressed FLAG/HA-
tagged Ago1 and Ago2 in HEK 293 cells. After 48 hr, the
cells were fixed and immunofluorescence studies were
performed with anti-FLAG antibodies. Both Ago1 and
Ago2 were concentrated in cytoplasmic P bodies (Fig-
ure 2A, left panel) as shown by costaining with anti-
bodies directed against the P body marker protein
GW182 (Figure 2A, middle and right panel). For colocal-
ization studies of Ago1 and Ago2 with the biochemically
Current Biology
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A stable HeLa-cell line that expresses EGFP carrying a sequence with perfect complementarity to miR-21 in its 30 UTR was transfected with con-
trol siRNAs complementary to the luciferase mRNA (1 and 2) or Ago1 (3 and 4), Ago2 (5 and 6), TNRC6B (7 and 8) and MOV10-specific siRNA
duplexes (9 and 10). Fluorescence and phase-contrast images were recorded 5 days after transfection with a TCS SP2 confocal laser micro-
scope (Leica Microsystems, Germany).identified complex components TNRC6B and MOV10,
we transiently expressed FLAG/HA-Ago1 and FLAG/
HA-Ago2 together with myc-TNRC6B or myc-MOV10
in HEK 293 cells (Figure 2B). Immunostaining with anti-
myc antibodies demonstrated that both TNRC6B and
MOV10 localized to cytoplasmic granules (Figures 2B1,
2B4, 2B7, and 2B10). Moreover, these granules also con-
tained FLAG/HA-Ago1 or FLAG/HA-Ago2 as shown by
probing the same cells with anti-HA antibodies (Figures
2B2, 2B5, 2B8, and 2B11). An overlay of the respective im-
ages shows that both Ago1 and Ago2 colocalize with
TNRC6B and MOV10 in cytoplasmic P bodies (Figures
2B3, 2B6, 2B9, and 2B12). No specific signal has been ob-
served when the primary anti-FLAG, anti-HA, or anti-
myc antibodies were omitted from the staining proce-
dure (Figure S1 in the Supplemental Data available
with this article online).
MOV10 and TNRC6B Are Required
for miRNA-Guided mRNA Cleavage In Vivo
To learn about the function of Ago2 and its complex
components TNRC6B and MOV10 in cultured cells, we
used a previously developed GFP-based positive-read-
out reporter cell line [7, 17]. In this cell line, the expres-
sion of GFP is repressed by miR-21. Transfection of 20-
O-methyl oligonucleotides antisense to miR-21 blocked
endogenous miR-21 and derepressed GFP expression
[7, 17]. In this reporter system, we depleted Ago1,
Ago2, TNRC6B, and MOV10 mRNAs by using siRNAs
(Figure 3). The knockdown of the specific mRNA was
monitored by quantitative RT-PCR (qRT-PCR, FigureS2). Similar to previous findings, depletion of Ago1 (Fig-
ure 33), as well as transfection of control siRNAs, (Figure
31) has no influence on GFP expression, whereas knock-
down of Ago2 resulted in strong upregulation of GFP
(Figure 35) [7]. Knockdown of MOV10 (Figure 39) as
well as TNRC6B mRNA (Figure 37) resulted in GFP-
signal upregulation comparable to targeting of Ago2, in-
dicating that MOV10 and TNRC6B were required for
miR-21-guided mRNA cleavage in cultured cells.
Very recently, it has been shown that also Caenorhab-
ditis elegans and D. melanogaster homologs of the
TNRC6 family are required for miRNA-guided gene si-
lencing and are present in P bodies [18, 19]. Because
members of the human Ago subfamily as well as miRNAs
and their target mRNAs were reported to localize to cyto-
plasmic P bodies [13–15], it is tempting to speculate that
some of the newly identified factors, including TNRC6B,
mediate targeting of Ago complexes to P bodies, while at
the same time they might act in assembly of the silencing
complexes and/or in guiding target recognition.
In Vitro Reconstitution of Target-RNA Cleaving
RISC/miRNPs Supplying dsRNA Precursors
Because Dicer copurified with FLAG/HA-Ago1 and
FLAG/HA-Ago2, we tested whether Dicer also associ-
ated with other Ago proteins and whether Dicer-contain-
ing Ago complexes showed biochemical Dicer activity.
We transiently expressed FLAG/HA-taggedAgo1 through
Ago4 and MOV10 in HEK 293 cells. After 48 hr, cells were
harvested and the FLAG/HA-tagged proteins were im-
munoprecipitated. The IP was incubated with internally
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products were subsequently analyzed by denaturing
PAGE (Figure 4, right panel). As a positive control, we in-
cubated pre-miR-27a with commercially available re-
combinant human Dicer (Stratagene). All of the FLAG/
HA-Ago IPs (lanes 2–5) as well as the positive control
(lane 7) supported pre-miRNA processing to 21-nt RNA
products, indicating co-IP of Dicer cleavage activity.
The FLAG/HA-MOV10 IP, however, did not contain Dicer
Figure 4. Human Ago2 Is Associated with Dicer, Allowing Cleavage
of miRNA Precursors, Incorporation of the miRNA into Ago2 Com-
plexes, and Cleavage of Complementary Target RNA
(A) HEK 293 cells were transiently transfected with FLAG/HA-tagged
Ago1, 2, 3, 4, and FLAG/HA-tagged MOV10 (lanes 2–6). Immunopre-
cipitates were incubated with a Dicer substrate RNA derived from
the miR-27a precursor that has been internally 32P labeled. The pro-
cessed RNA products were analyzed by 15% denaturing RNA PAGE
followed by phosphoimaging. In lane 7, recombinant Dicer was
used, and lane 1 shows a 21-nt-long RNA as size marker. An anti-
HA western blot indicating the amounts of FLAG/HA-tagged Ago
proteins used for the Dicer reaction is shown to the left.
(B) Immunoprecipitations of FLAG/HA-tagged Ago2 (lanes 1–4) or
FLAG/HA-tagged GFP (lanes 5–8) were washed with 150 mM, 300
mM, 500 mM, or 1500 mM NaCl and subsequently preincubated
with an in vitro-transcribed miR-124a-1 precursor followed by incu-
bation with a 32P-cap-labeled target RNA that carried a sequence el-
ement perfectly complementary to the mature miR-124.
The reactions shown in (C) were preincubated with single-stranded
or double-stranded siRNAs directed against a luciferase target RNA.
Cleaved RNA products shown in (B) and (C) were separated by 8%
denaturing RNA PAGE and visualized by phosphoimaging. Partial
nuclease T1 digestions of the miR-124 and the luciferase target
RNAs are indicated as T1. The target-RNA sequence element that
is covered by miR-124 and the siRNA against the luciferase mRNA
is shown as black lines to the left of the gels.activity, suggesting that MOV10 functions downstream
of the Dicer cleavage step (lane 6) or that it is only tran-
siently associated with the RISC loading or assembly
complex.
The coexistence of Dicer and Ago proteins in Ago-
purified complexes and the presence of Dicer activity
prompted us to examine whether RISC can be reconsti-
tuted in vitro by using pre-miRNAs as input. Previously,
it was shown that single-stranded 21-nt RNAs but not
duplex siRNAs reconstitute cleavage activity by using
partly purified or recombinant Ago2 [20, 21]. To avoid
contamination of endogenously expressed miRNAs
from HeLa or HEK 293 cells in such an assay, we chose
the neuron-specific pre-miR-124a-1. Pre-miR-124a-1
was transcribed in vitro and mimicked the Drosha pro-
cessing products carrying a 2 nt 30 overhang at the
base of the stem loop. FLAG/HA-Ago2 or FLAG/HA-
GFP IPs from HEK 293 cells were preincubated with
pre-miR-124a-1 and followed by the addition of a 32P-
cap-labeled substrate RNA perfectly complementary
to miR-124a. The cleaved RNA products were analyzed
by denaturing PAGE (Figure 4B). Only the incubation
with FLAG/HA-Ago2 IP (lane 1) but not the FLAG/HA-
GFP control IP (lane 5) resulted in a specific miR-124a-
guided cleavage product, which indicated that Dicer,
RISC-loading, and RISC activity coprecipitated with
FLAG/HA-Ago2. The activity of the complexes is in-
creased after a high-salt wash up to 1.5 M NaCl (lanes
1–4), possibly suggesting that endogenously associated
dsRNA may have been removed and the proteins were
free to incorporate the exogenously added pre-miR-
124a. We also examined whether RISC can be reconsti-
tuted by using duplex siRNA (Figure 4C). FLAG/HA-
Ago2 or FLAG/HA-GFP IPs were preincubated with the
duplex siRNA directed against firefly luciferase mRNA.
A 32P-labeled substrate RNA was subsequently added,
and the cleaved RNA products were analyzed as
described above. The FLAG/HA-Ago2 IP, but not the
FLAG/HA-GFP IP, supported target-RNA cleavage. The
cleavage activity reconstituted on FLAG/HA-Ago2 beads
when input duplex siRNA was used was about 10–20-
fold weaker than when single-stranded siRNA was used
at the same concentrations (lane 2), presumably as a
result of very low amounts of coprecipitated protein
complex(es) that are required for unwinding and/or
RISC loading. In summary, we demonstrated that human
Ago2 coprecipitated with components required for
miRNA processing, unwinding of the small RNA duplex,
RISC loading, and cleavage of a substrate RNA.
Integration of the Factors in an Interaction Network
Crystallographic studies of Ago proteins revealed unique
structural and enzymatic features required for binding
small RNAs processed by RNase III enzymes and for
guiding target-mRNA recognition as well as cleavage
[21–28]. To define the protein network of individual mem-
bers of the human Ago subfamily, we applied biochemi-
cal methods to identify such interactors. Among the
identifiedproteins,we foundDicerstablyassociatedwith
Ago1- and Ago2-containing complexes; Dicer was previ-
ously shown to bind to the PIWI-box of Ago proteins
through one of its RNase III domains [29]. Human Dicer
was also shown to be present in a complex together
with the dsRNA binding domain (dsRBD) protein TRBP,
Current Biology
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[9, 30]. However, it is only here where functional bio-
chemical studies support the existence of such a small-
RNA processing and targeting ‘‘holo-RISC’’ complex.
MOV10 is a human homolog of the D. melanogaster
DExD-box protein Armitage. In D. melanogaster lysates,
Armitage is required for early RISC assembly as demon-
strated in gel-shift experiments [12]. Armitage is also
essential for miRNA-guided translational regulation in
D. melanogaster and suggests a general role for Armit-
age in all RNA silencing processes [10, 12]. MOV10 might
have a similar function in assembling miRNA-containing
silencing complexes and/or acts in subsequent steps.
The arginine-methyltransferase PRMT5 specifically
generates symmetric dimethyl-arginines in its target
proteins [31]. Among other RNA binding proteins, such
targets are ‘‘like-Sm’’ proteins (LSm proteins), which
are involved in pre-mRNA splicing and mRNA turnover
[32]. Interestingly, LSm-proteins also localize to cyto-
plasmic P bodies [33], and it will be very interesting to
examine whether PRMT5 and/or LSm-proteins are re-
quired for the localization of Ago proteins to cytoplasmic
P bodies. Though we assume that PRMT5 is part of hu-
man ‘‘holo-RISC’’ and mediates methylation of arginine
residues on some yet-to-be-identified ‘‘holo-RISC’’
component(s), we did not identify classic target motifs
composed of arginines usually flanked by two glycines
in known components of silencing complexes. Further
biochemically studies are needed to address the role
of these new enzymatic activities present in RNA-silenc-
ing-mediating complexes.
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Note Added in Proof
This text differs slightly from the version previously published online,
in which MOV10 was incorrectly identified as a DEAD-box helicase;
MOV10 actually belongs to the DExD superfamily. In addition, the
authors wish to cite the following paper as evidence that Gemin3
and Gemin4 functionally interact with Ago2: Hutvagner, G., and Za-
more, P.D. (2002). A microRNA in a multiple-turnover RNAi enzyme
complex. Science 297, 2056–2060.
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ABstrAct
MicroRNAs (miRNAs) constitute a class of small non-coding RNAs that regulate 
gene expression on the level of translation and/or mRNA stability. Mammalian miRNAs 
associate with members of the Argonaute (Ago) protein family and bind to partially 
complementary sequences in the 3' untranslated region (UTR) of specific target mRNAs. 
Computer algorithms based on factors such as free binding energy or sequence conser-
vation have been used to predict miRNA target mRNAs. Based on such predictions, up 
to one third of all mammalian mRNAs seem to be under miRNA regulation. However, 
due to the low degree of complementarity between the miRNA and its target, such 
computer programs are often imprecise and therefore not very reliable. Here we report 
the first biochemical identification approach of miRNA targets from human cells. Using 
highly specific monoclonal antibodies against members of the Ago protein family, we 
co-immunoprecipitate Ago-bound mRNAs and identify them by cloning. Interestingly, most 
of the identified targets are also predicted by different computer programs. Moreover, 
we randomly analyzed six different target candidates and were able to experimentally 
validate five as miRNA targets. Our data clearly indicate that miRNA targets can be 
experimentally identified from Ago complexes and therefore provide a new tool to 
directly analyze miRNA function.
introduction
MiRNAs form a highly conserved class of small non-coding RNAs with regulatory 
functions in processes as diverse as development, cell differentiation or apoptosis.1-3 
MiRNA genes are often organized in genomic clusters, which give rise to one primary 
transcript containing multiple miRNAs. MiRNAs, however, also derive from one indi-
vidual transcript or frequently originate from intronic sequences.1-3 MiRNA genes are 
transcribed by RNA polymerases II or III to generate primary miRNA transcripts that 
are poly-adenylated and capped.4,5 Primary miRNA transcripts are processed by the 
nuclear microprocessor complex, which contains the RNase III enzyme Drosha and 
its co-factor DGCR8.6-8 Drosha produces stem-loop structured miRNA precursors 
(pre-miRNAs) with characteristic two nucleotide (nt) 3' overhangs.9 The pre-miRNA 
hairpin is further transported to the cytoplasm by the export receptor Exportin 5 where 
it is further processed by the RNase III enzyme Dicer.3,10,11 Dicer most likely recognizes 
the two nt overhangs and cleaves 21 nt from the ends to produce a short-lived double 
stranded (ds) miRNA/miRNA* RNA which is subsequently unwound and only one 
strand is incorporated into miRNA-protein complexes (miRNPs) and gives rise to the 
mature miRNA. 3,10,11
MiRNAs guide members of the Argonaute protein family to partially complementary 
sequences within the 3' UTR of target mRNAs to either regulate their translation into 
protein or their stability.12,13 Argonaute proteins are highly conserved and contain PAZ 
(PIWI-Argonaute-zwille) and PIWI domains. Structural studies have demonstrated that 
the PAZ domain forms a highly specific binding module for 2 nt 3' overhangs generated 
by RNase III enzymes. In contrast, PIWI domains fold similar to RNase H and may 
therefore function as endonucleases.14-16 Indeed, it has been demonstrated for some Ago 
proteins that they are endonucleolytically active and such proteins have therefore been 
termed “Slicer”. Interestingly, in mammalian cells Ago2 is the only member of the Ago 
protein family, which has endonuclease activity, although the critical amino acids are 
conserved in some other Ago proteins as well.17,18
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MiRNAs recognize partially complementary binding sites located 
in the 3' UTR of target mRNAs and function as guides for protein 
effectors such as Ago proteins.13 It has been shown that miRNP-
binding to specific target mRNAs can regulate gene expression in 
different ways. On target sites with a high degree of complementarity, 
miRNAs function alike siRNAs and guide sequence-specific cleavage 
of the target mRNA.19 Targets with low degree of complementarity 
can either be destabilized by recruiting de-capping and de-polym-
erization enzymes or their translation is repressed without altering 
mRNA levels.12 While sequence-specific cleavage of target RNAs is 
well understood, the mechanism of how miRNAs guide translational 
repression or destabilization is only poorly understood.
The mode of miRNA-guided translational repression is still a 
matter of debate. Initial studies in Caenorhabditis elegans (C.elegans) 
have shown that miRNAs as well as target mRNAs associate with 
polysomes in sucrose gradients and it has been suggested that 
miRNAs function after initiation and presumably at the elonga-
tion steps of translation.20,21 Later on, it has been reported that 
also mammalian miRNAs can be found on polysomes and a ribo-
some drop-off model has been suggested, which describes the rapid 
ribosome drop-off from mRNAs that are targeted by miRNAs.22-24 
Controversially, it has been demonstrated that miRNAs interfere 
with translation initiation steps. Moreover, cap-independent transla-
tion mediated by internal ribosome entry sites (IRES) is not sensitive 
to miRNA-guided regulation, indicating that miRNAs inhibit trans-
lation initiation.25,26 Very recently, two reports supported this model. 
First, miRNPs associate with the 60S ribosomal subunit and eIF6, a 
protein known to prevent assembly of 80S ribosomes.27 Second, in a 
Drosophila in vitro translation system, miRNAs induce the formation 
of dense miRNPs that co-migrate with polysomes.28 These structures 
have been termed pseudo-polysomes and may reflect the structures 
that have been interpreted as polysomes in other studies.
Novel mechanistic insights into miRNA function came from 
recent studies on Ago proteins. Mourelatos and co-workers identified 
a motif within Ago proteins, which specifically recognizes and binds 
the m7G cap of mRNAs, thus preventing binding of eIF4E binding. 
This Ago-m7G cap interaction therefore leads to the inhibition of 
translational initiation.29
Due to the low degree of complementarity between miRNAs and 
target mRNAs, only a few mammalian target mRNAs have been 
discovered and validated thus far. Computer algorithms have been 
developed to predict putative miRNA targets and it has been found 
that seven to eight nt at the 5' end of the miRNA is the most impor-
tant determinant for target specificity. Such sequences are also called 
“seed sequence”.30-33 Based on seed sequence conservation and free 
binding energy, miRNA targets have been predicted in a variety of 
different organisms. The different prediction programs find about 
100 to 150 different targets for one miRNA. Some algorithms even 
predict one third of all human mRNAs as miRNA targets. Computer 
programs usually predict targets on a genome wide scale irrespective 
of tissue-specific mRNA and miRNA expression patterns. Therefore, 
it is very difficult to find miRNA targets that are specific to tissues 
or cell lines. Interestingly, it has been proposed earlier, that miRNA-
mRNA interactions are restricted to specific tissues in C. elegans.34 
It is becoming more and more apparent that it is very important to 
develop biochemical tools to identify only subsets of miRNA targets 
from specific tissue material.
Here we report the first biochemical miRNA target identifica-
tion approach. Using specific monoclonal antibodies against human 
Ago1 and Ago2, we succeeded to co-immunoprecipitate Ago-bound 
mRNAs. We generated a cDNA library from the Ago-associated 
mRNAs and identified a significant number by sequencing. We 
further validated six Ago-bound mRNAs either by inhibiting or 
over-expressing miRNAs that have been predicted to regulate the 
respective mRNAs.
MAtEriALs And MEthods
Reporter constructs. To generate miRNA reporter plasmids 
which express the firefly luciferase mRNA with a 3'UTR sequence 
of interest and renilla luciferase as a transfection control, pMIR-
REPORT (Ambion) was modified as follows: The renilla luciferase 
gene with a SV40 promoter and a poly(A) site was PCR-amplified 
from the pRL-SV40 plasmid (Promega) and inserted into the SspI 
site of pMIR-REPORT. Additionally, an HSV-TK promoter was 
PCR-cloned from pRL-TK (Promega) and inserted into pMIR-
REPORT to replace the CMV promoter of the firefly luciferase gene.
Luciferase expression constructs were generated by cloning of 
the 3'UTRs of STMN1, HMGB1, Raver2, SERBP1, DNAJB11 
and SFPQ into the modified pMIR vector (pMIR-RL) described 
above. The 3'UTRs were cloned via PCR amplification from cDNA 
libraries and ligated into the corresponding SacI and NaeI sites of 
pMIR-RL. The primer sequences are:
SERBP1, 5'-CGCTGAGCTCCTGGATGCCATAAGACAACCCT, 
5'-CGCTGCCGGCTTAACTGGTACACACTGTTCAC;
Raver2, 5'-CGCTGAGCTCGTTAAGCTCTCTCCTAATAACC, 
5'-CGCTGCCGGCTCCCAATAAAAGTTTATTTATG;
SFPQ, 5'-CGCTGAGCTCATGTGATATTTAGGCTTTCATT, 
5'-CGCTGCCGGCTCATGTTTAACATCTTTAATTC;
DNAJB11, 5'-CGCTGAGCTCGAGTGAATAAAATTGGACTTTG, 
5'-CGCTGCCGGCTTCATGAAAAAAATAACAACAA;
HMGB1, 5'-CGCTGAGCTCGTTGGTTCTAGCGCAGTTTTTT, 
5'-CGCTGCCGGCTTACTGCAATTATTAGTTTATT;
STMN1, 5'-CGCTGAGCTCTTTGTTCTGAGAACTGACTTTC, 
5'-CGCTGCCGGCCTACAGCAGTACATAAAGTTTT.
The sequences of miR-let7a, miR-26a, miR-26b, miR-29b, miR-
99a, miR-100 and miR-141 were cloned as oligonucleotides into 
pSuper (oligoengiene) according to the manufacturer’s protocol. 
miR-let7a, 5'-GATCCCTGGGATGAGGTAGTAGGTTGTATAG
TTTTAGGGTCACACCCACCACTGGGAGATAACTATACAAT
CTACTGTCTTTCCTATTTTTA;
miR-26a, 5'-GATCCCGTGGCCTCGTTCAAGTAATCCAGGAT
AGGCTGTGCAGGTCCCAATGGGCCTATTCTTGGTTACTT
GCACGGGGACGCTTTTTA;
miR-26b; 5'-GATCCCCCGGGACCCAGTTCAAGTAATTCAG
GATAGGTTGTGTGCTGTCCAGCCTGTTCTCCATTACTTG
GCTCGGGGACCGGTTTTTA;
miR-29b, 5’-GATCCCCTTCAGGAAGCTGGTTTCATATGGT
GGTTTAGATTTAAATAGTGATTGTCTAGCACCATTTGAAA
TCAGTGTTCTTGGGGGTTTTTA;
miR-99a, 5'-GATCCCCCCATTGGCATAAACCCGTAGATCCG
ATCTTGTGGTGAAGTGGACCGCACAAGCTCGCTTCTATG
GGTCTGTGTCAGTGTGTTTTTA;
miR-100, 5'-GATCCCCCTGTTGCCACAAACCCGTAGATCC
GAACTTGTGGTATTAGTCCGCACAAGCTTGTATCTATAGG
TATGTGTCTGTTAGGTTTTTA;
miR-141, 5'-GATCCCCGGCCGGCCCTGGGTCCATCTTCC
AGTACAGTGTTGGATGGTCTAATTGTGAAGCTCCTAACA
CTGTCTGGTAAAGATGGCTCCCGGGTGGGTTCTTTTTA. 
2'O-methylated miRNA inhibitors were designed as antisense oligos 
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to the mature miRNAs according to the miRNA 
registry (microrna.sanger.ac.uk/sequences/index.
shtml).
Transfections and luciferase assays. Plasmid 
transfections for luciferase assays were performed 
with 50 ng pMIR-RL 3'UTR and 200 ng 
pSuper-miRNA vector or 40 pmol 2'OMe-
miRNA-inhibitor per 2x104 cells in a 48-well 
plate using EscortV transfection reagent (Sigma) 
as described by the manufacturer. For Co-trans-
fection of DNA and 2'OMe-miRNA-inhibitors, 
pMIR-RL 3'UTR were transfected 6 h after 
transfection with the 2'OMe-miRNA-inhibitors. 
Luciferase activity was measured 48 h after trans-
fection using a dual luciferase reporter system as 
described by the manufacturer (Promega).
Cell lysates and immunoprecipitations. 
HEK 293 cells were lysed in buffer containing 
25 mM Tris HCl pH 7.4, 150 mM KCl, 
0.5% NP-40, 2 mM EDTA, 1 mM NaF, 0.5 
mM DTT and protease inhibitors (Roche) 
and centrifuged at 10000 g for 10 min at 4°C. 
For immunoprecipitations 5 ml of hybridoma 
supernatant from monoclonal anti-Ago1-4B8 
and anti-Ago2-5D4 antibodies were coupled 
to approx. 80 µl Protein-G-Sepharose (GE 
Healthcare). Beads were subsequently incu-
bated with 10 ml of HEK 293 lysate (approx. 
10 µg/µl) for 5 h under constant rotation at 
4°C. After incubation, the beads were washed 
three times with washing buffer (300 mM KCl, 
50 mM Tris-HCl pH 7.4, 1 mM MgCl2, 0.1 
% NP-40). Finally, the beads were washed once 
with PBS. Co-precipitated RNA was extracted 
using one volume of phenol and subsequently 
precipitated from the aqueous phase using three 
volumes of Ethanol. The RNA pellet was used 
for oligo-dT purification and library generation.
cDNA synthesis and library generation. 
The cDNA library was generated by Vertis 
Biotechnology (Weihenstephan, Germany). Briefly, immunoprecipi-
tated mRNAs were subjected to oligo-dT purification. The purified 
mRNAs were reverse transcribed using reverse transcriptase and 
oligo-dT as primer. The single stranded cDNA was used for second-
strand synthesis using random hexamers as primers. The resulting 
cDNA was cloned into a TOPO vector (Invitrogen) according to the 
manufacturer’s instructions. The plasmids were subsequently trans-
formed into E.coli to generate cDNA libraries. In order to identify 
individual cDNAs from the libraries, bacteria were separated on agar 
plates and individual colonies were picked for plasmid DNA prepara-
tion. Plasmids were sequenced in a 96 well format by LARK (UK).
Monoclonal antibodies. For monoclonal antibody production 
Lou/C rats were immunized subcutaneously and intraperitoneally 
with a mixture of Ago1-GST or Ago2-GST fusion protein (50 µg), 
5 nmol CPG oligonucleotide (ODN 2006, TIB Molbiol, Berlin, 
Germany), 500 µl PBS and 500 µl IFA. After a six-week interval 
a final boost without adjuvant was given three days before fusion 
of the rat spleen cells with the murine myeloma cell line P3X63-
Ag8.653 (ZIT). Hybridoma supernatants were tested in an ELISA 
using bacterially expressed Ago1 or Ago2 fusion protein or an 
irrelevant GST fusion protein. mAbs reacting only with Ago1-GST 
or Ago2-GST fusion proteins were analyzed in western blotting and 
immunoprecipitation. Only Ago1-4B8 (rat IgG2a) recognized the 
protein specifically in western blotting. However, both Ago1-4B8 
and Ago2-5D4 recognized only Ago1 or Ago2 specifically and were 
used in this study.
rEsuLts
Isolation of Ago-bound mRNAs. Based on structural studies on 
archaeal Ago proteins, it is very likely that Ago proteins do not only 
bind to small RNAs but also directly contact the regulated target 
RNAs.35,36 We therefore hypothesized that Ago proteins may form 
stable Ago mRNPs that can be biochemically analyzed. We gener-
ated highly specific monoclonal antibodies against human Ago1 and 
Ago2. Clone Ago1-4B8 recognized specifically tagged Ago1 and a 
100 kDa band in human cell extracts (data not shown). Moreover, 
Ago1-4B8 immunoprecipitated only tagged Ago1 but not Ago2 
(Fig. 1A). Clone Ago2-5D4 did not show any signal in western 
blots but specifically immunoprecipitated tagged Ago2 but not Ago1 
Figure 1: Biochemical isolation of mRNAs that are associated with human Ago1 or Ago2. 
(A) Monoclonal antibodies against Ago1 (4B8, lanes 1 and 2), against Ago2 (5D4, lanes 3 
and 4) and the FLAG tag (lanes 5 and 6) were bound to Protein-G Sepharose beads and used for 
immunoprecipitations of FLAG/HA-tagged Ago1 (lanes 1, 3 and 5) and FLAG/HA-tagged Ago2 
(lanes 2, 4 and 6). Immunoprecipitated proteins were analyzed by western blotting using anti-HA 
antibodies. (B) Schematic presentation of the Ago1- and Ago2-associated mRNP purification proto-
col. (C) Monoclonal antibodies Ago1-4B8 (lane 3), Ago2-5D4 (lane 2) or a monoclonal antibody 
against the FLAG-tag (lane 4) were coupled to Protein-Sepharose beads and incubated with HEK 
293 lysates. Co-immunoprecipitated mRNAs were reverse transcribed and second-strand cDNA 
synthesis was performed using random hexamers. Lane 1 shows a DNA size marker.
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Table 1 continued
(Fig. 1A). Therefore, we used the antibodies for affinity purifica-
tion of Ago complexes (Fig. 1). Monoclonal antibodies Ago1-4B8 
or Ago2-5D4 were immobilized on Protein-G-Sepharose beads and 
incubated with HEK 293 cell lysates. After stringent washing, the 
co-immunoprecipitated Ago-bound RNAs were extracted and 
subjected to oligo-dT purification to purify mRNAs from other 
Ago-associated RNA species (Fig. 1B). The isolated mRNAs were 
reverse transcribed, cloned and subjected to second-strand synthesis 
using random hexamer oligos (Fig. 1C). Interestingly, both the Ago1 
and the Ago2-specific monoclonal antibodies pull-down mRNAs 
indicated by a RNA smear over a broad range of the agarose gel (lanes 
2 and 3). A monoclonal antibody directed against the FLAG-tag was 
used as a control and did not immunoprecipitate visible amounts of 
mRNAs (lane 4), indicating that the Ago1 and Ago2 mRNA signal 
is specific. Taken together, we have demonstrated that Ago1 and 
Ago2 form stable mRNPs in human cells that can be biochemically 
isolated.
Cloning and identification of Ago bound mRNAs. In order to 
identify and further analyze the mRNA pools that were isolated from 
Ago1 and Ago2 mRNPs, the cDNAs described above were cloned 
and transformed into E. coli to produce Ago-associated mRNA 
libraries. About 600 colonies from each of the libraries were picked 
and the corresponding plasmids were sequenced (Table 1 and Table 
2). Since it cannot be excluded that the libraries contain a limited 
number of mRNAs that are unspecifically bound to the beads, we 
removed all the single hits from the list and considered only enriched 
mRNAs as miRNA target candidates (all cloned mRNAs are shown 
in supplementary tables 1 and 2). To further analyze the list of Ago-
bound mRNAs that we have obtained, we employed three target 
prediction algorithms that are widely used (Miranda, targetScan, 
pictar). Surprisingly, only about 60% of the Ago1-bound mRNAs 
and about 50% of the Ago2–bound mRNAs are predicted as miRNA 
targets. Moreover, we also find high numbers of messages that are 
encoded by the mitochondrion indicating that pools of cellular 
mRNAs that have not been analyzed by target prediction programs 
so far are subject to miRNA regulation as well. In order to gain 
insight into Ago1 and Ago2 function, we compared the Ago1-bound 
mRNAs with the Ago2-bound mRNAs (supplementary table 3). We 
find that only a limited number of mRNA overlap between Ago1 
and Ago2 suggesting that many miRNA targets might be specific to 
one Ago protein.
Taken together, we have demonstrated that mRNAs specifically 
co-purify with human Ago1 and Ago2 complexes. Interestingly, 
prediction algorithms have not identified many of the identified 
Ago-bound mRNAs. Therefore, our data suggest that larger numbers 
of mRNAs as previously anticipated might be under the control of 
the miRNA pathway.
Validation of identified mRNAs. For detailed analysis of the 
specificity of the Ago-bound mRNAs, we validated a number of 
mRNAs by different experimental approaches. We chose six mRNAs 
from the Ago1-bound cDNA library that are also predicted as 
miRNA targets by different algorithms and cloned the 3' UTRs 
behind a firefly luciferase reporter gene (for predictions see supple-
mentary figure 1). Notably, all miRNAs that have been tested 
are also associated with Ago1 in HEK 293 cells (data not shown, 
submitted elsewhere). The reporter plasmids were co-transfected with 
2'O-methylated antisense inhibitors against endogenous miRNAs 
that are predicted to bind to the respective 3'UTRs (Figure 2, left 
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Table 2	 Ago2-associated	mRNAs
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panels). Inhibitors against miRNAs that are not predicted to regu-
late the analyzed mRNAs served as controls. Strikingly, inhibition 
of miR-29b led to an enhanced luciferase activity compared to the 
control transfection when fused to the full length 3'UTR of dnajb11, 
an mRNA that encodes for a hsp40 variant indicating the dnajb11 
is indeed a miRNA target (Fig. 2A). Similar results were obtained 
when inhibitors against miRNAs that have been predicted to regu-
late serbp1 (Fig. 3B), hmgb1 (Fig. 3C), raver2 (Fig. 3D) and sfpq 
(Fig. 3E) were co-transfected with reporter plas-
mids containing the full length 3'UTRs of these 
mRNAs. Notably, we were not able to validate 
stmn1 as miRNA target (data not shown). 
Therefore, our data suggest that the majority 
of the Ago1-bound mRNAs that have been 
validated are indeed under the control of endog-
enous miRNAs.
Inhibition of specific endogenous miRNAs 
resulted in enhanced expression of the above-
mentioned Ago1-bound mRNAs. If these 
mRNAs are indeed under the control of the 
miRNA pathway, we hypothesized that forced 
over-expression of those miRNAs may lead to 
a decreased expression of Ago1-bound mRNAs. 
We cloned different miRNA hairpins into the 
pSUPER vector to allow for over-expression. 
Strikingly, when we express miR-29b the expres-
sion of a luciferase reporter containing the 
full-length dnajb11 3'UTR was reduced to about 
40% indicating that dnajb11 is indeed regulated 
by miR-29b (Fig. 2A, right panel). Similarly, 
when over-expressing miR-26a, miR-26b and 
miR-141 the expression of a luciferase reporter 
containing the full-length 3'UTR of serbp1 was 
strongly reduced indicating that serbp1 is under 
the control of the miRNA pathway (Fig. 2B). 
Similar results were obtained with hmgb1 (Fig. 
2C), raver2 (Fig. 2D) and sfpq (Fig. 2E).
In summary, two independent validation 
approaches clearly demonstrate that all Ago1-
bound mRNAs that have been tested are indeed 
miRNA targets suggesting a high number of 
miRNA targets in our libraries. We also provide a 
novel tool to specifically identify miRNA targets 
from individual human cell lines or tissues.
discussion
Ago proteins specifically recognize and bind 
both ends of small non-coding RNAs and are 
therefore considered as key factors in RNA 
silencing 14-16. Moreover, structural studies 
demonstrated that Ago proteins might not only 
interact with the small RNA but also with target 
RNAs that are regulated. Using a biochemical 
approach, we purified Ago-mRNPs from human 
cells and identified about 600 Ago1-bound 
and about 600 Ago2-bound mRNAs. Since it 
cannot be excluded that our libraries also contain 
mRNAs that un-specifically co-purify, we elimi-
nated the single hits form the list to obtain all 
mRNAs that are enriched in the libraries. Using a luciferase-based 
reporter system, we have analyzed six Ago1-bound mRNAs and have 
validated five of them as miRNA targets. It is therefore tempting 
to speculate that a high percentage of our purified mRNAs are 
indeed miRNA targets. Notably, we have not validated Ago2-bound 
mRNAs yet. However, due to the specificity of the antibodies 
(Fig. 1A), it is likely that miRNA targets are enriched in the 
Ago2-associated mRNA fraction as well. Large-scale validation 
Figure 2. For legend, see page e8. 
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approaches will be needed to clearly show that the identified Ago-
bound mRNAs are regulated by the miRNA pathway.
Among our purifications we find very abundant mRNA including 
many that encode for ribosomal proteins. Such highly abundant 
mRNAs very often co-precipitate un-specifically. However, several 
lines of evidence argue against high background in our purifications. 
First, we do not find visible amounts of mRNAs that co-purify with 
the monoclonal anti-FLAG antibody (Fig. 1B) indicating that most 
of the Ago1 and Ago2-associated mRNAs are specific and not just 
bound to the beads. Second, among the Ago1 and Ago2 mRNP puri-
fications we find low abundant mRNAs with higher frequency than 
for example messages for ribosomal proteins. 
Third, beside a few overlapping mRNAs in the 
Ago1- and Ago2-bound mRNA fractions, we 
find many mRNAs that are specific to one or the 
other Ago protein again arguing against general 
mRNA background in our purifications.
The limited number of overlapping mRNAs 
could be considered as general background. 
However, it is equally reasonable that those 
mRNAs are targeted both by Ago1 and Ago2 since 
it has been suggested by computer predictions that 
individual mRNAs might be targeted by multiple 
miRNAs. An exhaustive sequencing approach 
of Ago-bound cDNA libraries in conjunction 
with large-scale validation approaches will be 
a powerful tool to identify all mRNAs that are 
targeted by the miRNA pathway. Analysis of 
target mRNAs that are not predicted as miRNA 
targets yet will also help to understand how the 
miRNA pathway in general and individual Ago 
proteins in particular function in gene silencing.
Most interestingly, only about 60% of the 
Ago-bound mRNAs, which have been identified 
in this study, are predicted by the three most 
widely used prediction algorithms Miranda, 
targetScan and pictar (tables 1 and 2).30-32 
Assuming that the mRNA background in our 
purifications is low, our data suggest that the 
currently used miRNA target prediction algo-
rithms may miss a significant number of miRNA 
targets. Moreover, many prediction programs 
do not cover all cellular RNAs including mito-
chondrial RNAs due to incomplete databases. 
It is therefore reasonable that we find mRNAs 
in our purifications that are not predicted as 
miRNA targets. However, only a comprehensive 
validation of the isolated mRNAs will allow 
for a conclusive comparison of bioinformatics 
and biochemical miRNA target identification 
approaches.
Detailed bioinformatic as well as biochemical 
analysis of biochemically-identified mRNAs will 
lead to a better understanding of how miRNPs 
function and how such particles are embedded 
into larger regulatory networks. It is reasonable 
that other protein factors bind to miRNA targets 
and either inhibit miRNA association or enhance 
miRNA and therefore Ago binding. Such factors 
might be specific to individual mRNAs that are 
targeted by miRNAs. The limited number of putative miRNA targets 
that we provide in this study is a perfect starting point to analyze 
consensus sequences for RNA binding proteins in the vicinity of 
predicted miRNA binding site.
Note
Supplemental materials can be found at: 
www.landesbioscience.com/supplement/beitzingerRNA4-2-sup.pdf
Figure 2. Validation of miRNA targets that are associated with human Ago1 mRNPs. (A) A lucif-
erase reporter construct containing the full length 3'UTR of dnajb11 was co-transfected either 
with a 2'O-methylated inhibitor antisense to miR-29b (left panel) or a plasmid over-expressing 
miR-29b (right panel). The empty vector served as control. Firefly luciferase expression was nor-
malized to Renilla luciferase expression. Error bars are derived from three individual experiments. 
(B) Experiments were performed as in (A). The full-length 3'UTR of serbp1 was fused to firefly lucif-
erase. Inhibitors against miR-26a, miR-103 and miR-107 were co-transfected (left panel). MiR-26a, 
miR-26b and miR-141 were over-expressed (right panel). (C) Experiments were performed as in 
(A). The full length 3'UTR of hmgb1 was fused to firefly luciferase. An inhibitor against miR-141 
was co-transfected (left panel). MiR-141 was over-expressed (right panel). (D) Experiments were 
performed as in (A). The full-length 3'UTR of raver2 was fused to firefly luciferase. Inhibitors against 
miR-99a, miR-99b and let-7a were co-transfected (left panel). MiR-99a, miR-99b and let-7a were 
over-expressed (right panel). (E) Experiments were performed as in (A). The full-length 3'UTR of 
sfpq was fused to firefly luciferase. Inhibitors against miR-29b and miR-141 were co-transfected 
(left panel). MiR-29b and miR-141 were overexpressed (right panel).
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Proteomic and functional analysis of Argonaute-
containing mRNA–protein complexes in human cells
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Members of the Argonaute (Ago) protein family associate with
small RNAs and have important roles in RNA silencing. Here, we
analysed Ago1- and Ago2-containing protein complexes in human
cells. Separation of Ago-associated messenger ribonucleoproteins
(mRNPs) showed that Ago1 and Ago2 reside in three complexes
with distinct Dicer and RNA-induced silencing complex acti-
vities. A comprehensive proteomic analysis of Ago-containing
mRNPs identified a large number of proteins involved in RNA
metabolism. By using co-immunoprecipitation experiments
followed by RNase treatment, we biochemically mapped inter-
actions within Ago mRNPs. Using reporter assays and knockdown
experiments, we showed that the putative RNA-binding protein
RBM4 is required for microRNA-guided gene regulation.
Keywords: Argonaute proteins; gene silencing; microRNA;
RNA interference
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INTRODUCTION
RNA silencing is a conserved gene-silencing pathway that is
triggered by double-stranded RNA (dsRNA). DsRNA molecules
are processed to small interfering RNAs (siRNAs) or microRNAs
(miRNAs), which are then assembled into various effector
complexes, including the RNA-induced silencing complex (RISC).
MiRNA precursors (pre-miRNAs) are excised from primary tran-
scripts by a nuclear complex containing the RNase III enzyme
Drosha and the dsRNA-binding domain protein DGCR8/Pasha. Pre-
miRNAs are subsequently exported to the cytoplasm by the export
receptor exportin 5, where dsRNAs and pre-miRNAs are further
processed by the RNase III enzyme Dicer to duplexes of approxi-
mately 22 nucleotides. In a manner similar to Drosha, Dicer
functions with the dsRNA-binding domain proteins TRBP (human
immunodeficiency virus transactivating response RNA binding
protein) and PACT (PKR activator; reviewed by Meister & Tuschl,
2004; Filipowicz et al, 2005; Zamore & Haley, 2005). Only one
strand of the siRNA–miRNA duplex intermediate is loaded into the
silencing effector complex to become the guide strand. SiRNAs
and miRNAs either guide the sequence-specific degradation of
complementary RNAs or inhibit the translation of partly comple-
mentary target messenger RNAs (Pillai et al, 2007). Recently, a third
pathway of miRNA function has been identified in Drosophila, in
which miRNAs guide the degradation of not perfectly complemen-
tary target mRNAs by recruiting de-adenylation and de-capping
enzymes (Behm-Ansmant et al, 2006; Wu et al, 2006).
Members of the Argonaute (Ago) protein family are crucial
components of RNA silencing effector complexes. Ago proteins
contain PAZ and PIWI domains, and structural studies of archaeal
Ago proteins show striking similarity between the PIWI domain and
RNase H. Further functional analyses have shown that some Ago
proteins contain endonucleolytic activity (Parker & Barford, 2006;
Peters & Meister, 2007). Recently, another Ago domain, which binds
to the m7G cap of mRNAs, was identified (Kiriakidou et al, 2007).
Biochemical purifications of Ago1 and Ago2 complexes from
HeLa cell lysates identified the DExD box protein MOV10
(Moloney leukaemia virus 10 homlogue) and a protein termed
TNRC6B (trinucleotide repeat containing 6B) as new components
of the Ago complex (Eulalio et al, 2007a). Interestingly, TNRC6B
is highly homologous to TNRC6A (GW182), which constitutes
a marker protein for cytoplasmic processing bodies (P-bodies).
P-bodies are cellular sites of RNA metabolism, and it has been
shown that Ago proteins also localize to P-bodies (Eulalio et al,
2007a). MiRNAs and artificially bulged miRNA target mRNAs are
also found in P-bodies, and it has been suggested that localization
of mRNAs to P-bodies might prevent their translation (Liu et al,
2005; Pillai et al, 2005). Furthermore, a recent study showed that
the P-body component RCK/p54 (DEAD box polypeptide 6) is
required for miRNA-guided translational repression in human
cells (Chu & Rana, 2006). Further studies showed that P-bodies are
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formed as a consequence of gene silencing, but their integrity is
not required for gene silencing (Eulalio et al, 2007b).
Here, we report the biochemical identification and isolation of
human Ago1 and Ago2 protein complexes. We identify three distinct
Ago1 and Ago2 complexes, which we refer to as Ago complexes
I–III. Using a comprehensive proteomic approach, we have
identified the protein composition of the Ago complexes. Among
these interactors, we found RBM4 (RNA binding motif protein 4) and
show that it is required for small RNA-guided gene silencing.
RESULTS AND DISCUSSION
Human AGO1 and AGO2 associate with mRNPs
Previously, it has been shown that mammalian Ago proteins and
miRNAs sediment with polyribosomes (Kim et al, 2004; Nelson
et al, 2004; Maroney et al, 2006; Nottrott et al, 2006). In many
studies, however, the majority of Ago proteins and miRNAs
migrate together with messenger ribonucleoproteins (mRNPs; Kim
et al, 2004; Nelson et al, 2004). For a detailed characterization of
Ago protein complexes, we revisited Ago sedimentation in poly-
ribosome fractionations (Fig 1A). Extracts from human embryonic
kidney (HEK) 293 cells were separated on a sucrose gradient
ranging from 17% to 51%. Fractions were analysed by western
blotting against the ribosomal protein S6 (rpS6) to identify
ribosome-containing fractions. RpS6 was detected in fractions
10–12, representing ribosomal subunits as well as monosomes, and
in fractions 14–26, indicative of polyribosomes. Probing with anti-
bodies against AGO1 showed that human AGO1 predominantly
migrated in the fractions with low sucrose density. In addition, a
small portion of AGO1 was found in higher molecular weight
fractions that also contained polyribosomes (fractions 18–24).
To investigate AGO-containing mRNPs, we established gra-
dient conditions that allowed further separation of the mRNP pool
(Fig 1B). HEK 293 cell lysate was loaded onto a 15–55% sucrose
gradient and fractionated by centrifugation for 18 h; AGO proteins
were then analysed as above. Both AGO1 and AGO2 sedimented in
three distinct complexes, which we refer to as AGO complexes I–III.
A large portion of AGO1 or AGO2 was found in complex I, which
has a molecular mass of about 250–350 kDa (lanes 2–7). Complex
II constitutes a second prominent peak, which sediments similarly
to a 19S particle and is about 600–700 kDa in size (lanes 10–13).
Complex III peaks in fractions 15 and 16 are indicative of a
molecular mass of more than 900 kDa or 25–30S (lanes 15,16).
The co-migration of AGO proteins with mRNPs in poly-
ribosome gradients prompted us to investigate whether Ago
complexes I–III contain mRNAs and form mRNPs (Fig 1C). HEK
293 cell lysates preincubated with or without RNase A were
separated as described previously. AGO1 complexes II–III were
clearly visible in the untreated lysates (upper panel), but not in the
RNase-treated extracts (lower panel). Together, our data show that
human AGO1 and AGO2 associate with three distinct RNA–protein
complexes. Furthermore, AGO complexes II and III are sensitive to
RNase treatment, suggesting that these complexes form mRNPs.
AGO complex III co-sediments with the KRAS mRNA
Next, we investigated whether AGO complexes II and III contain
miRNA target mRNAs. We transfected a luciferase reporter
construct carrying the 30-untranslated region (30-UTR) of KRAS
(Kirsten rat sarcoma viral oncogene homologue), which has been
shown to be translationally regulated by let-7a in human cells
( Johnson et al, 2005). Cell lysates were separated on a 15–55%
sucrose gradient. RNA was extracted from individual fractions and
analysed by quantitative reverse transcription–PCR (qRT–PCR;
Fig 1D). Strikingly, we detected high amounts of KRAS mRNA
co-sedimenting with AGO complex III, suggesting that AGO
complex III forms large mRNPs with miRNA target mRNAs.
AGO complexes I–III associate with miRNAs
A detailed molecular characterization of the AGO complexes I–III
requires immunoprecipitations and functional analyses of the
precipitates. As the antibodies used for western blotting proved
to be too inefficient for immunoprecipitation, we recapitulated
AGO protein complex associations using Flag/haemagglutinin
(HA)-tagged AGO proteins (Flag/HA–AGO; Fig 2A). Flag/HA–
AGO1 and Flag/HA–AGO2 were expressed in HEK 293 cells
and the lysates were separated by centrifugation as described
above. Individual fractions were analysed using HA antibodies.
Consistently, the same distinct AGO1 and AGO2 complexes as in
wild-type HEK 293 lysates were observed, indicating that Flag/
HA–AGO1 and Flag/HA–AGO2 associated with native protein
complexes and could therefore be used for further analyses.
As AGO proteins are the binding partners of mature miRNAs, we
analysed the miRNA content of various AGO complexes. HEK 293
lysates containing Flag/HA–AGO1 or Flag/HA–AGO2 were sepa-
rated as described above. Proteins were immunoprecipitated from
each fraction using Flag antibodies, and the associated RNA was
extracted and analysed by semiquantitative RT–PCR for miR-16 or
let-7a (Fig 2B). Notably, both miR-16 and let-7a were found in all
AGO-containing fractions, whereas only weak signals were found
in other fractions (Fig 2B). Together, the three distinct human AGO1
and AGO2 complexes associate with mature miRNAs.
Analysis of AGO-associated RISC and Dicer activity
AGO2 is the endonucleolytic component of human RISC (Liu et al,
2004; Meister et al, 2004); therefore, we investigated which of the
observed AGO2 complexes associates with RISC activity. Lysate
from HEK 293 cells transfected with Flag/HA–AGO2 was fractio-
nated and immunoprecipitated as described above. Individual
immunoprecipitates were incubated with a 32P-cap-labelled RNA
complementary to endogenous miR-19b (Fig 2C). Fractions 3–6, as
well as the total lysate, showed strong cleavage activity, whereas no
cleavage activity was observed in higher molecular weight fractions,
indicating that AGO2 complex I represents active human RISC.
It has been shown that human AGO proteins associate stably
with Dicer and that this complex is able to generate small RNAs
from dsRNA precursors (Gregory et al, 2005; Meister et al, 2005).
Therefore, we tested individual AGO complexes for Dicer activity.
HEK 293 lysates containing Flag/HA–AGO1 were fractionated and
immunoprecipitated using Flag antibodies. The immunoprecipi-
tates were incubated with an internally 32P-labelled miR-27a
precursor and the cleavage products were analysed by 15%
denaturing RNA polyacrylamide gel electrophoresis (Fig 2D).
AGO1 complex I (fractions 3–7) and AGO1 complex III (fractions
15–17) were associated with Dicer activity, whereas only very
weak Dicer activity was observed in AGO1 complex II (fractions
10–13). Together, we have shown AGO2 complex I is a low-
molecular-weight RISC, whereas AGO complexes I and III are
associated with Dicer. Interestingly, AGO complex II does not
contain RISC and shows little detectable Dicer activity.
Characterization of human Argonaute complexes
J. Ho¨ck et al
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Proteomic analysis of AGO complexes I–III
We analysed the protein composition of AGO complexes I–III to
identify cofactors that function together with AGO1 or AGO2. Flag/
HA–AGO1 or Flag/HA–AGO2 was transiently expressed in HEK 293
cells, and the lysates were separated by gradient centrifugation.
Fractions 3–8, 10–13 and 15–18, representing AGO complexes I, II
and III, respectively, were combined and AGO complexes were
immunoprecipitated using Flag antibodies. The co-immunoprecipi-
tated proteins were analysed using mass spectrometry (supplemen-
tary Fig 1 online). Antibodies that were not specific to the Flag tag
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Fig 1 | Human AGO1 and AGO2 associate with distinct protein–RNA complexes. (A) Individual fractions of polyribosome gradients were analysed by
western blotting against endogenous AGO1 (upper panel) or rpS6 (lower panel). (B) Lysates from wild-type HEK 293 cells were separated by sucrose
density centrifugation under conditions that allow the separation of mRNPs. Endogenous AGO1 and AGO2 were analysed using specific antibodies.
(C) Lysates were analysed as in (B). Lysates shown in the lower panel were treated with 100mg/ml RNase A before centrifugation. (D) A reporter
construct containing the KRAS 30-UTR was transfected into HEK 293 cells and lysates were separated as in (B). Total RNA was extracted from the
individual fractions and analysed by qRT–PCR. The distribution of the KRAS 30-UTR is shown as a percentage of the total amount of the KRAS 30-UTR.
AGO, Argonaute; HEK, human embryonic kidney; KRAS, Kirsten rat sarcoma viral oncogene homologue; mRNPs, messenger ribonucleoproteins;
qRT–PCR, quantitative reverse transcription–PCR; rpS6, ribosomal protein S6; 30-UTR, 30-untranslated region.
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were used for control purifications (supplementary Fig 2 online).
After investigating only a few visible bands in our previous study
(Meister et al, 2005), our aim was now to analyse all proteins that
were present in the AGO immunoprecipitates. Table 1 shows a list of
proteins that were specifically found in AGO precipitations, but not
in control purifications (see also the supplementary tables online).
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Table 1 | Proteins associated with human AGO1 and AGO2
Name Domains/motif AGO1 complex AGO2 complex Accession no.
Proteins involved in gene silencing
Dicer DEAD box, RNase III, PAZ, dsRBD, DUF I, III I, III* gi|21665773/gi|5019620
TNRC6B RRM — I gi|14133235
MOV10 DExH box III III gi|14424568
TRBP dsRBD I* I* gi|107904
Gemin3 DEAD box II* gi|14209614
Gemin4 Leucin zipper II*, III II, III gi|7657122
DEAD/DEAH box-containing proteins
RNA helicase A (RHA)/DHX9 DEAH box, helicase domain, dsRBD, DUF1605 II, III II, III gi|1806048/gi|1082769
DHX30 DEAH box, helicase domain, dsRBD, DUF1605 II, III II, III gi|20336294
RENT1/Upf1 DEAD box, exoV III — gi|1575536
DHX36 DEAH box, helicase domain, DUF1605 II*, III* II* gi|7959237/gi|23243423
DDX21/RNA helicase GuA DEAD box, helicase domain, GUCT II, III II gi|2135315
DDX50/RNA helicase GuB DEAD box, helicase domain, GUCT, RESIII III — gi|55664207
DDX46 DEAH box, helicase domain, DUF1605 II* II* gi|2696613
DDX48 DEAD box, helicase domain II*, III — gi|496902
DDX18 DEAD box, helicase domain III — gi|1498229
DDX5/p68 DEAD box, helicase domain — II*
DDX39/BAT1 DEAD box, helicase domain III* II* gi|1905998
DDX47 DEAD box, helicase domain, apolipoprotein L III — gi|20149629
Heterogeneous nuclear ribonucleoprotein particles
hnRNP-U SAP, SPRY, SCOP II, III II, III gi|32358
hnRNP-U-like SAP, SPRY, SCOP I* — gi|3319956
hnRNP-H2/H’ RRM, RNPHF zinc finger II* — gi|6065880
hnRNP-F RRM, RNPHF zinc finger II* I* gi|16876910
hnRNP-C RRM II, III II, III gi|13937888/gi|14250048
hnRNP-E2 KH1, KH2 III* —
NSAP1 Phox-like, PX-associated motif, RRM II, III — gi|5031512
hnRNP-L Enoyl-CoA hydratase/isomerase, RRM III* — gi|11527777
Messenger RNA-binding proteins
Poly-A-binding proteins RRM II, III II, III gi|46367787/gi|693937
Nuclear cap-binding protein 80 kDa MIF4G III — gi|3153873
YB-1 Cold-shock domain II II, III gi|181486/gi|55451
FMRp Agenet, KH1 III* — gi|182673
FXR1 Agenet, KH1 — III gi|1730139
FXR2 Agenet, KH1 III — gi|4758410
ZBP-1 RRM, KH1 II, III III gi|7141072/gi|56237027
ZBP-3 RRM, KH1 III — gi|30795212
HuR RRM III* — gi|1022961
RBM4 RRM, zinc finger — III* gi|4506445
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As expected from the Dicer activity assays, we found Dicer
only in AGO1/2 complexes I and III, whereas TRBP was identified
only in AGO complex I. TNRC6B, MOV10, RHA (DEAH box
polypeptide 9), Gemin3 and Gemin4, which have been found
in AGO complexes previously (Mourelatos et al, 2002; Meister
et al, 2005; Robb & Rana, 2007), were also among the identified
proteins. Proteins that have not yet been implicated in RNA
silencing in mammals were grouped according to their domains
and function (Table 1). Among the DEAD/DEAH box helicases,
we found DDX5, an orthologue of Drosophila p68, which has
been shown to associate with Drosophila Ago2 (Meister & Tuschl,
2004), and DDX18, a putative helicase that has been implicated
in Drosha function (Gregory et al, 2004). Consistent with the
hypothesis that AGO complexes II and III are mRNPs, we found
various isoforms of poly-A-binding proteins, indicating that
mRNAs were present in the purifications. Strikingly, we found
many mRNA-binding proteins that are involved in translational
regulation, including FMRp and its homologues FXR1 and FXR2. It
was reported previously that FMRp associates with Ago proteins as
well as miRNAs in both human and Drosophila cells (Meister &
Tuschl, 2004). Further identified proteins with regulatory functions
in translation are NSAP1/SYNCRIP, YB-1, HuR, RBM4, ZBP1 and
ZBP3. We also found various ribosomal proteins in the Ago
complexes (supplementary tables online), suggesting that ribosomal
proteins might have other functions as components of mRNPs.
Next, using western blotting, we examined whether the
identified factors specifically co-sediment with AGO-containing
fractions in sucrose gradients (Fig 3A). Consistent with the
proteomic data, hnRNP-U, NF-90, ZBP1 and ZBP3 co-migrated
with both AGO complexes II and III, whereas TRBP was
found in low-molecular-weight fractions co-migrating with AGO
complex I; however, NF-45 and YB-1 were detected in fractions
containing AGO complex III. For a more comprehensive analysis,
we expressed Flag/HA-tagged DDX47, DDX36, DDX30, RHA
(DHX9), hnRNPC, HuR as well as SART3 and investigated co-
sedimentation with AGO proteins. All tagged proteins migrated
in fractions also containing AGO complexes II and III. Notably,
we found a larger portion of the tagged proteins migrating at the
top of the gradient, presumably owing to overexpression.
To validate a specific association with AGO complexes,
we carried out co-immunoprecipitations (Fig 3B) and Flag/HA–
AGO1 or Flag/HA–AGO2 was immunoprecipitated from HEK 293
lysates using Flag antibodies. RNase A-treated and untreated
samples (supplementary Fig 3 online) were analysed using western
blotting. HnRNP-C1/C2, ZBP1, ZBP3 and YB-1 disappeared from
the Flag/HA–AGO1/2 immunoprecipitates when RNase A was
added, indicating that the tested proteins were not associated with
AGO proteins through protein–protein interactions, but bound to
the same RNAs. NF-90, SART3, DDX5 and DDB-1 immuno-
precipitated with Flag/HA–AGO1/2 in the presence of RNase A,
Table 1 | Continued
Name Domains/motif AGO1 complex AGO2 complex Accession no.
Proteins involved in RNA metabolism
NF90/ILF3/NFAR-1 dsRBD, DZF II, III II gi|1082856/gi|5006602
NF45/ILF2 DZF II, III II, III gi|532313
SART3 Lsm interaction motif, RRM I, II, III — gi|7661952
RBM10 D111/G-patch, RRM, zinc finger, Ran binding — I*, II* gi|12644371
Fibrillarin Fibrillarin motif — II*, III* gi|182592
NOP56 Pre-mRNA processing RNP, NOP5NT, NOSIC III — gi|2230878
Nucleolin RRM III — gi|128841
eIF2bd Initiation factor 2B I* — gi|6563202
eIF4b RRM — I* gi|288100
FLJ20758 Pentatricopeptide repeat II II gi|38683855
Other proteins
Myb-binding protein 1a DNA polymerase V III III* gi|7657351
Matrin 3 RRM, zinc finger III* III* gi|6563246
Motor protein — II, III gi|516764
ZNF326 AKAP95 II, III — gi|31807861/gi|47125447
Ku70 Ku70/80 motif, DNA-binding SAP — II* gi|57165052
DDB1 CPSF A subunit I I* gi|418316
RuvB-like II AAA ATPase, Tip49b I I, II gi|5730023/gi|12653319
Coatomer protein WD-40, COPB2 III II gi|1002369
*Identified by a single peptide.
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which is indicative of protein–protein interactions. To analyse a
specific AGO association of mRNP components for which no
specific antibodies were available, we expressed Flag/HA-tagged
fusions (Fig 3C). The tagged proteins were immunoprecipitated
using Flag antibodies and the precipitates were analysed by
western blotting using HA (lanes 1–33, lower panel), AGO1
(upper panel) or AGO2 (middle panel) antibodies. Endogenous
AGO1 and AGO2 clearly co-precipitated with all Flag/HA-tagged
proteins (lanes 1–33). The binding of DDX30, HuR, RBM4,
hnRNP-F, PABP-C1 and Matrin3 to AGO1 and AGO2 complexes
was sensitive to RNase A treatment, whereas the binding of
DDX36, DDX47, RHA and UPF1/RENT1 was not, suggesting
protein–protein interactions.
RBM4 is required for miRNA-guided gene silencing
To investigate the relevance of identified AGO mRNP components
for miRNA function, we generated a luciferase construct containing a
perfectly complementary miR-21 target site in the 30-UTR (Fig 4A). As
expected, knockdown of AGO1, AGO3 and AGO4 had no effect,
whereas siRNAs against AGO2 or TNRC6B led to a significant
increase of luciferase expression. No effect was observed with a
mutated miR-21-binding site (supplementary Fig 4 online). Strikingly,
knockdown of RBM4 resulted in a strong increase of luciferase
activity, indicating that RBM4 modulates miR-21-guided RNA
cleavage. Notably, the interaction of RBM4 and AGO2 is reduced
when RNase A is added (Fig 3C). It is reasonable to assume that
miRNA degradation by RNase A affects AGO2 interactions.
Alternatively, RBM4 could also enhance the binding of AGO proteins
to mRNAs by increasing the accessibility of miRNA target sites.
Next, we analysed whether RBM4 is also required for the
regulation of natural miRNA targets (Fig 4B). A luciferase construct
containing the KRAS 30-UTR was transfected into HEK 293 cells
in which let-7a was inhibited or TNRC6B, YB-1, RBM4, ZBP3 or
FMRp was depleted by RNA interference. Knockdown of
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Fig 3 | Proteins identified by mass spectrometry interact with Argonaute complexes. (A) HEK 293 cell extracts were separated by gradient
centrifugation and fractions were analysed by western blotting against the proteins indicated to the left (upper panels). HEK 293 cells were transiently
transfected with Flag/HA-tagged expression constructs as indicated to the left and analysed by western blotting using HA antibodies. (B) HEK 293 cells
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TNRC6B, RBM4, YB-1 and ZBP3 resulted in stronger luciferase
activity. Overexpression of RBM4 but not ZBP3 led to decreased
luciferase activity (supplementary Fig 6 online), suggesting that
RBM4 functions on the 30-UTR of KRAS.
Recently, hmga2, serbp, dnajb11 and raver2 have been identi-
fied and validated as miRNA targets (Beitzinger et al, 2007; Mayr
et al, 2007). Therefore, we transfected luciferase reporter con-
structs containing the respective 30-UTRs and measured luciferase
activity in an RBM4- or TNRC6B-knockdown background
(Fig 4C). Indeed, luciferase activity was significantly increased in
the RBM4- or TNRC6B-knockdown cells, indicating that RBM4
functions on different miRNA targets. As RBM4 contains two RNA
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recognition motifs (Fig 4D), we investigated whether RBM4 co-
immunoprecipitates with miRNAs (Fig 4E). Flag/HA–RBM4 was
immunoprecipitated using Flag antibodies and the associated
RNA was extracted. Strikingly, miR-19b was detected in the Flag/
HA–RBM4 precipitate, whereas no miR-19b was precipitated
in a control reaction.
Our data indicate that RBM4 co-immunoprecipitates with
miRNAs and functions in AGO-mediated gene silencing; therefore,
we have identified a new component of human gene silencing.
METHODS
Cell extracts and gradient centrifugation. Polyribosome fractio-
nation from HEK 293 cells was carried out according to Pillai et al
(2005). For complex purification and co-immunoprecipitations,
HEK 293 cells were lysed in buffer containing 25 mM Tris–HCl (pH
7.4), 150 mM KCl, 0.5% NP-40, 2 mM EDTA, 1 mM NaF, 0.5 mM
dithiothreitol and protease inhibitors (Roche, Penzberg, Germany)
and centrifuged at 10,000g for 10 min at 4 1C. For fractionations,
gradients from 15% (w/v) to 55% (w/v) sucrose in 150 mM KCl,
25 mM Tris (pH 7.4) and 2 mM EDTA were used. Lysates were
separated by centrifugation at 30,000 r.p.m. for 18 h in an SW41
rotor at 4 1C. To determine indicated S values, catalase (11S),
apoferritin (17S) and thyroglobin (19S) were used. For the analysis
of RNA-dependent interactions, extracts were preincubated with
100mg/ml RNase A (Qiagen, Hilden, Germany) at 4 1C for 1 h.
Immunoprecipitation of Flag/HA-tagged AGO complexes. AGO-
containing gradient fractions were pooled and incubated with
100 ml Flag M2 agarose beads (Sigma, Taufkirchen, Germany) for
2 h at 4 1C. Beads were subsequently washed with immuno-
precipitation buffer (300 mM NaCl, 5 mM MgCl2, 0.1% NP-40 and
50 mM Tris–HCl, pH 7.5) and phosphate-buffered saline (PBS).
Co-immunoprecipitation experiments. Lysates were incubated
with 30 ml Flag M2 agarose at 4 1C for 1.5 h, and washed with IP
buffer and PBS. Beads were distributed equally into two tubes and
1.5 ml PBS or PBS containing 100 mg/ml RNase A was added. After
incubation at 4 1C for 1.5 h, beads were washed with PBS and
denatured by adding 25ml of protein sample buffer.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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Strand-specific 59-O-methylation of siRNA duplexes
controls guide strand selection and targeting specificity
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ABSTRACT
Small interfering RNAs (siRNAs) and microRNAs (miRNAs) guide catalytic sequence-specific cleavage of fully or nearly fully
complementary target mRNAs or control translation and/or stability of many mRNAs that share 6–8 nucleotides (nt) of
complementarity to the siRNA and miRNA 59 end. siRNA- and miRNA-containing ribonucleoprotein silencing complexes are
assembled from double-stranded 21- to 23-nt RNase III processing intermediates that carry 59 phosphates and 2-nt overhangs
with free 39 hydroxyl groups. Despite the structural symmetry of a duplex siRNA, the nucleotide sequence asymmetry can
generate a bias for preferred loading of one of the two duplex-forming strands into the RNA-induced silencing complex (RISC).
Here we show that the 59-phosphorylation status of the siRNA strands also acts as an important determinant for strand selection.
59-O-methylated siRNA duplexes refractory to 59 phosphorylation were examined for their biases in siRNA strand selection.
Asymmetric, single methylation of siRNA duplexes reduced the occupancy of the silencing complex by the methylated strand
with concomitant elimination of its off-targeting signature and enhanced off-targeting signature of the phosphorylated strand.
Methylation of both siRNA strands reduced but did not completely abolish RNA silencing, without affecting strand selection
relative to that of the unmodified siRNA. We conclude that asymmetric 59 modification of siRNA duplexes can be useful for
controlling targeting specificity.
Keywords: RNA interference; RNAi; off-target effects; gene silencing; siRNA; RISC
INTRODUCTION
Duplexes of 21-nucleotide (nt) small interfering RNAs
trigger RNA interference (RNAi) in mammalian cells and
are widely used for functional genetic studies or screens
in cultured cells (for reviews, see Dorsett and Tuschl
2004; Echeverri and Perrimon 2006; Fuchs and Boutros
2006; Root et al. 2006; Krausz 2007). siRNA duplexes
are designed to mimic the RNase III processing intermedi-
ates of naturally expressed dsRNAs, such as miRNAs, to
effectively enter the RNAi pathway (for reviews, see Bartel
2004; Meister and Tuschl 2004; Filipowicz et al. 2005;
Tomari and Zamore 2005). Naturally processed siRNAs or
miRNAs carry 59 phosphates and 39-hydroxyl groups and
have symmetric 2-nt 39 overhangs (Elbashir et al. 2001; Lau
et al. 2001). Synthetic siRNA duplexes with 59-hydroxyl
ends are rapidly phosphorylated inside cells by the cellular
kinase Clp1 (Weitzer and Martinez 2007). Some classes of
small RNAs are additionally 29-O-methylated at their 39
ends, depending on the species (Ebhardt et al. 2005; Yu
et al. 2005; Vagin et al. 2006; Horwich et al. 2007; Kirino
and Mourelatos 2007; Ohara et al. 2007; Pelisson et al.
2007; Saito et al. 2007). Mammalian miRNAs or siRNAs
are not methylated, but the germline-specifically expressed
piRNAs are 39-end modified (Kirino and Mourelatos 2007;
Ohara et al. 2007).
One strand of the siRNA duplex or miRNA/miRNA*
molecule is assembled into an effector complex or RISC,
while the other strand is degraded during the assembly
process (Hutva´gner and Zamore 2002; Martinez et al.
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2002a). The effector complex contains at its heart an
Ago/PIWI protein member (Hammond et al. 2001;
Martinez et al. 2002a). Ago/PIWI proteins contain a
conserved Piwi-Argonaute-Zwille (PAZ) and PIWI domain
(for reviews, see Carmell et al. 2002; Peters and Meister
2007). The PAZ domain, which is also present in Dicer,
specifically binds the characteristic 2-nt 39 overhangs of
RNase-III-processed dsRNAs (Song et al. 2003; Yan et al.
2003; Lingel et al. 2004; Ma et al. 2004). The PIWI domain
contains a RNA 59-phosphate binding (MID domain) and
a RNase H domain (Parker et al. 2004, 2005; Song et al.
2004; Ma et al. 2005; Rivas et al. 2005; Yuan et al. 2005,
2006; Song and Joshua-Tor 2006). The MID domain
anchors the 59 end of the guide small RNAs (Ma et al.
2005; Parker et al. 2005; Rivas et al. 2005), and presumably
also plays a role during RISC-loading by receiving and
binding the guide strand 59 phosphate (Nyka¨nen et al.
2001).
Protein factors critically involved in siRNA or miRNA
silencing complex assembly were first identified in Dro-
sophila melanogaster. Duplex siRNAs are recognized by the
heterodimer of RNase III Dcr-2 and the dsRNA-binding-
domain protein R2D2, both of which are critical for
formation of the Ago2-containing RISC (Liu et al. 2003,
2006). miRNA maturation in D. melanogaster is catalyzed
by a heterodimeric complex of RNase III Dcr-1 and
the dsRNA-binding-domain protein Loquacious/R3D1
(Fo¨rstemann et al. 2005; Jiang et al. 2005; Saito et al.
2005). R2D2 preferably binds the thermodynamically more
stable end of the siRNA duplex and thereby directs strand
selection (Tomari et al. 2004b). The assembly of RISC is
ATP dependent, at least to a certain degree (for reviews, see
Filipowicz 2005; Preall and Sontheimer 2005). In mamma-
lian systems, Dicer, the dsRNA-binding proteins TARBP2
and/or PACT, and an Ago protein appear to form the
RISC-loading complex (Chendrimada et al. 2005; Gregory
et al. 2005; Haase et al. 2005; Maniataki and Mourelatos
2005; Lee et al. 2006).
Two pathways are known for the transition of the
duplex siRNAs or miRNA/miRNA* processing intermedi-
ate into a single-stranded RNA-containing effector complex
(Matranga et al. 2005; Rand et al. 2005; Leuschner et al.
2006). The first pathway requires near-perfect base-pairing
of the small RNA strands and depends on the RNase H
activity intrinsic to a subset of the siRNA-binding Ago
proteins (Liu et al. 2004; Meister et al. 2004; Parker
et al. 2004, 2005; Rand et al. 2004; Song et al. 2004; Ma
et al. 2005; Miyoshi et al. 2005; Rivas et al. 2005; Yuan et al.
2005). RNase H active Ago proteins are able to receive the
duplex siRNAs and guide the cleavage of the nonretained
siRNA strand (often referred to as passenger, nonguide,
or sense siRNA) (Matranga et al. 2005; Rand et al. 2005;
Leuschner et al. 2006). Upon release of the cleavage pro-
ducts, the retained guide (or anti-sense) siRNA is able
to recognize complementary or partially complementary
mRNA targets. The second RISC loading pathway is used,
when duplex siRNA or miRNA/miRNA* duplexes either
encounter a RNase-H-deficient Ago protein member or
when the duplexes are imperfectly paired across the center
and cleavage site (like most miRNA/miRNA* duplexes),
thereby preventing RNase H cleavage (Matranga et al. 2005).
Presumably, a RNA helicase activity residing or transiently
associating with the RISC-loading complex catalyzes the
second RISC loading process (Tomari et al. 2004a; Meister
et al. 2005; Robb and Rana 2007).
The duplex-initiated RISC assembly process appears
to be bypassed if high concentrations of single-stranded
siRNAs are added to cell lysates or transfected into cells
(Martinez et al. 2002a). The role and the requirement for a
59 phosphate in reconstituting RISC and its activity, how-
ever, remained somewhat controversial (Liu et al. 2004;
Song et al. 2004; Ma et al. 2005).
The specificity of small-RNA-guided mRNA degradation
was examined in detail including mRNA array analysis
(Jackson et al. 2003; Lin et al. 2005; Birmingham et al. 2006;
Jackson et al. 2006b). These studies revealed ‘‘off-targeting’’
activities of siRNAs that could not be separated from
the ‘‘on-targeting’’ activity by simply decreasing the siRNA
concentration. Some of the off-targets contained sequence
segments of extensive complementarity to the siRNA, but
many other off-targets showed only partial complementarity
within their 39-untranslated region (UTR) to the siRNAs,
notably at the 59 end of the siRNA guide strand. The latter
observation was reminiscent of miRNA ‘‘seed’’ sequence
(comprising positions 1–8) mediated target mRNA regula-
tion (Lai 2002; Lewis et al. 2003; Stark et al. 2003; Rajewsky
and Socci 2004; Lim et al. 2005; Linsley et al. 2007). Off-
target signatures can be identified for both the sense and
the anti-sense siRNA strands, although strand biases during
the assembly of RISC affect the targeting efficiencies of the
two strands (Khvorova et al. 2003; Schwarz et al. 2003). In
selecting siRNA sequences one takes now into consideration
the differential thermodynamic stability of the siRNA ends
to favor the incorporation of the target mRNA comple-
mentary guide siRNA (for review, see Pei and Tuschl 2006).
Other strategies proposed to control off-targeting activities
included the introduction of 29-O-methyl-ribose residues
into the seed sequences of the siRNAs, which reduces off-
targeting without detectable drop in on-targeting (Jackson
et al. 2006a).
Here we study the role of the 59-terminal phosphate
during RISC assembly from duplex and single-stranded
siRNAs using 59-O-methyl-modified siRNAs. We show that
the 59-phosphorylation status within a duplex siRNA is an
important determinant of strand incorporation into RISC,
and we demonstrate that selective 59-O-methylation can be
used to control strand-specific off-targeting activity. The
phosphorylation status of single-stranded siRNAs has little
impact on the nonnatural RISC assembly and the sub-
sequent activity of RISC.
Chen et al.
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RESULTS
59 phosphates are required for reconstitution of RISC
from double-stranded but not single-stranded siRNAs
To revisit the requirements for 59 phosphates described
for reconstituting RISC in D. melanogaster (Nyka¨nen et al.
2001) or human cell lysates (Martinez et al. 2002a; Liu et al.
2004; Song et al. 2004; Ma et al. 2005), we prepared single-
and double-stranded siRNAs with uridine and thymidine
59-end modifications (Fig. 1A). 59-O-methyl-thymidine is
currently the only nucleotide readily available for solid-phase
synthesis to render the ribose 59 ends of siRNAs refractory
to phosphorylation in cell lysates (Nyka¨nen et al. 2001).
HeLa cells and lysates contain hClp1 kinase, which rapidly
phosphorylates 59-hydroxyl termini of dsRNA or dsDNA
as well as single-stranded RNA (Martinez et al. 2002a;
Weitzer and Martinez 2007). To control for the concomitant
introduction of a 5-methyl group with 29-deoxythymidine
incorporation into RNA, we also prepared siRNAs with
59-hydroxyl-29-deoxythymidine, 59-hydroxyl-uridine, and
59-phosphorylated uridine-containing siRNAs.
HeLa S100 cell lysates were incubated with double-
stranded siRNA derivatives followed by addition of 59
32P-labeled complementary target mRNA segments. Irre-
spective of the modification of the sense (passenger) strand,
59-hydroxyl- or 59-phosphate-modified anti-sense strands
mediate target RNA cleavage. In contrast, 59-O-methylated
anti-sense siRNA showed substantially reduced activity
(Fig. 1B). The siRNA duplexes were cognate to firefly luci-
ferase (Pp-luc) mRNA, and they were cotransfected with
plasmids encoding the Pp-luc target and sea pansy control
luciferase (Rr-luc) genes into HeLa cells. Consistent with
the biochemical results, only the duplex with 59-O-methyl-
modified anti-sense strand showed reduced silencing ac-
tivity (Fig. 1C). Together, these observations were pointing
to a role of the 59 phosphate of the anti-sense strand during
RISC loading or RISC activity.
Two possibilities can be envisioned responsible for the
reduced silencing activity of 59-O-methylated anti-sense
strand duplex siRNAs: (1) loading of the anti-sense strand
into RISC was compromised, and/or (2) the anti-sense
strand-loaded RISC had reduced activity because of con-
formational restraints imposed by an unoccupied Ago2
59-phosphate binding pocket (Liu et al. 2004; Ma et al.
2005; Parker et al. 2005; Rivas et al. 2005). We therefore
tested if we were able to load RISC using the single-
stranded anti-sense siRNAs. Because single-stranded siRNAs
are more susceptible to nucleases present in cell lysates
than duplex siRNAs, we immunopurified FLAG/HA-affinity-
tagged Ago2 protein complexes from HEK 293 cell lysates,
and subsequently incubated them with single-stranded
siRNAs and target RNA substrate. Surprisingly, the single-
stranded siRNAs reconstituted RISC activity irrespective of
their 59 modification status (Fig. 1D).
These data suggest that the 59 phosphate plays an
important role during the process of RISC loading, that
a 59-phosphate-sensing mechanism can be bypassed using
single-stranded siRNAs, and that the Ago2 59-phosphate
binding pocket does not need to be occupied to mediate
target mRNA cleavage.
FIGURE 1. 59 phosphates are required for reconstitution of RISC
from double-stranded but not single-stranded siRNAs. (A) Schematic
presentation of the luciferase duplex siRNAs used in B and C. (B)
HeLa S100 extract was incubated with the siRNAs shown in A. After
preincubation, a 32P-cap-labeled RNA substrate was added, and the
cleaved RNA fragments were analyzed on a denaturing sequencing gel.
T1 refers to partial nuclease T1 digestion of the target RNA. The black
line to the left indicates the segment of the target RNA covered by the
used siRNAs. (C) The effect of duplexes 1–5 and a control siRNA
duplex on inhibition of the firefly luciferase (Pp-luc) expression
relative to Renilla luciferase (Rr-luc) in a dual-luciferase assay. The
ratios of the signals of Pp-luc/Rr-luc for duplexes 1–5 were normalized
to that of the control siRNA. The plotted data were averaged from
three independent experiments 6SD. (D) FLAG/HA-tagged Ago2 was
transiently transfected into HEK 293 cells. Tagged proteins were
immunoprecipitated from the lysates using anti-FLAG beads, and
RISC activity was reconstituted by adding single-stranded siRNA
against the luciferase mRNA either with a 59 phosphate (lane 1),
without a 59 phosphate (lane 2), with a 59-hydroxyl-29-dT (lane 3), or
with a 59-methoxy-29-dT (lane 4). The beads were subsequently
incubated with a 32P-cap-labeled RNA substrate and analyzed by
denaturing RNA-PAGE followed by phospho-imaging. T1 refers to
partial nuclease T1 digestion of the luciferase target RNA. p indicates
59 phosphate; Me, 59-O-methyl group.
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Asymmetric 59-O-methylation of duplex siRNAs
directs strand selection during RISC formation
The loss of silencing activity of duplex siRNAs in which
only the anti-sense strand was 59-O-methyl-modified could
be due either to preferential loading of the sense strand into
RISC under these conditions or to a defective recognition
of the siRNA duplex by some RNAi machinery protein at a
stage prior to RISC assembly. To monitor the asymmetry of
siRNA strand incorporation and target RNA cleavage, we
synthesized two pairs of siRNA duplexes that were pre-
dicted to be symmetrically and asymmetrically incorpo-
rated into RISC based on the differences in thermodynamic
stability at their duplex termini (Khvorova et al. 2003;
Schwarz et al. 2003).
We first characterized biochemically the symmetric
siRNA duplex (Fig. 2A) by incubating it in lysates from
HEK 293 cells transiently transfected with FLAG/HA-
affinity-tagged Ago2. HEK 293 cells were chosen because
they are efficiently transfected at large scale with FLAG/
HA-Ago2 expression plasmids. The siRNAs that coimmu-
noprecipitated with FLAG/HA-Ago2 were analyzed by
Northern blotting using probes complementary to either
the anti-sense or the sense strand. Signals for the anti-sense
strand were detected when the siRNA duplex contained
FIGURE 2. siRNA 59-O-methylation inhibits RISC loading and RISC activity. (A) Schematic presentation of the symmetric RISC loading siRNA
duplexes used in B, C, D, and E. (B) FLAG/HA-Ago2 and FLAG/HA-EGFP were transiently transfected into HEK 293 cells. Cell lysates were
preincubated with siRNA duplexes allowing for RISC loading. RISCs were immunoprecipitated using anti-FLAG antibodies, and the precipitated
proteins were analyzed using anti-HA antibodies (lower panel). Ig indicates the heavy chain of the immunoglobulin. The bound siRNA strands
were examined by Northern blotting (upper panel). (C) HeLa cell extracts were preincubated with the indicated siRNA duplexes allowing for RISC
loading. Control (Ctrl) refers to luciferase siRNA duplex. 32P-cap-labeled substrates either complementary to the sense strand or the anti-sense
strand were subsequently added and the cleaved RNA products were analyzed by 4% denaturing RNA PAGE. T1 indicates digestion of the
substrate using nuclease T1. The bar to the left of the image indicates the sequence of the substrate RNA, which is complementary to the used
siRNAs. (D) 59-O-methylated siRNAs inhibits RNAi in living cells. Plasmids encoding EGFP, EGFP fused to a complementary target site for the
anti-sense strand or EGFP fused to a complementary target site for the sense strand were cotransfected with control (ctrl), luciferase siRNAs, or
the indicated siRNA duplex. A plasmid encoding the DS Red gene was cotransfected and served as a transfection control. (E) Plasmids containing
either a Pp-luciferase gene fused to a complementary target site for the anti-sense strand or a complementary target site for the sense strand of the
siRNA were cotransfected with Rr-luciferase and the indicated siRNAs. GFP siRNA was utilized as control (ctrl) siRNA. The Pp-luc/Rr-luc ratios
were normalized to that of the control siRNAs.
Chen et al.
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unmodified or 59-O-methyl sense strand but not when the
anti-sense strand was 59-O-methylated (Fig. 2B). Signals for
the sense strand were detected when the siRNA duplex
contained unmodified or 59-O-methyl anti-sense strand
but not when the sense strand was 59-O-methylated (Fig.
2B). We then confirmed that symmetrically or asymmetri-
cally loaded FLAG/HA-Ago2 immunoprecipitates cleaved
siRNA-complementary 32P-cap-labeled target RNAs (Tuschl
et al. 1999) as expected from their strand-loading ratios
determined by Northern blotting (Fig. 2C).
To measure the cell-based silencing activities from the
assembly of the anti-sense and the sense siRNA strand into
RISC, we introduced anti-sense and sense-complementary
sequence segments into the 39 UTR of EGFP as well as
Pp-luc reporters. The results were consistent with our
biochemical observations in HEK 293 lysates (Fig. 2D,E).
Symmetric 59-O-methylation of both siRNA strands lead to
an overall reduced gene silencing activity in the luciferase
reporter assay, without changing the symmetry of the
residual cleavage activity when compared with the unmod-
ified siRNA duplex. In contrast, a single asymmetric
modification did not alter the activity attributable to the
unmodified siRNA strand. Together, these observations
indicate that the RISC assembly of symmetrical siRNA
duplexes can be influenced using asymmetric 59-O-meth-
ylation, whereby the methylation of one strand directs
incorporation of the complementary strand into RISC.
We next evaluated whether strand selection of a ther-
modynamically asymmetrical siRNA duplex could be con-
trolled by 59-O-methylation (Fig. 3A). The activities of the
modified and unmodified siRNA duplexes were determined
using the EGFP and luciferase reporter assay described
above (Fig. 3B,C). The unmodified siRNA duplex prefer-
entially repressed the target complementary to the sense
strand, as expected from the design of the siRNA. The 59-
O-methylation of the anti-sense siRNA reduced its cleavage
activity about twofold. Reciprocally, 59-O-methylation of
the sense siRNA strand reduced its cleavage activity two-
fold, while the anti-sense strand cleavage activity was
significantly increased. Similar to the observations made
for the symmetric siRNA duplex above, double 59-O-
methylation weakened the silencing activity of both the
anti-sense and sense strands. These observations indicate
that 59-O-methylation of siRNA strands can influence
siRNA strand incorporation into RISC, even in the context
of a thermodynamically asymmetric siRNA.
Strand-specific 59-O-methylation also controls siRNA
off-targeting activity
Off-target effects are, like on-target effects, strictly
sequence-specific and caused either by near-perfect com-
plementarity between the central region of the siRNA and
its targets or by seed-sequence complementarity between
the siRNA and the target 39 UTR (Jackson et al. 2003,
2006b; Birmingham et al. 2006). To assess if strand
selection from asymmetrically 59-O-methylated siRNA
duplexes could be used for controlling siRNA off-targeting
activity, we determined the gene expression profiles of HeLa
FIGURE 3. siRNA 59-O-methylation inhibits RISC loading and
RISC activity. (A) Schematic presentation of the asymmetric RISC
loading siRNA duplexes used in B and C. (B) The same experiments
and controls described in Figure 2D were carried out using the
asymmetrically RISC loading siRNAs duplex as well as complemen-
tary EGFP target constructs. (C) The same experiments and controls
described in Figure 2E were performed using the asymmetrical RISC
loading siRNAs.
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cells transfected with 59-O-methylated or unmodified siRNA
duplexes. The symmetrical siRNA duplex, whose both
sense and anti-sense strands are incorporated into RISC,
was selected for the analysis (Fig. 2A).
The choice of cell line and transfection reagents was
critical for identifying siRNA-strand-specific off-targets.
We first tested Lipofectamine 2000 Transfection Reagent
(Invitrogen) in HEK 293 cells, but variations in gene
expression, caused presumably by mild toxicity of the
formulated transfection reagent, made it impossible to
detect siRNA-sequence-dependent off-target signatures.
Next, we tested Lipofectamine RNAiMAX transfection
reagent (Invitrogen) in HEK 293 cells. Though the siRNA
and mock transfection yielded reproducible and stable
expression profiles, we did not detect any off-targeting
signature using either Affymetrix or Agilent mRNA micro-
arrays (data not shown). Finally, we examined HeLa cells
transfected with Lipofectamine RNAiMAX using Affymetrix
microarrays, and we were able to identify the expected
off-targeting effects. Using the same approach, we also
detected the previously reported off-targets of a siRNA
duplex targeting the PIK3CB gene (PIK3CB-6340) (Jackson
et al. 2006b), indicating that our Affymetrix array platform
was sufficiently sensitive for off-target analysis in this cell
type.
The off-target effects were quantified by analyzing the
frequency of seed-complementary sites (where the seed was
defined as nucleotides 1–7, 2–8, or 1–8 of the siRNA) for
real and randomized siRNAs within the 39 UTRs of mRNAs
that were down-regulated 1 d after siRNA transfection
(Fig. 4). Consistent with our biochemical analysis, which
indicated that both strands of our unmodified siRNA du-
plex were loaded into RISCs, we found seed-complementary
site enrichment for both siRNA strands. 59-O-methylation
of the sense strand increased the off-targeting activity of the
anti-sense strand, while decreasing its own off-targeting
activity, and vice versa. Note that the sense strand has
intrinsically fewer off-targets compared with the anti-sense
strand. This is because the sense strand contains a CG
dinucleotide in its seed sequence and CG-containing motifs
are underrepresented in the genome compared to other
dinucleotides. The random controls for the sense strand,
being selected to have a similar number of seed-comple-
mentary sites in the entire set of 39 UTRs as the sense strand,
also have low numbers of seed matches in the set of down-
regulated UTRs. This leads to a higher variance in the
expected number of seed-complementary sites for the sense
compared with the anti-sense strand. Nonetheless, the seed
enrichment for the sense strand is statistically significant in
the case of the s/as and s/meT-as constructs. These analyses
thus indicate that chemical modification can limit the off-
targeting activity to only one strand of the siRNA duplex.
Comparison of the effects of 59-O-methylation and
duplex-destabilizing mutations on strand selection
The differential thermodynamic stability of siRNA duplex
termini impacts siRNA strand selection (Khvorova et al.
2003; Schwarz et al. 2003). Thermodynamic biases can be
introduced by varying the G/C content of the termini of the
siRNA duplex or by placing destabilizing, non-Watson–
Crick base pairs (mismatches) at one of the termini. We
therefore wanted to compare the strand bias introduced by
59-O-methylation with that introduced by mismatches
using the asymmetrical siRNA duplex described above,
whose sense strand is preferentially incorporated into RISC.
We placed mismatches in the G/C-rich terminus by
altering the sequence of the anti-sense siRNA from posi-
tions 1 to 5 (Fig. 5A). According to the current model of
strand selection, destabilizing the G/C-rich termini should
lower the bias for incorporation of the sense strand of this
siRNA duplex and should enhance the incorporation of the
anti-sense strand into RISC. What we observed was that
mismatches only minimally reduced the activity of the
sense siRNA-containing RISC measured by the sense re-
porter, while 59-O-methylation of the sense siRNA showed
a more pronounced effect (Fig. 5B).
Anti-sense siRNA strand incorporation was determined
by the anti-sense reporter assay. Mismatches introduced
by altering the sequence of the anti-sense siRNA trivially
lead to mismatches between the anti-sense siRNA and
its reporter, resulting in the lack of cleavage activity for
mutants of positions 3–5 of the anti-sense siRNA. Muta-
tions placed at position 1 or 2 of the anti-sense siRNA
showed similar activity as the unmodified siRNA duplex,
consistent with unaltered behavior of the sense reporter,
indicating that mismatches at position 1 or 2 were insuf-
ficient to alter asymmetry of RISC assembly. In contrast,
the 59-O-methylation of the sense strand, led to a much
FIGURE 4. siRNA off-target analysis of the symmetric RISC loading
siRNA duplexes. Enrichment of ‘‘seed’’-complementary sequences for
sense (left panel) and anti-sense (right panel) strands relative to
random controls in the 39 UTRs of transcripts that are down-
regulated upon siRNA transfection (see Materials and Methods).
Dark gray and light gray bars show the number of occurrences of
seed-complementary sites for the siRNAs used in the study and
random controls, respectively. Double and single stars indicate
enrichments that are significant at 0.01 and 0.05 level.
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more pronounced activity of the anti-sense siRNA. To-
gether, these experiments showed that 59-O-methylation of
the 59 end of siRNAs was more effective in changing strand
preferences compared with alterations of thermodynamic
stability induced by duplex-destabilizing mismatches.
DISCUSSION
Our analysis describes for the first time the consequences
of strand-specific 59-O-methyl-modification of siRNA du-
plexes on the assembly and activity of RISC. 59-O-methyl-
ation of the terminal ribose blocked the phosphorylation of
siRNAs by cellular kinases (Nyka¨nen et al. 2001; Martinez
et al. 2002b; Weitzer and Martinez 2007). The requirement
for 59 phosphates during the assembly of RISC was noted
previously using symmetrically 59-O-methylated siRNA
duplexes in D. melanogaster embryo lysates (Nyka¨nen
et al. 2001), and similarly, we also found that double 59-
O-methyl modification reduced RISC assembly in human
cells. Strikingly, the placement of a single 59-O-methyl only
reduced the incorporation of the methylated strand with-
out impairing the incorporation of the unmodified siRNA
strand. It even appeared that modification of the sense
siRNA strand enhanced the incorporation of the unmod-
ified anti-sense strand, and vice versa. The effect of the
59-O-methyl modification was also strong enough to
counteract the otherwise strong strand preference of an
asymmetrically loading siRNA duplex. This observation em-
phasizes the importance of 59-phosphate recognition dur-
ing RISC assembly and its potential use for siRNA design
and application.
The molecular events responsible for 59 phosphate
recognition during RISC assembly remain to be defined.
Presumably the contacts are made while placing the 59
phosphate of the guide siRNA strand into the 59-phosphate
binding pocket of Ago (Ma et al. 2005; Parker et al.
2005). The sensing of the 59 phosphate also appears to
take place in the context of a duplex siRNA or a partially
unwound duplex siRNA, because artificial loading of RISC
with single-stranded 59-O-methyl-modified or unmodified
siRNAs was possible and led to similar RISC-mediated
cleavage activities. Interestingly, a bulky 59-fluorescein modi-
fication coupled via a 59-phosphodiester linkage to the
guide strand of a siRNA duplex did not affect its silenc-
ing efficiency (Harborth et al. 2003). It will be interesting
to explore the effects of other 59-hydroxyl modifications,
for example, bulky alkyl groups (e.g., tertiary butyl), on
RISC assembly.
Although siRNA duplexes are widely used in research as
reagents for gene silencing, sequence-specific off-target
effects can be problematic. Off-target effects are typically
caused by siRNA sense and anti-sense strands, and the
strand-specific reduction of off-target effects using 59-O-
methyl modifications will help to improve siRNA specificity.
However, 59-O-methylation will only eliminate off-target
effects caused by the 59-O-methylated strand of the siRNA
duplex. Moreover, this may also lead to an enhanced off-
target effect of the unmodified strand as its loading into
RISC may increase; it should nonetheless allow for lowering
the dose of siRNAs needed in gene silencing experiments
and will aid in controlling potential side effects caused
by competition of siRNA with miRNA pathways (Grimm
et al. 2006).
Because not all siRNAs that are cognate to a given target
mRNA are equally effective, computational tools have
been developed based on experimental data to increase
the likelihood of selecting effective siRNAs (for review, see
Pei and Tuschl 2006). Though these methods facilitate
selection of functional siRNAs, they do not yet alleviate
the need for experimental validation. 59-O-methylation of
the passenger strand adds an additional constraint and
might be useful in the context of generating genome-wide
siRNA libraries, where the validation of each single siRNA
is technically not feasible. Depending on the assay, high-
throughput RNAi screens are sensitive to seed-sequence-
mediated off-targeting effects (Lin et al. 2005), and reduc-
ing the likelihood for contributions of the passenger siRNA
is useful.
Although it has been proposed that thermodynamic
asymmetry can be readily introduced into siRNAs using
LNAs (Elme´n et al. 2005), minimizing the degree of
FIGURE 5. Influence of thermodynamic stability vs. 59-O-methyl
modification. (A) Schematic presentation of the asymmetric RISC
loading siRNA duplexes used in B. (B) Plasmids containing either a
Pp-luciferase gene fused to a complementary target site for the anti-
sense strand or a complementary target site for the sense strand of the
siRNA were cotransfected with Rr-luciferase and the indicated
siRNAs. GFP siRNA was utilized as control (Ctrl) siRNA.
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chemical modification needed to control asymmetry may
be beneficial from the point of view of manufacturing or
potential therapeutic use. It was also interesting to observe
that the introduction of conventional mismatches for
destabilizing one of the siRNA termini was less effective
then the selective placement of a 59-O-methyl group.
In summary, in this study we describe a novel approach
of biasing siRNA strand selection from duplex siRNA based
on 59-phosphate sensing during RISC assembly.
MATERIALS AND METHODS
Oligonucleotide synthesis
siRNAs were chemically synthesized using RNA phosphoramidites
(Pierce) on an A¨kta Oligopilot 10 DNA/RNA synthesizer (GE
Healthcare Life Sciences) at a 1 mmol scale. The synthesis,
deprotection and precipitation were performed according to the
manufacturer’s protocol. 59-O-methylated siRNAs were pur-
chased from Dharmacon. The sequences of the siRNAs used in
this study are as follows: luciferase siRNA anti-sense strand, 59-
UCGAAGUAUUCCGCGUACGUU, sense strand, 59CGUACG
CGGAAUACUUCGAUU; GFP siRNA anti-sense strand, 59-GGC
AAGCUGACCCUGAAGUUT, sense strand, 59-ACUUCAGGGU
CAGCUUGCCUT; symmetrically RISC-loaded siRNA anti-sense
strand, 59-UUGUCUUGCAUUCGACUAAUT, sense strand, 59-
UUAGUCGAAUGCAAGACAAUT; and asymmetrically RISC-
load siRNA anti-sense strand, 59-UUAAGAUCUGUUAUCCGC
AUT, sense strand, 59-UGCGGAUAACAGAUCUUAAUT. For
analysis of the importance of the 59 phosphate, the 59 uridine
residues were substituted by 59-O-methyl-29-deoxythymidine or
29-deoxythymidine as control.
Plasmids
The mammalian expression plasmids for FLAG/HA-tagged Ago2
and GFP were previously described (Meister et al. 2004) and are
available from www.addgene.org. Reporter plasmids for measur-
ing RISC activity of anti-sense and sense siRNA strands were
generated as follows: Complementary pairs of DNA oligonucleo-
tides bearing the siRNA target sequence and flanking SacI and
NaeI restriction sites were annealed, digested with SacI and NaeI,
and cloned into the 39 UTR of the reporter vectors, using the SacI
and NaeI sites of the pMIR-REPORT plasmid (Ambion) or the
SacI and SmaI sites of the pEGFP-C2 plasmid (Clontech),
respectively. Prior to this procedure, the pEGFP-C2 plasmid was
modified by the insertion of a stop codon into the BglII site. The
oligos containing the siRNA target sequences were as follows:
Target complementary to symmetric RISC loading anti-sense
siRNA strand, 59-CGCTGAGCTCATCGCCACCTTGTTTAAG
CCTTAGTCGAATGCAAGACAAATTAGACCTACGCACTCC
AGGCCGGCTCGC and 59-GCGAGCCGGCCTGGAGTGCGT
AGGTCTAATTTGTCTTGCATTCGACTAAGGCTTAAACAA
GGTGGCGATGAGCTCAGCG;
Target complementary to symmetric RISC loading sense siRNA
strand, 59-CGCTGAGCTCATCGCCACCTTGTTTAAGCCTT
GTCTTGCATTCGACTAAATTAGACCTACGCACTCCAGGC
CGGCTCGC and 59-GCGAGCCGGCCTGGAGTGCGTAGGT
CTAATTTAGTCGAATGCAAGACAAGGCTTAAACAAGGTG
GCGATGAGCTCAGCG;
Target complementary to asymmetric RISC loading anti-sense
siRNA strand, 59-CGCTGAGCTCATCGCCACCTTGTTTAAG
CCGCGGATAACAGATCTTAAAATTAGACCTACGCACTCC
AGGCCGGCTCGC and 59-GCGAGCCGGCCTGGAGTGCGT
AGGTCTAATTTTAAGATCTGTTATCCGCGGCTTAAACAA
GGTGGCGATGAGCTCAGCG; and
Target complementary to asymmetric RISC loading sense siRNA
strand, 59-CGCTGAGCTCATCGCCACCTTGTTTAAGCCTT
TAAGATCTGTTATCCGCATTAGACCTACGCACTCCAGGC
CGGCTCGC and 59-GCGAGCCGGCCTGGAGTGCGTAGGT
CTAATGCGGATAACAGATCTTAAAGGCTTAAACAAGGTG
GCGATGAGCTCAGCG.
Plasmids for in vitro transcription of RNA cleavage substrates
were generated by cloning of the annealed oligodeoxynucleotides
into the SacI/SmaI sites of the pIVEX2.4d plasmid (Roche).
In vitro transcription of RISC cleavage substrates
DNA templates for in vitro transcription of RNA cleavage
substrates were generated by linearization of the respective
pIVEX2.4d plasmids using BamHI restriction enzyme digestion.
The linearized plasmid was used for run-off in vitro transcription
using T7 RNA polymerase (Fermentas) according to the manu-
facturer’s protocol. The transcripts were purified by denaturing
PAGE, visualized by UV-shadowing, excised, and eluted overnight
in 0.3 M NaCl at 4°C. The eluted RNA was precipitated by
addition of 3 volumes of ethanol and collected by centrifugation.
The cleavage substrate complementary to the luciferase targeting
siRNAs was 32P-cap-labeled (Martinez et al. 2002a), and the
cleavage was assayed as described previously (Meister et al. 2004).
The sense and anti-sense 32P-cap-labeled cleavage substrates were
188 nt and 195 nt, respectively.
Northern blotting
The oligodeoxynucleotide probes 59-TTAGTCGAATGCAAGA
CAA, and 59-TTGTCTTGCATTCGACTAA were used for detec-
tion of the symmetrically RISC-loading siRNAs. Probes were
radioactively labeled with T4 polynucleotide kinase (New England
Biolabs) using [g-32P]-ATP. RNA samples were separated by 15%
denaturing PAGE and transferred to a nylon membrane (Hybond-
N+, Amersham) by semi-dry electroblotting. The membrane was
then subjected to UV cross-linking using the auto-crosslink
function on the Stratalinker (Stratagene) and subsequently baked
for 1 h at 80°C. The membrane was incubated with 15 mL of
prehybridization buffer (53 SSC/20 mM sodium phosphate
buffer (pH 7.2)/7% SDS/13 Denhardt’s solution/3 mg of soni-
cated salmon sperm DNA) in a hybridization oven for 1 h rotating
at 50°C. The prehybridization solution was then replaced with
15 mL of hybridization buffer containing 3,000,000 cpm of
32P-radiolabeled DNA probe and incubated overnight at 50°C.
The membrane was washed twice with 100 mL of wash solution
I (53 SSC/1% SDS) at 50°C for 10 min followed by a single
wash step with wash solution II (13 SSC/1% SDS) at 50°C.
The membrane was wrapped in plastic wrap and exposed to a film
for 2 d.
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Tissue culture and transfections
HEK 293 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), 100 unit/mL penicillin, and 100 mg/mL streptomycin at
37°C in a 5% CO2-containing atmosphere. The stably transfected
HeLa S3 FLAG/HA-Ago2 cell line (Meister et al. 2004) was
cultured under the same conditions with the addition of 0.5
mg/mL G418. HEK 293 cells were cotransfected with reporter or
control plasmids and siRNAs using Lipofectamine 2000 (Invitro-
gen) according to the manufacturer’s protocol in a 24-well format
24 h after seeding. Transfected cells were analyzed for luciferase
activity or GFP fluorescence 24 h after transfection. For immu-
noprecipitation experiments, HEK 293 cells were transfected using
the calcium chloride method. Cells were plated to 40% confluency
3–4 h before transfection on a 15-cm dish. Twenty micrograms of
plasmid DNA were diluted in 858 mL of water and 122 mL 2M
CaCl2. One milliliter of 23 HEPES-buffered saline (274 mM
NaCl, 1.5 mM Na2HPO4, 54.6 mM HEPES-KOH at pH 7.1) was
added drop-wise under gentle agitation. The transfection solution
was then sprinkled onto the cells.
Microscopy
HEK 293 cells were seeded on coverslips and were cotransfected
with either empty pEGFP-C2 as control or pEGFP-C2 bearing the
target complementary to siRNA strand-specific sequences (0.2 mg/
well), pDsRedmonomer-C1 (Clontech; 0.1 mg/well) and siRNA
(20 pmol/well). After 24 h, cells were fixed in PBS with 4%
formaldehyde for 30 min at room temperature, washed twice with
PBS, and mounted to slides using Vectashield mounting medium
(Vector Laboratories). Images were recorded using a Leica TCS
SP2 confocal laser microscope and a 203 immersion oil objective.
For GFP and DsRed images, 10 z-sections of the cells were
recorded and processed to average projections using the Leica
confocal software.
Dual luciferase assays
For experiments described in Figure 1C, 7000 HEK 293 cells per
well were transferred into 96-well plates the day before trans-
fection. The cells were then cotransfected with 0.2 mg pGL2-
control (Promega), 0.02 mg pRL-TK (Promega), and 3.75 pmol
siRNA duplexes (final concentration 25 nM) with Lipofectamine
2000 (Invitrogen; 0.75 mL). Luciferase activities were measured
20 h after transfection using the Dual Luciferase Assay Kit
(Promega) and a Bio-Tek Clarity luminometer. The ratios of
the signals of firefly (Pp) luciferase to seapansy (Rr) luciferase were
calculated and normalized by dividing by the ratio for control
siRNA against FLJ30525.3. The plotted data were averaged from
triplicates 6SD For Figures 2–5, HEK 293 cells were cultured in
24-well plates and each cotransfected with either empty pMIR-
REPORT (Pp-luc) control plasmid or pMIR-REPORT bearing the
target complementary to siRNA strand-specific sequences (0.2 mg/
well), pRL-SV40 control vector (Rr-luc) (Promega) (0.1 mg/well),
and siRNA (20 pmol/well). The cells were lysed and assayed 24 h
post-transfection following the Dual-Luciferase Reporter Assay
system (Promega) instructions. Samples were analyzed on a
Mithras LB 940 Multimode Microplate Reader (Berthold Tech-
nologies). All samples were assayed in triplicates.
Western blotting, extract preparation,
and immunoprecipitation
Western blotting was performed as previously described (Meister
et al. 2004). For immunoprecipitation, HEK 293 cells transiently
transfected with FLAG-/HA-tagged Ago2 and HeLa S3 cells stably
transfected with FLAG/HA-tagged Ago2 were harvested from
15 cm plates 48 h post-transfection. The cells were washed with
PBS (pH 7.4) and subjected to lysis with 700 mL of lysis buffer
(150 mM KCl, 25 mM Tris-HCl at pH 7.4, 2 mM EDTA at pH 8.0,
1 mM NaF, 0.5 mM DTT, 0.05% NP40, 0.5 mM AEBSF) for
10 min at 4°C. The cells were subsequently scraped off of the plate
and centrifuged at 17,200g for 10 min. The supernatant was
incubated with 15 mL of anti-FLAG M2 agarose beads (Sigma),
which were activated by washing once with 0.1 M glycine-HCl
(pH 2.5) and equilibrated by washing with 1.5 M Tris-HCl (pH
8.8), for 3 h at 4°C with rotation. The beads were collected and
washed three times with 300 mM NaCl/5 mM MgCl2/0.05%
NP40/50 mM Tris-HCl (pH 7.5) and once with PBS (pH 7.5). To
isolate the RISC-incorporated siRNA, the beads were then
incubated in 300 mL of proteinase K solution consisted of 23
proteinase K buffer (300 mM NaCl/25 mM EDTA at pH 8.0/2%
SDS/200 mM Tris-HCl at pH 7.5 and proteinase K at 1 mg/mL
concentration) for 10 min at 37°C. The RNA was phenol/
chloroform-extracted and ethanol precipitated.
RNA cleavage assays
In vitro transcribed cleavage substrates were 59-cap labeled as
described previously (Martinez et al. 2002a). In a typical RNA
cleavage reaction, 100 nM of siRNA was incubated in a 15 mL
reaction containing 50% HeLa S100 extract, 1 mM ATP, 0.2 mM
GTP, 10 U/mL RNasin (Promega), 100 mM KCl, 1.5 mM MgCl2,
0.5 mM DTT, 10 mM HEPES-KOH (pH 7.9) at 30°C. After
30 min, 5 nM of the cap-labeled cleavage substrate was added and
further incubated for 1.5 h at 30°C. The reactions were stopped by
adding 200 mL of proteinase K buffer containing 1 mg/mL pro-
teinase K. The RNA was subsequently isolated using phenol/
chloroform extraction, and the cleavage products were analyzed
by 8% denaturing RNA PAGE. The labeled RNA was detected by
phosphoimaging and autoradiography.
Microarray mRNA expression analysis
HeLa cells were plated in a six-well plate with a volume of 2.5 mL
at a density such that next day they are z75% confluenent for
transfection. A transfection solution of 0.5 mL was utilized for
transfection for the final siRNA duplex concentration of 50 nM
using RNAiMAX (Invitrogen). Total RNA was extracted 24 h
post-transfection with Trizol (Invitrogen) and purified using the
RNeasy Mini Kit (Qiagen). Three micrograms of purified RNA
was used to synthesize the first strand of cDNA using ArrayScript
reverse transcriptase (Ambion, catalog no. 1791) and an oligo(dT)
primer bearing a T7 promoter. The single-stranded cDNA was
converted into dsDNA by DNA polymerase I in the presence of
Escherichia coli RNase H and DNA ligase. After column purifica-
tion, the dsDNA was served as a template for in vitro transcription
in a reaction containing biotin-labeled UTP, unlabeled NTPs, and
T7 RNA polymerase. The amplified, biotin-labeled, anti-sense
RNA (aRNA) was purified, and quality was assessed using the
Agilent 2100 Bioanalyzer and the RNA 6000 Nano kit. Twenty
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micrograms of labeled aRNA were fragmented, and 15 mg of the
fragmented aRNA was hybridized to Affymetrix Human Genome
U133 Plus 2.0 Array for 16 h at 45°C as described in the
Affymetrix Technical Analysis Manual (Affymetrix). After hybrid-
ization, Gene Chips were stained with streptavidin-phycoerythrin,
followed by an antibody solution (anti-streptavidin), and a second
streptavidin-phycoerythrin solution, with all liquid handling
performed by a GeneChip Fluidics Station 450. Gene Chips were
then scanned with the Affymetrix GeneChip Scanner 3000. Agilent
Whole Human Genome Oligonucleotide Microarray (catalog no.
4112F) analysis was performed by Cogenics.
Computational analyses of putative off-targets
We normalized the probe intensities for the five microarrays
(transfection reagent only, symmetric RISC loading sense/anti-
sense, MeO-sense/anti-sense, sense/MeO-anti-sense, MeO-sense/
MeO-anti-sense siRNA duplexes) using the bioconductor (see
http://www.bioconductor.org and Gentleman et al. 2004) and
gcRMA software (Wu et al. 2004). To quantify off-target effects
based on the frequency of seed-complementary sites in the 39
UTRs, we selected, for each gene measured by the microarray, the
transcript with median 39-UTR length. This data set consisted of
14,997 transcripts. From all the probe sets corresponding unam-
biguously to a given gene, we selected the one that responded
best (exhibited the highest variance) across a large number of ex-
periments performed on the Affymetrix platform that we used.
This probe set was used to monitor the per-transcript expres-
sion level across our experiments. From each experiment (sense/
anti-sense versus mock transfection, MeO-sense/anti-sense versus
mock transfection, sense/MeO-anti-sense versus mock transfection,
MeO-sense/MeO-anti-sense versus mock transfection), we extracted
the top 1%, i.e., 149, most down-regulated transcripts and com-
puted the number of occurrences of matches to the 1–7, 2–8, 1–8
nucleotide positions of both the sense and the anti-sense strands
in these set of transcripts. We compared these numbers with the
number of occurrences expected for ‘‘random siRNAs,’’ which we
calculated as follows. For each of the anti-sense and the sense
strand, we determined the number of occurrences of seed-
complementary sites in the entire set of 39 UTRs. From all
octameric sequences, we then selected the 5% (3277) whose
reverse complements occurred with a frequency closest to that
of siRNA-complementary sites in the entire set of 39 UTRs. These
served as ‘‘random siRNA controls.’’ We determined the number
of occurrences of seed-complementary sites of these random
siRNAs in the down-regulated set of 39 UTRs, To correct for
slight variations in this number that can be expected simply
because the frequency of seed-complementary sites for real and
random siRNAs in the 39 UTRs overall are not identical, we
adjusted the observed counts by a factor equal to the ratio of
observed occurrences of the real siRNA-complementary sites to
the random siRNA-complementary sites in the entire set of
39 UTRs. We used the distribution of the values determined for
random siRNAs to estimate the P-value of the number of
occurrences of real siRNA-complementary sites.
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METHOD
A multifunctional human Argonaute2-specific
monoclonal antibody
SABINE RU¨DEL,1 ANDREW FLATLEY,2 LASSE WEINMANN,1 ELISABETH KREMMER,2 and GUNTER MEISTER1
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82152 Martinsried, Germany
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ABSTRACT
Small regulatory RNAs including small interfering RNAs (siRNAs), microRNAs (miRNAs), or Piwi interacting RNAs (piRNAs)
guide regulation of gene expression in many different organisms. The Argonaute (Ago) protein family constitutes the cellular
binding partners of such small RNAs and regulates gene expression on the levels of transcription, mRNA stability, or translation.
Due to the lack of highly specific and potent monoclonal antibodies directed against the different Ago proteins, biochemical
analyses such as Ago complex purification and characterization rely on overexpression of tagged Ago proteins. Here, we report
the generation and functional characterization of a highly specific monoclonal anti-Ago2 antibody termed anti-Ago2(11A9). We
show that anti-Ago2(11A9) is specific for human Ago2 and detects Ago2 in Western blots as well as in immunoprecipitation
experiments. We further demonstrate that Ago2 can be efficiently eluted from our antibody by a competing peptide. Finally, we
show that anti-Ago2(11A9) recognizes Ago2 in immunofluorescence experiments, and we find that Ago2 not only localizes to
cytoplasmic processing bodies (P-bodies) and the diffuse cytoplasm but also to the nucleus. With the anti-Ago2(11A9) antibody
we have generated a potent tool that is useful for many biochemical or cell biological applications.
Keywords: Argonaute proteins; microRNAs; RISC; RNAi; gene silencing
INTRODUCTION
RNA silencing, or RNA interference (RNAi), is an evolu-
tionarily conserved gene silencing pathway that is triggered
by dsRNA (Meister and Tuschl 2004). The dsRNA trigger
molecules are processed to small interfering RNAs (siRNAs)
or microRNAs (miRNAs), which are then assembled into
various silencing effector complexes, including the RNA-
induced silencing complex (RISC) (Meister and Tuschl
2004; Filipowicz et al. 2005; Zamore and Haley 2005).
Effector complexes containing miRNAs are often referred
to as miRNPs (Mourelatos et al. 2002). miRNA precursors
(pre-miRNAs) are excised from primary transcripts by a
nuclear endonucleolytic complex that contains the RNase
III enzyme Drosha and the dsRNA-binding domain
(dsRBD) protein DGCR8/Pasha (Chen and Meister 2005;
Zamore and Haley 2005). Pre-miRNAs are subsequently
exported to the cytoplasm by the export receptor Exportin5
for further maturation (Chen and Meister 2005; Zamore
and Haley 2005). In the cytoplasm, dsRNA and pre-
miRNAs are processed by the RNase III enzyme Dicer to
duplexes of z21–23 nucleotides (nt) (Meister and Tuschl
2004). Similar to Drosha, Dicer functions in concert with
dsRBD proteins as well. In humans, the immunodeficiency
virus trans-activating response RNA-binding protein
(TRBP) interacts with Dicer and contributes to the pro-
cessing of miRNA precursors (Chendrimada et al. 2005;
Haase et al. 2005). Recently, the dsRBD protein PACT has
been shown to functionally interact with human Dicer as
well (Lee et al. 2006). In a subsequent assembly process,
which is not yet fully understood and presumably involves
the action of ATP dependent helicases, only one strand of
the siRNA or miRNA duplex intermediate is loaded into
the silencing effector complex to become the guide se-
quence (Meister and Tuschl 2004). Notably, the putative
RNA helicases RNA Helicase A (RHA) as well as DDX5/p68
have recently been implicated in RISC loading (Robb and
Rana 2007; Salzman et al. 2007). An alternative model for
RISC loading and activation has been proposed. In this
model, the sense strand of the siRNA (also termed nonguide
or passenger strand) is cleaved by Ago2, and the short 10-
to 12-nt long cleavage products dissociate from the RISC
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presumably without the help of helicases (Matranga et al.
2005; Rand et al. 2005; Leuschner et al. 2006). The iden-
tification of a complex consisting of Ago2, TRBP, and Dicer
that can be loaded with dsRNA or pre-miRNAs without the
help of assisting helicases supports the above-mentioned
RISC loading model (Gregory et al. 2005). However, the
loading of endonucleolytically inactive human Ago1, Ago3,
and Ago4 complexes is not explained by such a model and
presumably involves different pathways.
Depending on the complementarity between the small
guide RNA and its target, siRNAs and miRNAs guide either
the sequence-specific degradation of complementary RNA
molecules or inhibit the translation of partially comple-
mentary target mRNAs (Pillai et al. 2007). Recently, a third
pathway of miRNA function has been identified in Dro-
sophila and zebrafish, in which miRNAs guide the degra-
dation of imperfectly complementary target mRNAs by
recruiting deadenylation and decapping enzymes (Behm-
Ansmant et al. 2006; Giraldez et al. 2006).
Members of the Ago protein family are key components
of RNA silencing effector complexes. Ago proteins contain
piwi-argonaute-zwille (PAZ) and PIWI domains (Carmell
et al. 2002; Peters and Meister 2007; Hutvagner and Simard
2008). Recently, structures of PIWI domains, isolated PAZ
domains, as well as full-length archaeal Ago proteins have
been solved by NMR and X-ray crystallography (Hall 2005;
Parker and Barford 2006; Patel et al. 2006; Song and
Joshua-Tor 2006). The PIWI domain structures of bacterial
proteins revealed striking similarity to RNase H, and it has
been demonstrated that these proteins contain endonu-
cleolytic activity (Parker et al. 2004; Song et al. 2004).
Studies on human Ago proteins revealed that Ago2 is the
endonuclease that cleaves the target RNA in RNAi (Liu
et al. 2004; Meister et al. 2004). The MID domain, which
is located N-terminally of the PIWI domain, forms the 59
phosphate binding pocket for the small RNA that sets the
register for target RNA cleavage (Ma et al. 2005; Parker
et al. 2005). Recently, a conserved tyrosine residue within
this binding pocket has been implicated in protein–protein
interaction as well (Till et al. 2007). The previously
characterized PAZ domain of Ago proteins specifically
recognizes and binds the single-stranded 39 ends of small
RNAs (Hall 2005; Song and Joshua-Tor 2006).
Besides Ago proteins as core components of RNA
silencing effector complexes, additional proteins have been
identified in different experimental systems (for review, see
Peters and Meister 2007). In humans, interactions of Ago2
with FMRP (fragile X mental retardation protein) have
been observed (Jin et al. 2004). Furthermore, human
miRNAs reside in a defined 15S complex that contains
Gemin3, Gemin4, and Ago2 (Mourelatos et al. 2002).
Recently, biochemical purifications of Ago1 and Ago2
complexes from HeLa cell lysates identified the DExD
box protein MOV10 and a protein termed TNRC6B as
novel Ago complex components. The precise function of
these different proteins in the RNA silencing process,
however, remains elusive (Meister et al. 2005). Interest-
ingly, TNRC6B is highly homologous with TNRC6A
(GW182), which has been implicated in small RNA-guided
gene silencing in many different organisms and constitutes
a marker protein for P-bodies (Ding et al. 2005; Jakymiw
et al. 2005; Liu et al. 2005a; Behm-Ansmant et al. 2006).
P-bodies are cellular sites of RNA metabolism (Eulalio et al.
2007a), and it has been shown that Ago proteins localize to
P-bodies as well (Liu et al. 2005b; Meister et al. 2005; Sen
and Blau 2005). Further studies revealed that miRNAs as
well as target mRNAs are also found in P-bodies, and it has
been suggested that localization of mRNAs to P-bodies may
prevent their translation (Liu et al. 2005b; Pillai et al. 2005;
Bhattacharyya et al. 2006). However, it has also been shown
that P-bodies form as a consequence of miRNA-guided gene
silencing but are not required for it (Eulalio et al. 2007b).
In human cells, Ago proteins are found in different pro-
tein complexes with distinct molecular weights (Martinez
et al. 2002; Mourelatos et al. 2002; Hock et al. 2007).
Furthermore, Ago proteins are embedded into large
mRNA-protein structures, and it has been shown that
miRNA-targeted mRNAs can be isolated and identified
from purified Ago complexes (Beitzinger et al. 2007; Easow
et al. 2007; Karginov et al. 2007). In combination with
bioinformatic miRNA target prediction algorithms, such
biochemical approaches provide a novel tool for fast and
reliable miRNA target identification. However, due to the
lack of potent and highly specific antibodies against human
Ago proteins, many biochemical studies rely on overexpres-
sion of a tagged Ago version, which sometimes interferes
with natural protein function.
Here, we report the generation and functional characteri-
zation of a monoclonal anti-Ago2 antibody. This antibody
recognizes human Ago2 in Western blots and does not
cross-react with other human Ago proteins. Furthermore,
we demonstrate that the anti-Ago2 antibody specifically
immunoprecipitates Flag/HA-tagged as well as endogenous
Ago2 without precipitating other Ago proteins. Moreover,
we show that bound Ago2 can be efficiently eluted from
the antibody matrix by competition with a short peptide
comprising the epitope of the antibody. Finally, we dem-
onstrate that the anti-Ago2 antibody recognizes cellular
Ago2 in immunofluorescence studies by presenting data on
endogenous Ago2 distribution without overexpression.
RESULTS
Anti-Ago2(11A9) discriminates between Ago2
and other human Ago proteins in Western blots
Due to the lack of potent and specific antibodies, most of
the biochemical studies on human Ago proteins used
overexpressed, tagged Ago proteins. In order to better
understand endogenous RISC function, we set out to
Monoclonal anti-hAgo2 antibody
www.rnajournal.org 1245
JOBNAME: RNA 14#6 2008 PAGE: 2 OUTPUT: Thursday May 8 00:16:27 2008
csh/RNA/152282/rna9738
 Cold Spring Harbor Laboratory Press on April 6, 2009 - Published by rnajournal.cshlp.orgDownloaded from 
generate a specific monoclonal anti-Ago2 antibody. A
peptide encompassing the very N-terminal end of human
Ago2 that is not conserved in other human Ago proteins
(Fig. 1A) was injected into rats for monoclonal antibody
production. We obtained hybridoma clone 11A9, which
reacted strongly in an initial ELISA screen coated with the
injected peptide (data not shown). Next, we analyzed anti-
Ago2(11A9) in Western blots. Flag/HA-tagged Ago1
through 4 (FH-Ago) were expressed in HEK 293 cells and
immunoprecipitated using anti-Flag antibody-coated aga-
rose beads (Fig. 1B). Similar amounts of FH-Ago1–4 as well
as FH-GFP were blotted onto nitrocellulose membranes
and subsequently probed with anti-HA (Fig. 1B, lanes 7–
12) or anti-Ago2(11A9) antibodies (Fig. 1B, lanes 1–6).
Strikingly, anti-Ago2(11A9) strongly reacted with FH-Ago2
in Western blots (Fig. 1B, lane 2), whereas FH-Ago1, 3, 4,
or FH-GFP were not detected by the antibody. Similar
results were obtained using myc-tagged Ago proteins (Fig.
1B, lanes 13–24), indicating that anti-Ago2(11A9) is highly
specific for Ago2 in Western blots.
Next, we investigated the Western blotting specificity of
anti-Ago2(11A9) in lysates from untreated cells (Fig. 1C).
Total cell lysates from RPE-1, HEK 293, and HeLa cells
were analyzed using anti-Ago2(11A9) (Fig. 1C, lanes 1–3).
Anti-Ago2(11A9) detected one single band with a molec-
ular weight of z100 kDa, indicating that the antibody is
highly specific for endogenous Ago2 as well. No signal
was observed when lysate from the mouse neuroblastoma
cell line N2A was analyzed, demonstrating that anti-
Ago2(11A9) does not recognize mouse Ago2. For further
validation of the antibody, we separated nuclear and
cytoplasmic extracts from the above-mentioned cell lines
(Fig. 1C, lanes 5–12). Consistently, anti-Ago2(11A9) rec-
ognized specifically Ago2 in the cytoplasmic fractions.
Interestingly, Ago2 is also detected in the nuclear fractions,
suggesting putative roles of Ago2 in the nucleus or
associated cellular compartments. Notably, two additional
bands of unknown identity were detected in the nuclear
fractions, which most likely reflect cross-reactivity with
nuclear proteins. However, these bands were not detected
in total cell lysates, presumably due to lower amounts of
nuclear proteins therein. Using anti-Ago2(11A9), we ana-
lyzed endogenous Ago2 levels in a variety of cell lines (Fig.
1D). Interestingly, anti-Ago2(11A9) detects an additional
band migrating slower than Ago2 in some cell lines, which
most likely reflects post-translational modification of Ago2.
In summary, we have generated a monoclonal antibody
that is highly specific for human Ago2 in Western blots.
This antibody is available form www.ascenion.de.
Anti-Ago2(11A9) specifically immunoprecipitates
human RISC
In order to perform biochemical studies on endogenous
RISC, we analyzed anti-Ago2(11A9) for its immunoprecip-
FIGURE 1. Anti-Ago2(11A9) is Ago2-specific in Western blots. (A)
Amino acid alignment of the Ago2 peptide used for antibody
generation. (B) Flag/HA-tagged Ago1 (FH-Ago1) through FH-Ago4
(lanes 1–5,7–11), FH-GFP (lanes 6,12), myc-Ago1 through 4 (lanes
13–17,19–23), and myc-GFP (lanes 18,24) were expressed in HEK
293 cells and immunoprecipitated using anti-Flag or anti-myc anti-
bodies. Blotted immunoprecipitates were probed with anti-Ago2(11A9)
(lanes 1–6,13–18), anti-HA (lanes 7–12), or anti-myc antibodies (lanes
19–24). Ig indicates heavy and light chains of the immunoglobulins.
(C) 30 mg of total cell lysate (lanes 1–4), cytoplasmic extract (lanes
5–8), or nuclear extract (lanes 9–12) from RPE-1, HEK 293, or
HeLa cells was blotted and probed with anti-Ago2(11A9). A West-
ern blot using antibodies against the ribosomal protein S6 (rS6)
served as a loading control (lower panel). (Asterisks) Unidentified
proteins. (D) Total cell lysate from various cell lines was ana-
lyzed using anti-Ago2(11A9) (upper panel) or anti-rS6 (lower panel)
as loading control. (Asterisk) Additional band recognized by
anti-Ago2(11A9), which might correspond to post-translational
modifications.
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itation capabilities. Myc-tagged Ago1 through 4 were ex-
pressed in HEK 293 cells, and the lysates were subjected to
anti-Ago2(11A9) immunoprecipitation (Fig. 2A). Immu-
noprecipitated proteins were further analyzed by Western
blotting using anti-myc antibodies. The monoclonal anti-
Ago2(11A9) antibody readily immunoprecipitated myc-
Ago2 (Fig. 2A, lane 6) whereas no myc-Ago1, myc-Ago3,
or myc-Ago4 (Fig. 2A, lanes 5,7,8) was immunoprecipi-
tated. Our results clearly show that anti-Ago2(11A9)
specifically recognizes and efficiently immunoprecipitates
myc-Ago2 and is therefore a valuable tool for biochemical
analysis of human RISC.
Ago proteins are known to bind miRNAs (Peters and
Meister 2007; Hutvagner and Simard 2008). Ago complex
isolation followed by small RNA cloning and sequencing can
be a useful tool for small RNA profiling in different cell lines
or primary tissues, because Ago association indicates func-
tional small RNA classes and clearly discriminates them
from cellular RNA degradation products. Therefore, we ana-
lyzed if anti-Ago2(11A9) coimmunoprecipitates endogenous
miRNAs. HEK 293 lysates were subjected to immunopre-
cipitation using anti-Ago2(11A9) (Fig. 2B). The coprecipi-
tated RNA was separated by denaturing RNA PAGE and
analyzed by Northern blotting using a probe complementary
to miR-19b. MiR-19b was detectable in the total RNA
sample (Fig. 2B, lane 1) and in the anti-Ago2(11A9)
coimmunoprecipitate (Fig. 2B, lane 3). No miR-19b signal
was observed in the anti-Flag control immunoprecipitation
(Fig. 2B, lane 2). Similar results were obtained for many
other miRNAs present in HEK 293 cells (data not shown).
It has been reported earlier that human Ago2 is the
catalytic subunit of RISC (Liu et al. 2004; Meister et al.
2004). In order to analyze if anti-Ago2(11A9) immuno-
precipitates functional RISC from human cell lysates, we
performed in vitro cleavage assays (Fig. 2C). Ago2 was
immunoprecipitated from untreated HEK 293 cell lysates
using anti-Ago2(11A9) and incubated with a 32P-cap-
labeled substrate RNA containing a fully complementary
binding site for endogenous miR-19b. Strikingly, a specific
RISC cleavage product was observed only in the anti-
Ago2(11A9) immunoprecipitate (Fig. 2C, lane 5), whereas
no specific signal was detected in the control experiment
(Fig. 2C, lane 4). Finally, we investigated if RISC activity
can be reconstituted in vitro by using synthetic siRNAs
in combination with anti-Ago2(11A9) immunoprecipitates
(Fig. 2C). Endogenous Ago2 was immunoprecipitated
using our monoclonal antibody and subsequently loaded
with a synthetic single-stranded siRNA. The siRNA-primed
Ago2 complex was further incubated with a radiolabeled
target RNA containing a fully complementary target site
for the synthetic siRNA. The immunoprecipitated Ago2
cleaved the target RNA (Fig. 2C, lane 2), whereas no
specific cleavage signal was observed in the control immu-
noprecipitate (Fig. 2C, lane 1).
In summary, we have shown that our monoclonal anti-
Ago2(11A9) antibody discriminates between Ago2 and
other human Ago proteins in immunoprecipitation experi-
ments and immunoprecipitates active RISC from untreated
human cell lysates.
Native RISC isolation using peptide elution
Biochemical studies on RISC function such as kinetic
measurements or proteomics often require soluble and
pure complex isolations. This can be achieved by specific
FIGURE 2. Anti-Ago2(11A9) specifically immunoprecipitates hu-
man Ago2 and therefore RISC. (A) myc-Ago1 through myc-Ago4
were expressed in HEK 293 cells and immunoprecipitated with anti-
Ago2(11A9) (lanes 5–8). Immunoprecipitated proteins were analyzed
by Western blotting using anti-myc antibodies. (Lanes 1–4) 3% of the
lysate that has been used for the immunoprecipitations. (B) Endog-
enous Ago2 was immunoprecipitated from HEK 293 cell lysates using
anti-Ago2(11A9) (lane 3). Associated RNA was extracted and ana-
lyzed by Northern blotting using a probe specific for the endogenous
miR-19b (upper panel), while immunoprecipitated proteins were
analyzed by Western blotting using anti-Ago2(11A9) (lower panel).
An anti-Flag antibody served as negative control (lane 2). (Lane 1)
7.5% or 0.4% input. (C) Anti-Ago2(11A9) (lanes 2,5) or anti-Flag
antibodies (lanes 1,4) were used for immunoprecipitation from
untreated HEK 293 cell lysates. Immunoprecipitates were either pre-
incubated with a single-stranded siRNA (lanes 1,2) or directly used for
cleavage assays (lanes 4,5). 32P-cap-labeled RNAs containing comple-
mentary target sites for the siRNA (lanes 1–3) or endogenous miR-19b
(lanes 4–6) were used as RISC target RNAs. The cleavage products
were analyzed by denaturing RNA PAGE followed by autoradiogra-
phy. (T1 lanes) Nuclease T1 digestion of the substrate RNA. The small
RNA target sites are indicated (black bars to the right of the gels), and
the individual cleavage positions are marked (arrows). (Asterisks)
Unspecific degradation products.
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elution of affinity-captured proteins by adding a peptide
encompassing the antibody epitope. We therefore set out to
establish a protocol for native elution of Ago2 from the
anti-Ago2(11A9) antibody matrix (Fig. 3A). We expressed
FH-Ago2 in HEK 293 cells and immunoprecipitated tagged
Ago2 with anti-Ago2(11A9). After stringent washing, a
peptide encompassing the epitope of anti-Ago2(11A9) was
added to compete for antibody binding (Fig. 3A). After
90 min of incubation with the Ago2 peptide, a considerable
amount of bound Ago2 was eluted from the column (Fig.
3B, upper panel, lane 4), whereas no Ago2 was detected
when the competing peptide was omitted from the reaction
(Fig. 3B, middle panel). Similar results were obtained when
endogenous Ago2 was immunoprecipitated from wild-type
HEK 293 cells (Fig. 3B, lower panel). Since antibody inter-
actions are often sensitive to slight pH shifts, we repeated
the experiment described above using different pH condi-
tions to identify the optimal pH range for efficient elution
(Fig. 3C). Lowering the pH from 7.5 to 7.0 had only a minor
effect on the elution efficiency. However, at pH 8.0 almost
all bound Ago2 was eluted from the column, indicating that
RISC can be efficiently dissociated from the anti-
Ago2(11A9) antibody. We next investigated if RISC activity
is maintained during the above-mentioned elution proce-
dure (Fig. 3D). Therefore, peptide-eluted RISC was incubated
with a target RNA complementary to endogenous miR-19b,
and the cleavage products were analyzed by denaturing RNA
PAGE. Strikingly, only in the reaction where eluted RISC was
present was a specific cleavage product detectable (Fig. 3D,
lane 5), demonstrating that Ago2 complexes can be effi-
ciently eluted by peptide competition.
Anti-Ago2(11A9) detects Ago2
in immunofluorescence experiments
Cellular Ago localization studies using immunofluores-
cence have been performed using tagged and overexpressed
human Ago proteins or sera that have not been tested for
cross-reactivity with other Ago proteins (Jakymiw et al.
2005; Liu et al. 2005b; Meister et al. 2005; Sen and
Blau 2005). In order to find an antibody that specifically
recognizes endogenous Ago2, we tested anti-Ago2(11A9) in
immunofluorescence experiments using confocal micros-
copy (Fig. 4). HEK 293 (upper panels), HeLa (middle
panels), or RPE-1 cells (lower panels) were fixed and stained
with anti-Ago2(11A9) and anti-LSm4 antibodies. LSm4 is
a component of the cellular RNA degradation machinery
and served as a marker protein for P-bodies. In all three cell
types, anti-Ago(11A9) showed a diffuse cytoplasmic stain-
ing. Moreover, distinct cytoplasmic foci that can be co-
stained with anti-LSm4 antibodies and therefore indicate
P-bodies are clearly visible (white arrows). Only a very weak
background staining was observed when anti-Ago2(11A9)
was omitted from the experiment (Fig. 4, panels 13,14).
Interestingly, the confocal images from all three cell types
revealed a detectable nuclear staining. In order to rule out
that the nuclear signals are caused by anti-Ago2(11A9)
cross-reactivities observed in Western blots (Fig. 1B), we
performed an Ago2 knock down prior to anti-Ago2(11A9)
staining (Fig. 4B). Notably, both the cytoplasmic and the
nuclear staining disappeared after Ago2 knock down,
indicating that the signals observed in anti-Ago2(11A9)
stainings represent intracellular Ago2 localization.
DISCUSSION
Human RISC or Ago protein complexes have been purified
using different biochemical approaches. RISC has been
reconstituted on biotinylated siRNAs, or tagged Ago
FIGURE 3. Peptide elution of Ago2 from anti-Ago2(11A9) anti-
bodies. (A) Schematic representation of the experimental set up used
in B–D. (B) FH-Ago2 was expressed in HEK 293 cells and immuno-
precipitated using anti-Ago2(11A9). Antibody-bound Ago2 was
incubated with (panel i) or without (panel ii) addition of an Ago2
peptide encompassing the anti-Ago2(11A9) epitope for the indicated
time intervals. (Lane 6) Denaturing elution of remaining Ago2. In
panel iii, untransfected HEK 293 cell lysate was used. (C) Experiments
were performed as described in B using pH 7 (upper panel), pH 7.5
(middle panel), or pH 8 (lower panel) for elution. (D) Endogenous
Ago2 was immunoprecipitated with anti-Ago2(11A9) and eluted as
described in B. Eluates were incubated with a 32P-cap-labeled target
RNA complementary to endogenous miR-19b, and RISC cleavage
assays were performed as described in Fig. 2C. (Lower panel) Western
blot of the eluates.
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proteins were expressed and purified using affinity chro-
matography (Martinez et al. 2002; Gregory et al. 2005;
Maniataki and Mourelatos 2005; Meister et al. 2005; Hock
et al. 2007). Although these studies were very successful and
key discoveries have been made, such approaches are for
three main reasons not ideal. First,
overexpression of tagged Ago proteins
may cause artificial protein–protein
interactions. Second, tagging of proteins
may interfere with function. This has
not been observed for RISC activity
when Ago2 was N-terminally tagged.
However, it cannot be excluded that
the tag affects other as yet unknown
Ago2 functions. Third, and most impor-
tantly, tagged Ago proteins can only be
introduced into transfectable cell lines.
Very often, purification from primary
cells or even tissue samples is more
conclusive. Therefore, we have gener-
ated the monoclonal anti-Ago2(11A9)
antibody in order to be independent
of transfection and overexpression. We
show that our monoclonal antibody is
specific for Ago2 and does not react with
the other highly conserved human Ago
proteins. Moreover, anti-Ago2(11A9)
immunoprecipitates active RISC from
untreated cell lysates with high effi-
ciency, providing a useful tool for Ago2
complex isolation from cells or tissues.
In many affinity purification proto-
cols, the elution from the affinity matrix
is often a critical step, because denatur-
ing conditions often result in the elu-
tion of contaminants as well that bind
unspecifically to the column. Strikingly,
Ago2 can be efficiently eluted from the
anti-Ago2(11A9) antibody by adding a
peptide encompassing the epitope of the
antibody, thus competing for binding.
Various small RNA cloning and
sequencing approaches have been per-
formed in organisms as diverse as
plants, nematodes, flies, and mammals.
Most of these studies were aiming at
the identification of novel or differentially
regulated miRNAs. However, by clon-
ing from total RNA, cellular degrada-
tion products and other so far
unidentified classes of small RNAs are
cloned and sequenced as well. It is very
often difficult to distinguish between
degradation products and functional
classes of small RNAs. Therefore, we
suggest that small RNA cloning approaches should be
carried out from isolated Ago complexes, since associated
small RNAs are most likely functional. Our monoclonal
anti-Ago2 antibody provides a powerful tool for the iden-
tification of Ago2-associated functional small RNAs. Of
FIGURE 4. Anti-Ago2(11A9) detects endogenous Ago2 in immunofluorescence experiments.
(A) HEK 293 cells (panels 1–4,13–14), HeLa cells (panels 5–8), or RPE-1 cells (panels 9–12)
were fixed and stained with anti-Ago2(11A9) (panels 1,5,9,13) and anti-LSm4 antibodies
(panels 2,6,10). (Panels 3,7,11) Merged images, (panels 4,8,12,14) DAPI staining. In panels 13
and 14, anti-Ago2(11A9) was omitted from the experiment. (B) HeLa cells were transfected
with siRNAs against Ago2 (panels 19–22) or control siRNAs (panels 15–18). Cells were fixed
and stained with anti-Ago2(11A9) (panels 15,19) or anti-LSm4 antibodies (panels 16,20).
(Panels 18,22) DAPI stainings.
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course, for comprehensive studies on Ago-associated small
RNAs, potent antibodies directed against human Ago1,
Ago3, and Ago4 will have to be generated in the future.
Ago complex purifications have recently been used for
the identification of miRNA targets (Beitzinger et al. 2007;
Easow et al. 2007; Karginov et al. 2007). Together with
bioinformatic studies, such biochemical miRNA target
identification approaches will be widely used in the future.
In particular, more and more miRNA profiling studies
aiming for the identification of differentially expressed
miRNAs are carried out in many types of human tumors.
Our antibody therefore provides a tool for the identifica-
tion of miRNA targets from such cancerous human tissue.
Immunofluorescence studies revealed that human Ago
proteins localize to P-bodies (Jakymiw et al. 2005; Liu et al.
2005b; Meister et al. 2005; Sen and Blau 2005; Leung et al.
2006). In many studies, a diffuse cytoplasmic staining has
been observed as well. Due to the lack of potent anti-Ago
antibodies for immunofluorescence experiments, these
studies have been carried out using either tagged Ago
proteins or poorly characterized anti-Ago sera. Strikingly,
anti-Ago2(11A9) clearly detects Ago2 in P-bodies as well as
a diffuse Ago2 distribution in the cytoplasm. Surprisingly,
we also observed a nuclear staining with our antibody.
Since such nuclear stainings have not been observed before,
we performed an Ago2 knock down and found that both
the cytoplasmic and the nuclear staining was strongly
reduced. We conclude that the nuclear signal that we have
observed represents a nuclear Ago2 pool. Notably, small
RNAs as well as Ago proteins have indeed been implicated
in nuclear functions before. It has been shown that siRNAs
or miRNAs directed against nuclear RNAs guide efficient
RNAi in nuclear extracts (Meister et al. 2004; Robb et al.
2005). Moreover, it has been suggested that siRNAs as well
as Ago proteins guide transcriptional silencing processes
on specific promoters in the nucleus (Morris et al. 2004;
Janowski et al. 2006; Kim et al. 2006).
Taken together, we have generated a specific and efficient
antibody against human Ago2 that will be highly valuable
for the scientific community. Anti-Ago2(11A9) is available
from www.ascenion.de.
MATERIALS AND METHODS
Cell lines and plasmids
Plasmids encoding Flag/HA-tagged proteins were described pre-
viously (Meister et al. 2004). For the expression of myc-tagged
proteins, the corresponding cDNAs were cloned into a modified
pCS2 plasmid kindly provided by Olaf Stemmann (Max Planck
Institute of Biochemistry, Germany).
Cell culture and transfection
All cell lines used in this study were cultured in Dulbecco’s
modified Eagle’s medium (PAA) supplemented with glucose
(4.5 g/L) and 10% (v/v) fetal bovine serum (Biochrom AG) in
the presence of penicillin and streptomycin (Gibco).
After transfection by calcium phosphate procedure (Meister
et al. 2005), HEK 293 cells were grown for an additional 48 h in
5% CO2 atmosphere without medium exchange.
Extract preparations and Western blotting
For total cell extract, cells were scraped off the culture plates in
lysis buffer (20 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.5%
Nonidet P-40; 2 mM EDTA; 0.5 mM DTT; 1 mM NaF; and 1 mM
Pefablock [Roche]) and centrifuged for 10 min at 17,000g.
Cytoplasmic and nuclear extract preparation according to
Dignam et al. (1983) was modified as follows: Cells were trypsi-
nized, washed once in PBS, resuspended in five volumes of
hypotonic Roeder A buffer (10 mM HEPES, pH 7.9; 10 mM
KCl; 1.5 mM MgCl2; 0.5 mM DTT; and 1 mM Pefablock), and
incubated for 10 min on ice. Swollen cells were homogenized with
10 strokes in two volumes Roeder A buffer, and the homogenate
was centrifuged for 10 min at 900g. The remaining nuclei pellet
was washed once in PBS and subsequently homogenized with 15
strokes in Roeder C buffer (20 mM HEPES, pH 7.9; 420 mM KCl;
1.5 mM MgCl2; 0.5 mM DTT; 5% glycerine; 0.2 mM EDTA; and 1
mM Pefablock). Nuclear extract was cleared at 17,000g for 30 min.
For Western blot analysis, proteins were separated by 10% SDS-
PAGE and transferred onto nitrocellulose membrane (Amersham
Bioscience). Membranes were blocked for 30 min in Western blot
wash buffer (30 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.25% [v/v]
Tween-20) containing 10% (w/v) dry milk (Roth) and sub-
sequently treated with the corresponding antibodies. The mono-
clonal anti-Ago2(11A9) was generated in cooperation with E.
Kremmer as described previously (Beitzinger et al. 2007). Hybrid-
oma supernatant was diluted 1:50 for Western blotting. Com-
mercial antibodies additionally used include monoclonal anti-HA
antibody (HISS Diagnostics), monoclonal anti-myc antibody
(Abcam), and anti-S6 ribosomal protein antibody (Cell Signaling
Technologies), as well as peroxidase-conjugated secondary anti-rat
IgG antibody (Jackson Lab), anti-mouse IgG antibody (Sigma),
and anti-rabbit IgG antibody (Sigma). They were diluted accord-
ing to the manufacturers’ recommendations for Western blotting.
Immunoprecipitations and peptide
elution experiments
Tagged proteins were immunoprecipitated from total cell extract
using anti-Flag- or anti-myc-conjugated agarose beads (both
Sigma). For precipitation of untagged proteins, saturating
amounts of the corresponding antibodies were coupled to protein
G sepharose beads (Amersham Bioscience) for 2 h at 4°C prior to
immunoprecipitation.
Beads and an excess of total extract were incubated for 90 min
at 4°C under slight rotation. Precipitates were washed twice with
IP wash buffer (IPB; 50 mM Tris-HCl, pH 7.5; 300 mM NaCl;
5 mM Mg2Cl; and 0.05% Nonidet P-40), once with PBS, and
finally transferred to a new tube and resuspended in the appro-
priate buffer.
Native RISC was captured with anti-Ago2(11A9) bound to
protein G sepharose during a standard immunoprecipitation
procedure (see above) and stringently washed: Twice with IPB
containing 0.5 M NaCl, followed by a 40-min incubation in the
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presence of 360 mM NaCl at 4°C under rotation, and one final
washing with 0.5 M NaCl. RISC precipitates were equilibrated in
PBS and eluted with 100 mg of synthetic Ago2 peptide in IPB per
25 mL of beads at 25°C and 600 rpm for 90 min. Eluate was
collected with a polyprep column (Biorad) equilibrated with IPB.
Ago2 complexes that remained on the beads were finally eluted
with 0.1 M glycine pH 2.3 and neutralized immediately after with
1 M Tris-HCl, pH 8.0.
To test the effect of different pH values on RISC elution, Ago2
peptide was solved in IPB of the respective pH.
For time course experiments, the elution reaction was incu-
bated directly in the polyprep column. For each time point, the
eluate was collected and an aliquot stored at 20°C while the
remaining reaction mixture was re-added into the column.
In vitro RISC assays
Preparation of cap-32P-labeled RNA used as RISC substrate was
described earlier (Martinez et al. 2002). The sequence of the
exogenous siRNA used in Figure 2C is UCGAAGUAUUCCGC
GUACGUdT (Meister et al. 2004). Assays were performed with
40% (v/v) RISC either eluted or bound to beads in a total volume
of 25 mL with 40 mM KCl, 4 mMMg2Cl2, 5 mM DTT, 1 mM ATP,
0.2 mM GTP, and 1.2 U RiboLock RNase inhibitor (Fermentas).
After adding 1 mL of substrate RNA (1.5 Bq/cm2), samples were
incubated for 90 min at 30°C. RNA extraction and analysis was
described before (Meister et al. 2004).
Northern blotting
Total RNA was extracted from HEK 293 cells according to Lagos-
Quintana et al. (2001). Coimmunoprecipitated RNA was isolated
by Proteinase K (AppliChem) treatment, followed by two extrac-
tion steps using first acidic phenol and second chloroform. For
RNA precipitation, aqueous phase was mixed with three volumes
of absolute ethanol and incubated overnight at 20°C. Without
any additional washing, RNA was finally solved in formamide
loading dye, separated by electrophoresis on 15% denaturing
polyacrylamide gels, and transferred to Hybond-N membrane
(Amersham Bioscience) by semidry blotting for 25 min with 5 V.
Membranes were dried, UV treated, and incubated for 1 h at 80°C.
Prehybridization was performed in 53 SSC; 20 mM Na2HPO4,
pH 7.2; 7% (w/v) SDS; Denhardt’s solution (0.02% [w/v] bovine
serum albumin V; 0.02% [w/v] Polyvinylpyrrolidone K30; 0.02%
[w/v] Ficoll 400), and 0.1 mg/mL sonicated salmon sperm DNA
for 1 h at 45°C before a 59-32P-labeled probe (see below) was
added overnight. Subsequently, the membrane was washed in 10-
min intervals twice with 53 SSC; 1% (w/v) SDS and once with 1x
SSC; 1% (w/v) SDS. Exposure to Kodak BioMax MS films was
performed with an intensifying screen (Kodak) at 80°C.
For Northern probe preparation, 20 pmol synthetic DNA-
oligonucleotides (Metabion) reverse complementary to miR-19b
were radiolabeled in a T4-Polynucleotide kinase (Fermentas)
reaction in the presence of g-32P-ATP (GE Healthcare) according
to standard protocols and subsequently purified by gel filtration
using MicroSpin G-25 columns (Amersham Bioscience).
Immunofluorescence
Cells were grown to 60%–70% confluency on cover slips and fixed
with 3.7% formaldehyde in PBS. After 15 min of fixation, the
reaction was stopped by addition of 100 mM glycine solved in
PBS. Subsequently, cells were incubated 10 min in PBS with 3%
(w/v) bovine serum albumin (BSA, Roth) and 0.2% (v/v) Triton X
100 to make them permeable as well as to block unspecific
antibody binding. After rinsing with 0.1% (v/v) Tween-20 and
0.2% (w/v) BSA, primary antibodies were added for 1 h. After in-
tensive washing, secondary antibodies were added for another hour
in the dark. DNA was stained with DAPI at a final concentration of
1 mg/mL for a few minutes. Immunofluorescence was observed
and recorded using a LEICA TCS SP2 Confocal Laser Scanning
microscope and Leica Confocal Software softWoRx. Monoclonal
anti-LSm4 antibody was purchased from Geneway, FITC-conjugated
anti-chicken IgY antibody from Sigma, and TexasRed-conjugated
anti-rat IgG antibody from Vector Laboratories.
siRNA transfection
HeLa cells were reverse transfected with siRNAs in six-well plates
at 40 nM final concentration using RNAiMAX (Invitrogen),
according to the manufacturer’s instructions. After 2 d, cells were
seeded to cover slips in six-well plates. Cells were fixed 5 d post-
transfection and stained for Ago2 and LSm4 (see above). The
following siRNAs were used (sense, antisense): Ago2 siRNA, 59-
GCACGGAAGUCCAUCUGAAUU, 59-UUCAGAUGGACUUCC
GUGCUU; non-silencing control siRNA, 59-UUGUCUUGCAU
UCGACUAAUT, 59-UUAGUCGAAUGCAAGACAAUT.
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ABSTRACT
Studies of RNA interference (RNAi) provide evidence
that in addition to the well-characterized cytoplas-
mic mechanisms, nuclear mechanisms also exist.
The mechanism by which the nuclear RNA-induced
silencing complex (RISC) is formed in mammalian
cells, as well as the relationship between the RNA
silencing pathways in nuclear and cytoplasmic com-
partments is still unknown. Here we show by apply-
ing fluorescence correlation and cross-correlation
spectroscopy (FCS/FCCS) in vivo that two distinct
RISC exist: a large ~3MDa complex in the cytoplasm
and a 20-fold smaller complex of ~158kDa in the
nucleus. We further show that nuclear RISC, con-
sisting only of Ago2 and a short RNA, is loaded in
the cytoplasm and imported into the nucleus. The
loaded RISC accumulates in the nucleus depending
on the presence of a target, based on an miRNA-like
interaction with impaired cleavage of the cognate
RNA. Together, these results suggest a new RISC
shuttling mechanism between nucleus and cyto-
plasm ensuring concomitant gene regulation by
small RNAs in both compartments.
INTRODUCTION
Small RNAs have emerged as key regulators of gene
expression, acting in an evolutionary conserved group of
gene-silencing pathways found in eukaryotes (1–3). The
short 19–24 nucleotide (nt) long dsRNA silencing trig-
gers are produced from endogenous or exogenous dsRNA
substrates of various secondary structure (4–7).
Short interfering RNAs (siRNAs) consist of a dsRNA
with a stem of 19 nt containing a 50-phosphate and 2 nt
overhangs at both 30-ends (5,7). To function as targeting
cofactors, siRNAs are bound by the RISC-loading com-
plex (RLC) consisting of Dicer, TRBP and a member of
the Argonaute (Ago) family (6,8,9). The siRNA-duplexes
are separated into single strands as they assemble into an
Argonaute protein, the core of the RNA-induced-silencing
complex (RISC) (10). The RLC speciﬁcally incorporates
the strand with the lowest thermodynamic stability at
the 50-end of the duplex, termed ‘guide’ strand, into
Argonaute, thereby forming activated RISC whereas the
‘passenger’ strand is removed from the complex and
degraded (11–13). Depending on the extent of complemen-
tarity between the guide RNA and the target mRNA
sequence, in conjunction with the associated Argonaute
family member, RISC can silence gene expression by
endonucleolytic cleavage, translational repression, deade-
nylation, decapping and/or by translocation into P-bodies
(14–16). Furthermore, it has been shown that siRNAs as
well as the nuclear encoded miRNAs, another class of
small dsRNA silencing triggers, depend on Exp5 mediated
nuclear export for cytoplasmic localization and eﬃcient
silencing (17,18).
Nuclear functions for Ago proteins have also been
reported, such as in Schizosaccharomyces pombe, where
Ago is involved in heterochromatin formation to promote
transcriptional gene silencing and in other organisms
including plants, Drosophila and Caenorhabditis elegans
(19–21). Although Ago proteins have been found in cyto-
plasmic and nuclear extracts from mammalian cells, it
could not be excluded experimentally that the nuclear
extracts were contaminated by Ago proteins associated
with the nuclear envelope (22,23). Further indications
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for the presence of Ago proteins in the nucleus are that the
small nuclear RNAs (snRNAs) 7SK and U6 could be
knocked down with siRNAs (23). Also, it has been
shown that exogenously introduced siRNAs complemen-
tary to target sequences within gene promotors (agRNAs,
antigene siRNAs) can either inhibit (transcriptional gene
silencing, TGS) or activate gene transcription in an
Argonaute protein dependent manner in mammalian
cells (24–26). The Argonaute proteins bind to an antisense
transcript or extended 50-untranslated region of the
mRNA that overlaps the gene promoter thereby mediat-
ing the formation of complexes with proteins and
chromosomal DNA necessary for the activation of tran-
scription or TGS in mammalian cells (27,28). However,
endogenous, small dsRNA triggers involved in transcrip-
tion regulation still need to be identiﬁed. In addition, it is
unknown where the nuclear RISC is assembled and how
the cell ensures the nuclear localization of agRNA-loaded
RISC. The knowledge of the localization of its assembly,
e.g. whether nuclear RISC is speciﬁcally loaded inside the
nucleus or originates from cytoplasmic loaded RISC is
important to better understand RNAi-mediated gene reg-
ulation and the interconnection between the cytoplasmic
and nuclear RNAi pathways.
In this study, we used ﬂuorescence correlation spectros-
copy (FCS) and ﬂuorescence cross-correlation spectros-
copy (FCCS) to quantitatively analyse siRNA
incorporation levels in Ago2 proteins and RISC-complex
sizes concomitant in the cytoplasm and nucleus in vivo.
FCS and FCCS are highly sensitive and speciﬁc optical
techniques used for the study of dynamics and interactions
of individual ﬂuorescently labelled molecules in solution
or living cells (for details see Methods section and
Supplementary data) (29–31).
We provide the ﬁrst direct characterization of nuclear
RISC and show that cytoplasmic RNA-induced silencing
complex (cRISC) and nuclear RNA-induced silencing com-
plex (nRISC) are two, clearly distinguishable RISC
complexes in vivo. Analyzing the asymmetric incorporation
of ﬂuorescently labelled siRNAs into nRISC and cRISC,
we found that nRISC originates almost predominantly
from loaded cRISC. Consequently, nRISC and cRISC
are interconnected by the dynamic exchange of RISCs
between the cytoplasm and the nucleus.
MATERIALS AND METHODS
Cell culture
ER293 cells stably transfected with the pERV3 vector
(Stratagene) were cultured at 378C in DMEM (high glu-
cose, Sigma) with 10% FCS (PAA Laboratories GmbH),
2mM glutamine (Gibco) and 0.3mg/ml G418 (50mg/ml,
Gibco).
For the generation of the stable EGFP-Ago2 cell line,
the pEGSH-EGFP-Ago2 vector was linearized with AseI.
ER293 cells were seeded at 4 104 cells/ml, 24 h before
transfection. Transfection was carried out using linearized
DNA and Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s protocols. After 24 h cells were trea-
ted with 0.4mg/ml selection antibiotic Hygromycin B
(50mg/ml, Gibco) for 3 weeks. Cells were diluted to
1 cell/0.2ml and transferred onto 96-well plates for reclon-
ing. Wells with single colonies were cultured, resulting in
EGFP-Ago2 positive clones that were conﬁrmed via west-
ern blot, immunoﬂuorescence and PCR. The generated
cell line 10G stably expressing EGFP-Ago2 was cultured
at 378C in DMEM (high glucose, Sigma) with 10%
fetal calf serum, 2mM glutamine, 0.3mg/ml G418 and
0.4mg/ml Hygromycin B. All cells were regularly pas-
saged at subconﬂuency and were plated with 1–5 104
cells/ml density.
siRNA sequences and calculation of the 5’-end free energy
All siRNA strands were obtained from IBA GmbH.
The RNA oligonucleotides were synthesized with a
50-phosphate and a 30-amino group on a C6-carbon linker
and were labelled with Cy5 succinimidyl ester (Cy5-NHS,
Amersham Biosciences) as described previously (17). The
nucleotides 18–21 were 20-O-methyl modiﬁed to protect the
label from degradation except for silencing assays were the
siRNAs were not modiﬁed. Target-RNA and siRNA
sequences are listed in the Supplementary data.
For siRNA control experiments, we used SilencerTM
Negative control #2 (NegsiRNA) from Ambion.
The free energies of the ﬁrst 4 bp of each siRNA strand
of the duplex at the 50-end was calculated in kcal/mol by
using the nearest-neighbour method and the mfold
algorithm (32,33).
Microinjection
For microinjection, 7–9 104 ER293/10G cells were trans-
ferred onto MatTek chambers coated with Fibronectin
(25 mg/ml in PBS including CaCl2 and MgCl2, Roche)
24 h before microinjection. The micropipette (Femtotip
2, Eppendorf) is loaded with 1.5–4 mM labelled siRNAs
(WGA 2.25mg/ml, Biomeda) in 110mM K-gluconate;
18mM NaCl; 10mM HEPES pH 7.4 and 0.6mM
MgSO4. The micromanipulator consists of a FemtoJet
and InjectMan NI2 which is mounted directly on a micro-
scope. Working pressure for injection was between 25 and
80 hPa for 0.1 s and a holding pressure of 15 hPa.
Fluorescence correlation spectroscopy setup
Fluorescence correlation spectroscopy and laser scanning
microscopy (LSM) were carried out on a commercial
system consisting of a LSM510 and a ConfoCor3 (Zeiss,
Jena, Germany). The 488 nm line of a Ar-Ion laser and the
633 nm line of a HeNe laser were attenuated by an
acousto-optical tunable ﬁlter to 3.5 and 1.05 kW/cm2
and directed via a 488/633 dichroic mirror onto the back
aperture of a Zeiss C-Apochromat 40, N.A.=1.2, water
immersion objective. Fluorescence emission light was col-
lected by the same objective and split into two spectral
channels by a second dichroic (LP635). To remove any
residual laser light, a 505–610 nm bandpass or 655 nm
longpass emission ﬁlter, respectively, was employed. The
ﬂuorescence was recorded by avalanche photodiode detec-
tors (APDs) in each channel. For EGFP-Ago2 autocorre-
lation measurements, a mirror substituted the second
dichroic and a 505-nm longpass emission ﬁlter was used
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in a one channel setup. Out-of-plane ﬂuorescence was
reduced with a 70-mm pinhole. The ﬂuorescence signals
were software-correlated and evaluated with MATLAB
(Mathworks, Natick, MA, USA) by using weighted
Marquardt non-linear least-square ﬁtting routine.
Laser scanning microscopy was performed using the
APD’s of the ConfoCor3 on the same setup. Cell measure-
ments were performed in air-buﬀer (150mM NaCl,
20mM HEPES pH 7.4, 15mM glucose, 15 mg/ml BSA,
10mM trehalose, 5.4mM KCl, 0.85mM MgCl2, 0.7mM
CaCl2) at RT.
Preparation and fractionation of cell extracts
Fractionated cell extracts were prepared from 10G, 293
and ER293 cells from four conﬂuent T175 chambers
essentially performed as previously described by Robb
et al. (23). Sucrose gradients were exactly performed as
has been described in (34).
Immunoprecipitation
ER293 and 10G cells were lysed with IP buﬀer (0.5% NP-
40, 150mM KCl, 25mM Tris–HCl pH 7.5, 2mM EDTA,
1mM NaF, 0.5mMDTT, protease inhibitors, Roche) and
centrifuged at 10 000g for 10min. Extracts were incubated
with anti-GFP (Roche) or anti-p53 for 2 h at 48C.
Antibodies were pulled down with protein G Sepharose
4 fast ﬂow beads (GE Healthcare) for 1 h at 48C. Beads
were subsequently washed with buﬀer (0.1% NP-40,
300mM KCl, 25mM Tris–HCl pH 7.5, 2mM EDTA,
1mM NaF, 0.5mM DTT, protease inhibitors, Roche)
and with PBS.
Western blotting
For western blot analysis, the cells were lysed with 1.5
loading buﬀer for denaturating polyacrylamide gel
electrophoresis. For immunoblotting, proteins were run
on 7.5–10% PAGE and transferred onto Protran
Nitrocellulose Transfer Membrane (Schleicher &
Schuell). Antibodies: a-EGFP (Abcam ab290, 1 : 2000),
a-Ago2 clone 11A9 (1:50), a-GAPDH (Abcam 9484,
1:2000), a-Actin (Abcam AC15). Immunoreactive signals
were detected using ECLTM Western Blotting Detection
Reagents according to the manufacturer’s protocol
(Amersham Biosciences).
qPCR
Total RNA was isolated using the Prep Ease kit (USB,
USA), according to the manufacturer’s instructions, using
DNaseI digestion on column. cDNA was synthesized with
random hexamer primers from 2 mg of total RNA using
the First Strand cDNA synthesis kit (Fermentas, Canada),
according to the manufacturer’s protocol. qPCR was per-
formed on a MyiQ cycler (BioRad, USA) using the Mesa
Green qPCRmastermix (Eurogenetec, Belgium) with prim-
ers at 100 nM ﬁnal concentration and a two-step PCR pro-
tocol (5min initial denaturation at 958C, 40 cycles with 10 s
at 958C and 1min elongation at 608C). The primers were
(forward, reverse): GAPDH, 50 TGGTATCGTGGA
AGGACTCATGAC, 50 ATGCCAGTGAGCTTCCCGT
TCAGC; 7SK, 50 CCTGCTAGAACCTCCAAACAAG,
50 GCCTCATTTGGATGTGTCTG. Data were evaluated
using the Ct method.
RESULTS
To investigate RISC by FCS/FCCS in vivo, we created a
293 based cell line, in which hAgo2 is tagged with the
enhanced green ﬂuorescent protein (EGFP). For this
study, hAgo2 was chosen, because it has been demon-
strated that it is involved in nuclear RNAi, is associated
with siRNAs and miRNAs, endonucleolytically active and
that tagging hAgo2 on the N-terminus with EGFP had no
eﬀect on hAgo2 RNAi activity and sub-cellular localiza-
tion (35,36). The characterization of the newly generated
cell line 10G revealed that the EGFP-Ago2 protein
reproduces the enzymatic activity, protein/RNA interac-
tions, sub-cellular localization, expression level and
function of endogenous hAgo2 protein (Supplementary
Figure S1A–D).
Nuclear RISC differs from cytoplasmic RISC
Although the human RISC complex has been intensely
studied, the protein composition is still not entirely
clear, with reported molecular weights from 160 kDa
to 2MDa (37,38). The huge deviation in molecular
mass might depend on extract generation or on the experi-
mental procedure for their estimation. To avoid prepara-
tion artefacts, we measured hAgo2 containing RISC
complexes in thermal equilibrium in vivo in 10G cells
and determined the molecular mass of the individual
RISC in diﬀerent cellular compartments by FCS (for
details see Supplementary materials). The autocorrelation
curves of EGFP in 293 cells resulted in almost identical
diﬀusion times in the cytoplasm and the nucleus of
EGFP(cytopl)= (354 13)ms and EGFP(nucl)= (368 8) ms,
corresponding to a diﬀusion coeﬃcient of DEGFP(cytopl)=
(25.5 0.9) mm2/s and DEGFP(nucl)= (24.5 0.5) mm2/s,
indicating that the viscosity and therefore the motility is
approximately the same in both compartments
(Figure 1A) (39). In contrast, measurements in 10G cells
displayed a signiﬁcant diﬀerence in diﬀusion time for
EGFP-Ago2 between the cytoplasm (EGFP-Ago2(cytopl)=
(1678 58)ms, DEGFP-Ago2(cytopl)= (5.4 0.2) mm2/s) and
the nucleus (EGFP-Ago2(nucl)= (657 22)ms, DEGFP-
Ago2(nucl)= (13.7 0.5) mm2/s). With respect to EGFP,
these diﬀusion times correspond to a molecular weight
of (3.0 0.6)MDa for cRISC and (158 26) kDa for
nRISC. While the obtained molecular weight for cRISC
is in the range of a previously isolated RISC of about
2MDa (37), the molecular weight of nRISC resembles
almost the distinct EGFP-Ago2 alone. It should be
noted that the molecular mass for cRISC could be over-
estimated due to a higher eﬀective viscosity a larger mole-
cule experiences in a crowded environment. Yet, due to
the 20-fold diﬀerence in molecular mass, we conclude
that cRISC represents a diﬀerent complex compared to
nRISC. Further analyses of the measurements indicate
that within the accuracy of the FCS technique no distinct
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EGFP-Ago2 is present in the cytoplasm (Supplementary
data).
Western blot analysis of nuclear and cytoplasmic 10G-
extracts with an EGFP-speciﬁc antibody yielded a single
speciﬁc band for EGFP-Ago2 at 130 kDa, demonstrating
the absence of contaminating EGFP-Ago2 fragments in
the nucleus (Figure 1B). Therefore, nRISC is not formed
by a truncated version of EGFP-Ago2. To corroborate the
FCS data, sucrose gradients with nuclear and cytoplasmic
extracts from 293 cells were performed. The cytoplasmic
extracts displayed the aforementioned hAgo2 containing
complexes I–III with a large portion of complexes being
bigger than 350 kDa. The large complexes II–III were
missing in nuclear extracts (Figure 1C). The same result
was obtained for hAgo1 (data not shown). The discrep-
ancy between the obtained molecular weights and the pro-
portions of diﬀerent RISC in sucrose density gradients
and FCS measurements lie within the diﬀerent experimen-
tal techniques. Whereas FCS is a real-time acquisition
technique in vivo, the gradient extract preparation includes
a centrifugation step which excludes the analysis of high
molecular weight complexes. Furthermore, the sucrose
gradients are performed over a period of 20 h which
might lead to the disassembly of the majority of RISC
complexes. However, the results obtained by FCS are sup-
ported by sucrose gradients illustrating the absence of
higher molecular weight complexes in the nucleus.
To characterize the sub-cellular distribution of hAgo2
containing complexes, we quantiﬁed the amount of
EGFP-Ago2 in the nucleus and the cytoplasm by FCS
and imaging. EGFP-Ago2 preferentially localized to the
cytoplasm with a cytoplasmic to nuclear ratio of
(4.2 0.5) : 1 determined by FCS and (4.7 0.5) : 1 deter-
mined by imaging (for details see Supplementary materi-
als). The higher value for imaging might be caused by the
accumulation of EGFP-Ago2 into P-bodies, which are not
accessible with FCS.
We could directly characterize RISC sizes in the nucleus
in thermal equilibrium by FCS in vivo without preparation
artefacts and contaminations by cRISC. Our data demon-
strate that cytoplasmic EGFP-Ago2 is part of a large
complex and diﬀers from nRISC which most probably
represents the discrete EGFP-Ago2 protein. We obtained
a cytoplasmic to nuclear EGFP-Ago2 concentration of
4–5, indicating that hAgo2 is not as underrepresented
in the nucleus as estimated by previous imaging studies.
This might result from the high expression levels in tran-
sient systems in previous reports, compared to the almost
endogenous expression levels of EGFP-Ago2 in 10G
cells (35,36).
Asymmetric guide strand incorporation into
nuclear and cytoplasmic RISC
The incorporation of siRNAs into nRISC and the eﬀects
of target interactions on the distribution of activated
RISC in the cytoplasm and the nucleus in mammalian
cells are largely unknown. To assess siRNA incorporation
levels and asymmetric loading of the guide strand into
RISC by FCCS in vivo (for details see Supplementary
materials), we covalently labelled siRNAs on the 30-end
of the guide or passenger strand with Cy5 (illustrated in
Figure 2C and D top) and delivered them directly into
10G cells via microinjection to avoid siRNA segregation
within endocytic compartments. This resulted in silencing
active and homogeneous localized cytoplasmic siRNAs
required for FCCS (17). The siRNA siTK3 targets the
mRNA of Renilla luciferase encoded on the plasmid
pRL-TK. The 50-end hybridization energy of siTK3 was
calculated as described (12) to deﬁne the guide and pas-
senger strand of the siTK3 duplex (Figure 2A). The siTK3
siRNA was used as it displayed high levels of Renilla
luciferase silencing, demonstrating the incorporation of
the guide strand into endogenous RISC (Figure 2B).
Microinjection of the passenger strand labelled siTK3
resulted in cross-correlation amplitudes between 0% and
5% in the cytoplasm and nucleus up to 12 h, indicating the
exclusion of the passenger strand from RISC (Figure 2C).
On the contrary, guide strand labelled siTK3 lead to sig-
niﬁcant cross-correlation amplitudes in the nucleus and
the cytoplasm gradually increasing for up to 6 h with a
slight decline thereafter (Figure 2D). As the relative ampli-
tude of the cross-correlation function is directly propor-
tional to the concentration of double labelled species, this
result demonstrates the speciﬁc incorporation of the guide
strand into nuclear and cytoplasmic RISC whereas the
passenger strand is excluded during the loading process.
The speciﬁc incorporation of the guide strand could be
Figure 1. Nuclear RISC diﬀers from cytoplasmic RISC. (A) Normal-
ized FCS curves of EGFP-Ago2 as measured in the nucleus (dashed
black line) and cytoplasm (black line) of 10G cells. The graph exhibits
the autocorrelation functions G() at lag time  (for more details on
FCS and the autocorrelation function see Supplementary materials).
Curves are the average of at least 10 measurements. As control, FCS
curves were recorded for EGFP alone in ER293 cells (nucleus: green
dashed line, cytoplasm: green line). (B) Western blot of 10G nuclear
and cytoplasmic extracts for EGFP-Ago2. To show the purity of the
nuclear and cytoplasmic fractions, western blot analysis was performed
with a-Cyclin T1 and a-GAPDH antibody. (C) HEK 293 cytoplasmic
and nuclear extracts were separated by sucrose density centrifugation
under conditions that allow the separation of diﬀerent hAgo2 contain-
ing mRNPs that were analysed by western blot with speciﬁc a-hAgo2
antibody.
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observed down to a 50-hybridization energy diﬀerence of
0.5 kcal/mol (siGL2) (data not shown). Interestingly, the
incorporation levels in the nucleus and the cytoplasm syn-
chronistically increased and declined, in the nucleus
however to a lower level, reaching saturation after 6 h
(Figure 2D, bottom panel). Similar results were obtained
with other siRNAs: siTK2 (Supplementary Figure S3),
siRNA targeting Fireﬂy luciferase (siGL2) and
siGAPDH (data not shown). Guide strand labelled
siRNAs could be examined for longer time periods com-
pared to passenger strand labelled siRNAs, due to the loss
of the Cy5 signal in passenger strand containing cells. This
most probably results from a stabilization of the guide
strand caused by the interaction with RISC whereas the
passenger strand gets degraded. Control experiments with
EGFP supplemented with guide strand labelled siTK3
exhibited no cross-correlation amplitude, whereas a
double labelled control resulted in 80% cross-correlation
amplitude in vitro (Supplementary Figure S4A and B).
For the ﬁrst time, we could monitor the asymmetry
dependent incorporation into nRISC and show that
nuclear levels of guide strand incorporation correlate
with cytoplasmic incorporation levels in time in vivo.
The speciﬁc guide strand incorporation into nRISC pro-
vides additional evidence for the speciﬁc loading and func-
tion of nRISC.
nRISC loading levels are affected by target RNA
interactions
The snRNA 7SK can be speciﬁcally silenced with an
siRNA (23). In the previous section, we showed that
siRNAs can be detected in nRISC independently of
endogenous targets. To elucidate the eﬀect of a nuclear
target, we microinjected guide or passenger strand labelled
si7SK1 (23) targeting 7SK snRNA. In conformity with
our previous experiments, the asymmetric incorporation
of the guide strand into cytoplasmic and nuclear RISC
was observed, whereas the passenger strand was excluded
from both complexes (Figure 3A). Interestingly, the
si7SK1 loaded RISC accumulated much stronger in the
nucleus between 1 h and 6 h after microinjection compared
to all siRNAs tested (Figure 3A and B). Knock down of
7SK snRNA with two unrelated siRNAs 48 h before
microinjection resulted in a decrease in cross-correlation
amplitude that resembles the values of siTK3 (Figure 3C)
and other siRNAs (data not shown) indicating a target
dependent si7SK1-loaded RISC accumulation in the
nucleus. A control transfection with NegsiRNA did
not aﬀect si7SK1-RISC accumulation in the nucleus
(Figure 3C). Interestingly, another siRNA targeting
7SK snRNA (si7SK2) did not result in increased cross-
correlation amplitudes in the nucleus, suggesting that the
presence of a nuclear target per se is not suﬃcient for
target dependent nRISC accumulation (Figure 3B and
C). The target sites of the two siRNAs within 7SK
snRNA structure are diﬀerent (40), si7SK1 hybridizes
with its seed sequence in a single stranded loop where
the cleavage site is masked in a dsRNA stretch, whereas
si7SK2 binds to a relatively unstructured part of 7SK
snRNA (Figure 3D). By analyzing the silencing eﬃciency
of si7SK1 and 2, we found that si7SK2 silences 7SK
snRNA down to 20% whereas si7SK1 resulted in 60%
of relative 7SK levels (Figure 3E). It has been shown that
dsRNA structures in close proximity to the cleavage site
from the 30-end inhibit cleavage (41). Furthermore, a
target site in a small loop structure leads to steric problems
resulting in reduced cleavage rates. These results are con-
sistent with our silencing data (Figure 3E). To test the idea
that binding of RISC to its target RNA without endonu-
cleolytic cleavage leads to accumulation of loaded RISC in
the nucleus, we compared an siRNA forming a central
bulge (si7SK3-bulge) with the target site in an unstruc-
tured part of the 7SK snRNA to its perfect matching
siRNA (si7SK3). The silencing eﬃciencies of the two
siRNAs were analysed by qRT-PCR. Si7SK3 eﬃciently
Figure 2. Asymmetric guide strand incorporation into nuclear and
cytoplasmic RISC. (A) Illustration of the sequence and free energies
of the siRNA siTk3. To follow the incorporation of the individual
strands, the duplexes were either labelled on the 30-end of the guide
or passenger strand. (B) ER293 cells were transfected with the indicated
amounts of siTK3 or NegsiRNA together with the ﬁxed concentration
of the pGL2-control and pRL-TK reporter plasmids. After 48 h, the
ratios of target to control luciferase concentrations were normalized
to the NegsiRNA control indicated in dark grey; siTK3 is indicated
in grey. The plotted data were averaged from three diﬀerent
experimentsSD. (C) Normalized cross-correlation curves of EGFP-
Ago2 and the labelled passenger strand of siTK3 in the cytoplasm for
diﬀerent incubation times after microinjection in 10G cells in vivo (top).
Curves are the average of at least 10 measurements. The resulting cross-
correlation amplitudes in the cytoplasm (ﬁlled boxes) and nucleus
(open circles) are displayed in the bottom graph. (D) Normalized
cross-correlation curves for the labelled guide strand of siTK3 in
the cytoplasm (top). The bottom graph depicts the resulting cross-
correlation for diﬀerent incubation times in the cytoplasm (ﬁlled
boxes) and nucleus (open circles) as indicated by the cartoon. Data
are represented as mean SEM.
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silenced 7SK down to 16% whereas a central mismatch at
position 9–11 completely impaired silencing (si7SK3-
bulge; Figure 3E). Evaluation of the incorporation levels
in the cytoplasm and the nucleus also displayed the accu-
mulation of silencing impaired si7SK3-bulge loaded RISC
in the nucleus, whereas the perfect match siRNA resulted
in a 2-fold lower cross-correlation amplitude inside the
nucleus. The cytoplasmic incorporation levels were not
aﬀected (Figure 3F). Additionally, the inhibition of
target RNA cleavage by the si7SK3-bulge resulted in
higher incorporation levels in the nucleus compared to
the si7SK1 for incubation times longer than 6 h (Supple-
mentary Figure S5A). The si7SK1 nuclear cross-correla-
tion amplitude decreased after 6 h, a result of reduced
levels of 7SK RNA due to the marginal silencing activity
of si7SK1 during the time course compared to si7SK3-
bulge with impaired cleavage. The analysis of the cytoplas-
mic to nuclear ratio of EGFP-Ago2 concentration did not
show signiﬁcant changes that can be related to the accu-
mulation of EGFP-Ago2 loaded with si7SK3 and si7SK3-
bulge siRNA in the nucleus (Supplementary Figure S5B).
Therefore, we could show that EGFP-Ago2 levels remain
stable, leading only to the accumulation of the particularly
loaded RISCs in the nucleus.
We also analysed the sub-cellular localization of si7SK1
in living cells by quantifying ﬂuorescence intensity.
We could not detect increased levels of si7SK1 RNA
labelled on either strands in the nucleus of 10G or
ER293 cells compared to other siRNAs (Supplementary
Figure S5C). The analysis of siRNA sub-cellular localiza-
tion by imaging does not correlate with target RNA loca-
lization, since the majority of siRNAs is not bound by the
RLC/RISC and therefore the sub-cellular localization is
mainly aﬀected by Exp5 mediated export illustrated by
siRNA incorporation levels of <35%.
Taken together, our data show that nRISC loaded with
a speciﬁc guide RNA can accumulate in a target and dura-
tion of the interaction dependent fashion, indicating that
this process is dynamic and does not result from a stable
fraction of RISC in the nucleus. The nuclear hAgo2 pro-
tein concentration seems to be highly regulated, since a
2-fold increase of speciﬁcally loaded nRISC did not
change the overall cytoplasmic to nuclear concentration
ratio of EGFP-Ago2.
Cleavage impaired RISC-target interactions
mediate RISC accumulation in the nucleus
To directly investigate the eﬀect of RISC-target-RNA
interactions in the nucleus and cytoplasm by FCCS, we
microinjected a 50 nt long RNA into 10G cells that is
labelled with Cy5 on the 50-end, contains the siTK3
target site and is modiﬁed with 20-O-methyl on each end
Figure 3. nRISC loading levels are aﬀected by target RNA interactions. (A) Cross-correlation amplitude in the cytoplasm (ﬁlled boxes) and nucleus
(open circles) of the nuclear targeting siRNA 7SK1 for diﬀerent incubation times. Values were obtained by either labelling the guide strand (blue) or
passenger strand (grey) and measuring in at least 10 cells. The sequence and free energies of the siRNA is illustrated. (B) Cross-correlation
experiments of the nuclear targeting siRNA 7SK1 as shown in (A), graphed as ratio of the cross correlation in the nucleus over the cross-correlation
in the cytoplasm. In addition, the ratios of other tested siRNAs are plotted. (C) Target speciﬁcity of the nuclear accumulation of the siRNA 7SK1.
Plotted are the cross-correlation ratios nucleus to cytoplasm after 3 h of incubation for 7SK1 and for 7SK1 after the transfection (48 h) of a
NegsiRNA, the siRNA 7SK2 and 7SK3. Additionally, the ratios for si7SK2 and siTK3 are depicted for comparison. (D) Schematic overview of
the target sites of the used 7SK siRNAs used to analyse the inﬂuence of target interaction. (E) Quantitative PCR (qPCR) analysis of 7SK snRNA
knockdown with diﬀerent indicated siRNA duplexes. (F) Cross-correlation amplitude in the cytoplasm (ﬁlled bars) and nucleus (open bars) after 3 h
of incubation for the siRNAs 7SK1, 7SK3-bulge, 7SK3, 7SK2 and for comparison GAPDH. Mean values SEM.
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to protect the target-RNA molecule against cellular
RNases. The interaction of the EGFP-labelled RISC con-
taining an unlabelled siRNA with the target-RNA can
then be visualized by increased cross-correlation ampli-
tudes (Figure 4A). The target-RNA localized to the cyto-
plasm and displayed a slight accumulation of ﬂuorescence
signal in the nucleus and even stronger in nucleolar struc-
tures (Figure 4B). FCCS measurements in non-transfected
and NegsiRNA transfected 10G cells after 1 and 3 h of
target-RNA delivery showed no interaction of RISC
with the target-RNA illustrating assay speciﬁcity and the
absence of miRNA target sites within the target-RNA
(Figure 4C). Longer incubation times were not tested as
already 30% of target-RNA was degraded after 3 h in S20
extracts as determined by PAGE (data not shown).
Despite that, transfection of perfectly matching siTK3
resulted in very low levels of EGFP-Ago2-target-RNA
interactions (Figure 5C). In contrast, transfection of
siTK3-B2 which forms a central bulge with the siTK3-
target site yielded high levels of RISC-bound target-
RNA in the cytoplasm. In the nucleus however, levels
were 3-fold lower after 1 h with an increase after 2 and
3 h almost reaching cytoplasmic interaction levels
(Figure 4C). The complete inactivation of the siTK3-B2
cleavage activity was veriﬁed by a dual luciferase assay
(Figure 4D).
These results demonstrate (i) the localization of func-
tional guide strand loaded RISC to the nucleus, (ii) the
short interaction time of RISC loaded with a perfectly
matching guide strand with the target-RNA and that
(iii) bulges in the centre of the guide-target-RNA hybridi-
zations increase the lifetime of RISC-target-RNA interac-
tion, resulting in the accumulation of the complex in the
nucleus over time. This is in strong agreement with our
previous results showing the accumulation of speciﬁcally
loaded RISC in a target- and duration of the interaction
dependent fashion. Therefore, the target-dependent accu-
mulation of nRISC is caused by the stable interaction of
RISC with its target and not by the nuclear localization of
Figure 4. Cleavage impaired RISC-target interactions mediate RISC
accumulation in the nucleus. (A) An outline of the experiment is illu-
strated. EGFP-Ago2 serves as a ﬂuorescent label for RISC that can
interact with the Cy5 labelled target-RNA. The interaction with the
target-RNA is determined by FCCS in vivo. (B) LSM images of a
target-RNA microinjected 10G cell (green: EGFP-Ago2, red: target-
RNA, right panel: overlay). Scale bars indicate 10 mm. (C) Cross-
correlation measurements were performed 1 or 3 h after microinjection.
Data are represented as mean SEM, ﬁlled bars indicate measurements
in the cytoplasm, open bars in the nucleus. (D) ER293 cells were
transfected with the indicated amounts of NegsiRNA, siTK3 and
siTK3-B2 together with the ﬁxed concentration of the pGL2-Control
and pRL-TK reporter plasmids. After 48 h, the ratios of target to
control luciferase concentrations were normalized to the NegsiRNA
control (black); siTK3-B2 (grey) and siTK3 (white). The plotted data
were averaged from three diﬀerent experiments SD.
Figure 5. Nuclear activated RISC originates from the cytoplasm. The
incorporation of the guide strand of 7SK1 into RISC was measured for
a cytoplasmic microinjection, a cytoplasmic injection together with
wheat germ agglutinin (WGA) to inhibit active transport through the
nuclear pore and a nuclear injection of 7SK1 and WGA. LSM images
(red: Cy5, green: EGFP, yellow: overlay) and cross-correlation mea-
surement were taken 3 h after incubation. Scale bars indicated 10 mm,
data are represented as mean SEM; ﬁlled bars indicate measurement
in the cytoplasm, open bars in the nucleus.
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7SK snRNA, again underlining the dynamic levels of spe-
ciﬁcally loaded nRISC.
Nuclear activated RISC originates from the cytoplasm
The fact that we could detect a target dependent accumu-
lation of nRISC raises the question of the origination of
nRISC. Two mechanisms are possible: First, RISC is
loaded both inside the nucleus and the cytoplasm or
second, RISC is loaded in the cytoplasm and can than
be imported into the nucleus to regulate gene expres-
sion/function. The ﬁrst hypothesis is less likely for several
reasons. The nRISC that was characterized by FCS in vivo
displayed a molecular mass of 158 kDa which is too
small for the RLC (containing EGFP-Ago2, TRBP and
Dicer which should result in a complex of approximately
380 kDa). In addition, siRNAs are too short to contain
localization signals, therefore the RLC is incapable to
locate the appropriate cellular compartment for individual
silencing triggers until RISC interacts with its target RNA.
And last, miRNAs and siRNAs depend on their cytoplas-
mic localization, mediated by Exp5, for eﬀective silencing
to occur (17,18,42). To elucidate the cytoplasmic origin of
nRISC, we microinjected si7SK1 into the cytoplasm of
10G cells and allowed for exchange between nucleus and
cytoplasm. This resulted in a preferential cytoplasmic
localization of the siRNAs with 24% of EGFP-Ago2
loading levels in the cytoplasm with the corresponding
nuclear levels of 21% after 3 h (Figure 5). In the second
experiment, we microinjected siRNAs into the cytoplasm
together with wheat germ agglutinin (WGA), an inhibitor
of nuclear pore-mediated active transport. The sub-
cellular localization of the siRNAs was still preferentially
in the cytoplasm, but due to their small size could still be
detected in the nucleus (Figure 5). The cytoplasmic incor-
poration levels were unaﬀected compared to WGA-free
microinjected cells showing that WGA did not interfere
with the RISC loading process. The nuclear incorporation
level decreased 3-fold down to 7%, indicating that most
of nRISC is originating from the cytoplasm. The same
decrease in EGFP-Ago2 nuclear incorporation levels
were detected by nuclear microinjection of si7SK1
together with WGA. The drop of loaded EGFP-Ago2
with si7SK1 in the cytoplasm results from reduced
siRNA levels in the cytoplasm mediated by WGA. The
preferential delivery of siRNAs via microinjection into
the nucleus could be detected by the higher ﬂuorescence
intensity in the nucleus in comparison with the cytoplasm
(Figure 5). The same results were obtained for si7SK3-
bulge (Supplementary Figure S6). The inhibitory function
of injected WGA on import and export processes was
veriﬁed with the stress kinase Mk2 tagged with EGFP.
Upon stress this predominantly nuclear protein shuttles
into the cytoplasm (43). We could show that EGFP-
MK2 shuttles into the cytoplasm after treatments with
Anisomycin for 3 h that could be stopped with the addi-
tion of Leptomycin B which is an inhibitor of the exporter
of MK2 (Supplementary Figure S7A, upper panel and
S7B). The microinjection with WGA inhibited the
export of EGFP-MK2 very eﬃciently (Supplementary
Figure S7A, bottom panel and S7B). Treatment with
cycloheximide did not change incorporation levels of
EGFP-Ago2 in the nucleus, thereby excluding that the
accumulation of speciﬁcally loaded RISC in the nucleus
results from de novo synthesis of EGFP-Ago2 which is
transported in the nucleus and subsequently loaded
(Supplementary Figure S8).
Our results show that RISC is loaded in the cytoplasm
and is imported into the nucleus. Therefore, the RLC is
strictly localized in the cytoplasm. The accumulation of
the si7SK1 and si7SK3-bulge siRNA indicates a dynamic
exchange of RISC between the nucleus and the cytoplasm.
Furthermore, the interaction with the target RNA seems
to interfere with the export of RISC leading to the accu-
mulation of this particularly loaded RISC in the nucleus.
RISC shuttling between the cytoplasm and the nucleus
represents a mechanism to access targets in both cellular
compartments.
DISCUSSION
To summarize our ﬁndings, we propose the following
model for human RISC loading and shuttling between
the cytoplasm and the nucleus (Figure 6). (i) We could
show for the ﬁrst time that the RLC is localized and inter-
acts with siRNAs/miRNAs exclusively in the cytoplasm.
This is supported by Exp5 mediated nuclear export of
small dsRNAs that actively reduces the concentration of
silencing triggers in the nucleus and hence would lower the
loading eﬃciency of nRISC (17,18). Consequently,
miRNAs as well as siRNAs depend on the cytoplasmic
localization for eﬃcient silencing activity. The RLC
senses the asymmetry of the duplex and speciﬁcally incor-
porates the guide strand into hAgo2, thereby forming
cRISC. This process seems to be regulated, as FCCS mea-
surements immediately after microinjection yielded low
Figure 6. Model for human RISC loading and shuttling between the
cytoplasm and the nucleus. (i) Asymmetric guide-strand incorporation
is localized to the cytoplasm only, (ii) Guide-strand mediated target
recognition in the cytoplasm, (iii) A perfect match results in RISC
mediated target degradation, (iv) A fraction of cytoplasmic loaded
RISC is imported into the nucleus to ensure cell wide target regulation.
Cytoplasmic co-factors dissociate from hAgo2 protein, thereby forming
nRISC, (v) Guide-strand mediated target recognition in the nucleus.
A perfect RISC-target interaction leads to free RISC which can be
exported into the cytoplasm, and (vi) whereas a miRNA-like interac-
tion leads to the accumulation of RISC in the nucleus resulting in
eﬃcient regulation in the nucleus.
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levels of loaded RISC. Most of the guide strands were
incorporated within the ﬁrst 3–12 h, followed by a decline
for longer incubation times. (ii) We proved that the major-
ity of activated cRISC remains in the cytoplasm as a com-
plex of 3MDa to regulate gene expression of mRNAs.
(iii) In case of perfectly priming guide strands to target
RNAs, cRISC catalyses RNA degradation. For
miRNAs, cRISC remains bound to the mRNA to
regulate its expression and/or translocation to P-bodies.
(iv) Our results indicate a partial translocation of acti-
vated cRISC into the nucleoplasm thereby forming
nRISC of 158 kDa, most likely composed of only
hAgo2. We were not able to monitor whether EGFP-
Ago2 loses the RLC components Dicer, TRBP and
other factors before or during the translocation, but
RLC disassembly after guide strand incorporation is sup-
ported by previous reports in vitro (44,45). The partial
translocation of loaded hAgo2 is in agreement with the
ﬁndings by Robb et al. (23) who observed cleavage activity
in cytoplasmic and nuclear extracts. (v) In contrast to
Robb et al., we were able to directly compare guide
strand incorporation levels with hAgo2 concentration
and intracellular localization as well as the interaction
dynamics of RISC with its target RNA. We therefore
could demonstrate that perfectly priming guide-target
RNA hybridizations lead to target RNA cleavage, imme-
diately causing RISC-target RNA-complex disassembly,
resulting in free nRISC which is in agreement with the
kinetic analysis of minimal RISC in vitro (41). (vi) On
the contrary, cleavage impaired nRISC, e.g. caused by
dsRNA regions or bulges, results in the accumulation of
this particularly loaded RISC in the nucleus, facilitated by
its prolonged interaction with the target RNA. Due to the
artiﬁcially induced target-RNA-RISC accumulation, we
can exclude that the target dependent accumulation of
nRISC is facilitated by the strict nuclear localization of
7SK snRNA and therefore results from the stable interac-
tion of RISC with its target. Since we never detected a
concentration increase of nRISC, we reason that a stable
equilibrium between n- and cRISC exists that is shifted for
a particularly loaded nRISC depending on the target
interaction.
Taken together, our results propose a RISC exchange/
shuttling mechanism between the cytoplasm and the
nucleus. Due to the absence of nuclear localization signals
in siRNAs and miRNAs, this shuttling mechanism ensures
the accessibility of activated RISC to target containing
cellular compartments. The shuttling of hAgo2 into the
nucleus also explains why agRNAs can function in the
nucleus. Due to the identical localization patterns of
hAgo1 and hAgo2 (23), we propose that nuclear hAgo1
also originates from the cytoplasm to mediate transcrip-
tion activation or TGS. In agreement with our model, the
ﬁndings that also let-7 miRNA is incorporated into
nuclear hAgo2 and that computational approaches
showed that many identiﬁed miRNAs have substantial
complementarity to sequences within gene promotors pro-
vide further evidence for the existence of an endogenous
RNA-mediated transcription regulation machinery origi-
nating from cytoplasmic activated Argonaute proteins
(23,28).
In a previous report, Berezhna and colleagues observed
by confocal imaging that siRNAs targeting 7SK and U6
snRNAs localize into the nucleus as duplexes whereas an
siRNA targeting cytoplasmic hepatitis C virus replicon
RNA dissociates into the cytoplasmic localized guide
strand and a degraded passenger strand after transfection.
From this Berezhna et al. (46) concluded the existence of a
mechanism by which the RISC-loading machinery orches-
trates a target-determined localization of siRNAs and pro-
vide evidence for RISC-loading in the nucleus. In contrast
to their ﬁndings, we showed that the analysis of siRNA
sub-cellular localization by imaging is mainly aﬀected by
Exp5 mediated export, since the majority of siRNAs is not
bound by the RLC/RISC thereby excluding a target-deter-
mined localization. Further arguing against the target-
determined siRNA localization hypothesis is the stable
hAgo2 concentration that we observed in the nucleus inde-
pendent of the incorporated guide strand and our direct
evidence for exclusive cytoplasmic RISC-loading. In addi-
tion, RISC has been shown to identify its target and
deﬁnes the silencing mode after the removal of the passen-
ger strand depending on the complementarity to its target,
supporting our observations (47). The localization of the
complete siRNA duplex in the nucleus, as observed by
Berezhna et al., would imply that the RLC is able to
sense whether the bound siRNA duplex has a nuclear or
cytoplasmic target. However, siRNAs are only bound
brieﬂy to the RLC in form of a duplex as we could not
detect signiﬁcant levels of incorporated passenger strand
in neither RISCs. Findings by Robb et al. (23) also
showed the target independent localization of guide
RNAs in nuclear extracts. In addition, we showed that
nRISC consists of a distinct hAgo2 protein that cannot
bind dsRNA (48).
Underlining our model, it was shown that miR-138 is
restricted to distinct cell types, whereas its precursor pre-
miR-138-2 is ubiquitously expressed and cytoplasmically
localized, thus showing the regulation on the post-
transcriptional level in the cytoplasm (49). In combination
with our results that the RLC is restricted to the cyto-
plasm, this post-transcriptional control of miRNA
maturation in the cytoplasm applies to the regulation of
guide strand incorporation into c- and nRISC.
As the interaction of nRISC with its target seems to
prevent its export, this mechanism might prevent speciﬁc
RNA transcripts from entering the cytoplasm and asso-
ciating with the translation machinery. Further studies on
the eﬀect of nRISC-target RNA interactions and the
sequencing of miRNAs or other classes of small RNAs
in nRISC are needed to unravel the biological role of
the nuclear RNAi machinery.
The advantage of our newly established experimental
platform is the detailed real-time monitoring of the incor-
poration process into RISC in vivo. It represents a unique
tool to address so far inaccessible questions from a new
perspective. Our FCCS assay is superior in studying the
impact of siRNA sequence and structure on RISC loading
and strand asymmetry compared to standard silencing
readouts that are normally used in high-throughput
assays. Therefore, our technique can contribute to the
development of improved siRNA duplexes with diﬀerent
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functions suitable for the application as therapeutic
agents. It can be used for screening chemicals that aﬀect
the activity of the RLC or the interaction of RISC with the
target RNA which was not possible in vivo until now.
Furthermore, the possibility of studying RISC-target
interactions can lead to the engineering of RNAs that
can inhibit speciﬁc RNA functions, structures or aﬀect
for example alternative splicing and other RNA depen-
dent mechanism.
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Small noncoding RNAs function in concert with Argo-
naute (Ago) proteins to regulate gene expression at
the level of transcription, mRNA stability, or transla-
tion. Ago proteins bind small RNAs and form the
core of silencing complexes. Here, we report the anal-
ysis of small RNAs associated with human Ago1 and
Ago2 revealed by immunoprecipitation and deep
sequencing. Among the reads, we find small RNAs
originating from the small nucleolar RNA (snoRNA)
ACA45. Moreover, processing of ACA45 requires
Dicer activity but is independent of Drosha/DGCR8.
Using bioinformatic prediction algorithms and lucif-
erase reporter assays, we uncover the mediator sub-
unit CDC2L6 as one potential mRNA target of ACA45
small RNAs, suggesting a role for ACA45-processing
products in posttranscriptional gene silencing. We
further identify a number of human snoRNAs with
microRNA (miRNA)-like processing signatures. We
have, therefore, identified a class of small RNAs in
human cells that originate from snoRNAs and can
function like miRNAs.
INTRODUCTION
Small noncoding RNAs, including microRNAs (miRNAs), short
interfering RNAs (siRNAs), and Piwi-interacting RNAs (piRNAs),
are important regulators of gene expression (Filipowicz et al.,
2005; Meister and Tuschl, 2004; Seto et al., 2007). miRNAs and
siRNAs guide sequence-specific cleavage, deadenylation, or
translational repression of target mRNAs (Chen and Rajewsky,
2007; Pillai et al., 2007). piRNAs are specifically expressed in
testes (Seto et al., 2007) and control retrotransposition in the
mammalian germ line (Aravin et al., 2007).
In many gene-silencing pathways, small RNAs are generated
from double-stranded RNA (dsRNA) molecules by distinct pro-
cessing steps (Tomari and Zamore, 2005). miRNA genes are tran-
scribed by RNA polymerases II or III as primary miRNAs that are
further processed to hairpin-structured miRNA precursorsMole(pre-miRNAs) by the nuclear microprocessor complex containing
the RNase III enzyme Drosha and its cofactor DGCR8 (Borchert
et al., 2006; Denli et al., 2004; Gregory et al., 2004; Landthaler
et al., 2004; Lee et al., 2003, 2004). Pre-miRNAs are transported
to the cytoplasm, where the RNase III enzyme Dicer cleaves off
the loop of the miRNA hairpin, thereby generating a short dsRNA
of about 20–25 nucleotides (nt) in length (Bohnsack et al., 2004;
Grishok et al., 2001; Hutva´gner et al., 2001; Lund et al., 2004).
Such dsRNA intermediates are subsequently unwound, and the
single-stranded mature miRNA is incorporated into effector
complexes often referred to as miRNPs (Mourelatos et al.,
2002). In the siRNA pathway or RNA interference (RNAi), long
dsRNA is processed by Dicer as well (Bernstein et al., 2001).
The mature siRNA is incorporated into the RNA-induced silencing
complex (RISC). The biogenesis of piRNAs is only poorly under-
stood and probably does not require the function of Drosha or
Dicer.
Argonaute (Ago) proteins are the cellular binding partners of
small RNAs and form the core of gene silencing effector com-
plexes (Parker and Barford, 2006; Peters and Meister, 2007). In
humans, eight different Argonaute genes exist, which can be
phylogenetically divided into four Ago and four Piwi subfamily
members (Peters and Meister, 2007; Tolia and Joshua-Tor,
2007). Whereas Piwi proteins interact with piRNAs in the germ
line (Seto et al., 2007), Ago subfamily members associate with
miRNAs in somatic cells. Argonaute proteins are generally char-
acterized by Piwi-Argonaute-Zwille (PAZ) and PIWI domains
(Parker and Barford, 2006; Peters and Meister, 2007). A third
domain, termed MID domain, anchors the 50 end of the small
RNA (Ma et al., 2005; Parker et al., 2005). The PAZ domain binds
the 30 end of the small RNA, and the PIWI domain, which is struc-
turally similar to RNase H, cleaves the complementary target
RNA (Parker and Barford, 2006; Patel et al., 2006; Tolia and
Joshua-Tor, 2007). However, not all Argonaute proteins are en-
donucleases, although critical residues within the PIWI domain
are conserved. In mammals, only Ago2 has been shown to act
as endonuclease in RNAi (Liu et al., 2004; Meister et al., 2004).
Argonaute proteins with endonuclease activity are often referred
to as Slicers. Although Ago subfamily members have been exten-
sively studied in the past, only little is known about their individual
small RNA-binding specificities. It has been reported that all
Ago proteins bind miRNAs or siRNAs indiscriminately of theircular Cell 32, 519–528, November 21, 2008 ª2008 Elsevier Inc. 519
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Identification of Argonaute-Associated Small RNAssequence (Liu et al., 2004; Meister et al., 2004). However, a recent
study analyzed small RNAs that are associated with human Ago2
and Ago3 and suggested that Ago proteins might have
preferences for individual miRNA species, although all miRNAs
that have been investigated bind to both Ago2 and Ago3
(Azuma-Mukai et al., 2008).
Here, we report the characterization of small RNAs associated
with human Ago1 and Ago2 by immunoprecipitation and deep
sequencing. We find that Ago1 and Ago2 bind to similar sets of
miRNAs, although some miRNAs are more prominent in Ago2
libraries and vice versa. More importantly, we find small RNAs
that originate from small nucleolar RNAs (snoRNAs). snoRNAs
are nucleolar noncoding RNAs, which have important functions
in the maturation of other noncoding RNAs such as ribosomal
RNAs (rRNAs) or small nuclear RNAs (snRNAs) (Matera et al.,
2007). We demonstrate that the bona fide snoRNA ACA45 is
processed to small 20- to 25-nt-long RNAs that stably associate
with Ago proteins. Processing is independent of the Drosha/
DGCR8 complex but requires Dicer. Finally, we identify a cellular
target mRNA that is regulated by the ACA45-derived small RNA,
indicating that snoRNA-derived small RNAs can function like
miRNAs.
Figure 1. Small RNAs Associated with Ago1 and Ago2
Complexes
(A) Characterization of monoclonal anti-Ago1 and anti-Ago2 anti-
bodies. FLAG/HA-tagged Ago1 through 4 were subjected to immuno-
precipitations using anti-Ago1(4B8) (lanes 1–4), anti-Ago2(11A9)
(lanes 5–8), and anti-FLAG (lanes 9–12). Immunoprecipitated FLAG/
HA-Ago proteins were analyzed by western blotting using anti-HA
antibodies.
(B) Endogenous Ago1 (lane 1) and Ago2 (lane 5) complexes were im-
munoprecipitated using the specific monoclonal antibodies described
in (A). An anti-FLAG (lane 2) or an anti-GST antibody (lane 6) served as
controls. Coimmunoprecipitated RNAs were extracted, cloned, and
sequenced. Cloned PCR products containing 50 adaptors, poly(A)
tails, and 30 adaptor sequences were loaded onto an agarose gel
and visualized by ethidium bromide staining.
(C) Summary of the sequencing data obtained from deep sequencing
of human Ago1 and Ago2 associated small RNAs.
(D and E) Schematic representation of individual small RNA classes
that are associated with human Ago1 or Ago2 complexes.
RESULTS
Small RNAs Associated with Human
Ago1 and Ago2
Different Ago proteins associate with the same miRNA
species regardless of their sequence (Azuma-Mukai
et al., 2008; Meister et al., 2004). However, the spectrum
of Ago-associated small RNAs in human somatic cells is
presently not known. Therefore, we used monoclonal an-
tibodies specific to human Ago1 (Ago1 [4B8]) (Beitzinger
et al., 2007) and Ago2 (Ago2 [11A9]) (Rudel et al., 2008)
for Ago isolation from total HEK293 cell lysates (Figure 1A).
Coimmunoprecipitated RNAs were extracted and cloned
without size fractionation (Figure 1B). Using 454 deep
sequencing, we obtained 20448 reads from the Ago1-
associated and 42604 reads from the Ago2-associated
small RNA libraries (Figures 1C–1E). Using a Dicer substrate iden-
tification algorithm (Friedla¨nder et al., 2008), the presence of 166
known miRNAs in the combined Ago1 and Ago2 libraries was
confirmed. We next investigated whether miRNAs are differen-
tially bound to Ago1 or Ago2 in HEK293 cells (Table S1 available
online). All miRNAs that are present in the libraries bind to Ago1 as
well as Ago2. Similarly to the published data on Ago2 and Ago3
miRNA association (Azuma-Mukai et al., 2008), some miRNAs
are more highly represented in one or the other library, suggesting
a preferential Ago binding.
Processing of Functional Small RNAs from theBona Fide
snoRNA ACA45
In the Ago-associated RNA libraries, we have identified small
RNAs with a length of about 20–22 nt that originate from snoRNAs
particularly from ACA45 (Figure 2A). Notably, the sequenced
reads derive only from the hairpin formed by the 30 half of
ACA45. The found reads are conserved in mammals (Figure 2B),
suggesting that they are, indeed, specific processing products.
Although ACA45 was identified in a screen for functional
snoRNAs (Kiss et al., 2004), it is conceivable that it represents
a miRNA gene that has been misannotated as snoRNA. Due to520 Molecular Cell 32, 519–528, November 21, 2008 ª2008 Elsevier Inc.
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(A) Sequence reads found in Ago1 and/or Ago2 libraries are high-
lighted in orange and blue. Numbers of individual sequences are
shown in parentheses.
(B) Specific ACA45-processing products are conserved across spe-
cies. The ACA45 sequences for Homo sapiens, Rattus norvegicus,
Musmusculus, andCanis familiaris are shown by sequence and struc-
ture. Independent deep sequencing data from each species have
been obtained and mapped against the corresponding homolog
(data sets referenced in Experimental Procedures). The bars indicate
the positions of mapped reads; consensus positions are shown where
small variations exist. The blue bars represent putative ‘‘mature’’ Dicer
products, while the red bars represent putative ‘‘star’’ products. The
numbers above the bars indicate the number of reads.
(C) ACA45 associates with the snoRNP component GAR-1. HEK293
lysates were immunoprecipitated using anti-GAR-1 (lane 3) or control
antibodies (lane 4). Coimmunoprecipitated RNA was extracted and
analyzed by northern blotting using a probe specific to ACA45. Lane
2 shows total RNA extracted from 10% of the input lysate, and lane
1 shows a size marker.
(D) Total RNA from HEK293 cells (30 mg) was blotted, and the
membrane was incubated with a probe complementary to nt 65–85
(lane 2) of ACA45. A size marker is shown in lane 1.
(E) Endogenous Ago1 (lane 2) or Ago2 (lane 4) were immunoprecipi-
tated from HEK293 lysates, and the coimmunoprecipitated RNAs
were extracted and analyzed by northern blotting using the probe
described in (D). Lane 1 shows 10% of the extracts used for the immu-
noprecipitations, and lane 3 shows a control immunoprecipitation.Molecular Cell 32, 519–528, November 21, 2008 ª2008 Elsevier Inc. 521
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in H/ACA and Box C/D class snoRNAs. snoRNAs associate with
specific protein components such as GAR-1 (H/ACA) or fibrillarin
(Box C/D) to form functional snoRNPs (Matera et al., 2007). In
order to prove that ACA45 is, indeed, a functional snoRNA, we
analyzed GAR-1 binding to ACA45 (Figure 2C). Endogenous
GAR-1 was immunoprecipitated using anti-GAR-1 antibodies.
Associated RNAs were extracted and further analyzed by north-
ern blotting using the probe specific to ACA45. Indeed, full-length
ACA45 was readily detectable in the anti-GAR-1 (lane 2), but not
in control immunoprecipitates (lane 3). Our data, therefore,
confirm that ACA45 represents a functional snoRNA.
We next validated the processing of ACA45 to small RNAs by
northern blotting (Figure 2D). A probe complementary to the 50
arm (Figure 2A, indicated in blue) detected the full-length ACA45
snoRNA as well as a band of 22–23 nt in total RNA, indicating
that a portion of the cellular ACA45 pool is, indeed, processed
to small RNAs. Using quantitative northern blotting, we analyzed
ACA45 sRNA molecule numbers per cell (data not shown). We
find that less than 1000 molecules are present per cell, which is
similar to a low abundant miRNA (Lim et al., 2003). Since only a
minor portion of ACA45 is processed to small RNAs, we next
investigated whether ACA45 processing products are specifi-
cally enriched in Ago protein complexes (Figure 2E). Endogenous
Ago1 (lane 2) or Ago2 (lane 4) were immunoprecipitated, and
associated RNAs were analyzed by northern blotting against
ACA45-processing products. Consistent with the cloning data,
the small RNA derived from ACA45 was enriched in Ago1 as
well as Ago2 immunoprecipitates, indicating that ACA45-pro-
cessing products specifically associate with Ago proteins. There-
fore, we refer to this functional small RNA as ACA45 small RNA
(ACA45 sRNA).
ACA45 Small RNAs Can Function Like miRNAs
The striking similarity of ACA45-processing products to miRNA
precursors prompted us to investigate whether ACA45 sRNAs
are functionally similar to miRNAs. We generated a luciferase
reporter construct containing a complementary binding site for
the abundant 50 arm of the snoRNA precursor (Figure 3A). Lucif-
erase activity was strongly increased when the endogenous
ACA45-derived small RNAs were inhibited using 20-O-methyl-
ated (20-OMe) antisense inhibitors (Figure 3A). Moreover, lucifer-
ase activity was also increased when the RNAi endonuclease
Ago2 was depleted (Figure 3B), indicating that small RNAs that
are processed from ACA45 can function like miRNAs.
ACA45Processing Is Independent of theDrosha/DGCR8
Complex but Requires Dicer
The cleavage signature of the stem-loop-structured processing
intermediate is different than the typical 2 nt 30 overhangs gener-
ated by Drosha. Therefore, we analyzed whether ACA45 pro-
cessing requires activity of the Drosha/DGCR8 complex using
in vitro as well as in vivo approaches (Figures 3B and 3C).
FLAG/HA(FH)-tagged DGCR8 was immunoprecipitated, and
the immunoprecipitate was incubated with either a 32P-labeled
primary miR-27a transcript or ACA45. A specific cleavage prod-
uct representing pre-miR-27a was observed in the anti-DGCR8
immunoprecipitates, whereas no signal was observed when522 Molecular Cell 32, 519–528, November 21, 2008 ª2008 ElsevierACA45 was used as substrate. We further investigated Drosha
requirements using the luciferase reporter construct described
above (Figure 3B). Indeed, we did not observe elevated lucifer-
ase activity upon Drosha depletion (siRNAs have been validated
in Landthaler et al. [2004]), whereas luciferase activity of a
miR-19b-responsive reporter was significantly increased. Taken
together, our results suggest that ACA45 processing is indepen-
dent of the Drosha/DGCR8 complex.
Next, we investigated Dicer requirements for ACA45 process-
ing. It has been demonstrated that Ago proteins form a stable
complex with Dicer, and Dicer activity can be coimmunoprecipi-
tated with antibodies against Ago proteins (Gregory et al., 2005;
Maniataki and Mourelatos, 2005; Meister et al., 2005). Therefore,
FH-tagged Ago proteins, as well as FH-Dicer, was immunopre-
cipitated from HEK293 lysates and incubated with 32P-labeled
pre-miR-27a or full-length ACA45 (Figure 3D). As expected, both
FH-Ago2 and FH-Dicer immunoprecipitates efficiently pro-
cessed the miR-27a precursor (Figure 3D, left panel). Further-
more, FH-Ago1, FH-Ago2, and FH-Dicer immunoprecipitates
processed the 32P-labeled full-length ACA45 as well (Figure 3D,
right panel), suggesting that Dicer is required for the generation
of ACA45 small RNAs. To further investigate Dicer’s function in
ACA45 processing, we analyzed whether Dicer alone is sufficient
for ACA45 processing in vitro. 32P-labeled ACA45 was incubated
with increasing amounts of recombinant Dicer, and cleavage
products were analyzed by RNA-PAGE (Figure 3E). Indeed,
recombinant Dicer produced small RNAs from the full-length
ACA45 in a concentration-dependent manner, suggesting that
Dicer alone is sufficient for ACA45 processing. Notably, Dicer
generates longer RNAs as well, which might represent process-
ing intermediates (see asterisk in Figure 3D). Finally, we analyzed
the role of Dicer in ACA45 processing in vivo. Total RNA from
mouse embryonic stem (ES) cells carrying homozygous or
heterozygous Dicer deletions (Murchison et al., 2005) was ana-
lyzed for the presence of ACA45 small RNAs by semiquantitative
real-time PCR (qRT-PCR) (Figure 3F). Strikingly, no PCR product
was detectable in the Dicer/ cells, whereas a PCR product
originating from the ACA45 small RNA was readily detectable
in Dicer+/ cells. Notably, the full-length ACA45 was present in
both Dicer/ and Dicer+/ cells. Similar results were obtained
when total RNA from Dicer/ and Dicer+/ cells was analyzed
by northern blotting using a probe complementary to the ACA45
small RNA (Figure 3G). In summary, our data indicate that Dicer
processes ACA45 to small RNAs independently of the Drosha-
containing microprocessor complex.
Validation of an Endogenous ACA45-Derived
Small RNA Target
It is thought that complementary Watson-Crick base pairing of
the seed (nucleotides 2–8 counted from the 50 end) is a key
feature of miRNA:mRNA target recognition. It is also known
that highly conserved 7-mers in 30UTRs are often complemen-
tary to seed sequences of known miRNAs (Chen and Rajewsky,
2007). Remarkably, the seed of ACA45 22-nt-long processing
product is perfectly complementary to a significantly conserved
30UTR motif (top 3% of all possible seed sites). Using the miRNA
target prediction algorithm PicTar (Krek et al., 2005), we have
predicted target mRNAs for the ACA45-derived small RNAInc.
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Identification of Argonaute-Associated Small RNAsFigure 3. ACA45 Processing Requires Dicer but Is Indepen-
dent of Drosha
(A) A luciferase reporter construct containing a perfectly comple-
mentary binding site for the ACA45 sRNA or the empty vector was
cotransfected with 20-O-methylated antisense inhibitors directed
against the ACA45 sRNA.
(B) The luciferase reporter described in (A), the empty vector, and
a luciferase reporter containing a complementary binding site to
miR-19b were transfected into HEK293 cells that have been pre-
transfected with control siRNAs, siRNAs directed against Drosha,
and siRNAs against Ago2. Firefly luciferase activity was normalized
to Renilla activity. Error bars are derived from four individual
experiments.
(C) FH-DGCR8 or untreated cells were immunoprecipitated using
anti-FLAG antibodies. Immunoprecipitates were incubated with
32P-labeled pri-miRNA-27a (lanes 2 and 3) or ACA45 (lanes 4 and
5). Lane 1 represents a size marker, and lanes 6 and 7 represent
the protein input.
(D) FH-Ago2 (lanes 4 and 10), FH-Ago1 (lanes 3 and 9), and FH-Dicer
(lanes 5 and 11) were incubated with 32P-labeled pre-miR-27a (lanes
2–6) or ACA45 (lanes 8–12) and analyzed by RNA PAGE. In lanes 6
and 12, lysate from untransfected HEK293 cells was used. Lanes
13–15 show anti-HA western blots of the protein input. Lanes 1
and 7 show size markers.
(E) 32P-labeled pre-miR-27a (lanes 1–3) or ACA45 (lanes 5–7) were
incubated with increasing amounts of recombinant Dicer. Cleavage
products were analyzed by RNA PAGE. Lane 4 shows a size marker.
A putative processing intermediate is indicated by an asterisk.
(F) Total RNA from Dicer/+ (lane 2) or Dicer/ cells was analyzed by
semi-qRT-PCR using primers specific for the ACA45 sRNA (upper
panel), miR-125b (middle panel), and 7SK RNA (lower panel). The
origin of the PCR products indicated as A and B are highlighted in
bold below the figure.
(G) Total RNA from Dicer+/ (lane 1) or Dicer/ (lane 2) cells was
analyzed by northern blotting using probes specific for the ACA45
small RNA described above. Lane 3 shows a size marker.Molecular Cell 32, 519–528, November 21, 2008 ª2008 Elsevier Inc. 523
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of 30UTRs that we selected from the predicted target mRNAs to
a luciferase reporter gene. Luciferase reporter constructs were
cotransfected with 20-OMe oligonucleotides antisense to the
ACA45 small RNA. Many of the tested 30UTRs, however, did
not respond to the 20-OMe inhibitors, suggesting that the small
RNA does not target these mRNAs or that small RNA-target
mRNA interactions are not relevant in the cell line that has
been used (Figure 4A and data not shown). Strikingly, we found
that activity of the luciferase reporter fused to the CDC2L6
(CDK11) 30UTR is increased when the endogenous ACA45 small
RNA is inhibited. The CDC2L6 gene product is a component of
the mediator complex and, therefore, important for transcription
(Conaway et al., 2005). For further validation of ACA45 sRNA
Figure 4. ACA45-Derived Small RNAs Regulated CDC2L6 Expres-
sion
(A) Luciferase reporter constructs containing the 30UTR of CDC2L6 or BAP-1
(no target) or the empty vector were cotransfected with increasing concentra-
tions of 20-OMe inhibitors against the ACA45 sRNA. Firefly luciferase activity
was normalized to Renilla activity. Error bars are derived from four individual
experiments.
(B) Luciferase reporter constructs containing the 30UTR of CDC2L6 or the
CDC2L6 30UTR with mutated ACA45 sRNA-binding sites were cotransfected
with 20-OMe inhibitors against the ACA45 sRNA. Firefly luciferase activity
was normalized to Renilla activity. Error bars are derived from four individual
experiments.524 Molecular Cell 32, 519–528, November 21, 2008 ª2008 Elseviereffects on CDC2L6 expression, we mutated all predicted
ACA45 sRNA-binding sites in the CDC2L6 30UTR (Figures 4B
and S1). Indeed, a luciferase reporter containing the mutated
CDC2L6 30UTR was not upregulated when endogenous ACA45
sRNA was inhibited (Figure 4B), indicating that ACA45 sRNA
seed sequence matches are important for CDC2L6 expression.
In summary, our data demonstrate that ACA45 is processed to
a small RNA that can function like a miRNA on the endogenous
target CDC2L6, identifying the ACA45 sRNA as a potential
transcriptional regulator in human cells.
Cellular snoRNAs with miRNA Processing Signatures
The intriguing finding that ACA45 can function like a miRNA
prompted us to analyze processing of other snoRNAs. We gener-
ated small RNA libraries from human Ago1–4 complexes and
mapped the sequence reads to snoRNAs (the detailed composi-
tion of the Ago1–4 libraries are currently analyzed and will be
published elsewhere). We find reads originating from stem-loop
structures within the snoRNAs ACA47, ACA36b, U92, HBI-100,
ACA56, ACA3, and ACA50 (Figure 6). Both arms of the individual
stems are present in the libraries, and the sequence with the
lower abundance is indicated as ‘‘star’’ sequences in Table S1
(see also Tables S2 and S3 for individual snoRNA-derived
sequence reads and read lengths). Our data obtained from larger
sequencing data sets suggest that processing of snoRNAs to
functional small RNAs is not unique to ACA45 and can be
observed for other snoRNAs as well.
DISCUSSION
snoRNAs form a highly abundant class of noncoding RNAs in
many different organisms. snoRNAs localize to the nucleolus
and guide specific modifications of rRNAs or snRNAs (Matera
et al., 2007). Moreover, snoRNAs have also been implicated in
alternative splicing events (Kishore and Stamm, 2006). Here,
we show that the snoRNA ACA45 is processed to a small RNA
that can function like a miRNA. ACA45 processing is independent
of the Drosha-containing microprocessor complex but requires
Dicer. At least in vitro, Dicer can process the full-length ACA45,
although it does not structurally represent a classical Dicer sub-
strate. In northern blots, however, the strongest signal originates
from the full-length ACA45, and only a minor portion is processed
to a small miRNA-like RNA. This observation is consistent with
the finding that ACA45 exists as a functional snoRNA that forms
snoRNPs with the protein factor GAR-1 (Matera et al., 2007).
Therefore, we propose a model in which ACA45 is transcribed
and functions in the nucleolus of human cells (Figure 5). However,
a minor portion is transported to the cytoplasm by a so far un-
known export receptor. In the cytoplasm, Dicer immediately
processes the full-length snoRNA to a miRNA-like small RNA
that functions in gene silencing. This hypothesis is supported
by our finding that recombinant Dicer, as well as Dicer-containing
Ago protein complexes, are capable of generating ACA45 small
RNAs in vitro. However, it cannot be excluded that other nucle-
ases contribute to ACA45 processing in the cytoplasm. Alterna-
tively, ACA45 is cleaved in the nucleus already, and one half is
recognized as miRNA precursor by the miRNA pathway. How-
ever, such a scenario might be unlikely because a nuclearInc.
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which is needed for classical snoRNA functions. Moreover, only
one half of ACA45 would be exported by this model, although
the other half folds like a typical miRNA precursor as well. Alter-
natively, a potential nuclear snoRNA cleavage activity could be
physically separated from the snoRNAs as well. Further experi-
ments aiming at the identification of specific snoRNA export
pathways will help to elucidate the biogenesis pathways of small
RNAs derived form snoRNAs.
Many small RNA cloning and sequencing projects have been
carried out, but small RNAs derived from snoRNAs or other non-
coding RNAs have not been reported. Here, we have immunopre-
cipitated endogenous Ago complexes, and it is very likely that
small RNAs that associate with Ago proteins are functional RNA
molecules rather than just degradation products. Most published
cloning approaches size fractioned total RNA before cloning and,
therefore, all unspecific degradation products are present in the
libraries and it is difficult to find classes of functional small
RNAs. Therefore, we suggest that cloning projects aiming at
the identification of new classes of Ago-associated small
noncoding RNAs of about 18–35 nt in length should be carried
out from anti-Ago immunoprecipitations.
Using cloning and sequencing approaches, a variety of differ-
ent snoRNA genes have been identified in the past (Bachellerie
et al., 2002). However, many of these snoRNA candidates have
not been characterized in detail, and it is unknown whether or
Figure 5. Model for ACA45 Processing and ACA45 sRNA Function in
Human Cells
ACA45 snoRNA is transcribed in the nucleus, and the majority localizes to the
nucleolus where it fulfills its specific functions by modifying other noncoding
RNAs. However, a minor portion of ACA45 is exported to the cytoplasm, where
Dicer, probably with the help of other nucleases, processes it to small RNAs
that are specifically loaded into Ago protein-containing complexes. The
ACA45-derived small RNA guides Ago protein complexes to partially comple-
mentary binding sites in the 30UTR of target genes and represses its expres-
sion. AAAA, poly(A) tail.Molecnot these candidates represent functional snoRNAs. Therefore,
it is tempting to speculate that more snoRNAs are specifically
processed to functional small RNAs. Indeed, by analyzing larger
data sets, we find several small RNAs with miRNA-like process-
ing signatures that originate from snoRNAs (Figure 6). These
candidate sRNAs are derived from a subset of snoRNAs
comprised of H/ACA snoRNAs and small Cajal body RNAs
(scaRNAs), whose secondary structure is characterized by two
hairpins linked by a hinge similar to ACA45 (Figure 2A). These
findings support our hypothesis that a considerable number of
snoRNAs are natural precursors for functional small RNAs.
Moreover, we add another so far unrecognized function in post-
transcriptional gene silencing to the list of snoRNA functions. A
detailed functional characterization of all mammalian snoRNAs
will help to elucidate the impact of snoRNA processing in
RNA-guided gene silencing.
EXPERIMENTAL PROCEDURES
Ago Complex Purification
HEK293 cells were lysed in buffer containing 20 mM Tris HCl (pH 7.5), 150 mM
NaCl, 0.25% NP-40, and 1.5 mM MgCl2 and centrifuged at 10,000 3 g for
10 min at 4C.
For immunoprecipitation of endogenous Ago complexes, 100 ml protein G
Sepharose (GE Healthcare) was washed with phosphate-buffered saline
(PBS) and incubated with 10 ml anti-Ago1-4B8, anti-Ago2-11A9, anti-FLAG-
3H3, or anti-GST at 4C with gentle agitation overnight. After washes with
PBS, beads were incubated with HEK293 cell lysate of 6 3 15 cm plates for
3 hr. Anti-Ago1-coated beads were extensively washed with 300 mM NaCl,
2.5 mM MgCl2, 0.5% NP40, and 20 mM Tris-HCl (pH 7.5) followed by
a wash with PBS. Anti-Ago2-coated beads were washed five times using
RIPA buffer (50 mM Tris-HCl, 500 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS). RNA was isolated with 40 mg Proteinase K in 200 ml
Proteinase K buffer (300 mM NaCl, 25 mM EDTA, 2% SDS, 200 mM Tris
HCl [pH 7.5]) followed by Phenol/Chloroform extraction and Ethanol
precipitation.
For immunoprecipitation of FLAG/HA-tagged Ago complexes, cell lysate
from two 15 cm dishes were incubated with 20 ml FLAG M2 agarose beads
(Sigma) for 2 hr at 4C with rotation. Beads were extensively washed, and
coimmunoprecipitated RNA was extracted as described above.
Small RNA Cloning
Small RNA cloning was carried out by Vertis Biotechnology (Weihenstephan,
Germany) and has been described earlier (Tarasov et al., 2007). Without any
size fractionation, extracted Ago-associated RNAs were poly(A)-tailed using
poly(A) polymerase, and an adaptor was ligated to the 50 phosphate of the
miRNAs: (50 end adaptor [43 nucleotides]: 50-GCCTCCCTCGCGCCATCAG
CTNNNNGACCTTGGCTGTCACTCA-30). NNNN represents a ‘‘barcode’’ se-
quence. Next, first-strand cDNA synthesis was performed using an oligo(dT)-
linker primer and M-MLV-RNase H reverse transcriptase (30 end oligo [dT] linker
primer [61 bases]: 50-GCCTTGCCAGCCCGCTCAGACGAGACATCGCCCCG
C[T]25-3
0). The resulting cDNAs were PCR amplified in 22 cycles using the
high-fidelity Phusion polymerase (Finnzymes). The 120–135 bp amplification
products were confirmed by polyacrylamide gel electrophoresis (PAGE) analy-
sis. Both cDNAs pools were mixed in equal amounts and subjected to gel
fractionation. The 120–135 bp fraction was electroeluted from 6% PAA-gels.
After isolation with Nucleospin Extract II (Macherey and Nagel), cDNA pools
were dissolved in 5 mM Tris/HCl (pH 8.5) with a concentration of 10 ng/ml and
used in single-molecule sequencing. Massively parallel sequencing was
performed by 454 Life Sciences (Branford, USA) using the Genome Sequencer
20 system as well as MWG Biotech (Germany). The complete sequencing data
is available at the Gene Expression Omnibus (GEO, Accession number:
GSE13370.)ular Cell 32, 519–528, November 21, 2008 ª2008 Elsevier Inc. 525
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In vitro transcribed pri-27a substrate used in this study was described
previously in Landthaler et al. (2004) and Meister et al. (2005). The template
for pre-27a transcription was created by annealing the following primers: 50-T
TAATACGACTCACTATAGCTGAGGAGCAGGGCTTAGCTGCTTGTGAGCAG
GGTCCACACCAAGTCGTGTTCACAGTGGCTAAGTTCCGCCCCCCAGC and
50-GCTGGGGGGCGGAACTTAGCCACTGTGAACACGACTTGGTGTGGACCC
TGCTCACAAGCAGCTAAGCCCTGCTCCTCAGCTATAGTGAGTCGTATTAA.
ACA45 was cloned from genomic DNA using the primers 50-ACGAGCTCCTGG
AGACTAAGAAAATAGAGTCCTTGA and 50-ACGGTACCTGCTGTTGGTAGAT
AAGTAGGTCTTGAA, digested with SacI and KpnI, and inserted into the SacI
and KpnI restriction sites of the pBluescript. Plasmid was linearized using the
KpnI restriction site and in vitro transcribed as described in Landthaler et al.
(2004). The construction of human FLAG/HA-Ago1, FLAG/HA-Ago2, and
FLAG/HA-Dicer was reported earlier (Meister et al., 2005). FLAG/HA-DGCR8
was purchased from Addgene.
Figure 6. Several Human snoRNAs Show
miRNA-Like Processing Signatures
(A) Small RNA reads originating from human snoRNAs
that have been found in large sequencing data sets
from Ago immunoprecipitates. The more abundant
read is indicated as ‘‘mature,’’ and the complementary
strand is indicated as ‘‘star’’ read. All reads that have
been found for individual snoRNAs are indicated as
‘‘total reads.’’
*The official genomic sequence is tctgatcgttcccctcc
gta, but all of the reads mapping to this position
have a mismatch, and all have ‘‘a’’ at position 18 and
there is an annotated SNP at this position.
**The ACA36b sRNA candidate is identical to the
annotated miRNA miR-664.
(B) Schematic representation of the secondary struc-
ture of full-length snoRNAs. Ago-associated reads
are highlighted in purple and yellow.
Immunoprecipitations were performed as described
above. For cleavage activity assays, 10 ml of Ago or
Dicer complex-containing anti-FLAG beads were incu-
bated in 20 ml PBS containing 5 mM ATP, 7.5 mM
MgCl2, 10 U/ml RNasin (Promega), and about 100
counts (50 fmol) of internally labeled RNA for 1 hr at
37C. The reaction was stopped by adding 200 ml pro-
teinase K buffer (300 mM NaCl, 25 mM EDTA, 2% SDS,
200 mM Tris HCl [pH 7.5]) containing proteinase
K (0.2 mg/ml). RNA was isolated with Phenol/Chloro-
form and analyzed by 8% or 12% denaturing RNA
PAGE. Signals were detected by autoradiography.
Northern Blotting and Semiquantitative
RT-PCR
Immunoprecipitated RNA and 30 mg total RNA isolated
from HEK293 cells using Trifast (Peqlab) was sepa-
rated by 12% denaturing RNA PAGE and transferred
to a nylon membrane (GE Healthcare) by semidry elec-
troblotting. Membranes were crosslinked by 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide (EDC) chemical
crosslink incubating for 1 hr at 50C, prehybridized for
1 hr, and hybridized overnight at 50C with probes
complementary to snoRNA ACA45 or tRNA. The fol-
lowing probes have been used: 50-AAGACCTGTTCTA
TCTACCT complementary to snoRNA ACA45 and 50-C
TGATGCTCTACCGACTGAGCTATCCGGGC comple-
mentary to lysine tRNA. After hybridization, mem-
branes were washed twice 10 min with 5 3 SSC and
once 10 min with 1 3 SSC. Radioactive signals were detected by exposure
of BioMax MS film (Kodak) using an intensifying screen (GE Healthcare).
For semiquantitative RT-PCR, extracted RNA was modified by addition of
poly(A) tail using poly(A) tailing kit from Ambion. Reverse transcription was per-
formed using the cDNA synthesis kit (Fermentas) with the universal RT primer 50
AACGAGACGACGACAGACTTTTTTTTTTTTTTT (described in Hurteau et al.
[2006]). DNA was amplified using Mesa Green qPCR MasterMix Plus (Eurogen-
tec), a universal reverse primer identical to the 18 bp tag added during the RT
step and the following specific primers: 50-AAGGUAGAUAGAACAGGUCUUG
for ACA45, 50-TCCCTGAGACCCTAACTTGTGA for miR-125b, and 50-ACA
CATCCAAATGAGGCG for 7SK. The PCR products were analyzed by 4% aga-
rose gel electrophoresis.
Conserved Processing of ACA45
The human ACA45 sequence was obtained at the snoRNABase (http://
www-snorna.biotoul.fr/). The ACA45 mouse, rat, and dog homologs were526 Molecular Cell 32, 519–528, November 21, 2008 ª2008 Elsevier Inc.
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only unambiguous matches. Subsequently, a number of deep sequencing
data sets were mapped to the ACA45 homologs. Each data set was mapped
to the homolog of the species from which the data set originated, and only
perfect matches were retained. The human data consisted of the data sets
produced for this study using the 454 Life Sciences technology, as well as
a data set produced by deep sequencing the small RNA fraction of HeLa cells
using the Solexa/Illumina technology (GEO accession number GSE10829)
(Friedla¨nder et al., 2008). The mouse data sets were produced by deep
sequencing small RNAs from mouse brain and kidney tissues using the 454
technology (unpublished data). The rat data set was produced by deep se-
quencing column-purified small RNAs from testes extracts using the 454 tech-
nology (GEO accession number GSE5026) (Lau et al., 2006). The dog data set
was produced by sequencing small RNAs from dog lymphocytes using the Sol-
exa technology (GEO accession number GSE10825) (Friedlander et al., 2008).
Computational Methods
A total of 64733 reads was obtained by deep sequencing the RNA that immu-
noprecipitated with Ago1 and Ago2. Of this, 20834 belonged to the Ago1 set
and 43899 to the Ago2 set. Upon removal of adapters, the sequences shorter
than 17 nt were discarded, resulting in 20448 and 42604 reads in Ago1 and
Ago2 sets, respectively. These reads were mapped to human genome
(hg 18, UCSC database [Karolchik et al., 2003]) using NCBI blastn (Altschul
et al., 1990) with the minimum word length set to 7. The mapping with the
best E value was associated with each read. The only mismatches allowed
were the first nt at the 50 end or the last three nt at the 30 end of the read. In
case a read mapped with the same E value to several locations, they were all
taken into consideration. The genomic loci of best matches were annotated us-
ing the tables from UCSC database (Karolchik et al., 2003). A read was anno-
tated as a DNA repeat (including LINE, SINE, LTR) only if the genomic locus it
mapped to had no other annotation.
For purposes of identification of known and novel miRNAs, reads from the
Ago1 and Ago2 libraries were combined and mapped to the human genome us-
ing NCBI megablast with the following options: W 12 p 100. Only perfect
mappings (full length, 100% identity) were retained. These were used as input
to miRDeep, an algorithm designed for the discovery of Dicer substrates such
as miRNAs from deep sequencing data (Friedla¨nder et al., 2008). The algorithm
intersects the mappings with local genomic sequence to identify potential Dicer
hairpin substrates. These are then scored according to the distribution of posi-
tionsand frequenciesof the reads mapped to the individual hairpin, using Bayes-
ian statistics. The energetics and stability of the hairpins and the cross-species
conservation of the seed sequence also contribute to the score. Human snoRNA
sequences were downloaded from snoRNABase (Lestrade and Weber, 2006).
To map the total of 17362367 sequence reads obtained by sequencing
Ago1–4 IP using Solexa technology to the genome, we used the locally devel-
oped suffix array-based tool (to be published elsewhere). Candidate snoRNAs
with miRNA-like processing were selected (Table S1) if the combined Ago1–4
data set contained reads mapping to both strands of a hairpin and if these
reads represented more than 85% of all reads mapping to a given snoRNA.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, one
figure, and three tables and can be found with this article at http://www.
molecule.org/supplemental/S1097-2765(08)00733-8.
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Small regulatory RNAs including small interfering
RNAs (siRNAs) and microRNAs (miRNAs) guide Argo-
naute (Ago) proteins to specific target RNAs leading
to mRNA destabilization or translational repression.
Here, we report the identification of Importin 8 (Imp8)
as a component of miRNA-guided regulatory path-
ways. We show that Imp8 interacts with Ago proteins
and localizes to cytoplasmic processing bodies (P
bodies), structures involved in RNA metabolism.
Furthermore, we detect Ago2 in the nucleus of HeLa
cells, and knockdown of Imp8 reduces the nuclear
Ago2 pool. Using immunoprecipitations of Ago2-
associated mRNAs followed by microarray analysis,
we further demonstrate that Imp8 is required for the
recruitment of Ago protein complexes to a large set
of Ago2-associated target mRNAs, allowing for effi-
cient and specific gene silencing. Therefore, we
provide evidence that Imp8 is required for cytoplasmic
miRNA-guided gene silencing and affects nuclear
localization of Ago proteins.
INTRODUCTION
Small noncoding RNAs including microRNAs (miRNAs), small
interfering RNAs (siRNAs), and Piwi-interacting RNAs (piRNAs)
are important regulators of gene expression in many different
organisms (Filipowicz et al., 2005; Seto et al., 2007; Zamore
and Haley, 2005). miRNA genes are transcribed by RNA poly-
merases II and III generating primary miRNA transcripts, which
are further processed to stem-loop-structured miRNA precur-
sors by the nuclear RNase III Drosha and its partner DGCR8/
Pasha (Bushati and Cohen, 2007). Pre-miRNAs are exported to
the cytoplasm where processing of Dicer, another RNase III
enzyme, generates 21–23 nucleotide (nt) long double-stranded496 Cell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc.(ds) miRNA/miRNA* intermediates with characteristic 2 nt 30
overhangs and 50 phosphate groups (Meister and Tuschl,
2004; Zamore and Haley, 2005). After further processing and/or
unwinding steps, one strand gives rise to the mature miRNA
and is incorporated into miRNA-protein complexes often
referred to as miRNPs (Leuschner et al., 2006; Matranga et al.,
2005; Mourelatos et al., 2002; Rand et al., 2005).
Members of the Argonaute protein family constitute the
cellular binding partners of miRNAs as well as other small
RNAs and are therefore key components of miRNPs. The human
genome encodes for eight different Argonaute genes, which can
be phylogenetically divided into four Ago and four Piwi subfamily
members (Peters and Meister, 2007; Tolia and Joshua-Tor,
2007). Expression of the Piwi subfamily members HIWI1-3 and
HILI seems to be restricted to testes, and different Piwi subfamily
members bind to different classes of testes-specific piRNAs
(Aravin et al., 2006; Girard et al., 2006). The mouse Piwi member
MILI, for example, binds to a developmentally regulated piRNA
cluster and influences transposon expression (Aravin et al.,
2007). The individual members of the human Ago subfamily,
namely Ago1–4, are ubiquitously expressed and most likely
bind to similar populations of miRNAs.
Depending on the degree of complementarity between the
miRNA and the target RNA, miRNAs guide sequence-specific
cleavage, deadenylation, or translational repression of specific
target mRNAs (Pillai et al., 2007). It has been shown by in vitro
translation assays that miRNAs inhibit translation of reporter
constructs at early stages of translational initiation (Mathonnet
et al., 2007; Thermann and Hentze, 2007; Wakiyama et al.,
2007; Wang et al., 2006). In contrast, on the basis of the finding
that miRNAs cosediment with polysomes it has been proposed
that miRNAs function on the level of translational elongation
(Maroney et al., 2006; Olsen and Ambros, 1999; Seggerson
et al., 2002). Other models of miRNA functions suggest rapid
ribosome drop-off from mRNAs upon miRNA inhibition or
miRNA-guided degradation of the nascent polypeptide chain
by the proteasome (Nottrott et al., 2006; Petersen et al., 2006).
mRNA profiling studies have recently shown that miRNAs affect
the stability of many mRNAs that contain imperfect miRNA
binding sites. Moreover, it appears that miRNA effects on
mRNA levels are as common as translational repression (Bagga
et al., 2005). Consistently, miRNAs guide mRNA deadenylation
processes followed by decapping and degradation (Behm-
Ansmant et al., 2006; Giraldez et al., 2006; Humphreys et al.,
2005; Wu et al., 2006).
While miRNA processing is well understood, target mRNA
recognition and binding is only poorly understood. It has been
demonstrated that HuR (ELAV1) can release miRNA repression
of the CAT-1 mRNA upon cellular stress (Bhattacharyya et al.,
2006). Moreover, a protein termed dead end 1 (Dnd1) can occupy
miRNA binding sites on the 30 untranslated regions (UTRs) of
specific target mRNAs and thus inhibit miRNA-guided gene
silencing (Kedde et al., 2007). Although only a few mRNA binding
proteins with effects on miRNA function have been identified thus
far, it is very likely that many more protein factors exist that influ-
ence recruitment or stable binding of miRNPs to specific mRNAs.
Here, we report the identification of Imp8 as component of
human Ago protein complexes. We show that Imp8 is required
for binding of Ago proteins to a variety of mRNA targets and
that depletion of Imp8 interferes with miRNA-guided gene
silencing. Furthermore, we demonstrate that Imp8 modulates
nuclear localization of Ago2. We have therefore identified Imp8
as specificity factor in the miRNA pathway, which may fulfill addi-
tional functions in nuclear Ago import.
RESULTS
Imp8 Interacts with Human Ago Proteins
Human Ago1 and Ago2 complexes have been analyzed bio-
chemically in the past (Gregory et al., 2005; Hock et al., 2007;
Liu et al., 2004; Meister et al., 2005). However, the function of
Ago3 and Ago4 in human cells has not been addressed yet.
Therefore, we performed biochemical purification studies using
FLAG/HA (FH)-tagged Ago3 and Ago4. HEK293 cells were trans-
fected with FH-Ago3 or FH-Ago4, and immunoprecipitates were
analyzed by mass spectrometry (Figure 1A, Tables S1 and S2
available online). We found known Ago-associated proteins
such as TNRC6B, but also a variety of factors that have not
been linked to Ago function thus far. Among them, we found
the Importin b-like import receptor Imp8 (Gorlich et al., 1997).
Cosedimentation studies revealed that FH-Imp8 comigrates
with Ago proteins in sucrose gradients (Figure S1). For in vitro
interaction studies, recombinant GST-Imp8 was immobilized
on glutathione-coated beads and incubated with [35S]-labeled
Ago1–4 (Figure 1B). All Ago proteins interacted with GST-Imp8
(lanes 1–4), whereas no signal was observed in control reactions
where GST alone was immobilized (lanes 6–9). Next, we investi-
gated the interaction of Ago proteins with Imp8 in vivo. HEK293
cells were cotransfected with myc-tagged Ago proteins and
FH-Imp8. Consistent with the in vitro data, all myc-Ago proteins
were readily detectable in the anti-FLAG immunoprecipitates
(Figure 1C, lanes 2, 5, 8, and 11). No myc-Ago was detected in
FH-GFP control experiments (lanes 3, 6, 9, and 12). Furthermore,
treatment of the immunoprecipitates with RNase A demon-
strated that interaction of Ago proteins with Imp8 is independent
of RNA (lanes 1, 4, 7, and 10). In contrast, interaction of Ago2 withthe poly-A binding protein C1 (PABPC1) was impaired upon
RNase A treatment (lane 13), demonstrating efficient RNase A
digestion. In order to validate endogenous Imp8-Ago2 interac-
tions, we generated a polyclonal antibody against Imp8. The
purified anti-Imp8 serum immunoprecipitates transfected FH-
Imp8 (Figure 1D, lane 2) and endogenous Imp8 (lane 4, lower
panel). Moreover, with an antibody against Ago2 (Ru¨del et al.,
2008), endogenous Ago2 was detectable in the Imp8 immuno-
precipitate (lane 4, upper panel). Import receptors require inter-
action with the GTPase Ran for cytoplasmic substrate binding
and nuclear transport. Therefore, we added recombinant Ran
or RanQ69L, a mutant that promotes the dissociation of the
cargo-Importin complexes, to the FH-Imp8 immunoprecipitate
(Figure 1E, lanes 2 and 3). RanQ69L strongly reduced Ago2
binding to Imp8 (lane 3) compared to Ran (lane 2) or a sample
where no protein was added (lane 1), indicating that Ago proteins
bind to Imp8 in a Ran-dependent manner. By using a proteomics
approach, we have identified and validated Imp8 as Ago-inter-
acting protein in human cells.
Imp8 and Ago Proteins Colocalize in P Bodies
Human Ago proteins localize to P bodies and stress granules
(Leung et al., 2006; Liu et al., 2005; Sen and Blau, 2005). We
therefore analyzed the subcellular localization of Imp8. FH-
Imp8 was transfected into HEK293 cells, and fixed cells were
stained with anti-HA antibodies (Figure 2A). FH-Imp8 was
detectable in the nucleus as well as cytoplasmic structures
that were positive for the P body marker LSm4, indicating that
Imp8 localizes to P bodies. Moreover, Imp8 localizes to arse-
nite-induced stress granules, as indicated by the colocalization
with the known stress granule marker FMRp. As control, FH-Im-
portin 4 (Imp4) was analyzed, and it localizes neither to P bodies
nor to stress granules (Figure S2). We next analyzed whether Ago
proteins colocalize with Imp8 in P bodies (Figure 2B). Myc-Ago2
and FH-Imp8 were cotransfected and fixed cells were analyzed
with anti-myc or anti-FLAG antibodies. Indeed, Ago2 colocalizes
with Imp8 in P bodies, suggesting a function for Imp8 in RNA
metabolism. Similar results were obtained when other human
Ago proteins were analyzed (data not shown and Figure S3B).
Consistently, the anti-Imp8 serum stained P bodies in cells ex-
pressing FH-Ago2 (Figure 2B, panels 5–8) or the known P body
component FH-TNRC6B (panels 9–12) (Meister et al., 2005),
indicating that endogenous Imp8 is present in P bodies as well.
The Ran-dependent interaction of Imp8 and Ago proteins
prompted us to analyze whether localization of Imp8 to P bodies
depends on Ran as well (Figure 2C). FH-Imp8 was cotransfected
with myc-Ran (panels 1–4), myc-RanQ69L (panels 5–8), or myc-
RanT24N (panels 9–12), a mutant that stabilizes importin-cargo
interaction, into HEK293 cells and localization was analyzed
with anti-HA antibodies. Coexpression of RanWT or RanT24N
had no effect on Imp8 P body localization. However, cotransfec-
tion of RanQ69L, which promotes the dissociation of import
receptors from their cargo proteins, resulted in disruption of
Imp8 P body localization, whereas P body formation itself was
not impaired, as indicated by LSm4 analysis. Interestingly, Ago
protein localization remained unaffected when RanQ69L was ex-
pressed (Figure S3). Of note, in the RanQ69L expression exper-
iments, FH-Imp8 could be detected in cytoplasmic granules thatCell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc. 497
Figure 1. Imp8 Interacts with Human Ago1–4
(A) SDS-PAGE analysis of proteins interacting with human Ago4. FH-Ago4 or FH-GFP plasmids were transfected into HEK293 cells. FH-Ago4 (lane 1) and FH-GFP
(lane 2) were immunoprecipitated from cell lysates, and immunoprecipitates were separated by SDS-PAGE. Lane 3 shows a molecular weight standard. Proteins
interacting with FH-Ago4 but not with FH-GFP are shown to the left. A complete list of FH-Ago4- and FH-Ago3-interacting proteins is shown in Tables S1 and S2.
(B) GST-Imp8 (lanes 1–5) or GST alone (lanes 6–10) was immobilized on glutathione sepharose beads and incubated with [35S]-methionine-labeled in vitro-
translated His-Ago1–4 or His-Gemin2 control protein. Autoradiograms of bound [35S]-labeled proteins (lanes 1–10) and radioactive input signals (lanes
11–15) are shown in the upper panels. Lower panels show coomassie stainings of coupled GST-Imp8 (lanes 1–5) or GST (lanes 6–10).
(C) FH-Imp8, FH-GFP or FH-PABPC1 plasmids were cotransfected with myc-Ago1 (lanes 1–3), myc-Ago2 (lanes 4–6, 13–15), myc-Ago3 (lanes 7–9), or myc-
Ago4 plasmids (lanes 10–12) into HEK293 cells. FH-tagged proteins were immunoprecipitated from cell lysates with anti-FLAG sepharose beads in the presence
or absence of 20 mg/ml RNase A. The immunoprecipitate was analyzed by anti-myc western blotting (upper panel) and anti-HA western blotting (lower panel). Ig,
Immunoglobulin heavy chain.
(D) Left panel: HEK293 cells were transfected with FH-Imp8. Immunoprecipitation was performed from cell lysates using preimmune serum (lane 1) or anti-Imp8
(lane 2). FH-Imp8 was detected with anti-HA antibodies. Right panel: Lysate from untransfected HEK293 cells was immunoprecipitated with preimmune serum
(lane 3) or anti-Imp8 (lane 4). The immunoprecipitate was analyzed by anti-Ago2 western blotting (upper panel) and anti-Imp8 western blotting (lower panel).498 Cell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc.
(E) myc-Ago2 and FH-Imp8 plasmids were cotransfected into HEK293 cells. FH-Imp8 was immunoprecipitated from cell lysates with anti-FLAG antibodies. The
immunoprecipitate was incubated with PBS/5mM GTP containing either 100 mM RanWT (lane 2), RanQ69L (lane 3) or no protein (lane 1). Myc-Ago2 and FH-Imp8
proteins were detected by western blotting (upper panel and lower panel).are clearly distinct from P bodies (panel 7) and might correspond
to stress granules. Thus, Imp8 colocalizes with Ago proteins to
P bodies in a Ran-dependent manner.
Imp8 Affects Nuclear Localization of Ago Proteins
Import receptors target cargo proteins to the nucleus. Since
human Ago proteins have been shown to function in the nucleus
(Janowski et al., 2006; Kim et al., 2006), we investigated nuclear
Ago protein import (Figure 3). The monoclonal anti-Ago2 (11A9)
antibody stained P bodies, as well as the diffuse cytoplasm
and the nucleus of fixed HeLa cells (panels 1–4) (see Ru¨del
et al., 2008 for a detailed characterization of anti-Ago2 [11A9]).
Knockdown of Ago2 led to a loss of the cytoplasmic and the
nuclear signal, indicating that Ago2 is indeed in the nucleus (Ru¨-
del et al., 2008). We quantified nuclear and cytoplasmic signals
from average pixel intensities and calculated ratios of cyto-
plasmic versus nuclear Ago2 for each set of samples
(Figure 3B). We found that upon Imp8 knockdown, the localiza-
tion of Ago2 is shifted from the nucleus to the cytoplasm,
whereas the total amount of soluble Ago2 remained unaffected
(Figure 3B). Similar results were obtained when a HEK293 cell
line stably expressing EGFP-Ago2 was analyzed by fluores-
cence correlation spectroscopy (Figure 3C) (Ohrt et al., 2008).
As control, Imp4 knockdown was performed, and it had no effect
on nuclear EGFP-Ago2 localization. The used Imp4 siRNAs were
as efficient as the Imp8 siRNAs (data not shown). In summary, we
provide evidence that Imp8 can influence nuclear import of Ago
proteins in human cells.
Imp8 Is Required for miRNA-Guided Gene Silencing
The interaction and colocalization of Ago proteins with Imp8
prompted us to analyze whether Imp8 is functionally involved in
miRNA-guided gene silencing. We first analyzed the conse-
quence of Imp8 depletion on sequence-specific cleavage of a
luciferase reporter perfectly complementary to miR-21 (Fig-
ure 4A). As expected, knockdown of the slicer endonuclease
Ago2 (Liu et al., 2004; Meister et al., 2004) led to a strong increase
of luciferase expression. However, luciferase activity was not
altered after Imp8 depletion, indicating that Imp8 is not required
for Ago2-mediated cleavage of target RNA (for siRNA validation,
see Figure S4).
Next, we investigated whether Imp8 is necessary for miRNA-
guided silencing of known target mRNAs (Figure 4B). Luciferase
reporters fused to full-length 30 UTRs of previously validated
miRNA targets (Beitzinger et al., 2007) were transfected into
HeLa cells where either Imp8 or as controls Ago2 or TNRC6B
had been depleted by RNAi. Depletion of Ago2 or TNRC6B,
which are required for miRNA function, resulted in elevated lucif-
erase expression from all constructs. Strikingly, knockdown of
Imp8 led to an increase of luciferase activity as well, indicating
that Imp8 is required for repression of the tested 30 UTRs. We
further tested whether the observed Imp8 effects on gene
expression are linked to the miRNA pathway or whether Imp8
functions independently of Ago proteins on 30 UTRs. For furtherstudies, we used the 30 UTR of Hmga2, which is strongly dere-
pressed when endogenous let-7a is inhibited with 20-O-methyl-
ated antisense oligonucleotides (Figure 4C). Knockdown of
TNRC6B or Imp8 led to increased luciferase activity similar to
other miRNA targets. As specificity control, we mutated all let-
7a binding sites in the Hmga2 reporter construct (Figures 4C
and 4D and Figure S5). Indeed, the mutated 30 UTR did not
respond to Imp8 knockdown anymore, indicating that Imp8
functions together with Ago proteins in the miRNA pathway.
Since miRNAs can trigger target mRNA degradation, we investi-
gated whether knockdown of Imp8 affects the level of endoge-
nous miRNA target mRNAs (Figure 4E). We found that Imp8
depletion led to a moderate increase of some miRNA targets
relative to GAPDH or b-Actin mRNAs (Figure S6). Thus, Imp8 is
required for silencing of endogenous miRNA targets.
Imp8 Is Involved in Loading of Ago Complexes
onto mRNA Targets
We next investigated individual steps of the miRNA pathway for
Imp8 requirement. It has been suggested that Importin b-like
proteins function as chaperones and increase the solubility of
RNA binding proteins by preventing unspecific aggregation
with nucleic acids (Jakel et al., 2002). Therefore, we analyzed
soluble Ago protein levels after Imp8 knockdown in HeLa cells
(Figure 5A). Cells transfected with siRNAs against Imp8 or
control siRNAs were analyzed by western blotting with specific
antibodies against endogenous Ago1–4 or b-actin as loading
control. Because of the low Ago3 and Ago4 expression levels,
Ago3 and Ago4 were immunoprecipitated prior to western
blotting. Knockdown of Imp8 had no effect on the steady-state
levels of soluble Ago proteins. Next, we analyzed Ago2 protein
turnover using pulse-chase experiments (Figure 5B). HEK293
cells were cotransfected with a construct expressing FH-Ago2
and a plasmid expressing short hairpin RNAs (shRNAs) against
Imp8 or control shRNAs. After 3 days, cells were pulsed with
[35S]-methionine-containing medium followed by chase in
normal medium, and [35S]-labeled Ago2 complexes were immu-
noprecipitated with anti-FLAG antibodies. Both in control and
Imp8 knockdown cells, [35S]-labeled Ago2 was strongly reduced
after 13 hr chase. Therefore, our data suggest that Imp8 has no
effect on the steady-state levels or turnover of Ago proteins in
human cells.
Next, we asked whether Imp8 is involved in miRNA biogen-
esis, which would explain the effects of Imp8 on miRNA target
expression (Figure 5C). HeLa cells were transfected with siRNAs
directed against Dicer or Imp8, and total RNA was analyzed by
northern blotting with probes specific for let-7a, miR-21, or
miR-16. As expected, Dicer knockdown resulted in lower miRNA
levels (lane 1). However, Imp8 knockdown had no effect on
mature miRNA levels, suggesting that Imp8 is not involved in
miRNA biogenesis (lanes 3 and 4). Using anti-Ago2 immunopre-
cipitations, we further investigated whether Imp8 affects the
loading of Ago2 with miRNAs (Figure 5D). Endogenous Ago2
was immunoprecipitated from cell lysates transfected withCell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc. 499
Figure 2. FH-Imp8 Localizes to P Bodies
and Stress Granules
(A) HEK293 cells were transfected with FH-Imp8.
Cells were fixed and stained for FH-Imp8 with
anti-HA antibody (1) and for endogenous LSm4
(2). Lower panel: Cells were treated with 500 mM
sodium arsenite for 30 min, fixed, and stained for
FH-Imp8 with anti-FLAG antibody (5) and for
endogenous FMRp (6). DAPI was used as nuclear
counterstain (4 and 8).
(B) Upper panel: HEK293 cells were transfected
with FH-Imp8 and myc-Ago2, fixed, and stained
with anti-FLAG antibody (1), anti-myc antibody
(2), and DAPI (4). Lower panels: HEK293 cells
were transfected with FH-Ago2 (5-8) or FH-
TNRC6B (9-12), fixed, and stained with anti-HA
antibody (5 and 9), anti-Imp8 antibody (6 and 10),
and DAPI (8 and 12).
(C) HEK293 cells were cotransfected with FH-
Imp8 and myc-RanWT (1–4), myc-RanQ69L (5–
8), or myc-RanT24N (9–12), fixed, and stained
with anti-HA antibody (1, 5, and 9), anti-LSm4
antibody (2, 6, and 10), and DAPI (4, 8, and 12).
Scale bars represent 10 mm.500 Cell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc.
control siRNAs (lanes 1 and 3) or siRNAs directed against Imp8
(lanes 2 and 4), and the presence of let-7a or miR-21 in the immu-
noprecipitate was analyzed by northern blotting. Knockdown of
Imp8 did not change the levels of miRNAs coprecipitated with
Ago2 complexes, suggesting that Imp8 is not required for
loading of Ago proteins with miRNAs.
Finally, we analyzed Imp8 requirements for binding of Ago2 to
miRNA target mRNAs (Figure 5E). We and others have reported
earlier that Ago complexes stably associate with miRNA targets
(Beitzinger et al., 2007; Easow et al., 2007; Karginov et al., 2007).
Endogenous Ago2 complexes were immunoprecipitated with
anti-Ago2 antibodies, and the coprecipitated mRNAs were
further analyzed by quantitative real-time PCR (qRT-PCR). As
expected, endogenous Hmga2 mRNA was strongly enriched in
the anti-Ago2 immunoprecipitate. Specific binding was abro-
gated when either let-7a antisense inhibitor or an Ago2 siRNA
was transfected, indicating that the enrichment in the immuno-
Figure 3. Imp8 Affects nuclear Localization of Ago
Proteins
(A) HeLa cells were transfected with a control siRNA (1–4)
or Imp8 siRNAs (5–8 and 9–12), fixed, and stained with
anti-Ago2 (11A9) antibody (1, 5, and 9), anti-LSm4 anti-
body (2, 6, and 10), and DAPI (3, 7, and 11). The scale
bar represents 10 mm.
(B) Upperpanel: Cells were treated as in (A), and nuclear and
cytoplasmic Ago2 signal intensities were quantified from at
least 15 cells per sample. The figure shows the mean ratio of
cytoplasmic versus nuclear signal intensities ± SEM. Lower
panel: siRNA-transfected cells were lysed, and total Ago2
levels were assessed by western blotting, with b-Actin
used as a loading control.
(C) A HEK293 subline stably transfected with EGFP-Ago2
was transfected with a control siRNA, an Imp4 siRNA, or
an Imp8 siRNA. The fluorescence intensities of cyto-
plasmic and nuclear EGFP-Ago2 were quantified with
live microscopy, and mean ratios (± SEM) of cytoplasmic
versus nuclear EGFP-Ago2 signals were calculated from
20 cells per sample.
precipitate is miRNA specific and depends on
the presence of Ago2. Strikingly, Hmga2
mRNA enrichment was significantly reduced (p
< 0.01) when Imp8 was targeted by two different
siRNAs, suggesting a role for Imp8 in recruiting
Ago proteins to miRNA target mRNAs. Similar
results were obtained when myc-Ago2 was
analyzed (Figure 5F, left panel).
Our finding that Imp8 is required for Ago2
binding to miRNA targets as well as nuclear
Ago import could potentially be explained by
recruitment of Ago proteins to target mRNAs in
the nucleus. In order to analyze binding of
Ago2 to mRNAs in the nucleus, we fused Ago2
to a SV40-NLS, leading to Imp8-independent
nuclear localization (Figure S7). Binding of
SV40 NLS-Ago2 to the miRNA target HMGA2
is still dependent on Imp8 (Figure 5F, right panel,
and Figure S8), suggesting that Imp8 functions
in the miRNA pathway independently of nuclear
Ago import and that Ago proteins are loaded onto mRNAs in the
cytoplasm.
Imp8 Is Required for Binding of Ago2 to a Large Set
of Target mRNAs
Next, we analyzed Imp8 effects on global Ago2 transcript
binding. Endogenous Ago2 was immunoprecipitated from cell
lysates that were transfected with control siRNAs or siRNAs
directed against Imp8. Coimmunoprecipitated mRNA was ex-
tracted and investigated by affimetrix microarray analysis
(Figure 6A and Table S3). The Ago2-associated transcripts that
were most enriched compared to total RNA levels were identified
in the data set where control siRNAs had been transfected.
Indeed, most of the top 30 Ago2-associated mRNAs are reduced
in Ago2 immunoprecipitates from Imp8-depleted cells, indi-
cating that Imp8 not only affects Ago2-binding to HMGA2 but
also many other mRNA targets (Figure 6B).Cell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc. 501
Figure 4. Imp8 Is Required for miRNA Function, but Not for RNAi
(A, B, and D) HeLa cells were sequentially transfected with the indicated siRNAs and pMIR-RL dual luciferase reporter plasmids. Firefly/renilla luminescence
ratios are displayed as mean derepression of the reporter constructs (± SEM), which is calculated by normalization of the luminescence ratios of the construct
of interest to the corresponding values of the empty plasmid.
(C) A Hmga2 30 UTR dual luciferase reporter construct or a corresponding reporter construct bearing mutated let-7 binding sites was cotransfected with either
hsa-let-7a antisense 20O-methyl oligonucleotide or a control oligonucleotide into HeLa cells. Data are displayed as mean derepression of luciferase activity
(± SEM), normalized to negative control oligonucleotide transfections.
(E) HeLa cells were transfected with Imp8 or control siRNAs. RNA was isolated and reverse transcribed, and miRNA target mRNA levels were quantified by qPCR.
Data were normalized to GAPDH mRNA levels and to control siRNA-transfected samples.502 Cell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc.qRT-PCR (Figure 6F). None of the Ago2-associated mRNAs
analyzed in Figure 6C, however, were enriched in the Imp8
immunoprecipitate, suggesting that Imp8 does not bind to
Ago2 on mRNA targets. Alternatively, Imp8-miRNA target inter-
actions may not be stable enough to resist immunoprecipitation
conditions. Our data suggest that Imp8 is required for binding of
Ago2 to a broad set of mRNAs. Thus, Imp8 is a general gene-
silencing factor that regulates target mRNA repression on the
level of miRNP-mRNA interactions.
DISCUSSION
Ago proteins bind to miRNAs and mediate repression of target
mRNA expression. However, only little is known about how
Ago proteins find their specific binding sites on the 30 UTRs ofThe requirement of Imp8 for Ago2 mRNA binding was further
validated by qRT-PCR (Figure 6C). Indeed, knockdown of Imp8
reduced the Ago2 association of all mRNAs that have been
tested. Moreover, the 30 mRNAs analyzed in Figure 6B are
significantly stabilized when TNRC6B, a component of the
miRNA pathway guiding mRNA destabilization processes, is
depleted (Figure 6D). In contrast, a control set of mRNAs, which
is not specifically enriched on Ago2, was not stabilized upon
TNRC6B knockdown (Figure 6D). These results strongly suggest
that the analyzed Ago2-bound mRNAs are indeed targets of the
miRNA pathway. This is further supported by the finding that
miRNA seed sequence matches are enriched in Ago2-associ-
ated mRNAs (Figure 6E). In order to investigate the step at which
Imp8 affects Ago2 mRNA target binding, endogenous Imp8 was
immunoprecipitated and the associated mRNAs analyzed by
Figure 5. Imp8 Functions in Ago Protein
Recruitment to Target mRNAs
(A) RNAi depletion of Imp8 does not affect soluble
Ago protein levels in human cells. HeLa cells were
transfected with a control siRNA (lane 1) or Imp8
siRNA (lane 2). Cells were lysed, and insoluble
cellular fractions were pelleted by centrifugation.
Supernatants were analyzed for Ago1/2 levels by
SDS-PAGE/western blotting, with b-Actin used
as loading control. Note that because of the low
abundance of endogenous Ago3 and Ago4 in
HeLa cells, Ago3 and Ago4 were immunoprecipi-
ated with specific monoclonal antibodies prior to
western blot analysis to obtain detectable signals.
(B) Plasmids for the expression of FH-Ago2 and an
Imp8 shRNA (lanes 5–8) or a control shRNA (lanes
1–4) were cotransfected into HEK293 cells. Cells
were pulsed with medium containing [35S]-labeled
amino acids, incubated with nonradioactive chase
medium, and harvested at the indicated time
points. FH-Ago2 was immunoprecipiated with
anti-FLAG beads. The immunoprecipitate was
analyzed for [35S]-labeled FH-Ago2 (upper panel)
and for total FH-Ago2 levels by western blotting
(lower panel).
(C) HeLa cells were transfected with a Dicer siRNA
(lane 1), control siRNA (lane 2), or Imp8 siRNAs
(lanes 3–4). Total RNA was analyzed by denaturing
RNA-PAGE/northern blotting for let-7a, miR-21,
and miR-16, with lys-tRNA used as loading
control.
(D) HeLa cells were transfected with a control
siRNA (lanes 1 and 3) or Imp8 siRNA (lanes 2 and
4). IP was performed from cell lysates with a
control antibody (lanes 1 and 2) or anti-Ago2
(11A9) monoclonal antibody (lanes 3 and 4). The
immunoprecipitate was analyzed for Ago2 by
western blotting (lower panel) and for let-7a and
miR-21 by northern blotting (upper and middle
panels, respectively).
(E) Cells were transfected and treated as in (D), except that additional siRNAs and a let-7a antisense 20O-methyl inhibitor were used. RNA was isolated from immu-
noprecipitates and reverse transcribed. The levels of Ago2-associated Hmga2 mRNA were quantified by qPCR relative to GAPDH mRNA. For each anti-Ago2 IP
sample, relative Hmga2 mRNA levels were normalized to the corresponding input samples.
(F) HeLa cells were sequentially transfected with Imp8 or control siRNAs and myc-Ago2 (left panel) or myc-SV40-NLS-Ago2 (right panel). Myc-tagged proteins
were immunoprecipitated from cell lysates with anti-myc beads. Associated mRNAs were analyzed as in (E).
(E and F) Data are displayed as mean ± SEM.repression of many known miRNA targets. Therefore, we
propose that Imp8 might be a general factor in the miRNA
pathway. Specific factors negatively regulating miRNA binding
to target 30 UTRs have been identified recently. It has been
shown in liver cells that HuR (ELAV1), which binds to AU-rich
elements on target mRNAs, antagonizes miR-122 repression
on the CAT-1 30 UTR upon cellular stress (Bhattacharyya et al.,
2006). Moreover, Dnd1, a protein expressed in primordial germ
cells, prevents miRNA-guided repression by binding to the
vicinity of miRNA binding sites (Kedde et al., 2007). In contrast,
Imp8 is required for efficient binding of miRNAs to 30 UTRs and
therefore functions in the opposite manner of factors such as
HuR or Dnd1. Interestingly, Imp8 is not required for RNAi, sug-
gesting that the assembly of miRNP-mRNA structures might
be a highly coordinated process, which may differ from
sequence-specific cleavage events. Notably, imb-5, the closest
C. elegans homolog of human Imp8, has been identified intarget mRNAs. In this study, we provide evidence that Imp8 is
required for efficient binding of Ago proteins to target mRNAs.
We have identified Imp8 in proteomic analyses of Ago complex
purifications (this study and Hock et al. [2007]) and show that
Imp8 is required for binding of Ago2 to the let-7a target
Hmga2. Imp8 knockdown had no effect on Ago stability, miRNA
biogenesis, or miRNA loading onto Ago proteins. However,
Hmga2 mRNA was strongly reduced in anti-Ago2 immunopre-
cipitations when Imp8 was depleted by RNAi, suggesting that
Imp8 is involved in loading of Hmga2 mRNA with Ago2
complexes or in stabilizing the Ago2-target interaction. Similar
results were obtained for many other mRNA targets, as shown
by affymetrix arrays. However, we show that Imp8 is not stably
associated with Ago2-bound mRNAs, suggesting that Imp8
may be required for efficient binding of Ago2 to target mRNAs
rather than for stabilization of such interactions. We further
show that depletion of Imp8 interferes with efficient miRNACell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc. 503
Figure 6. Imp8 Is Required for Binding of Ago2 to a Large Set of Target mRNAs
(A) HeLa cells were transfected with control or Imp8 siRNAs. Each sample was divided into two parts for total RNA extraction (upper arrow), and anti-Ago2 immu-
noprecipitation followed by RNA extraction (lower arrows). Total RNA samples and immunoprecipitated RNA samples were hybridized to separate Human
Genome U133 Plus 2.0 Affymetrix microarrays. The specific enrichment of each individual transcript was calculated from its normalized measurement value
in the immunoprecipitation sample, divided by its value in the total RNA sample.
(B) A heat map of 30 transcripts most highly enriched in anti-Ago2 immunoprecipitates from control siRNA-transfected cells. The heat map shows normalized
measurements for total RNA from control siRNA-transfected cells (lane 1), Imp8 siRNA-transfected cells (lane 2), and Ago2-associated RNA from control
siRNA-transfected cells (lane 3) and Imp8 siRNA-transfected cells (lane 4).
(C) Ago2 association of transcripts was validated by qRT-PCR and quantified relative to GAPDH and to input lysate samples. Ago2 association of transcripts in
control siRNA transfected cells was normalized to 1.
(D) Box-whisker plot for log2 changes in transcript abundance after TNRC6B knockdown. The plot shows the top 30 Ago2-associated transcripts (right side) and
transcripts which are not specifically associated (enrichment = 1 ± 0.05; left side). Outliers are denoted by asterisks. Mean changes of Ago2-associated transcript
levels are significant (p = 0.017; Student’s t test from four microarray replicates from immunoprecipitated RNA).
(E) The number of 6-mer (left panel) and 7-mer (right panel) seed sequence matches was calculated for 30 UTRs of all transcripts more than 2-fold Ago2-enriched
in at least three out of four microarray replicates compared to seven control groups of not enriched transcripts (enrichment = 1 ± 0.1). Enrichment was calculated
for nine miRNAs highly expressed in HeLa cells and nine absent miRNAs, followed by normalization to 30 UTR length.
(F) HeLa cell lysates were immunoprecipitated with anti-Imp8 antibodies. RNA was isolated from immunoprecipitates, and the specific association of transcripts
with Imp8 was calculated relative to the input sample and to GAPDH.504 Cell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc.
of Imp8 reduced the pool of nuclear Ago2, suggesting that Imp8
is involved in targeting Ago proteins to the nucleus. Biochemical
analyses have suggested before that miRNAs as well as Ago
proteins localize and function in the nucleus (Meister et al.,
2004; Robb et al., 2005). siRNAs directed against nuclear
RNAs such as 7SK RNA efficiently reduced 7SK RNA levels in
nuclear fractions, suggesting that Ago2-mediated cleavage of
target RNA occurs in the nucleus (Robb et al., 2005). Notably,
a significant portion of Ago2 remained in the nucleus after
Imp8 depletion, suggesting that alternative nuclear import path-
ways for Ago proteins may exist. Human Ago proteins have been
implicated in transcriptional silencing processes (Janowski et al.,
2006, 2007; Kim et al., 2006; Morris et al., 2004). It is possible
that the nuclear Ago pool might also be involved in small RNA-
guided transcriptional silencing processes in human cells. It is
also conceivable that novel nuclear Ago functions exist that
have yet to be defined.
Our data strongly suggest that Imp8 plays a major role in Ago-
mediated gene silencing (Figure 7). In the cytoplasm, Imp8 local-
izes together with Ago proteins to P bodies and is involved in effi-
cient loading of Ago proteins onto a variety of different target
mRNAs. Moreover, Imp8 may also direct Ago proteins to the
nucleus of human cells. Currently, it is unclear which factors
direct Imp8 for nuclear import and which factors for Ago protein
loading onto mRNA targets. It is likely that other factors that are
present in our proteomic data set might be involved in regulating
Imp8 function in small RNA pathways.
EXPERIMENTAL PROCEDURES
Antibodies and Recombinant Proteins
The following antibodies were used: mouse-anti-HA (Covance, Princeton, NJ),
rabbit-anti-FLAG (Sigma, St. Louis, MO), rabbit-anti-myc (Abcam, UK), mouse
anti-b-Actin AC15 (Abcam, UK), chicken-anti-Lsm4 (Genway, San Diego, CA),
anti-rabbit-HRP (Sigma), anti-mouse-HRP (Sigma), anti-rat-HRP (Jackson,
West Grove, PA), goat-anti-rat-Texas Red, goat-anti-rabbit-Texas Red,
horse-anti-mouse-fluorescein, horse-anti-mouse-Texas Red (all Vector Labo-
ratories, Burlingame, CA), and anti-chicken-fluorescein (Sigma).
Anti-Ago2 clone 11A9 has been described elsewhere (Ru¨del et al., 2008). Rat-
anti-Ago1 clone 1C9, rat-anti-Ago3 clone 5A3, and rat-anti-Ago4 clone 6C10
were generated as described (Beitzinger et al., 2007). Anti-Imp8 polyclonal anti-
serum was generated by immunization of KLH-CMQSNNGRGEDEEEEDDDWD
into rabbits. Purification of anti-Imp8 polyclonal antibody was performed with
CNBr-activated Sepharose 4 Fast Flow (GE Healthcare) according to the manu-
facturer’s instructions. Recombinant GST-Importin 8 dialyzed against coupling
buffer (0.1 M NaHCO3 [pH 8.3], 0.5 M NaCl) served as ligand.
Coupled sepharose beads were washed with 10 ml PBS and subsequently
incubated with 10 ml serum overnight at 4C. Serum was removed from the
columnbygravity flow, and beadswerewashed twicewith10mlPBS.Forelution
of the purified antibody, 1 ml fractions of elution buffer (0.1 M Glycine [pH 2.3])
were added to the beads, and the column was emptied by gravity flow into reac-
tion tubes containing 0.1 ml 1M Tris-HCl (pH 8.8) to neutralize the eluate.
Recombinant GST-Imp8 was expressed and purified as follows: pGEX6P1-
Imp8 was transformed into E. coli BL21 Rosetta bacteria. Overnight cultures
were diluted into fresh medium, grown to 0.8 OD600, and induced at 18
C
with 1 mM IPTG for 18 hr. Bacteria were disrupted by sonication in purification
buffer [500 mM NaCl/50 mM Tris/HCl (pH 7.5)/5 mM MgCl2/1 mM 4-(2-Amino-
ethyl) benzenesulfonyl fluoride hydrochloride (AEBSF)], and debris was
removed by centrifugation. Supernatants were incubated with Glutathione
sepharose beads (GE healthcare) for 2 hr. Beads were washed twice with
purification buffer (pH 8.0). GST-Imp8 was eluted in purification buffer
(pH 8.0) containing 3 mg/ml glutathione and dialyzed against PBS.a genetic screen for factors essential for small RNA-guided gene
silencing (Kim et al., 2005).
Notably, among the most highly enriched Ago2-associated
transcripts we found the noncoding RNAs H19 and MALAT-1.
Most miRNA target predictions published thus far have been
restricted to 30 UTRs of mRNAs. Our data suggest that other non-
coding RNAs are targeted by miRNAs as well. On the basis of the
analysis of Ago2-associated mRNAs, we suggest that miRNA
target searches should be extended to the entire transcriptome
and should include larger noncoding transcripts.
Interestingly, Imp8 localizes together with Ago proteins to P
bodies in human cells. It is therefore tempting to speculate that
Ago proteins bind to Imp8 in P bodies presumably after target
mRNA degradation and that Imp8 subsequently transfers free
Ago-miRNA complexes to new target mRNAs (Figure 7). Since
Imp8 has no obvious RNA binding domain, Imp8 might tran-
siently interact with other protein factors that interact with
specific binding sites on target 30 UTRs. Alternatively, binding
of Imp8 to Ago proteins may alter the structure of Ago proteins,
allowing for efficient binding to target mRNAs.
Ago proteins have been implicated in transcriptional silencing
processes in different organisms (Lippman and Martienssen,
2004). The intriguing finding that the import receptor Imp8 asso-
ciated with human Ago complexes led us to investigate whether
or not Ago proteins are imported into the nucleus. Using a mono-
clonal anti-Ago2 antibody, we provide evidence that Ago2 is
indeed found in the nucleus of human cells. Moreover, depletion
Figure 7. A Model for Imp8 Function
Imp8 may bind to Ago proteins in P bodies, followed by shuttling to the
nucleus. Alternatively, Imp8 assists Ago protein recruitment to miRNA target
mRNAs in the cytoplasm by delivering Ago proteins to target mRNAs, followed
by dissociation of the Imp8-Ago protein complex and aggregation of
repressed mRNPs. Please note that the Ran binding cycle was omitted from
the figure for simplification.Cell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc. 505
Coimmunoprecipitation and Mass Spectrometry
For coimmunoprecipitation (Co-IP) experiments, 3 3 15 cm plates of HEK293
cells per sample were transfected with appropriate plasmids for 2 days. Cells
were washed twice with PBS and lysed in 500 ml lysis buffer (150 mM KCl/25
mM Tris-HCl [pH 7.5]/2 mM ethylenediaminetetraacetic acid [EDTA]/1 mM
NaF/0.5% NP-40/0.5 mM dithiothreitol [DTT]/0.5 mM AEBSF) per plate. Ribo-
lock (Fermentas, 1 ml per ml of lysis buffer) was added for RNA IPs. Lysates
were cleared by centrifugation at 16,000 g for 10 min. For IP of FLAG-tagged
proteins, lysates were incubated with 60 ml anti-FLAG M2 agarose beads for
3 hr at 4C with or without RNaseA (QIAGEN, 20 mg/ml). For IP of endogenous
proteins, 6 ml monoclonal antibody-containing hybridoma supernatant was
coupled to 60 ml protein G-Sepharose (GE Healthcare) for 2 hr at 4C. Coupled
beads were washed twice with PBS and subsequently incubated with cell
lysate for 3 hr at 4C. All IP samples were washed three times with IP wash
buffer (300 mM NaCl/50 mM Tris [pH 7.5]/1 mM NaF, 0.01% NP-40/5 mM
MgCl2) and once with PBS. For the detection of proteins, beads were boiled
in protein sample buffer. For the detection of associated RNAs, proteins
were digested with 1 mg/ml proteinase K for 1 hr at 42C, followed by
phenol/chloroform/isopropyl alcohol extraction and precipitation of RNA in
80% ethanol at 20C. Mass spectrometry of Ago complexes was performed
as previously described (Hock et al., 2007).
Ago2-Associated mRNA Analysis
HeLa cells were reverse transfected in 10 cm plates with Imp8 or control
siRNAs. For the analysis of mRNA binding to myc-tagged Ago2, cells were
transfected 2 days later with 15 mg/plate pCS2-Ago2 or pCS2-SV40-NLS-
Ago2 with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
instructions. Three days after plasmid transfection, cells were lysed and
treated analogous to IP samples. IP for myc-tagged proteins was performed
for 2.5 hr at 4C with 40 ml anti-myc beads (Sigma) per sample. For analysis
of mRNA binding to endogenous Ago2, siRNA-transfected cells were har-
vested 5 days after transfection and treated as described for IP samples.
Immunoprecipitates were washed three times with IP wash buffer and once
with PBS. IP samples and corresponding samples containing 10% of input
lysate were proteinase K digested, followed by phenol/chloroform/isopropyl
alcohol extraction and precipitation of RNA in 80% ethanol at 20C. RNA
was pelleted, dried, and treated with DNaseI (Fermentas) for 30 min at 37C,
followed by thermal inactivation of DNaseI. RNAs were detected via cDNA
synthesis and qPCR. Hmga2 mRNA levels were normalized to GAPDH
mRNA or Ile tRNA levels for input and IP samples. Specific binding of
Hmga2 mRNA to Ago proteins was calculated from the relative Hmga2
mRNA abundance in IP samples, divided by the relative abundance in the
corresponding input samples.
Microarray Hybridization and Data Analysis
RNA for microarray analysis was isolated with PrepEase Kit for total RNA (USB,
Cleveland, OH) and phenol/chloroform/isopropyl alcohol extraction for IP
samples. RNA was processed and hybridized with the Gene Chip (Affymetrix)
kit and the hybridization procedure for eukaryotic samples, used according
to the manufacturer’s instructions. Samples were hybridized to Human
Genome U133 Plus 2.0 arrays. All arrays were performed in at least two biolog-
ical replicates.
Microarray data were analyzed with Agilent Genespring software. Expres-
sion values below 0.01 were set to 0.01. Each measurement was divided by
the 50th percentile of all measurements in that sample. All IP samples were
normalized to the corresponding total RNA samples: the IP sample from control
siRNA-transfected cells was normalized against the median of the correspond-
ing total RNA sample, and the IP sample from Imp8 siRNA-transfected cells
was normalized against the median of the corresponding total RNA sample.
Each measurement for each gene in the IP samples was divided by the median
of that gene’s measurements in the corresponding total RNA samples.
Using this normalization procedure, the normalized expression value of each
transcript in IP samples directly reflects its over- or underrepresentation in the
immunoprecipitated transcript pool relative to the total RNA pool. So that tran-
scripts bound by Ago2 could be filtered, all transcripts with raw measurements
over 50 that were more than 4-fold enriched in immunoprecipitates from
control siRNA-transfected cells were displayed (Table S3). p values for506 Cell 136, 496–507, February 6, 2009 ª2009 Elsevier Inc.enriched transcripts were calculated on the basis of expression levels with
the Genespring software.
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Small regulatory RNAs such as short interfering RNAs (siRNAs), microRNAs (miRNAs), and Piwi inter-
acting RNAs (piRNAs) have been discovered in the past, and it is becoming more and more apparent
that these small molecules have key regulatory functions. Small RNAs are found in all higher eukary-
otes and play important roles in cellular processes as diverse as development, stress response, or
transposon silencing. Soon after the discovery of small regulatory RNAs, members of the Argonaute
protein family were identified as their major cellular protein interactors. This review focuses on the
various cellular functions of mammalian Argonaute proteins in conjunction with the different small
RNA species that are known today.Introduction
Double-stranded (ds) RNA is the trigger molecule in small
RNA-guided gene-silencing pathways that have been
characterized in mammals thus far. Long dsRNA can de-
rive from various sources such as simultaneous sense
and antisense transcription of specific genomic loci or
viral replication intermediates. The predominant form
of dsRNA in mammalian cells, however, is derived from
endogenously expressedmiRNAs. miRNA genes are tran-
scribed by RNA polymerase II and III (Borchert et al., 2006;
Lee et al., 2004) as primary transcripts that are subse-
quently processed to stem-loop-structured miRNA pre-
cursors (pre-miRNAs) by the RNase III enzyme Drosha.
Like all RNase III enzymes, Drosha leaves two nucleotide
(nt) 30 overhangs and 50 phosphate groups. Pre-miRNAs
are further transported to the cytoplasm via the export-re-
ceptor Exportin-5. Both long dsRNA and secondary fold-
back structures such as hairpins are recognized and pro-
cessed by the cytoplasmic RNase III enzyme Dicer (for
a comprehensive overview, see Ambros [2004] and Mei-
ster and Tuschl [2004]). Dicer binds and cleaves dsRNA
preferentially from the ends and generates a 21–25 nt
long dsRNA with characteristic 50 phosphate groups and
2 nt 30 overhangs (Zhang et al., 2002, 2004). Both strands
of such dsRNA intermediates are separated, and one
strand is incorporated into an effector complex where it di-
rectly binds to a member of the Argonaute protein family.
The RNA-induced silencing complex (RISC) contains
a small RNA that guides the sequence-specific cleavage
of complementary target RNAs, a process termed RNA in-
terference or RNAi (Hammond et al., 2000; Martinez et al.,
2002). Most mammalian miRNAs, however, do not guide
cleavage of target mRNAs by RNAi-like mechanisms. In
contrast, mammalian miRNAs predominantly repress
gene expression on the level of translation or affect
mRNA stability by guiding cellular decay processes, in-
cluding mRNA deadenylation and decapping. To distin-
guish them from mRNA cleavage reactions mediated byRISC, effector complexes containingmiRNAs are often re-
ferred to as miRNPs (Mourelatos et al., 2002).
Recently, a novel class of small RNAs has been cloned
frommammalian testes and termed Piwi interacting RNAs
(piRNAs) because of their interaction with specific mem-
bers of the Argonaute protein family (Aravin et al., 2006;
Girard et al., 2006; Grivna et al., 2006; Lau et al., 2006).
However, the biogenesis of piRNAs, including transcrip-
tion and processing, as well as their cellular functions
remains elusive.
In Schizosaccharomyces pombe (S. pombe), siRNAs
derive from centromeric repeats and associate with
Argonaute proteins to form the RNA-induced initiation of
transcriptional gene silencing (RITS) complex (reviewed
in Lippman and Martienssen [2004]). RITS guides methyl-
transferases to specific chromatic regions, allowing for
the methylation of H3/lysine 9 (H3/K9) and therefore the
establishment of silenced heterochromatin. Repeat-
associated small interfering RNAs (rasiRNAs) have been
discovered in various organisms, including flies and nem-
atodes (Aravin et al., 2003; Sijen and Plasterk, 2003; Vagin
et al., 2006). In mammals, a class of small RNAs that might
be similar to rasiRNAs has been described recently (Wata-
nabe et al., 2006; Yang and Kazazian, 2006). However, the
function of this mammalian class of small RNAs remains
unclear.
The Argonaute Protein Family
Argonaute proteins were named after the characteristic
squid-like phenotype of plants lacking functional Argo-
naute proteins (Bohmert et al., 1998). In the past years,
Argonaute proteins have been extensively studied inmany
different organisms, including S. pombe, Caenorhabditis
elegans (C. elegans), Drosophila melanogaster (D. mela-
nogaster), and various mammals. It is becoming more
andmore apparent that Argonaute proteins are key actors
in many different RNA silencing pathways. Gene inactiva-
tion studies revealed that Argonaute proteins areMolecular Cell 26, June 8, 2007 ª2007 Elsevier Inc. 611
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Argonaute Protein Slicer Activity Catalytic Triad Associated Small RNAs Reference(s)
Homo sapiens
Ago1  DDR si-, miRNAs Liu et al., 2004;
Meister et al., 2004
Ago2 + DDH si-, miRNAs Liu et al., 2004;
Meister et al., 2004
Ago3  DDH si-, miRNAs Liu et al., 2004;
Meister et al., 2004
Ago4  DGR si-, miRNAs Liu et al., 2004;
Meister et al., 2004
HIWI1 Not investigated DDH Not investigated
HIWI2 Not investigated DAH Not investigated
HIWI3 Not investigated DDH Not investigated
HILI Not investigated DDH Not investigated
Mus musculus
Ago1 Not investigated DDR Not investigated
Ago2 Not investigated DDH Not investigated
Ago3 Not investigated DDH Not investigated
Ago4 Not investigated DGR Not investigated
Ago5 Not investigated NDH Not investigated
MIWI Not investigated DDH piRNAs Girard et al., 2006
MIWI2 Not investigated DDH Not investigated
MILI Not investigated DDH piRNAs Aravin et al., 2006important for embryonic development, cell differentiation,
and stem cell maintenance.
The number of Argonaute genes is highly variable be-
tween species, ranging from one in S. pombe to 27 in C.
elegans. Both human and mouse express eight Argonaute
family members (Sasaki et al., 2003). Based on sequence
similarities, the mammalian Argonaute protein family has
been separated into the Ago and Piwi subfamilies. In hu-
man, the Ago subfamily consists of hsAgo1–4, in mouse
of mmAgo1–5 (Table 1). Members of the Piwi subfamily
are phylogenetically closer related to PIWI, the founding
member in D. melanogaster (Carmell et al., 2002). Al-
though the human genome encodes four members of
this subfamily, only three are found in the mouse genome
(see below). Expression studies revealed that the Ago
subfamily is ubiquitously expressed, whereas expression
of the Piwi subfamily seems to be restricted to germ cells
(Meister et al., 2004; Sasaki et al., 2003). However, a com-
prehensive expression study analyzing all mammalian tis-
sues has not been performed yet.
Argonaute proteins have a molecular weight of about
100 kDa and are characterized by piwi-argonaute-zwille
(PAZ) and PIWI domains (Cerutti et al., 2000). Structural
studies on isolated PAZ domains in complex with a ds
siRNA revealed that the PAZ domain forms a specific
binding module for the characteristic 2 nt 30 overhangs612 Molecular Cell 26, June 8, 2007 ª2007 Elsevier Inc.generated by RNase III-type enzymes such as Dicer (for
a comprehensive overview of structural studies on Argo-
naute proteins, see Parker and Barford [2006] and Song
and Joshua-Tor [2006]). X-ray crystallography studies of
bacterial Argonaute proteins found a third functionally im-
portant domain, which is located between the PAZ and the
PIWI domain and therefore referred to as MID domain
(Parker et al., 2005; Yuan et al., 2005). The MID domain
contains a highly basic pocket, which specifically binds
the characteristic 50 phosphate of small RNAs and there-
fore anchors the small RNA onto Argonaute proteins. Fur-
ther structural studies indicated that the PIWI domain
folds similar to RNase H. Consistently, some Ago proteins
are indeed endonucleases and cleave substrate RNAs
complementary to the bound small RNA. In analogy to
Dicer, such proteins are often referred to as ‘‘Slicer.’’
Like RNase H, three residues within the PIWI domain
form a catalytic triad. Based on mutation studies, the cat-
alytic triad of human Ago2 has been identified as D(597),
D(669), and H(807) (Rivas et al., 2005; Song et al., 2004).
In vitro assays using RNA substrates complementary to
exogenous siRNAs (Liu et al., 2004) as well as endoge-
nous miRNAs (Meister et al., 2004) identified Ago2 as
the only member of the human Ago subfamily with endo-
nuclease activity. Interestingly, human Ago3 is catalyti-
cally inactive, even though the catalytic triad DDH is
Molecular Cell
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such as posttranslational modification or interaction with
specific proteins may modify the activity of Ago proteins.
Members of the mammalian Piwi subfamily have not
directly been analyzed for Slicer activity thus far. Interest-
ingly, Drosophila PIWI shows Slicer activity in vitro, al-
though the putative catalytic triad is formed by DDK (Saito
et al., 2006). Furthermore, it has been shown that highly
pure fractions from rat testes containing the Piwi subfam-
ily member RIWI and piRNAs contain Slicer activity as
well, suggesting that RIWI might be endonucleolytically
active (Lau et al., 2006). The most intriguing question is,
however, what natural RNAs are targeted by mammalian
Piwi proteins. Answering this question will clearly be a
major research focus in the next few years andwill provide
new interesting insights into RNA-guided gene silencing in
general.
Loading of Argonaute Proteins with Small RNAs
Ago proteins most likely recognize the characteristic 2 nt
30 overhangs of ds small RNA duplexes by their PAZ do-
mains. Because the affinity of recombinant bacterial Ago
proteins to dsRNA is very low (Yuan et al., 2005), it is likely
that the small RNA is unwound while one strand stably as-
sociates with Ago as guide strand. The opposing strand,
often referred to as passenger strand, is most likely de-
graded by nucleases. A yet to be identified helicase may
contribute to the unwinding process and help to load
Ago proteins with small RNAs. Recently, a model for
Ago loading involving cleavage-competent Ago proteins
has been suggested. Drosophila Ago proteins as well as
hsAgo2 are capable of cleaving the passenger strand of
the siRNA duplex, which will therefore not be incorporated
into Ago complexes (Matranga et al., 2005; Miyoshi et al.,
2005; Rand et al., 2005). Because of their short length,
helicase activity is presumably not required to remove
the cleavage fragments. However, such a model does
not explain how cleavage-incompetent Ago proteins are
loaded. Moreover, miRNA precursors that are unpaired
at the cleavage position can also not be loaded as pre-
dicted by such a model, indicating that alternative mech-
anisms for Ago loading exist.
For most miRNAs, only one strand accumulates as ma-
turemiRNA. Such asymmetric loading is guided by the rel-
ative thermodynamic stability of the 50 ends of the small
RNA duplex. The strand whose 50 end is less stably paired
is preferentially incorporated into Ago complexes (Khvor-
ova et al., 2003; Schwarz et al., 2003). In Drosophila, the
dsRNAbinding domain (dsRBD) protein R2D2 forms a het-
erodimer with Dicer2 and binds the more stable end of the
siRNA, thereby positioning the duplex in order to allow in-
corporation of the right strand (Tomari et al., 2004). In hu-
man, the dsRBD proteins TRBP and PACT, which are
highly homologous to Drosophila R2D2, are involved in
RNA silencing as well (Chendrimada et al., 2005; Haase
et al., 2005; Lee et al., 2006). Both TRBP and PACT reside
independently in a complex with hsAgo2 and Dicer. Such
a trimeric complex is capable of generating small RNAsfrom dsRNA precursors, transferring one strand to Ago2
and cleaving complementary substrate RNAs (Gregory
et al., 2005). Moreover, inactivation of TRBP as well as
PACT results in a loss of mature miRNAs. Therefore, these
proteins may have a similar role in strand selection and/or
Ago loading as R2D2 in Drosophila, albeit this speculation
remains to be experimentally investigated.
Ago-Mediated Posttranscriptional Gene
Silencing Pathways
Depending not only on the bound small RNA but also on
the specific mRNA that is targeted, Ago protein com-
plexes mediate different posttranscriptional gene silenc-
ing mechanisms. Such Ago complexes are often referred
to as effector complexes, and their individual functions will
be discussed in the following paragraphs.
Ago Proteins and Translational Regulation
Initial studies in C. elegans showed that the miRNA lin-4
binds to the 30 untranslated region (UTR) of the lin-14
mRNA. Further expression studies revealed that the
mRNA levels of lin-14 are not affected by lin-4 but the
lin-14 protein levels dropped dramatically when lin-4 is
present, indicating that this miRNA inhibits gene expres-
sion at the level of translation (Lee et al., 1993; Olsen
and Ambros, 1999; Wightman et al., 1993). However,
these initial observations have been challenged recently.
Although not perfectly complementary, lin-4 as well as
other miRNAs can inhibit target gene expression during
C. elegans development by altering mRNA levels (Bagga
et al., 2005), indicating that inhibition of gene expression
on the translational level might not be the predominant
function of miRNAs. Nevertheless, it has also been shown
in mammals that miRNAs can inhibit protein production
without changing mRNA levels (O’Donnell et al., 2005;
Poy et al., 2004). Because Ago proteins are the cellular
binding partners of miRNAs and miRNAs most likely func-
tion as guides to the target RNA, it is reasonable that Ago
proteins are the mediators of translational repression. In-
deed, tethering of Ago proteins to the 30UTR of an artificial
reporter mRNA inhibited translation of the mRNA (Pillai
et al., 2004). However, in this study, Ago loading has not
been experimentally addressed. Therefore, it is unclear if
Ago proteins can repress translation independently of
small RNAs.
The molecular mechanism of how miRNPs inhibit the
translation of target mRNAs is highly controversial. Early
studies in C. elegans and later on in mammals demon-
strated that both Ago proteins and miRNAs cosediment
with polyribosomes in sucrose gradients (Maroney et al.,
2006; Nottrott et al., 2006; Olsen and Ambros, 1999; Pe-
tersen et al., 2006; Seggerson et al., 2002). Therefore, it
has been proposed that miRNPs regulate translation after
initiation. Indeed, several lines of evidence support such
a model. First, artificial or natural mammalian miRNA tar-
gets comigrate with polyribosomes as well. Second, de-
struction of polyribosomes by different agents results in
a shift of Ago proteins andmiRNAs to smaller mRNP com-
plexes, indicating that indeed miRNPs associate withMolecular Cell 26, June 8, 2007 ª2007 Elsevier Inc. 613
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ReviewFigure 1. Mammalian Ago Proteins Localize to Cytoplasmic P Bodies
FLAG/HA-tagged human Ago1 was transfected into HEK 293T cells and stained with anti-FLAG antibodies (panel 1). DNA was stained with DAPI
(panel 2). The merged image is displayed in panel 3. P bodies are indicated by arrows.polyribosomes (Maroney et al., 2006; Nottrott et al., 2006;
Petersen et al., 2006). Consistently, a ‘‘ribosome drop-off’’
model has been suggested. This model describes the
rapid ribosome ‘‘drop-off’’ from mRNAs that are targeted
by miRNPs (Petersen et al., 2006). A logical consequence
of translational inhibition at the elongation step would be
the production of nascent polypeptide chains that have
to be removed after inhibition (Figure 2). Moreover, the as-
sociation of miRNPs with actively translating ribosomes
suggests that miRNAs directly influence the destruction
of growing polypeptide chains. Indeed, using antibodies
against the N terminus of a growing polypeptide that is un-
der the control of a miRNA, Richter and coworkers re-
cently showed that the N terminus is not accessible either,
because it is rapidly degraded or it is masked and targeted
for destruction by other proteins (Nottrott et al., 2006). Fur-
ther biochemical studies that aim for the identification of
factors that link Ago proteins with the protein degradation
machinery such as the proteasome or the ubiquitin-conju-
gating system will help to elucidate the mode of transla-
tional repression mediated by Ago proteins and associ-
ated miRNAs.
However, the model described above does not explain
two experimental observations. First, Ago proteins and
miRNAs as well as artificial and also natural target mRNAs
localize to processing bodies (P bodies), cellular sites
where ribosomal proteins have not been found thus far
(Figure 1, see below). Second, miRNPs do not affect
cap-independent translation initiated by internal ribo-
somal entry sites (IRES) (Humphreys et al., 2005; Pillai
et al., 2005). Indeed, it has been shown that efficient re-
pression of miRNA targets requires the 50 cap structure
as well as a poly(A) tail, indicating that the translation initi-
ation step rather than the elongation step is affected by
miRNPs (Humphreys et al., 2005). Moreover, the CAT-1
mRNA, which is released from miRNP-122-mediated re-
pression upon cellular stress in liver cells, reassociates
with polyribosomes, indicating that the initiation step is
blocked by miR-122 (Bhattacharyya et al., 2006).
The two models of miRNP function in translation are
controversial, and some results are even contradictory.614 Molecular Cell 26, June 8, 2007 ª2007 Elsevier Inc.A simple explanation of this controversy would be that
translational inhibition mediated bymiRNPs could be spe-
cific to cellular conditions or the individual miRNA targets
that have been used. Moreover, different experimental
systems as well as different miRNA targets and reporter
constructs that have been used in different studies might
also contribute to controversial data. A more comprehen-
sive study analyzing many different natural miRNA targets
in different cell types will be needed to understand the
controversial results reported thus far.
RISC and RNA Turnover
Ago proteins affect the stability of target RNAs by different
mechanisms. In human RNAi, exogenous siRNAs guide
RISC to highly complementary RNA molecules where
Ago2 sequence specifically cleaves the target RNA. The
cleavage reaction itself requires Mg2+ ions, is ATP inde-
pendent, and leaves 50 phosphate as well as 30 hydroxyl
groups (Martinez and Tuschl, 2004; Schwarz et al.,
2004). Endogenous miRNAs are capable of guiding the
same cleavage reaction and are therefore functionally
not distinguishable from siRNAs (Hutva´gner and Zamore,
2002). Indeed, the HoxB8 mRNA shows an extensive
complementarity to miR-196 in mammals, and it has
been experimentally demonstrated that RISC indeed
cleaves the HoxB8 message during mouse development
(Yekta et al., 2004). However, most cellular target mRNAs
are not perfectly complementary to the miRNA, indicating
that sequence-specific destruction of mRNAs is not the
predominant function of miRNA-loaded Ago complexes.
Indeed, it has been demonstrated in Drosophila, Zebra-
fish, and mammals that miRNAs, although not perfectly
complementary to the target, can induce its destruction
by recruiting deadenylating anddecapping enzymes to the
message (Behm-Ansmant et al., 2006; Giraldez et al.,
2006; Mishima et al., 2006; Wu et al., 2006). Moreover,
genome-wide analyses of siRNA effects in human cells
have shown that, beside the complementary target RNA,
a large portion of other mRNAs are affected by specific
siRNAs, although they were not perfectly complementary
(Jackson and Linsley, 2004). Consistently, studies on hu-
man miRNAs revealed that large portions of mRNAs are
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complementarity of 10–14 nt between the target mRNA
and the siRNA is sufficient for mRNA destabilization (Jack-
son and Linsley, 2004).
Because miRNAs function as guides, it is very likely that
Ago proteins interact either directly or through adaptor
proteins with specific factors of the deadenylation and de-
capping machinery. In Drosophila, Ago1 directly interacts
with GW182, an RNA binding domain containing protein
that recruits the CCR4:NOT complex to the mRNA
(Behm-Ansmant et al., 2006). The CCR4:NOT complex
is one of the two major deadenylase complexes in
Drosophila, and it has been shown that miRNA target
mRNAs are destabilized by deadenylation mediated by
the CCR4:NOT complex. GW182 belongs to a conserved
family of proteins that has three paralogs in mammals
(Behm-Ansmant et al., 2006). The human members of
this protein family are termed trinucleotide repeat contain-
ing (TNRC) 6A (GW182), 6B, and 6C. Experimental evi-
dence indicates that both TNRC6A (GW182) and TNRC6B
interact with members of the Ago subfamily (Table 2) and
are functionally involved in miRNA function in mammalian
cells (Jakymiw et al., 2005; Liu et al., 2005a; Meister et al.,
2005). It is tempting to speculate that TNRC6A and/or B
may recruit specific deadenylase complexes to miRNA
target mRNAs by interacting with human Ago proteins
similarly to Drosophila. Furthermore, it will be interesting
to analyze if TNRC6C has a function in themiRNApathway
as well.
P Bodies, Stress Granules, and Ago Function
Localization studies using immunofluorescence ap-
proaches and tagged Ago proteins revealed that Ago pro-
teins are enriched in distinct cytoplasmic foci (Figure 1).
Colocalization studies with antibodies against diverse
marker proteins such as Dcp1, LSm4, or GW182 identified
Ago proteins as components of cytoplasmic P bodies (Liu
et al., 2005b; Sen and Blau, 2005). Remarkably, P bodies
are cellular sites where mRNA turnover occurs (for a com-
prehensive overview, see Eulalio et al. [2007]). mRNA de-
capping and degradation enzymes localize to P bodies to
ensure rapid and efficient mRNA turnover. Therefore, it
has been suggested that Ago proteins may identify target
mRNAs by sequence complementarity to the bound
miRNAs and target those mRNAs to P bodies where
cleavage and degradation occur. In support of such
amodel, it was found that depletion of the P body compo-
nents TNRC6A (GW182), TNRC6B, MOV-10, and Dcp1/2
inhibited miRNA-guided RISC activity (Jakymiw et al.,
2005; Liu et al., 2005a; Meister et al., 2005; Rehwinkel
et al., 2005). Consistently, Ago mutants that can no longer
bind to miRNAs do not localize to P bodies, suggesting
that Ago proteins have to be incorporated into higher-or-
der structures such asmRNA protein complexes (mRNPs)
via miRNA-mRNA interactions in order to localize to P
bodies (Liu et al., 2005b). Because Ago complexes can
stably associate with specific mRNAs without affecting
their stability, a model in which Ago proteins target theirtranslationally repressed mRNA targets to P bodies,
thereby separating them spatially from the translation ma-
chinery, has been suggested (Figure 2). Such a model is
supported by findings in yeast, where a movement of
mRNAs between polyribosomes and P bodies as well as
localization of nontranslating mRNAs to P bodies has
been observed (Brengues et al., 2005; Teixeira et al.,
2005). A model of mRNA storage also implies that mRNAs
can relocalize to the cytoplasm and re-enter polyribo-
somes for translation. Indeed, the CAT-1 mRNA is re-
pressed by the liver-specificmiR-122 and stored in P bod-
ies under normal conditions. Upon cellular stress, the
translational block is released and the CAT-1 mRNA is ac-
tively translated to produce CAT-1 protein, which is re-
quired for the cellular stress response (Bhattacharyya
et al., 2006). Therefore, at least for the very specific
CAT-1 mRNA, the model of P body storage and release
has been experimentally proven. Interestingly, the release
of the CAT-1mRNA from Ago repression involves the RNA
binding protein HuR. Under normal conditions, HuR local-
izes to the nucleus. Upon cellular stress, HuR localizes to
the cytoplasm, where it helps to release the CAT-1 mRNA
from Ago repression. How such release mechanisms
function is still unclear. Most likely, other mRNA binding
proteins may contribute not only to Ago-mediated inhibi-
tion but also to possible mRNA release mechanisms.
Whether such mechanisms apply to other mRNAs than
the CAT-1 mRNA, however, remains unclear. At least
one recent study revealed that disruption of P bodies by
depletion of LSm1 had no effect on miRNA-guided trans-
lational inhibition of an artificial reporter construct (Chu
and Rana, 2006).
Very recently, a more quantitative analysis has shown
that Ago proteins localize not only to P bodies but also
to the diffuse cytoplasm and stress granules (SGs) (Leung
et al., 2006). EGFP tagging of Ago2 followed by three-di-
mensional measurements revealed that only about 1.3%
of EGFP-Ago2 localizes to P bodies. After inhibition of
translational initiation with hippuristanol, EGFP-Ago2 ac-
cumulated in SGs. Moreover, using photobleaching, it
was demonstrated that the P body pool of Ago proteins
seems to be static, whereas a more dynamic behavior
has been observed for Ago proteins that localize to SGs.
However, SGs form when cells experience different forms
of stress such as heat shock or oxidative stress, and
a physiological role for SGs under stress-free conditions
has not been established yet. A possible explanation of
the controversial data on SGs and P bodies could be
that, under normal conditions, mRNAs that are required
for stress response, like the CAT-1 mRNA, might be re-
pressed by Ago proteins and stored in P bodies. Under
stress conditions, however, such mRNAs could be re-
leased and translated, whereas many other Ago contain-
ing mRNPs accumulate in SGs during stress response
(Figure 2). A detailed analysis of the localization and trans-
lational repression of other miRNA targets will clearly help
to better understand the contribution of P body and SG
localization to Ago function.Molecular Cell 26, June 8, 2007 ª2007 Elsevier Inc. 615
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Associated
Protein Domains/Motifs
Function in Gene
Silencing Cellular Localization Reference(s)
hsAgo1
Dicer DExH box, PAZ,
RNase III, dsRBD
Small RNA processing Cytoplasm Meister et al., 2005
TNRC6B RRM, GW repeats miRNA-guided
cleavage
Cytoplasm, P bodies Meister et al., 2005
DCP1a  Not investigated Cytoplasm, P bodies Liu et al., 2005b
DCP2 Nudix Not investigated Cytoplasm, P bodies Liu et al., 2005b
MOV10 DExH box miRNA-guided
cleavage
Cytoplasm, P bodies Meister et al., 2005
PRMT5 Methyl-transferase Not investigated Cytoplasm, nucleus Meister et al., 2005
hsAgo2
Dicer DExH box, PAZ,
RNase III, dsRBD
Small RNA processing Cytoplasm Gregory et al., 2005;
Meister et al., 2005
TNRC6A/
GW182
RRM, GW repeats miRNA-guided cleavage,
translational repression
Cytoplasm, P bodies Jakymiw et al., 2005;
Liu et al., 2005a
TNRC6B RRM, GW repeats miRNA-guided
cleavage
Cytoplasm, P bodies Meister et al., 2005
DCP1a  Not investigated Cytoplasm, P bodies Liu et al., 2005b
DCP2 Nudix Not investigated Cytoplasm, P bodies Liu et al., 2005b
TTP Zn-finger AU-rich mRNA
destabilization
Cytoplasm Jing et al., 2005
MOV10 DExH box miRNA-guided
cleavage
Cytoplasm, P bodies Meister et al., 2005
PRMT5 Methyl-transferase Not investigated Cytoplasm, nucleus Meister et al., 2005
eIF4E  Not investigated Nucleus, cytoplasm,
P bodies
Chu and Rana, 2006
Rck/p54 DEAD box Translational repression Cytoplasm, P bodies Chu and Rana, 2006
Gemin3 DEAD box miRNA-guided
cleavage
Nucleus, cytoplasm Mourelatos et al., 2002
Gemin4  Not investigated Nucleus, cytoplasm Mourelatos et al., 2002
PACT dsRBD Small RNA processing,
RISC activity
Cytoplasm Lee et al., 2006
FMRp KH domain, RGG box Not investigated Nucleus, cytoplasm Jin et al., 2004
FXR1 KH domain, RGG box Not investigated Nucleus, cytoplasm Jin et al., 2004
FXR2 KH domain, RGG box Not investigated Nucleus, cytoplasm Jin et al., 2004
hsAgo3
Dicer DExH box, PAZ,
RNase III, dsRBD
Small RNA processing Cytoplasm Meister et al., 2005
hsAgo4
Dicer DExH box, PAZ,
RNase III, dsRBD
Small RNA processing Cytoplasm Meister et al., 2005
TTP Zn-finger AU-rich mRNA
destabilization
Cytoplasm Jing et al., 2005
MIWI
Dicer DExH box, PAZ,
RNase III, dsRBD
Small RNA processing Cytoplasm Kotaja et al., 2006a616 Molecular Cell 26, June 8, 2007 ª2007 Elsevier Inc.
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Associated
Protein Domains/Motifs
Function in Gene
Silencing Cellular Localization Reference(s)
KIF17b Kinesin motor Not investigated Cytoplasm,
chromatoid body
Kotaja et al., 2006b
MVH DEAD box Not investigated Cytoplasm,
chromatoid body
Kuramochi-Miyagawa
et al., 2004
MAEL HMG box Not investigated Cytoplasm, chromatoid
body, XY-body, nucleus
Costa et al., 2006
MILI
MAEL HMG box Not investigated Cytoplasm, chromatoid
body, XY-body, nucleus
Costa et al., 2006Mammalian Ago Proteins in the Nucleus—
Transcriptional Silencing?
It is well established that the predominant function of the
sole S. pombe Ago protein is to guide transcriptional
gene silencing processes by recruitingmethyltransferases
to heterochromatic regions of the genome (for a detailed
overview, see Lippman and Martienssen [2004] and
Matzke and Birchler [2005]). Until now, nuclear functions
for Ago proteins have been reported in a variety of different
organisms, including plants, fungi, Drosophila, and C. ele-
gans (reviewed in Matzke and Birchler [2005]). A nuclear
function ofmammalian Ago proteins in somatic cells, how-
ever, is still a matter of debate. Initial biochemical fraction-
ations separating nuclear from cytoplasmic extracts dem-
onstrated that Ago proteins as well as mature miRNAs
could be found both in cytoplasmic and nuclear fractions
(Meister et al., 2004; Robb et al., 2005). However, it was
not excluded that Ago proteins associated with the outer
nuclear envelope and therefore contaminated the nuclear
fractions. In further studies, it has been shown that siRNAs
against the nuclear RNAs 7SK and the U6 snRNA are func-
tional, suggesting that Ago2, the cleavage-competent
Ago protein in mammals, is present in the nucleus as
well (Robb et al., 2005). More recent approaches showed
that siRNAs directed against the promoter of a GFP re-
porter construct repress GFP expression by transcrip-
tional gene silencing (Kim et al., 2006; Morris et al.,
2004). Knockdown of human Ago1 suppressed the ob-
served gene silencing effect, indicating that Ago proteins
are involved in this process. Moreover, siRNAs against
the transcription start sites of endogenous genes such
as huntingtin or the progesterone receptor (PG) inhibited
transcription as well (Janowski et al., 2006). In this study,
no transcriptional silencing was observed when either hu-
man Ago1 or Ago2 was depleted. Additionally, chromatin
immunoprecipitations revealed that both Ago proteins as-
sociate with the PG promoter, suggesting that Ago1 and
Ago2 are involved not only in posttranscriptional gene
silencing but also in transcriptional gene silencing.
Although it is becoming more and more apparent that
Ago proteins also function in the nucleus, immunofluores-
cence approaches using antibodies against tagged ver-sions of Ago proteins show only a cytoplasmic Ago local-
ization. Possible explanations for this discrepancy could
be that only a minor portion of Ago proteins localize to
the nucleus and are not detected by classical immunoflu-
orescence experiments. Furthermore, the nuclear locali-
zation of Ago proteins could be transient or highly dy-
namic, and under steady-state conditions, most Ago
protein is detected in the cytoplasm. It is also reasonable
that Ago proteins act on chromatin structures specifically
during the cell cycle after nuclear envelope breakdown
and could therefore not be detected in the nucleus of
interphase cells. Finally, nuclear Ago proteins could be
incorporated into large protein complexes and are pre-
sumably not accessible for antibodies. Further studies
such as the identification of specific nuclear interactors
will be required to elucidate the nuclear function of human
Ago proteins.
The Piwi Subfamily and piRNAs
The human Piwi subfamily of Argonaute proteins is com-
posed of HIWI, HIWI2 (also termed piwi-like2 or piwil2),
HIWI3 (piwil3), and HILI (piwil). In mouse, only MIWI,
MIWI2, and MILI exist. The Piwi subfamily was originally
named after the Drosophila piwi gene and has been impli-
cated in germ cell development, stem cell self-renewal,
and retrotransposon silencing (Cox et al., 2000; Kalmy-
kova et al., 2005). Based on primary sequence, different
members of the Piwi subfamily have been identified in var-
ious organisms. Moreover, many of these proteins are
germ cell specific, suggesting a phylogenetically con-
served function in the germline. Interestingly, gene inacti-
vation approaches in mouse revealed that MILI as well as
MIWI is essential for spermatogenesis (Deng and Lin,
2002; Kuramochi-Miyagawa et al., 2004). Female mili/
mice are fertile with no abnormalities in the ovaries,
whereas male mili/ mice are sterile with smaller testes.
In MILI null mice, sterility is due to meiosis defects leading
to an arrest in spermatogenesis from zygotene to pachy-
tene stages (Figure 3). Similarly to MILI null mice, miwi/
mice are female fertile and male sterile as well. However,
in miwi/mice, defects are manifested at later stages
of spermatogenesis, presumably after the formation ofMolecular Cell 26, June 8, 2007 ª2007 Elsevier Inc. 617
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ReviewFigure 2. A Model for Ago-Mediated Translational Repression and RNA Turnover
Ago proteins repress translation either on the level of actively translating polyribosomes (A) or initiation of translation (B). Repressed Ago containing
mRNPs aggregate to P bodies where repressed mRNAs can either be stored or degraded involving deadenylation and decapping enzymes (C). Upon
cellular stress, actively translating polyribosomes aggregate and form stress granules. Ago proteinsmay repress the translation of mRNAs that are not
needed for an efficient stress response (D). For further details, see text. m7G,m7G-cap; AAA, polyA-tail; NH2, N terminus of nascent polypeptides; and
40S and 60S, ribosomal subunits.spermatids (Figure 3) (Deng and Lin, 2002). Not much is
known about the function of MIWI2 and HIWI3 so far.
Gene targeting approaches as well as biochemical exper-
iments using testes extracts will be needed to find out if
MIWI2 andHIWI3 are involved in spermatogenesis aswell.618 Molecular Cell 26, June 8, 2007 ª2007 Elsevier Inc.In Drosophila, germ cells are characterized by a cyto-
plasmic structure containing dense material, which is
called nuage and contains the Argonaute proteins PIWI
and Aubergine (Aub). A similar structure has been identi-
fied in mammalian germ cells and termed the chromatoid
Molecular Cell
ReviewFigure 3. Function of Mammalian
Argonaute Proteins in Spermatogenesis
The stages of spermatogenesis and the devel-
opmental stages of the corresponding cell
types are displayed in the middle and right
panels. The expression of MILI and MIWI dur-
ing spermatogenesis is shown on the left
side. MILI associates with 26–28 nt piRNAs
and is expressed until the pachytene stage in
meiosis I. Correspondingly, mili/ spermato-
cytes are arrested between the zygotene and
pachytene stages in the early prophase of mei-
osis I. The expression of MIWI, which associ-
ates with 29–31 nt piRNAs, is detectable from
the pachytene stage in meiosis I until round
spermatids are formed in early spermiogene-
sis. MIWI/ spermatocytes are arrested at
the stage of round spermatids, coinciding
with the final phase of MIWI expression.body (reviewed in Kotaja and Sassone-Corsi [2007]). Inter-
estingly, chromatoid bodies contain P body components
such as Argonaute proteins both from the Ago and the
Piwi subfamily, Dcp1a or GW182, miRNAs, and polyade-
nylated mRNAs. Therefore, chromatoid bodies might be
the male germ cell counterparts of somatic P bodies and
may have similar functions in gene silencing (Kotaja
et al., 2006a).
Very recently, a novel class of small RNAs has been
identified that specifically interacts with members of the
Piwi subfamily. Therefore, these small RNAs have been
termed piRNAs (Aravin et al., 2006; Girard et al., 2006;
Grivna et al., 2006;Watanabe et al., 2006). Immunoprecip-
itations from mouse testes using antibodies directed
against MIWI or MILI identified MIWI-associated piRNAs
of 29–31 nt and MILI-associated piRNAs of 26–28 nt in
length. Both HILI- and HIWI-associated piRNAs derive
from genomic clusters. Although many piRNAs are not
conserved from mouse to human on the sequence level,
piRNA clusters are embedded into syntenic genomic re-
gions. Consistently with the MILI and MIWI protein func-
tion, the MILI-associated piRNAs accumulate at the onset
of meiosis in male germ cells, whereas the MIWI-associ-
ated piRNAs seem to have functions at later stages of
spermatogenesis (Figure 3).
Interestingly, cloning studies frommouse oocytes found
a class of 20–24 nt long RNAs, which are derived from ret-
roelements such as LINE, SINE, and LTR retrotranspo-
sons (Watanabe et al., 2006). Furthermore, injection of
a reporter construct containing a perfectly complemen-
tary binding site for such a small RNA into oocytes led to
the inactivation of the reporter, suggesting that retroele-
ments are suppressed by an RNAi-like mechanism in
mouse oocytes. However, it remains unclear if the
mRNA of the reporter construct is cleaved sequence spe-
cifically, because neither cleavage products nor an asso-ciation of the identified small RNAs with Argonaute pro-
teins has been analyzed.
Although the analysis of themammalianmembers of the
Piwi subfamily is at a very early stage, far more is known
about the function of this subfamily in Drosophila. PIWI
is required both for posttranscriptional and transcriptional
gene silencing (TGS) phenomena in flies (Pal-Bhadra et al.,
2002). Moreover, it has been shown that PIWI is required
for transcriptional silencing of selfish genetic elements
such as retrotransposons in the male germline (Aravin
et al., 2004; Kalmykova et al., 2005). An interesting hint
of how Piwi subfamily proteins function in TGS came
from mutant flies that lack functional PIWI or Aub, two
Piwi subfamily proteins that are enriched in germ cells.
As a consequence of loss-of-function mutations in the
piwi and aubergine genes, H3/K9 methylation, a hallmark
of heterochromatin, was strongly reduced. Consistently,
the heterochromatin proteins HP1 and HP2 were delocal-
ized from heterochromatic regions and therefore tran-
scriptional silencing was suppressed (Pal-Bhadra et al.,
2004). Interestingly, both PIWI and Aub bind to rasiRNAs,
which constitute a class of small RNAs that derive from re-
petitive genetic elements (Aravin et al., 2003; Vagin et al.,
2006). The most intriguing finding, however, was that ra-
siRNAs are most likely not generated by Dicer and there-
fore constitute a third gene silencing pathway in Drosoph-
ila (Vagin et al., 2006).
The findings inDrosophilamay also help to elucidate the
function of mammalian Piwi proteins and even piRNAs. It
is tempting to speculate that members of the mammalian
Piwi subfamily may function similarly to their Drosophila
homologs and guide the formation of silenced heterochro-
matin. The analysis of HP1 localization in mammalian cells
that lack functional proteins of the Piwi subfamily will
clearly help to address this speculation. It is also reason-
able that piRNAs or other classes of small RNAs protectMolecular Cell 26, June 8, 2007 ª2007 Elsevier Inc. 619
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Reviewthe mammalian germline frommobile genetic elements as
shown for some Drosophila Piwi subfamily members.
However, only a minor portion of mammalian piRNAs is
derived from repetitive elements, suggesting that piRNAs
may have different, probably mammalian-specific func-
tions as well.
The small RNA content of male and female germ cells is
clearly different, leading to the very interesting question of
why the two genders need the action of different classes
of small RNAs for germ cell development. Further bio-
chemical and genetic analyses such as genetic inactiva-
tion of piRNA clusters in the mouse genome are needed
to elucidate the detailed molecular functions of piRNAs
and associated Argonaute proteins of the Piwi subfamily
during spermatogenesis and germ cell development.
Concluding Remarks
Although the mammalian Argonaute protein family was
identified only a few years ago, some of their cellular func-
tions, such as the Slicer function of mammalian Ago2, are
well understood. Nevertheless, many questions about Ar-
gonaute proteins are still not answered and will clearly be
subject of extensive research in the future. Why is only hu-
man Ago2 a Slicer endonuclease even though the cata-
lytic residues are conserved in other Ago proteins? What
is the contribution of posttranslational modifications
such as phosphorylation to the activity of Argonaute pro-
teins? What are the cellular interaction partners of Argo-
naute proteins, and how do they contribute to their func-
tion? Other very important questions that still remain
mysterious are what mRNAs are regulated by Ago-con-
tainingmiRNPs andwhat are the biological consequences
of such regulatory events. Although several very promis-
ing and conclusive bioinformatics approaches that predict
mammalian miRNA targets have been published (Krek
et al., 2005; Lewis et al., 2003; Stark et al., 2003), clear bio-
chemical strategies that aim for a detailed characteriza-
tion of miRNP-mRNA interactions are still lacking. Ago
proteins are most likely embedded into large regulatory
networks that have to be analyzed systematically. Such
networks are most likely unique to each individual
mRNA, and other specific mRNA binding proteins may
contribute to Ago protein function. Only a detailed and
systematic analysis of such networks will provide an un-
derstanding of the Ago proteins in particular and posttran-
scriptional gene silencing in general.
Ago proteins have also been associated with different
diseases. It has been shown that Ago proteins as well as
miRNAs interact with FMRp, the disease gene product af-
fected in the inherited fragile X syndrome (Jin et al., 2004).
Members of the Piwi subfamily have been reported to be
misexpressed in some specific forms of cancer, and
many other forms have not been analyzed yet (Taubert
et al., 2007). Finally, in some forms of autoimmune dis-
eases, autoantibodies against Ago proteins have been
found, indicating a possible role of Ago proteins in such
diseases (Jakymiw et al., 2006). A detailed investigation
of the function of all mammalian Ago proteins will therefore620 Molecular Cell 26, June 8, 2007 ª2007 Elsevier Inc.also provide a better understanding of themolecular basis
of many different diseases.
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